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Abstract 
Characterisation and Molecular Typing of Clinical and 
Environmental Isolates of Vibrio parahaemolyticus 
Aklak Miah 
Vibrio parahaemolyticus is a natural inhabitant of coastal waters worldwide and is the 
leading cause of seafood-borne gastroenteritis.This study reports on the use of several 
molecular characterisation methods to screen clinical and environmental isolates of V 
parahaemolyticus to assess whether such techniques can be used to distinguish pathogenic 
isolates reliably. 
In a total of 86 isolates mainly of V parahaemolyticus but also including V cholerae, V 
vulnijicus and several other species, serotypes of the more virulent clonal group 03:K6 
were identified, but otherwise there appeared no association with serotype and phenotype. 
The tdh and trh genes encoding haemolysins that are typically associated with virulent 
isolates were found in a significantly large number of isolates; however, poor concordance 
between haemolytic activity and the presence of the gene tdh was found. In an effort to 
establish more accurate relationships amongst clinical and environmental isolates of V 
parahaemolyticus, four molecular typing systems were employed; namely pulsed-field gel 
electrophoresis (PFGE), intergenic transcribed spacer (ITS) analysis, tDNA intergenic 
length polymorphisms (tDNA-ILPs) and randomly amplified polymorphic DNA (RAPD). 
Typing patterns and clustering analysis using these methods differentiated V 
parahaemolyticus from other marine species as well as at the subspecies level. PFGE with 
Noti was shown to be the most discriminative but suffered from not being universally 
applicable. Both ITS and tDNA-ILP methods were sufficiently discriminatory with 
discrimination indices (DI) of between 0.568 and 0.724, depending on the primers 
employed. The discriminatory ability of RAPD was also affected by the primers used (DI= 
0.959 - 0.965) but closely matched that of PFGE (Dl = 0.976). Additionally, both RAPD 
methods were able to distinguish putative markers for the pandemic clonal group. Typing 
systems appeared largely stable in duplicate and triplicate analyses with multiple primer 
pairs with some obvious variability in the reproduction of faint amplicons. All methods 
except PFGE were simple to execute but none of the methods could distinguish V 
parahaemolyticus into obvious lineages based on the clinical or environmental source. 
With the recent implication of a type Ill secretion system {TTSS) involved in the 
pathogenicity of V parahaemolyticus, a multiplex PCR system using PCR primers that 
spanned both TTSS l and TTSS2 regions was developed. Dot-blot analysis confirmed 
TTSS2 genes in at least 30% of environmental isolates. Nucleotide sequence analysis 
revealed lOO% sequence homology in three loci of TTSS2 putative structural genes. In 
comparison, a total of 34 single nucleotide polymorphisms (SNP) were identified in three 
TTSSI regions. In two of the regions, the SNPs were synonymous, whereas a non-
synonymous substitution in the structural gene vcrDJ resulted in valine replacement with 
isoleucine. In addition, nucleotide deletions in TTSS 1 with resultant frameshift mutations 
were identified. The finding that significant numbers of environmental isolates also possess 
TTSS2 genes is contrary to currently held opinion that TTSS2 is only present in clinical 
isolates. It is hypothesed that the high incidences of V parahaemolyticus infections may be 
related to active TTSS2 genes, whereas a high degree of polymorphisms in TTSS 1 suggest 
it may be inactive. 
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Chapter One 
INTRODUCTION 
1.1 Introduction 
Vibrio parahaemolyticus IS a bacterium found in the marine environment. It is 
phylogenetically close to V cholerae, the etiological agent of cholera and can cause human 
disease upon ingestion of seafood contaminated with the bacteria. Worldwide, V 
parahaemolyticus is a significant cause of food borne gastroenteritis, especially in warmer 
coastal regions. In Japan and the USA it is the leading cause of seafood related 
gastroenteritis (Pan et al., 1997). In the UK and Europe, V parahaemolyticus is an 
increasing concern due to the rise in consumption of raw or undercooked seafood and the 
rise of seawater temperatures. The first UK outbreak was recorded in 1974 when 12 
holiday makers became ill after eating dressed crab (Hooper et al., 1974) and since then 
there have been several other reports of sporadic outbreaks of V parahaemolyticus food 
poisoning in Europe (Hervio- Heath et al., 2002; Lozano-Leon et al., 2003; Mame & 
Aznar, 1988; Robert-Pillot et al., 2004). Although most harvested fish and shellfish, 
especially those from brackish, estuarine and coastal environments contain V 
parahaemolyticus, only a small proportion of isolates are thought to be pathogenic (Cook 
et al., 2002; DePaola et a/, 2003a; Deepanjali et al., 2005). 
For many years the isolation and distinction of V parahaemolyticus from the closely 
related Vibrio species that inhabit marine and estuarine habitats, as well as from 
contaminated seafood, have proved to be arduous and long. The detection of virulent V 
parahaemolyticus amongst a numerically greater number of avirulent V parahaemolyticus 
thus poses an even greater problem. To date, there appears to be no widely accepted 
method for the enumeration of virulent isolates with increasing uncertainties of using the 
total V parahaemolyticus count to predict the risk of infection (Zimmennan et al., 2007). 
These methods of V parahaemolyticus detection usually require several days using 
conventional techniques (De Sousa et al., 2004). The approach is based on presumptive 
incubation in a non-selective broth followed by confinnatory growth on selective agar and 
biochemical and nutritional tests. This process together with a lack of distinct phenotype to 
ascertain pathogenic isolates and the inherent nature of a self-limiting gastroenteritis 
infection means that most cases of infection either remain unreported or the pathogen is not 
detected. It is usually only in severe cases requiring hospitalisation that tests for pathogenic 
V parahaemolyticus can be carried out, hence, adequate surveillance methods have long 
been overdue for this organism. 
In recent years a number of molecular methods have been developed to aid the process of 
detection, identification and enumeration of potentially pathogenic V parahaemolyticus 
using polymerase chain reaction (PCR) based approaches (Kim et al., 1999; Miwa et al., 
2003; Panicker et al., 2004). These include the use of species specific and recognised 
virulence gene markers, and in many cases multiple gene targets are detected in multiplex 
PCR reactions (Bej et al., 1999). However, due to a lack of understanding of what 
constitutes a true pathogenic strain of V parahaemolyticus, there are no satisfactory 
detection methods to identify pathogenic isolates. Traditional typing systems such as 
biochemical and nutritional profiling and 0 and K antigenic serotyping, although useful in 
identifying certain pandemic clones, have failed to provide a reliable means for 
discriminating strains that are pathogenic, due to a remarkable degree of phenotypic and 
serological uniformity (Bhuiyan et al., 2002; Binta & Nyaga, 1982; lguchi et al., 1995; 
Martinez-Urtaza et al., 2006; Rahman et al., 2006). Thus, an increasing number of single 
and multiple molecular characterisation systems are currently being developed and 
assessed, to enable reliable, reproducible and robust analysis of genetic diversity amongst 
virulent and avirulent strains. These include pulsed field gel electrophoresis (PFGE) 
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methods (Wong et al., 2007), various PCR methods (Ward & Bej, 2006) and the increasing 
use of genomic sequencing data for applications such as mapping intergenic spacer regions 
(Gonzalez-Escalona et al., 2006a) and multilocus sequence typing (MLST) Gonzalez-
Escalona et al., 2008) 
The use of a variety of molecular subtyping systems almost always generates divergent 
phylogenetic clusters as each typing system works by utilising different loci or traits. 
Therefore the dependence on a few properties or just one typing system may lead to errors 
that may not be apparent whilst elucidating relatedness amongst isolates (Maslow & 
Mulligan, 1996). For example, clonally related pathogenic strains of V parahaemolyticus 
may show identical PFGE profiles with respect to the restriction fragment produced but 
fall into two distinct serovars (Chowdhury et a/ 2000a). Hence another enzyme or second 
method must be employed to validate the degree of relatedness. Generally, at least two 
reproducible and reliable typing systems should be used, together with further 
characterisation of specific markers of variation in order to confirm epidemiological 
relatedness between isolates. 
All bacterial molecular typing systems are based upon the principle that epidemiologically 
related isolates are derivatives of a single parent isolate (Struelens, 1998). Therefore the 
pathogenic isolate shares characteristics that may differ from those of non-pathogenic 
isolates within the same species. Thus typing systems are able to discriminate between 
epidemiologically related and non-related isolates, although typing methods are more 
frequently used to characterise organisms below the species level (Kostman, 1995). 
1.2 Aims and Objectives 
Despite the large progress in identification and detection of V parahaemolylicus, only two 
major virulence genes encoding for thermostable haemolysins have been used in detection 
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protocols having been found in 94% - 97% of clinical cases (Suzuki et al., 1997). These 
genes are rarely detected from environmental and food samples so the significance of 
finding environmental reservoirs of haemolysin genes remains unclear. 
Although various serovars of V. parahaemolyticus can cause infections, to date there is no 
method of biochemically, serotypically or pbenotypically differentiating clinical (virulent) 
and environmental (mostly avirulent) isolates of this organism. Current molecular typing 
systems relate pathogenic isolates or outbreaks of disease to epidemiological purposes and 
clonal relatedness yet there are no standardised, robust methods in use and as such 
considerable variability in data and its interpretation seriously hamper characterising 
virulent isolates. This, together with inadequate means to differentiate clinical and 
environmental isolates further exacerbates the problem. The overall aim of the work 
presented in this thesis was to assess the use of molecular characterisation to differentiate 
clinical and environmental isolates of V. parahaemolylicus. 
The specific objectives were: 
i) to assess existing biochemical and molecular typing systems in the specific 
characterisation and differentiation of V. parahaemolyticus using phenotypic 
and genotypic characteristics including growth, haemolysis and subtyping 
systems of PFGE and 16S-23S intergenic spacer analysis (chapters 4, 5 & 6) 
ii) to develop previously described typing systems for use with V. 
parahaemolylicus including ITSI, tRNA typing and RAPD, (chapters 6, 7 and 
8) 
iii) to use the recently identified type Ill secretion system (TTSS) (Makino et al., 
2003; Park et al., 2004b; Ono et al., 2006) to assess differentiation between 
clinical and environmental isolates of V. parahaemolyticus (chapter 9) 
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2.1 Tbe Organism 
Chapter Two 
LITERATURE REVIEW 
2.1.1 General characteristics 
V. parahaemolyticus is a Gram-negative, motile, rod-shaped bacterium possessing both 
polar and lateral flagella that enable it to swim and swarm respectively (Atsumi et al., 
1992; Kim & McCarter, 2000; McCarter, 200 I). The organism is generally oxidase 
positive, facultatively aerobic and non-spore forming. It is a member of the Vibrionaceae 
of the y-Proteobacteria family, originally termed Pasture/la parahaemolytica (Fujino, 
1966). In common with other vibrios, V parahaemolyticus has a strong requirement for 
sodium ions for growth (Pace, 1989) and is abundant in the marine and estuarine 
environments (Baross & Liston, 1970; Larsen et al., 1981; Binta & Nyaga, 1982). Together 
with V cholerae and V. vulnificus, V. parahaemolyticus form a group of organisms that are 
responsible for most bacterial seafood and water-borne extra-intestinal infections (Johnson 
et al., 1971; Thomton et al., 2002). Recently, a number of advances in molecular methods 
have facilitated the study of the dynamics and pathogenicity of these organisms. 
2.1.2 Genome organisation of V. paralraemolyticus 
Pulsed-field gel electrophoresis (PFGE, section 2.7.3) of intact genomic DNA shows V. 
parahaemolyticus to possess two chromosomes (replicons) of approximately 3.2 and 1.9 
Mb (Y amaichi et al., 1999) and that the two-chromosome configuration is common 
amongst members of the Vibrionaceae (Tagomori et al., 2002; Okada et al., 2005). The 
larger replicon ranged from 3.0 to 3.3 Mb in size whereas the smaller replicon varies 
considerably (0.8 to 2.4 Mb) amongst 34 species of vibrios, suggesting that this smaller 
chromosome has been more flexible in the evolution of V parahaemolyticus (Okada et al., 
2005). Genome sequencing of a clinical strain, RIMD2210633, confirmed V 
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parahaemolyticus to contain two circular chromosomes and to possess 11 copies of 
ribosomal operons which correlate well with its rapid growth rates. Complete genome 
sequencing also revealed, for the first time, that V parahaemolyticus harboured genes for 
type Ill secretion systems clustered together with pathogenicity islands and virulence 
effectors (Makino et al., 2003). These are summarised in Table 2.1. 
Table 2.1: Overview of V. parahaemolyticus genome organisation in a 
clinical strain RIMD2210633 (Adapted from Makino et al., 2003) 
Ch.l Ch.2 
Length or sequence 3,288,558 bp 1,877,212 bp 
G+C ratio 45.4% 45.4% 
Open reading frames 3,080 1,752 
(ORFs) 
Protein coding regions 86.9% 86.9% 
Average ORFs length 926.9 bp 931.3 bp 
rRNA (16S-23S-SS) 10 I 
tRNA 112 14 
Secretion systems 0 2 
Genomic Islands 5 2 
2.1.3 Ecological nicbes 
Coastal filter-feeding invertebrates such as oysters concentrate vibrios. However, the 
relationships between anthropogenic effects on coastal ecosystems (i.e. fish or shellfish 
farming), the natural hosts (i.e., filter feeders) and the environmental niches of vibrios are 
complex, dynamic and not very well understood. V parahaemolyticus has been shown to 
possess multiple cell types that may explain its habitat in a variety of niches (McCarter, 
1999). A planktonic free-swimming state, a sessile existence within a microbial 
community such as the commensal relationship in shellfish, or attached to under sea 
surfaces (boats, seaweeds, fishes etc) and attachment to host organism in pathogenesis are 
just some of the adaptations of this organism (Kaneko & Col well, 1973, 1975). Extensive 
in-vitro studies have revealed two cell types; a "swimmer cell" and a "swarrner cell." 
(McCarter, 1999). The swimmer cell consists of a single polar flagellum, powered by the 
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sodium motive force (Atsumi et al. , 1992) ideally suited for the survival and proliferation 
in the marine environment at a pH of approximately 8.0 (Kogure, 1998). The swarrner cell 
type is believed to be more adapted for growth and colonisation of V parahaemolyticus on 
surfaces or viscous environments (McCarter, 1999). Electron micrographs show a 
differentiated cell type with numerous lateral peritrichously arranged flagella (Fig. 2. I). 
Figure 2.1: Electron micrograph of a swimmer cell (A) and swarmer cell (B) types of V. 
parallaemolyticus. Bar indicates approximately I mm. (Reproduced with permission; McCarter, 1999) 
Densities of V parahaemolyticus in environmental and seafood samples vary considerably 
depending on water temperatme, salinity, location, sample types, faecal pollution and the 
method used for analysis (Kelly & Stroh, 1988; DePaola et al. , 1988). DePaola and 
colleagues showed a significant log10 correlation between seasonal abundance of V 
parahaemo/yticus, salinities and temperatme in Alabama oysters (DePaola et al., 2003a). 
Total V parahaemolyticus abundance was highest in May and June with sea temperatmes 
over 25°C and salinities close to the optimum of 17 parts per thousand (ppt). It was 
estimated that an increase of one degree Celsius resulted in a 1.2 fold increase in the 
number of V parahaemolyticus colony forming units (cfu) per gram of oyster homogenate. 
Similar findings in seasonal abundance have also been reported in several other studies 
(Kelly & Stroh, 1988; DePaola et al. , 1988, 2000). 
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Despite a trophism for warmer temperatures and tropical climates, there are an increasing 
number of reports of pathogenic V parahaemolyticus in colder climates such as Alaska 
and Southern Chile, that up until now were considered regions too cold to support the 
growth of this organism (McLaughlin et al., 2005; Gonzalez-Escalona et al., 2005a; 
Fuenzalida et al., 2006) These recent findings suggest remarkable changes in the 
organism's ability to quickly adapt, survive and proliferate in different niches. The 
prevalence of these pathogenic V parahaemolyticus in colder climates may also be 
indications of global warming and thus an increasing cause for worldwide concern. 
2.1.4 Viable but non-culturable state of V. paralraemolyticus 
As with many human pathogens, V parahaemolyticus is also thought to exist in the viable 
but non-culturable (VBNC) state and this may explain the low detection rates of V. 
parahaemolyticus in cold temperatures. For example, Baffone et al. (2006) recently 
identified unculturable V parahaemolyticus in plankton fractions by PCR. Several 
laboratory studies have induced the VBNC state in V parahaemolyticus by exposing cells 
to low temperatures under starvation conditions (Jiang & Chai, 1996; Mizunoe et al., 2000; 
Wong & Wang, 2004). Temperature upshifts have been reported to "resuscitate" a sub-
population of cells. In a recent study, VBNC V parahaemolyticus that were subjected to 
temperature upshifts showed a remarkably heterogeneous population of cells that were 
coccoid or flatted in shape and in some cases showed asymmetrical cell divisions (Coutard 
et al., 2007). These findings are also similar to VBNC in other Vibro spp. (Vattakavan et 
al., 2006; Pruzzo et al., 2003). Remarkably, despite morphological and structural 
differences, the VBNC cells have been shown to retain their virulent properties (Bates & 
Oliver, 2004; Baffone et al., 2003) thus the possible existence of environmental VBNC V 
parahaemolyticus pose a significant public health concern and will hamper 
epidemiological investigations of this pathogen. 
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2.2 Worldwide distribution of V. paralraemolyticus 
Food borne poisoning due to V. parahaemolyticus has been identified in many countries 
worldwide (Barker, 1974; Cabassi & Mori, 1976). Incidents are more common in countries 
when seawater temperatures rise over 15°C during the summer season and where seafood 
consumption is high (A lam et al., 2003; DePaola et al., 2003a; Lozano-Leon et al., 2003). 
2.2.1 Europe 
In Europe, V. parahaemolyticus has been isolated in several countries including the UK 
(Hooper et al., 1974; Ayres & Barrow, 1978), Demark (Kristensen, 1974), Norway (Gjerde 
& Boe, 1981; Bauer et al., 2006) and Eastern European countries of Romania and Bulgaria 
(Aldova, 1989). However to date, most reports of the isolation of pathogenic V. 
parahaemolyticus are in southern Europe and the Mediterranean including France (Hervio-
Heath et al., 2002; Robert-Pillot et al., 2004; Quilici et al., 2005), Spain (Lozano-Leon et 
al., 2003; Marne & Aznar, 1988; Martinez-Urtaza et al., 2004, 2005; Molero, et al., 1989), 
Italy and Greece (Masini, et al., 2007). 
In 1999 a large outbreak of V. parahaemolyticus related food poisoning occurred in 
Galicia, northwest Spain where a total of 64 people were admitted to hospital with acute 
diarrhoea after consumption of raw oysters (Lozano-Leon et al., 2003). Temporary 
surveillance of Vibrio spp. employed at the time ensured the accurate identification of the 
etiological agent (Martinez-Urtaza et al., 2004). Another outbreak involved 80 cases of 
illnesses associated with consumption of boiled crab (Martinez-Urtaza et al., 2005). These 
sporadic cases in Spain may highlight possible deficiencies in the identification of V. 
parahaemolyticus by national reference laboratories and overall lack of surveillance and 
awareness of this pathogen. 
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2.2.2 East Asia 
In Asia, where illness due to V parahaemolyticus food poisoning is most prevalent, both 
pathogenic and non-pathogenic isolates have been characterised and reported in most 
countries including Korea, (Chun et al., 1974) Japan (Arakawa et al., 1999), Taiwan 
(Wong et al., 2005b), China (Yano et al., 2006) and Indonesia, (Marlina et al., 2007). For 
example, in Japan, where it was first recognised as a major cause of seafood related illness 
in 1950, an outbreak of 272 illnesses resulting in 20 deaths were associated with the 
consumption of raw sardines (Daniels et al., 2000). Since then, V parahaemolyticus has 
been estimated to account for over 30% of all annual reported cases of food poisoning in 
Japan (Aiam et al., 2002) and the leading cause of food poisoning (171 0 incidents, 24,373 
cases) between 1996 and 1998 as reported by the Infectious Disease Surveillance Centre 
(IDSC) of Japan (Su & Liu, 2007). 
2.2.3 Southern Asia and Africa 
Pathogenic isolates in the Indian subcontinent have been reported in an increasing number 
of environmental samples in Bangladesh (Islam et al., 2004), Sri Lanka (Palasuntheram et 
al., 1977), and India where, together with V cholerae infection, fatalities have been the 
highest in the malnourished and immuno-compromised populations (De, 1977; Deepanjali 
et al., 2005; Parvathi, et al., 2006; Sen et al., 2007) (section 2.3). Gastroenteritis related to 
V parahaemolyticus has also been reported in Africa, (Bockmuhl & Triemer, 1975) as 
well as an incident during the V cholerae El Tor cholera epidemic in West Africa 
(Bockemuhl et al., 1975). A recent report also highlighted the presence of the more 
virulent pandemic strain (section 2.4.4) of V. parahaemolyticus in Mozambique. 
(Ansaruzzarnan et al., 2005) (Fig. 2.2). 
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2.2.4 North America 
Sporadic outbreaks of V parahaemolyticus food poisioning have been reported in the USA 
since 1972 (Molenda et al., 1972). Between 1973 and 1998, 40 outbreaks of V 
parahaemolyticus food poisoning were reported to the Centers for Disease Control (CDC) 
in the USA (Daniels et al., 2000). Among them, four major outbreaks involved over 700 
cases of food poisoning due to raw oyster consumption, most prevalent during the warmer 
months of each year (Daniels et al., 2000; DePaola et al., 2000). Perhaps more significant 
for the North European community are the two recent reports of virulent V 
parahaemolyticus, in Washington, British Columbia and Alaska (McLaughlin et a!, 2005). 
Despite the colder Alaskan and Canadian sea water temperatures, V parahaemolyticus 
related food poisoning resulted in 14 and 177 cases of infection, in 2004 and 2006 
respectively (Khaira & Galanis, 2007; McLaughlin et a!, 2005). 
2.2.5 South America 
Environmental reservoirs of V parahaemolyticus were identified in South America as 
early as 1977 (Casellas et al., 1977; Franca et al., 1980). Several studies have indicated the 
virulence potential of V parahaemolyticus (Magalhaes et al., 1992) with an outbreak of V 
parahaemolyticus food poisoning amongst military personnel in Peru (Begue et al., 1995). 
More recently, Cordova and colleagues reported two outbreaks, in 1998 and 2004 in Chile 
(Cordova et al., 2002; Gonzalez-Escalona, et al., 2005a). Between November 1997 and 
March 1998, over 300 cases were reported in northern Chile with another outbreak 
affecting 1500 people between January and March 2004 in Puerto Montt, a region of 
usually cold coastal water (Gonza1ez-Escalona et al., 2005a). A further outbreak between 
January and April 2005 in the same region resulted to 3,725 cases of acute diarrhoea. As 
Puerto Montt is one of the main shellfish producing areas of in Chile, contaminated 
shellfish had rapidly spread to other urban regions. By the end of March 2005, a total of 
I 0, 783 cases were reported, making it the largest documented occurrence of V 
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parahaemolyticus food poisoning in the world (Cabello et al., 2007). The occurrence of 
these large outbreaks indicates that the contamination of V. parahaemolyticus in oysters is 
a great safety concern to the UK shellfish industry and public health. 
2.3 Pandemic serotypes of V. parallaemolyticus 
Antigenic serotypes based on the somatic (0) and capsular (K) antigen of V. 
parahaemolyticus have been described since 1969 (Miwatani et al., 1969; Zen-Yoji et al., 
1970). To date, antiserum for 13 0 and 71 K antigens have been reported and are 
commercially available to type V parahaemolyticus isolates. Diverse serotypes have 
caused outbreaks worldwide. However, since 1996 an increasing number of cases are 
related to the 03:K6 serotype (Nair et al., 2007). This serovar was first identified in 
Calcutta after a sudden increase in incidences during a hospital-based active surveillance 
program (Okuda et al., 1997b ). Between September 1996 and April 1997 this serovar 
accounted for 63% of all reported cases and since then this highly virulent serovar has 
dominated in a large number of outbreaks worldwide (Chiou et al., 2000; Chowdhury et 
al., 2000b). In the USA the largest outbreak of V parahaemolyticus food poisoning, with 
416 cases, was attributed to the 03:K6 serovar with the same serovar later involved in 
another outbreak in 1999 (Daniels et a!, 2000; Su & Liu, 2007). This serovar was also 
responsible for the outbreaks in Chile Gonzalez-Escalona et al., 2005a), and Spain 
(Martinez-Urtaza et al., 2005). 
Since the year 2000, a number of reports have identified several other serovars prevalent in 
outbreaks. Amongst them, serovars of 01 :KUT, 01 :K25, and 04:K68, have been 
responsible for a large number of food poisoning cases worldwide (Chiou et al., 2000; 
Chowdhury et al., 2004b; Ansaruzzarnan et al., 2005; Rizvi et al., 2006; Serichantalergs, et 
al., 2007). All three serotypes have been shown to possess remarkable homology in 
molecular typing profiles to the 03:K6 serovar, thus it is believed that all three serovars of 
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01 :KUT, 01 :K25, and 04:K68 are derived from the parent 03:K6, despite possessing 
different 0 and K antigens (Chowdhury et al., 2000a; Chowdhury et al., 2004a; 
Chowdhury et al., 2004b; Nair et al., 2007). Clearly, these changes in the 0 and K antigens 
demonstrate the dynamic nature of the evolution of virulent V parahaemolyticus by the 
acquisition of 0 and K antigens. 
2.4 Virulence factors and pathogenicity 
2.4.1 Human infection 
Clinical manifestations of V parahaemolyticus infection follow an incubation period of 
between 12 - 46 hours and symptoms that include a self-limiting diarrhoea, abdominal 
cramps, nausea, vomiting, headache, fever and chills may last up to seven days (Nolan et 
al., 1984). Extra-intestinal infections have also been known to occur including wound, eye 
and ear infections (Tacket et al., 1982; Johnson, et al., 1984; Sautter et al., 1988; Kelly & 
Stroh, 1988). Between 1988 and 1997, 345 sporadic V parahaemolyticus infections were 
reported to the CDC of which 45% were hospitalised (Daniels et a/, 2000). Of these, 59% 
were gastroenteritis, 34% were wound infections, 5% were septicaemia, and 2% were from 
other exposures. In most cases of gastroenteritis, rehydration therapy is sufficient and 
antibiotic treatment is not required. For more serious infections tetracycline has long been 
the drug of choice, although several other antibiotics have commonly been used (Morris & 
Black, 1985). However, as in most cases of food poisoning, and due to the self-limiting 
symptoms of infection, mild cases of infections are not reported and consequently, actual 
figures of infection remain largely unknown. 
Most strains isolated from infected patients demonstrate a major virulence factor known as 
thermostable direct haemolysin (TDH) that has been shown to exhibit ~-haemolysis on 
Wagatsuma agar (Sakurai et al., 1973). This characteristic phenotype is also known as the 
Kanagawa phenomenon (section 2.4.2). Another virulence factor, TDH related haemolysin 
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(TRH), is typically associated with Kanagawa negative or urease positive isolates of V 
parahaemolyticus (Eko, 1992; Kelly & Stroh, 1989; Suthienkul et al., 1995) and both TDH 
and TRH have been isolated from the same organism (Xu et al., 1994). However, most 
strains of V. parahaemolyticus isolated from the environment express neither TDH nor 
TRH even if they harbour the tdh or trh gene sequences respectively (Nishibuchi et al., 
1989; Nishibuchi & Kaper, 1995). Furthermore, the infectious dose of pathogenic isolates 
may be high or low, with the more pathogenic strains of V parahaemolyticus having been 
described as having multiple copies and varying expression of TDH and TRH (Honda et 
al., 1989a; Nishibuchi & Kaper, 1990; Nagayama et al., 1995). 
2.4.2 Thermostable direct haemolysin (TDH) 
The gene for TDH is present in 93-96 % of clinical isolates and can be found in two or 
three copies either on the smaller chromosome flanking the pathogenicity island or on 
plasmids (Makino et al., 2003; Nishibuchi & Kaper, 1990; Baba et al., 1991a). The cloned 
tdh gene has a GC content of 35.6% and produces a 21.1 k.Da homodimer protein product 
consisting of 189 amino acid residues including signal peptides (Taniguchi et al., 1985). 
Although the mechanism of TDH action has not been fully elucidated, workers have 
described TDH as a pore forming toxin (Honda et al., 1992; Takahashi et al., 2006) 
forming a cation channel (Lang et al., 2004) and its most extensively studied effect is the 
ability to induce haemolysis of erythrocytes from different mammalian species (Huntley & 
Hall, 1994, 1996; Douet et al., 1996). Beta-haemolysis on specialised blood agar, 
Wagatsuma agar is the most common phenotype used to ascertain TDH positive isolates of 
V parahaemolyticus. However it has been shown that expression of both tdh genes are 
required for an adequate ~-haemolysis phenotype (Nishibuchi & Kaper, 1990). The 
workers showed that all cloned TDH genes exhibited at least 96.7% nucleotide sequence 
homology but tdh specific RNA transcripts were missing in some of the clones. Therefore, 
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differences at the transcriptional control level are likely to be responsible for the variation 
in haemolytic phenotypes. Clearly, the variability in haemolysis amongst different isolates 
needs to be addressed if the haemolytic activity is to be used as a virulence marker of V 
parahaemolyticus (Chapter 4). Variants ofTDH have also been isolated from V cholerae 
non-01, V mimicus and V hollisiae (Nishibuchi et al., 1990; Baba et al., 1991a; Yoh et 
al., 1989; Terai, et al., 1990). The nucleotide sequences of various tdh genes are well 
conserved and their protein products immunologically indistinguishable (Nishibuchi & 
Kaper, 1995). 
TDH has also been shown to induce cytotoxic effects consisting mainly of cell 
degeneration, which often leads to loss of viability (Sakurai et al., 1976). Using human and 
rat monolayers Raimondi et al demonstrated a TDH dose dependent increase in 
intracellular free Ca2+ and er secretion leading to cell death (Raimondi et al., 2000). This 
work together with previous work reported by Tang et a/, showed that cytotoxity due to 
TDH is mediated by a Ca2+ independent pathway (Tang et al., 1995). The haemolysin TDH 
has also been described as a cardiotoxin found to stop the spontaneous beating of cultured 
rat and mouse myocardial cells (Goshima et al., 1976) and intravenous injection of TDH 
into rats resulted in rapid death through cardiac arrest (Honda et al., 1976). 
2.4.3 Thermostable direct haemolysin related haemolysin (TRH) 
Thermostable direct haemolysin related haemolysin (TRH) has typically been isolated 
from clinical cases of V parahaemolyticus food poisoning in almost half of Kanagawa 
negative isolates (Yoh et al., 1992). More recently it has also been isolated from V 
alginolyticus (Xie et al., 2005; Gonzalez-Escalona et al., 2006b). Other than a lack of~-
haemolysis on Wagatsuma agar, TRH is similar in attributes to TDH and the proteins share 
up to 68% nucleotide sequence and 62% amino acid similarity (Xu et al., 1994; Nishibuchi 
et al., 1989). Up to two copies of variants trh 1 and trh2 respectively have been reported in 
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a single genome (Kishishita et al., 1992) and in some cases is correlated with the presence 
of the urease gene cluster. Consequently, urea production may be used as a possible marker 
for TRH and potential virulence in V parahaemolyticus (Eko, 1992; Kaysner et al., 1994; 
Suthienkul et al., 1995; Chiu et a/, 2007). lida et a/ have shown genetic linkage between 
the urease gene cluster, the genes ure and trh by identifying both ure and trh on the same 
Notl digested PFGE fragment (Iida et al., 1997; 1998). They were able to show that both 
trh and ure were within 8.5 kb of each other and that the trh and tdh genes were localized 
within a 40 kb region. A low and aberrant CG content relative to the genome in this region, 
and presence of phage-like integrases subsequently led to characterisation of several 
genomic islands (Hurley et al., 2006). 
2.4.4 Other haemolysins in V. parallaemolyticus 
Taniguchi et a/ described another thermostable haemolysin (delta-VPH) that was found in 
all clinical and environmental V parahaemolyticus isolates (Taniguchi et al., 1990). This 
haemolysin had no homology to that of TDH or TRH and was also found present in V 
damse/a but its significance in human disease is not known. Similarly, Sakurai and 
colleagues demonstrated the presence of an additional haemolysin in V parahaemolyticus 
that unlike TDH or TRH, was deactivated upon heating at 60 for 10 mins (Sakurai et al., 
1974). The mature thermolabile haemolysin (TLH) was found to be of 45.5 kDa and its 
gene had a GC content similar to that of the genome (Taniguchi et al., 1986). Whilst TDH 
was found only in Kanagawa positive isolates, TLH was found in all strains tested (Sakurai 
et al., 1974). Since then, the gene for TLH has been used as a species specific marker for 
V parahaemolyticus (section 2.6.3). 
2.4.5 Cytotoxicity and enterotoxicity of V. paralraemolyticus 
Both TDH and TRH, together with several uncharacterised factors have been shown to be 
responsible for the cytotoxic and enteropathogenic properties of V parahaemolyticus. In 
18 
some early studies, Carruthers (1975) demonstrated cytotoxicity to HeLa cells and 
scanning electron microscopy of cells derived from human amniotic membrane revealed a 
decrease in microvilli and damage to cell morphology with sub lethal amounts of TDH. 
Higher dosage caused complete structural damage to the cytoplasm (Sakurai et al., 1976). 
Nairn et a/ used osmotic stabilizers to show that the mode of action by TDH on 
erythrocytes was different from that on cultured embryonic fibroblast cells (Nairn et al., 
2001). 
2.4.6 Other potential pathogenicity determinants 
In one of the largest cl inica1 studies to date, Suzuki and colleagues demonstrated that 3. 7% 
of V. parahaemolyticus isolated from 1319 cases of traveller's diarrhoea lacked both tdh 
and trh genes (Suzuki et al., 1997). Indeed, when tdh deletion mutants lacking both copies 
of tdh were created by homologus recombination, the mutants lost their haemolytic activity 
yet still demonstrated toxicity to HeLa cells as well as partial fluid accumulation in rabbit 
intestine (Park et al., 2004a). Therefore, it is likely that additional factors are involved in 
the pathogenicity of V parahaemolyticus. 
2.4. 7 Serine protease 
Work carried out by Lee et al. (2002) demonstrated a serine protease from a clinical strain 
lacking both tdh and trh genes. The protease showed significant effects on the growth of 
Chinese hamster ovary (CHO), HeLa, Vero and Caco-2 cells. The protease lysed 
erythrocytes, caused tissue haemorrhage and death in m1ce when injected both 
intraperitoneally and intravenously, but it was heat labile unlike TDI·I. It was shown that 
the serine protease was widely distributed in V. parahaemolyticus and V alginolyticus 
(Ishihara et al., 2002). 
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2.4.8 Adherence and colonisation factors 
An early report in 1977 demonstrated an increase in adherence by Kanagawa positive 
isolates to human foetal intestinal cells, whereas Kanagawa negative isolates adhered at a 
much slower rate or not at all on cultured HeLa cells (Carruthers, 1977). The work 
suggested a carbohydrate molecule on the surface of the Kanagawa positive bacterial cell 
wall was responsible for this interaction. However, no specific receptor molecules have yet 
been discovered although it has been reported that V parahaemolyticus shows an increase 
in adherence under starvation conditions (Wong et al., 2005a). Nakasone et al. 
demonstrated that pili play a key role in the adhesion and colonisation in the rabbit 
intestine by isolating pili that were adhesive to the intestinal epithelium (Nakasone et al., 
1990, 1992). These pili were found to be indistinguishable in morphology to pili of a 
pandemic 03:K6 strain, yet were antigenically distinct (Nakasone et al., 2000). Further 
work is required to establish mechanisms of V parahaemolyticus adherence. 
2.4.9 Siderophores 
Several workers have described the potential role of siderophores in V parahaemolyticus 
pathogenicity (Yamamoto et al., 1992b, 1994, 1995; Tanabe et al., 2003, 2006; Funahashi 
et al., 2003). In conditions of iron limitation, Dai et al. (1992) showed an increase in 
haemolytic activity of Kanagawa positive strains, together with the production of a 
siderophore, an increase in adherence, and lethality of V parahaemolyticus to mice cells. 
Similar findings were obtained with Kanagawa negative isolates suggesting that virulence 
factors may be induced or enhanced under iron-limited conditions. The siderophore, named 
vibrioferrin (Y amamoto et al., 1994) was found to sequester iron from 30% iron saturated 
human transferrin for growth, suggesting that V parahaemolyticus may be able to utilise 
host iron through the action of vibrioferrin for survival and proliferation (Y amamoto et al., 
1994). Under iron limiting growth conditions, clinical isolates showed higher production of 
vibrioferrin than strains isolated from seafood thus suggesting a selective advantage of the 
20 
survival of clinical isolates in the human intestine (Y amamoto et al., 1999). Although 
vibrioferrin has been well characterised (Tanabe et al., 2003, 2006), and the receptor genes 
found widely distributed amongst V. parahaemolyticus (Funahashi et al., 2003) in both 
clinical and environmental isolates, its significance in the role of pathogenicity remains 
unclear. 
2.4.10 Insertion Sequences 
The possible role of insertion sequences in the spread of tdh genes was described by Terai 
et al. ( 1991) upon the characterisation of tdh in related species, V. cholerae non-0 I, V. 
mimicus and V. hollisae (Nishibuchi et al., 1990). Analysis of 7 tdh genes and their 
flanking regions revealed insertion sequence like elements, termed insertion sequences of 
Vibrio species (ISVs) or sequences that were derived from the genetic rearrangement of the 
ISVs. The possible role of ISVs in transferring V. parahaemolyticus pathogenicity 
determinants have also been described by several others including (Burstyn et al., 1980; 
Baba et al., 1991 a; Park et al., 2000) and Okura et al., (2005) who identified a large 16-kbp 
insertion sequence which was present in almost all pandemic strains but not in non 
pandemic strains tested. 
2.4.11 Phage associated virulence 
A large number ofbacteriophages (vibriophages) with either a specific host or a broad host 
range have been described (lnoue et al., 1995; Hardies et al., 2003; Comeau et al., 2006), 
including those found in the pandemic 03:K6 clone (Nakasone et al., 1999; Chang et al., 
1998). Indeed, Chang et al. (2000) showed that filamentous phage genomes of the 
previously described phages Vfl2 and Vf33, integrated into genomic DNA of V. 
parahaemolyticus at distinctive regions and were also distributed on some plasmids and 
total cellular DNAs of one V. damsela and one non-agglutinable vibrio strain tested 
(Taniguchi et al., 1984; Chang et al., 1998). However, the potential of these phages as 
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tools for genetic transmission of virulence factors in V parahaemolyticus has yet to be 
determined. 
Within the pandemic 03:K6 serovars, the open reading frame ORF8, from filamentous 
phage f237, has been extensively characterised and has been described as a marker for 
pandemic strains (Nasu et al., 2000). The phage genome was originally found in a common 
plasmid p03K6, in all 24 pandemic 03:K6 strains tested and genetic organisation 
resembled that of a previously characterised phage Vf33 (Taniguchi et al., 1984). The 
double stranded DNA obtained from the treatment of f237 with DNA polymerase was 
identical to that of p03K6 suggesting that p03K6 is a replicative form of f237. The 
sequence of ORF8 (orj8) has since been used to identify pandemic strains by several 
workers (Myers et al., 2003; Laohaprertthisan et al., 2003) although there have been 
reports by others that ORF8 has poor correlation with the pandemic genotype (Bhuiyan et 
al., 2002; Okura et al., 2003). To date, there appears to be no evidence of lysogenic phage 
conversion, like that of the cholera toxin in V. parahaemolyticus (Waldor & Mekalanos, 
1996) 
2.4.12 Type Ill secretion systems 
Type III secretion enables Gram-negative bacteria to secrete and inject pathogenicity 
proteins into the cytosol of host cells (Hueck, 1998). The presence of genes for a type Ill 
secretion system (TTSS) was first described upon genomic sequencing of V 
parahaemolyticus (Makino et al., 2003) and since then TTSS genes have also been 
characterised in V. cholerae non-01 and non-0139 (Dziejman et al., 2005). The TTSS is 
the principle virulence factor of diarrhoea causing bacteria such as Shigella, Salmonella, 
and enteropathogenic Escherichia coli, which cause gastroenteritis by invading or 
interacting with intestinal epithelial cells (Hueck, 1998). The presence of TTSS 
homologues was also demonstrated in other vibrios, such as V. alginolyticus, V. harveyi, 
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and V. tubiashii, suggesting that the TTSS may have a role in protein secretion in these 
organisms during interaction with eukaryotic cells (Park et al., 2004b) 
Park and colleagues characterised two sets of genes termed TTSS I and TTSS2. By 
constructing mutant strains of TTSS 1 and TTSS2 they were able to show reduced 
cytotoxic and enterotoxic activities compared with the parent strains (Park et al., 2004b). 
Molecular characterisation of the TTSS I of V. parahaemolyticus most closely resembled 
that of Yersinia spp., with over 30 gene homologues and a large inversion of the yscA to 
yscQ region together with an additional 12 hypothetical genes within the ysc region that are 
not found in Yersinina spp. or other species. Work carried out by Ono et al. (2006) later 
identified some of these genes to encode effector proteins found translocated into HeLa 
cells and that the cytotoxicity to HeLa cells was related to one of the newly identified 
secreted proteins encoded by VP1680 (Chapter 9). The second secretion system, TTSS2 
was found on the smaller chromosome (section 2.1.2) in an area characterised as a 
pathogenicity island. In this region only 9 genes had homologues to Yersinina spp. and 
resembled the TTSS found recently on V cholerae (Dziejman et al., 2005) 
Kodama et al. (2007) showed that TTSS2 induced a cytotoxic effect on human epithelial 
intestinal cell lines (HCT-8 and Caco-2) partly due to a putative ADP-ribosyltransferase. A 
further two TTSS2-dependent secretion proteins necessary for TTSS2-dependent 
cytotoxicity and enterotoxicity were also characterised (Kodama et al., 2008). However, 
despite the functional characterisation of TTSS2, the distribution of TTSS systems remains 
unclear. According to Park et a/, (2004b) and Ono et a/, (2006) the TTSS2 was only found 
in Kanagawa positive clinical strains tested thus suggesting that TTSS2 had a major role in 
the pathogenicity of V parahaemolyticus (Chapter 9). 
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2.5 Conventional methods for identification 
2.5.1 Identification and detection methods of V. parahaemolyticus 
V. parahaemolyticus is one of the fastest growing organisms with doubling times as short 
as 9 min in optimum growth conditions (Katoh, 1965). These include a pH of 7.8 to 8.6 
and a temperature of 37°C, although it has been found to grow in a wide range of pH and 
temperatures (Yeung & Boor, 2004). This, together with a toleration of moderately high 
alkaline conditions up to pH 9, forms the basis of a variety of selective media used to grow 
and enrich food samples and in use since 1971 (Twedt & Novelli, 1971 ). 
2.5.2 Isolation 
Isolation of V. parahaemolyticus from environmental and food sample usually requires 
homogenisation of sample with enrichment broths such as alkaline peptone water (APW) 
or glucose salt teepol broth (GSTB). Salt polymyxin broth (SPB) and salt colistin broth 
(SCB) containing the appropriate antibiotics for isolation of V parahaemolyticus from 
other marine vibrios have also been used. Beuchat, (1977) identified other selective 
enrichment broths including 7%NaCI tryptic soy broth (TSBS), arabinose-ethyl violet 
broth (HAEB) and water-blue-alizarin yellow broth (WBA Y) for the enrichment and 
recovery of cold- and heat-stressed V parahaemolyticus. The use of a pre-enrichment step 
before selective enrichment has also been shown to increase V. parahaemolyticus counts 
(Ray et al., 1978; Ho fer & Silva, 1984; Hara-Kudo et al., 200 I). 
2.5.3 Culture and growth 
The most probable number method (MPN) described in the US Food and Drug 
Administration Bacterial Analytical Manual (Elliot et al., 1995) is the most commonly 
used method for the detection of V. parahaemolyticus. The MPN method is both labour 
intensive and time-consuming (Su & Liu, 2007). Since 1963, thiosulphate citrate bile salt 
sucrose agar (TCBS) has been used widely as a selective medium for many Vibrio spp. 
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including V. parahaemolyticus. This medium uses a combination of ox bile, NaCl, a high 
pH and an indicator system for acid production from sucrose. However, TCBS cannot 
differentiate V parahaemolyticus from other Vibrio species that may be sucrose negative 
such as V mimicus or V vulnificus. Several workers have evaluated TCBS supplied by 
different manufacturers to reveal inconsistencies in the recovery and quality of growth of 
each species (West et al., 1982) suggesting the need for better quality controls. Due to the 
common presence of more than one Vibrio species in environmental and food samples, it 
may be more favourable to use TCBS in clinical cases than culturing from environmental 
samples. 
V parahaemolyticus has also been isolated on a variety of other media including mannitol 
salt agar (Carruthers, 1976), sucrose teepol tellurite agar (Chatterjee et al., 1977), and 
thiosulphate chloride iodide agar (Pfeffer & Oliver, 2003) although none have been used 
extensively. Trypticase soy agar containing triphenyl tetrazolium was developed to 
enhance differentiation between V parahaemolyticus and V alginolyticus (Kourany, 1983) 
but also does not appear to have been widely used. The performance of CHROMagar 
Vibrio (CV), a medium containing a chromogenic beta-galactosidase system was also 
studied (Hara-Kudo et al., 2001). In comparison to TCBS, a greater proportion of samples 
were positive in CV and less interference from other vibrios as V parahaemolyticus 
appears violet in colour whilst other vibrios appear pale blue. Unlike TCBS, the colour of 
the colonies did not change with prolonged incubation or storage. 
2.5.4 Biochemical profiling 
The screening of presumptive V parahaemolyticus is necessary to exclude as many non-
target organisms as possible before further identification. These basic screening tests 
include assessing cell growth, morphology, motility, swarming on growth surface, Gram 
staining and several biochemical tests including arginine dihydrolase (ADH) and Voges-
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Proskauer tests. Kaper et al. (1979) described a medium for screening of presumptive V. 
parahaemolyticus. This includes seven tests in one medium including the utilisation of 
mannitol, sucrose and lactose together with ADH, indole reactions, gas and H2S 
production. Although it was able to differentiate V parahaemolyticus from other Vibrio 
spp. some combinations of positive reactions were found to interfere with detection of 
other tests. 
A full list of biochemical tests differentiating between closely related species have been 
described (Elliot et al., 1995). Of the many tests it has been noted that an increasing 
number of V parahaemolyticus are resistant to 150J.lg of di-isopropyl pteridine phosphate 
(0/129). Several workers have also reported oxidase negative and urease positive strains 
that coincide with pathogenic V parahaemolyticus (Eko, 1992). 
2.5.5 API and commercial identification systems 
The use of API 20E and API 20NE (BioMerieux) has been shown to be the most reliable 
and quickest method to identify V parahaemolyticus (Overman et al., 1985, 1986). In the 
most recent study, Croci et al., (2007) evaluated API 20E, API 20NE and a set of 32 
conventional tests described previously by Alsina and Blanch ( 1994) for the rapid 
identification of vibrios. Intra- and inter-laboratory test findings showed the Alsina and 
Blanch scheme to be the most sensitive in correctly identifying V parahaemolyticus. 
Veretta et al. compared the API20E and API20NE identification systems to a BBL Crystal 
enteric/nonfermenter (E/NF) identification system using Gram negative rods from clinical 
samples (V arettas et al., 1995). The workers found that the Crystal system was more 
convenient than API for routine clinical use because it required fewer repeats and was 
easier and less time consuming to use. O'Hara and eo-workers applied these and several 
other systems that included MicroScan Neg ID2, Rapid Neg ID3, Vitek GNI+ and ID-
GNB to identify members of the Vibrionaceae family (O'Hara et al., 2003) with varying 
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levels of accuracy. Overall percentage accuracy ranged from 63.1% to 80.9% with the 
MicroScan Neg ID2 and Crystal E/NF respectively. 
In what appears to be the first study of its kind on V parahaemolyticus, Martinez-Urtaza et 
al. (2006) used an API 20E system to biochemically characterise differences between 
clinical and environmental isolates of V parahaemolyticus. By using 2% and 0.85% NaCI 
as diluent (as recommended by the manufacturer), they showed that environmental isolates 
gave more accurate identification using a 2% NaCI, whereas clinical isolates were 
correctly identified using 0.85% NaCI, consistent with previous findings (MacDonell et al., 
1982). Additionally, clinical and environmental isolates demonstrated significant 
differences in up to 5 tests. Both gelatine utilisation (GEL) and arabinose fermentation 
(ARA) were positive in the environmental group and negative in the clinical isolates tested. 
Environmental isolates analysed using 2% NaCl showed higher positive reactions for 
citrate utilisation, urease, melibiose and amygdalin than those using 0.85% NaCI thus 
suggesting small yet significant differences in metabolism amongst clinical and 
environmental isolates. 
2.5.6 Characterisation of pathogenic V. parahaemolyticus 
The difficulty in obtaining reliable identification of V parahaemolyticus by conventional 
biochemical procedures alone is widely recognised and summarised above. Once 
identified, there is no biochemical test or series of tests that would confirm a pathogenic 
isolate. However, the haemolytic properties of TDH have been well documented and 
correlated with human pathogenicity since 1969 (Miyamoto et al., 1969) and ~-haemolysis 
of human or rabbit erythrocytes on Wagatsurna agar is a commonly used indicator for TDH 
related virulence (section 2.4.2). The related haemolysin, TRH, is more active against calf 
and sheep red blood cells than human or rabbit cells but does not produce haemolysis on 
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Wagatsurna agar although the presence of TRH has been associated with the production of 
urease in some findings (section 2.4.3, Eko, 1992; Iida et al., 1997; Park et al., 2000). 
2.5.7 Immunological detection of pathogenic V. parallaemolyticus 
Honda et al. modified a BTB-Teepol agar and arabinose-ammonium sulphate-cholate agar 
(MAAC) for the immunological detection of TDH producing isolates (Honda et al., 1980, 
1982). Using a modified Elek test and immunohalo test with antiserum or anti haemolysin 
lgG, it was possible to identify the Kanagawa phenomenon on a single plate. Workers of 
the same group later developed several ELlS A methods for the detection of TDH and TRH 
(Honda et al., 1985, 1989b, 1990) and subsequently developed and evaluated two assay 
kits for TDH and TRH that are commercially available (Yoh et al., 1995). The two kits, 
reversed passive latex agglutination (RPLA) and Bead-ELISA, although originally 
developed for detection of TDH, were found to detect TRH with a minimum concentration 
of 10 ng/ml. 
2.6 Molecular detection methods 
2.6.1 PCR methods for V. parallaemolyticus 
A number of successful PCR-based assays have been developed to assist in the specific 
detection of V parahaemolyticus and its toxin genes. Most of the species specific gene 
targets used by workers include the genes toxR, tlh, and gyrB, the genes encoding for ToxR 
transmembrane protein, thermolabile haemolysin (section 2.4.4) and DNA gyrase subunit 
B respectively (Kim et al., 1999; Davis et al., 2004; Venkateswaran et al., 1998). Other 
gene targets that have been used with varying degrees of success include the heat shock 
protein hsp60 gene, the species specific pR72H fragment and to some extent the 16S- 23S 
spacer regions (Kwok et al., 2002; Lee et al., 1995; Sparagano et al., 2002). Several of 
these gene targets have been used collectively as multiplex PCR systems and quantitative 
real-time PCR (QRT-PCR) methods. 
28 
2.6.2 toxR gene based PCR methods 
ToxR is a trans-membrane protein and the transcriptional activator of Vibrionaceae (Miller 
et al. 1987; Lin et al., 1993). It has been found in many Vibrio spp. and shown to be well 
conserved amongst its members (Higgins et al., 1996; Li et al. , 2000; Okuda et al., 2001 ). 
However, some variations in sequence identity and divergence of toxR (Fig. 2.4) allow the 
design of PCR primers for specific Vibrio spp (Osorio & Klose, 2000). 
A P. damse/ae subsp. dam se/Be 
--.;.;.;..-f 
P. damselaesubsp. plsc/c/da 
Vibrio a/glnolytlcus 
Vibrio parshsemolyt/cus 
.. t--- Vibrio fluvia/ls 
10% Divergence 
'---- VIbrio vulniflcus 
B Vibrio uulnl(lcus 
Vibrio fluvi•li• 
Vibrio alglnolyticus 
Vibrio parDhaemolylicus 
VIbrio mlm/cus 
P. dsmSIIIIHI subsp. d11mu/ae 
P. damselao subsp. prsc/clda 
"---- VIbrio ho/1/ue 
'----- P. pro/undum 
1% Divergence 
Figure 2.3: Unrooted trees constructed by the neighbor-joining method showing the phylogenetic 
interrelationships of the different Vibrio and P!Jotobacterium species based on toxR gene nucleotide 
sequences (A) and 16S rRNA genes (B) (Osorio & Klose, 2000) 
Using PCR targeted to toxR, Kim et al. ( 1999) showed that all 373 V parahaemolyticus 
isolates tested were positive for toxR and that the gene was present in other members of 
Vibrio spp. Some of the PCR reactions exhibited amplicons of different sizes and 
intensities suggesting toxR sequence variation in Vibrio species that may reflect 
phylogenetic relationships (Fig. 2.3). This was shown to be true in a follow up study by 
Osorio & Klose (2000). The toxR region has been widely used as a species specific marker 
in various PCR protocols including multiplex PCRs and real time PCRs (Kim et al. , 1999; 
Lin et al., 1993; Alam et al., 2002; Dileep et al., 2003). In a comparison with toxR and two 
other loci (tlh and pR 72H) Croci et al. were able to show that toxR provided the best 
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results in the identification of V parahaemolylicus with an inclusivity of 96%, no false 
positives, and a concordance between repeated determinations of97% (Croci et al., 2007). 
2.6.3 PCR targeted to tilt 
Several workers have used tlh, the gene for thermolabile haemolysin (section 2.4.4) as a 
species specific marker (Bej et al., 1999; Kaufman et al., 2002, Miwa et al., 2003). Work 
by McCarthy et al. demonstrated the use of an alkaline phosphase and digoxygenin (DIG) 
labelled tlh probe that worked equally as well as the tlh PCR protocol (McCarthy et al., 
1999). The tlh PCR based probe showed 97% agreement with the API 20E diagnostic 
strips in the identification of V parahaemolyticus (section 2.5.5) and was found to be 
considerably more efficient and reduce time and effort. In addition to the tlh PCR, several 
other targets such as a collagenase and metalloprotease gene have also been used as targets 
for the identification of V parahaemolyticus with varying degrees of success (Di Pinto et 
al., 2005; Luan et al., 2007). However, these targets have yet to be assessed and validated 
by others. 
2.6.4 Primers for gryB 
Venkateswaran and workers developed V parahaemolyticus specific DNA gyrase subunit 
B (gyrB) primers. They showed that V parahaemolyticus and V alginolyticus shared a 
86.8% homology in nucleotide sequences and developed a set of primers that correctly 
detected I 17 strains of the target strain from 267 non-target strains (V enkateswaran et al., 
1998). Using sequence data from gyrB, and other genes from multilocus sequence typing 
(section 2.7.10) Chowdhury et al. were able to assess evolution of the pandemic 03:K6 
strains that had arisen since 1996 (Chowdhury et al., 2004b ). Other workers have 
developed multiplex, microarray and real-time PCR assays for the specific detection of V 
parahaemolylicus (Gonzalez et al., 2004; Cai et al., 2006). 
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2.6.5 PCR ofpR72H 
Several workers have used the pR72H fragment obtained from a Hindlll DNA digest of V 
parahaemolyticus DNA cloned into pUCII9. This fragment was found in all strains of V 
parahaemolyticus tested and thus it was recommended as a species specific DNA probe. 
(Lee et al., 1995; Croci et al., 2002, 2007) Using this fragment Hervio-Heath and 
colleagues identified a novel 320bp amplicon, atypical of the 387bp fragment usually 
found, in 24.4% of the V. parahaemolyticus isolates (Hervio-Heath et al., 2002). Workers 
in Chile identified two other amplicons using the same primers; a 400bp fragment and a 
340bp fragment in both clinical and environmental samples. However, a third group of 
isolates of V. parahaemolyticus did not show a PCR band (Cordova et al., 2002) and 
consequently the use ofpR72H as a species specific marker remains questionable. 
2.6.6 PCR methods for toxin genes 
PCR for tdh and trh have widely been used both as a marker for pathogenic isolates in 
environmental samples as well as confirmation in clinical studies (Lee et al., 1993; 
Karunasagar et al., 1996; Wong et al., 1999a; Alam et al., 2002; Robert-Pillot et al., 2004). 
The most widely used sets of primers are those developed by Tada et al. ( 1992) that target 
the tdh2 and trhl regions. The gene tdh2 is the more representative of tdh genes and is 
found to be more strongly associated with haemolysis of Kanagawa positive isolates than 
tdh I genes (Nishibuchi & Kaper, 1990; lida et al., 1990). Although the haemolysin TDH 
can be assayed using immunological tests and to some extent Wagatsuma agar, to date 
there appears to be no conventional tests for TRH production. 
2.6. 7 Multiplex PCR 
The development of multiplex PCR (M-PCR) for pathogenic isolates have been reported 
by several workers using both tdh, trh and several species specific genes (Bej et al., 1999; 
Kong et al., 2002; DePaola et al., 2003b; Okura et al., 2003; Panicker et al., 2004; Tarr et 
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a/.,2007). Using M-PCR Lee et al. (2003) showed the detection of V. parahaemolyticus 
and related species from shellfish using tl (tlh) primers. The amplicons were then subjected 
to colorimetric CovaLink™ NH microwell plate sandwich hybridisation using 
phosphorylated and biotinlylated tlh probes. 
Panicker et al. (2004), used tdh, trh, tlh and orj8 amplicons derived from a multiplex PCR 
as targets for oligonucleotide probes. The probes were deposited onto Teflon-masked 
slides by using a MicroGrid ll arrayer and hybridisation detected by using tyramide signal 
amplification with Alexa Fluor 546 fluorescent dye. This microarray approach detected 102 
to 103 CFU/ml of target organism in pure cultures and 1 CFU in 1 g of oyster tissue 
homogenate after Sh of sample enrichment with 100% specificity. Consequently, the 
authors suggested the use of a microarray approach together with multiplex PCR for 
efficient detection of pathogenic V. parahaemo/yticus from shellfish samples. 
2.6.8 DNA hybridisation probes and ELISA methods 
DNA-DNA hybridisation probes have been used extensively as they can usually be applied 
directly onto plate grown cultures allowing identification of target genes and test all the 
colonies on a plate at the same time. Both digoxigenin (DIG) and alkaline phosphatase-
conjugated probes have been used by several workers to target species specific and 
virulence genes (Yamamoto et al., 1992a; McCarthy et al., 1999; Gooch et al., 200 I; 
Nordstrom et al., 2006; Raghunath et al., 2007). In comparison with API 20E identification 
strips, McCarthy et al. showed that specificity in identifying V. parahaemolyticus using the 
alkaline phosphatase probe and DIG-labelled method was 97% and 98% respectively. 
However, although the probes were specific, the sensitivity of this detection method was 
less than expected (McCarthy et al., 2000; Gooch et al., 200 I). Lee et al. subsequently 
developed a CovaLink™ NH microwell plate approach using tlh primers that was reported 
to detect 102 cells/g of oyster tissue homogenate (Lee et al., 2003) and offered a shorter 
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hybridisation time, higher sensitivity and high throughput sample processing, although this 
has not been tested with pathogenic isolates or using tdh or trh probes. 
2.6.9 Quantitative real-time PCR (QRT-PCR) 
Increasingly, a number of workers have reported QRT-PCR methods usmg various 
markers including tdh, trh, t/h, toxR, gyrB and both tlurogenic and TaqMan probes (Davis 
et al., 2004; Iijima et al., 2004; Kaufman et al., 2004; Takahashi et al., 2005; Cai et al., 
2006). Blackstone et al. (2003) used a tlurogenic tdh probe to test 131 Alabama oyster 
samples that were enriched in alkaline peptone water (APW). In comparison to using a 
streak plate method followed by tdh probe, the 24 hour QRT-PCR method was able to 
detect the gene tdh in 61 samples, whereas previously the streak plate/probe method 
detected tdh in 15 samples, a procedure reported to take 3 days (Blackstone et al., 2003). 
Similarly, Bej and coworkers multiplexed four targets tdh, trh, tlh and orj8, for a count of 
total and potentially pathogenic V parahaemolyticus for a QRT-PCR procedure that was 
sensitive for 200 pg of purified genomic DNA and I 04 CFU per ml for pure cultures (Ward 
et al., 2006; Rizvi et al., 2006). The high sensitivity of QRT-PCR was also demonstrated 
by Nordstrom et al. (2007) to detect total and potentially pathogenic V. parahaemolyticus. 
2.7 Strain differentiation by molecular typing methods 
2.7.1 Epidemiological typing of clinically significant strains 
Due to the large number of outbreaks of V. parahaemolyticus food poisoning worldwide 
and an increasing number of environmentally isolated, potentially pathogenic strains, there 
have recently been numerous strategies developed to delineate patterns of transmission. In 
some cases, typing has contributed to epidemiological surveillance and evaluation of 
control measures by assessing prevalence and distribution of epidemic and pandemic 
clones. Several molecular typing techniques for V parahaemolyticus are under 
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development and more recently, there has been a growing concern for standardised typing 
methods for V. parahaemolyticus. 
2. 7.2 Principles and properties of a molecular typing method 
The accurate recognition and differentiation of subtypes within a bacterial species and the 
use of subtype identification methods to determine sources of infection, rates of spread of 
infection and mechanisms of transmission is referred to as typing. The basis for all 
molecular typing methods is that an outbreak of an infectious disease is the result of 
exposure to a pathogen that is derived from a single cell or clone and its subsequent 
progeny will be genetically identical or closely related to the source organisms (Streulens, 
1998). The assumption is that at species level there is sufficient genetic diversity so that 
organisms isolated from different sources and/or at different times and locations can be 
classified as different isolates, subtypes or strains (Olive & Bean, 1999). The criteria for 
evaluating performance of typing systems may include assessments on typeability, 
discriminatory power, reproducibility, stability, epidemiological concordance and 
comparative study (Streulens, 1998). 
Ideally, the techniques used in a molecular typing system should be standardised and 
reproducible so that they can be carried out in any laboratory and give informative and 
comparable data, which is applicable to all isolates. The system should be sufficiently 
discriminatory to distinguish a reasonable number of types amongst which isolates can be 
roughly equally distributed. Furthermore, a typing system should be able to differentiate 
unrelated strains such as those which are geographically distinct from the source organisms 
but at the same time demonstrate the relationships that exist between organisms isolated 
from individuals infected through the same source (Olive & Bean, 1999). 
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2.7.3 Pulsed field gel electrophoresis (PFGE) 
Over recent years, pulsed field gel electrophoresis (PFGE) has emerged as the "gold 
standard" in molecular typing methodology and is the current method of choice for typing 
nosocomial and community acquired pathogens (Tenover et al., 1997). PFGE IS an 
extremely sensitive and sophisticated method that uses whole intact genomic DNA 
prepared by embedding bacteria in agarose plugs. Bacterial cells are lysed in situ, followed 
by restriction enzyme digestion of the intact genomic DNA with an infrequently cutting 
enzyme after removal of proteins. The large DNA fragments generated are then separated 
in highly purified agarose using specialist gel electrophoresis systems. Differences in the 
length and number of restriction fragments arise as a result of the changes in restriction 
enzyme sites caused by duplication, mutation, deletion, insertion or inversion (Tenover et 
al., 1997). 
PFGE has been used widely in regions of South East Asia where gastroenteritis due to V 
parahaemolyticus food poisoning is endemic. Selections of different restriction enzymes 
including Notl, Sfil and Apal have been used with various protocols and pulse times (Bag 
et al., 1999; Wong et al., I999a; Lu et al., 2000; Ma1tinez-Urtaza et al., 2004; Yeung et 
al., 2002; Chowdhury et al., 2004a; Tanil et al., 2005). One of the first reports of an 
extensive use of PFGE for subtyping of V parahaemolyticus was reported for 130 clinical 
isolates in Taiwan in 1996 (Wong et al., 1996). Although comprehensive fingerprinting 
data were not presented, they reported clustering of the 130 isolates into 14 PFGE types 
one of which seemed to be clonally related to an isolate from Japan. Conversely, clonal 
diversity within the serotype 03 :K6 was demonstrated by Bag and colleagues (1999), who 
combined the use of PFGE with ribotyping (section 2.7.4). Although there had been 
genetic reassortment among the 30 clinical 03:K6 strains tested, they were still 
predominantly one clone. A similar study incorporated the use of an arbitrarily primed 
PCR (AP-PCR) method with PFGE to identify a second serovar, 04:K68 in Thailand and 
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India that shared 78-91% genomic similarity to that of 03:K6 strains (Chowdhury et al., 
2000a). Using PFGE, Okura et al. (2003) also suggested that the 01 :K25, 01 :K26, and 
01 :K untypeable pandemic serovars were derivatives of one clone. 
Since the use of PFGE in typing V parahaemolyticus in 1996, a number of methods with 
variations in the use of restriction enzymes (Not], Sfil and Apal), pulse switch times, 
equipment and other parameters have been employed with varying degrees of success 
(Marshall et al., 1999). The main concern is a lack of typeabilty as DNA degradation 
occurs over the long preparation and processing times, not just in V parahaemolyticus but 
also in V cholerae and V vulnificus (Gonzalez-Escalona et al., 2007). A number of 
workers have recently adopted the 'One day (24-28 h) Standardised Laboratory Protocol 
for Molecular Subtyping of Non-typhoidal Salmonella by PFGE' (PulseNet; CDC, Atlanta, 
Ga) with increased typeability. However, with an increasing number of outbreaks 
worldwide, and with PFGE as the preferred method of subtyping, there have been growing 
concerns for a standardised PFGE V parahaemolyticus protocol to facilitate inter-
laboratory strain comparisons. To this end, two standardised PFGE procedure for V 
parahaemolyticus have recently been described (Parsons et a/, 2007; Wong et al., 2007) 
and remain to be validated by others. 
2.7.4 Restriction fragment length polymorphism (RFLP) analysis 
Restriction fragment length polymorphism (RFLP) analysis has been used on a variety of 
occasions, usually in conjunction with other methods (Gendel et al., 200 l; Yeung et al., 
2002; Wong et al., l999c). RFLP analysis uses restriction enzymes to digest genomic 
DNA and the resulting fragments are separated according to size by agarose gel 
electrophoresis in much the same way as PFGE without the need for sophisticated gel 
electrophoresis apparatus. This method has been used to characterise polymorphisms in 
virulence genes tdh and trh (Suthienkul et al., 1996) and genes encoding for components of 
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polar flagellar, Fla locus of V parahaemolyticus (Marshall et al., 1999). However, 
because of the complexity of the resulting pattern due to a large number of restriction 
fragments in a genome, the DNA is transferred to a membrane (i.e. Southern blot) and 
probed by DNA hybridisation using a labelled probe. Several probes have been used to 
characterise V parahaemolyticus, the most common being ribosomal based probes 
(ribotyping), (Wong et al., 1999b). 
In what appears to be the first of two comparative studies of several molecular typing 
techniques, Marshall and colleagues used the rrnB rRNA operon of E. coli to ribotype 60 
isolates (Marshall et al., 1999). Although full genotypic data was not shown, Bgll digested 
genomic ON A was reported to reveal 14 different types in comparison to 15 and 13 types 
as shown by PFGE and enterobacterial repetitive intergenic consensus sequence PCR 
(ERIC-PCR, section 2.7.8) respectively. Using Simpson's index of diversity (DI) described 
by Hunter and Gaston (1988), the authors concluded that both ribotyping and ERIC PCR 
(section 2.7.8) provided the best discrimination, similar to that of PFGE discrimination 
while Fla locus RFLP analysis provided the lowest discrimination index (Marshall et al., 
1999). Another method employing RFLP that does not appear to have been assessed in V 
parahaemolyticus include the use of insertion sequence (IS) probes, especially as there is 
evidence to suggest that tdh has been found to be spread by insertion sequence like 
elements (ISVs) (Baba et al., 1991b; Terai et al., 1991). IS probes such as IS200 have been 
used successfully to type Salmonella spp, Streptococcus pneumoniae (IS IS1167) and 
Mycobacterium tuberculosis (lS6110) (Stanley & Saunders, 1996; Luna et al., 2000). 
2.7.5 Randomly amplified polymorphic DNA (RAPD) PCR 
Randomly amplified polymorphic DNA PCR (RAPD) is a widely used method that 
examines nucleotide variation throughout the entire genome and can be more 
discriminatory than methods that examine variation at a specific locus, particularly in 
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studies of highly conserved species. It employs the use of short oligonucleotide primers of 
arbitrary sequence that bind to any region in the genome bearing the complementary 
sequence. Banding patterns are due to mismatches or appearances of new primer sites and 
the length of amplified region between the primer sites. RAPD has been used by several 
workers to characterise diverse strains of V. parahaemolyticus with various degrees of 
success (Wong et al., 1999c; Islam et al., 2004; Maluping et al., 2005; Hayat et al.,2006; 
Parvathi et al., 2006). 
In one of the first reported studies of RAPD-PCR with V parahaemolyticus, Wong et al. 
screened 100 different 10-mer primers (UBC RAPD primer set 100/3, Finnzymes Oy, 
Espoo, Finland) with a single clinical and environmental strain and proceeded to type 308 
clinical isolates to identify 41 polymorphic RAPD patterns (Wong et al., 1999). Although 
quality of data was not apparent, the RAPD clustering identified 5 major clinical subtypes 
that accounted for 91% of all the isolates and were phylogenetically more closely related to 
each other indicating a largely homogeneous group amongst the clinical strains tested. In 
another study that involved 1500 environmental isolates of V. parahaemolyticus in 
Bangladesh, the workers identified and characterised five tdh positive and clinically 
significant strains (Islam et al., 2004). These five isolates were found to belong to three 
different serotypes; two that belonged to 03:K6 however, believed to be clonally related, 
showed identical RAPD bands. Similar results were also published by Hayat et al. (2006) 
who showed 0.3% of environn1ental isolates to be toxigenic and to possess identical RAPD 
bands to that of pandemic reference strains. Similar findings were reported by others on the 
application of RAPD using arbitrary primers to distinguish between V. parahaemolyticus 
strains (Matsumoto et al. 2000; Chowdhury et al., 2000b; Okura et al., 2003). These 
methods employed one or more of the primers provided with the Ready-To-Go RAPD 
Analysis Kit (Amersham Biosciences). However, a low number of amplicons and the use 
of different control strains do not facilitate meaningful comparison of data. 
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2.7.6 Ribosomal DNA intergeoic spacer (ITS) region analysis 
The genes encoding subunits of bacterial rRNA are typically arranged in a characteristic 
formation, 16S, 23S and SS. Regions between the 16S and 23S rRNA genes and between 
23S and SS rRNA genes are known to be more variable in both size and nucleotide 
sequence than the flanking genes and are termed ITS 1 and ITS2 respectively. The 
acronyms, IGS (intergenic spacer) and ISR (intergenic spacer region) have also been 
frequently used. Within a species, the 16S rRNA is often highly conserved with variable 
regions often used for phylogentic and taxonomic purposes. The intergenic spacer region 
shows greater variability and can be used to distinguish between closely related bacterial 
species and, sometimes, between strains and isolates. A number of copies of the rRNA 
operon are known to exist throughout the genome in different species and this may provide 
adequate variation for epidemiological typing purposes (Gurtler & Stanisich, 1996). 
Variation in the ITS I and ITS2 regions have been the basis for the development of a 
number of subtyping systems for a wide number of species although sequence variation in 
the ITS 1 region has been more widely used due to its larger size and consequently higher 
probability of nucleotide polymorphisms. In the recent genome sequencing project of V 
parahaemolyticus, 11 rRNA operons (rrn) that fell into 6 classes were identified (Makino 
et al., 2003) with identical 16S rRNA genes (rrs) (Gonzalez-Escalona et al., 200Sb). 
Although this large number of operons may produce complex ITS 1 banding patterns, the 
relative frequency and distribution of rRNA genes throughout the genome amongst strains 
of V parahaemolyticus may provide a significant tool for intraspecies subtyping of this 
organism. For example, a strain of V parahaemolyticus that had been isolated in 19S1 only 
contained two rrn sequence types, one of which was found in seven of the 11 rrn operons 
and the other in four (Maeda el al., 2000). 
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The ITS I region was first analysed in V cholerae by Coelho and colleagues (1995) who 
used primers that flanked 16S and 23S rDNAs of E. coli to show that ITS I PCR patterns 
from 01 classical, 01 El Tor and 0139 strains were different and therefore provide a 
potential tool for studying the epidemiology of V cholerae. In a follow up study by Chun 
et al., (1999), V cholerae and V mimicus ITS I regions were studied using more specific 
primers based on sequences from E. coli, Pseudomonas aeruginosa, V cholerae and V 
vulnificus (Chun et al., 1999). Perhaps not surprisingly due to a high specificity of primers 
and the use of only I 0 isolates in the study, only four ITS I variants were identified in both 
V cholerae and V mimicus where up to I 0 rrn operons had previously been described 
(Nandi et al., 1997). 
2.7.7 Transfer DNA-PCR analysis 
Conserved genes encoding tRNAs can be found widely distributed throughout a genome, 
usually clustered in multiple tandem-repeat units (Green & Void, 1993). DNA that encodes 
for RNA is termed tDNA and the intergenic space between these tRNA genes can vary 
considerably between species and sub species (Welsh & McCelland, 199la). tDNA gene 
regions appear to be hot-spots for the integration of prokaryotic genetic elements (Reiter et 
al., 1989; section 2.4.1 0, insertion sequences) and has been shown in E. coli to confer 
specific traits such as enhanced virulence, antibiotic resistance and fitness traits necessary 
to adapt to certain niches (Dobrindt et al., 2004; Hayashi et al., 2001; Welch et a/ 2002). 
Low stringency PCR products based on primed tDNA regions can amplify comparable 
inter-length polymorphisms (tDNA-ILPs) between different strains and species and can be 
used to assess genome wide variation (Welsh & McCelland, 1991a). tDNA-ILPs have been 
used by several workers to rapidly subtype a wide variety of bacterial species including 
Acinetobacter spp., Staphylococcus spp., Renibacterium salmoninarum, Enterobacter 
cloacae and Lactobacillus spp., (Ehrenstein et al., 1996, Maes et al., 1997; Alexander et 
al., 200 I; Clementino et al., 200 I, Baele et a/ ., 2002). 
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Welsh and McCielland developed a set of 'consensus' tRNA gene primers from multiple 
alignments of tRNA genes from a wide variety of bacterial species including E. coli. The 
primers were designed to face outwards from the end of the tRNA genes to amplify a 
tDNA-ILP fingerprint determined by the arrangement of tRNA genes on the bacterial 
genome. Due to the conserved order and arrangement of tRNA genes on the genome, the 
banding profiles that are generated using consensus primers are often characteristic of a 
particular species and can be identical or nearly identical within every species (Welsh & 
McCelland, 1991a, 1992). Considering the relatively large number of tRNA genes that 
have been found in the Vibrionaecae, (Maeda et al., 2000), and in particular, 126 in V 
parahaemolyticus, (Makino et al., 2003) that coincide with multiple rrn operons, tDNA-
ILPs show significant potential as a method of sub typing V parahaemolyticus. 
2.7.8 Repetitive extragenic palindromic sequence PCR (REP-PCR) 
Repetitive extragenic palindromic (REP) sequences are repetitive elements that also appear 
to be distributed throughout bacterial genomes and consist of a conserved 33 bp inverted 
repeat region (Stem et al., 1984). The function of the REP sequence in the prokaryotic 
genome remains largely unknown although the sequences appear to stabilise upstream 
mRNA regions and influence gene expression (Newbury et al., 1987). Although a high 
discrimination index was shown by Wong et al. (2001) in subtyping V parahaemolyticus, 
Maluping et al. demonstrated less reproducibility even though the same primers and PCR 
conditions were used (Maluping et al., 2005) 
Another system that employs the use of conserved regions that have widely been used for 
bacterial typing includes ERIC- PCR. These sequences are a family of repetitive elements 
that were first described in the genomes of E. coli and Salmonella Typhimurium and also 
found in other species including V cholerae (Hulton et al., 1991). The sequence is 126 bp 
long and has been shown to be highly conserved and restricted to transcribed regions of the 
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genome, either in the intergenic regions of polycistronic operons or in the untranslated 
regions that lie upstream or downstream of open reading frames (Oebruijn, et al., 1992). 
Although ERIC sequences are highly conserved, their chromosomal locations are known to 
vary between different bacterial species. ERIC-PCR has been widely used to characterise 
V cholerae since 1991 and more recently used for V parahaemolyticus with varying 
degrees of success (Khan et al., 2002; Maluping et al., 2005; Tanil et al., 2005). 
As well as ERIC and REP sequences, repetitive BOX sequences that appear dispersed 
throughout the genome have also been used to subtype microorganisms. BOX elements 
have been shown to consist of three subunits termed boxA, boxB, and boxC. Sequence 
analysis relevealed that boxA was highly conserved in bacteria, whilst boxB and boxC were 
highly variable and found only within S. pneumoniae (Versalovic et al., 1995) and since 
then primers for the boxA region have been used widely in several species and more 
recently in Aeromonas spp. (Tacao et al., 2005) and B. pseudomallei (Currie et al., 2007). 
In a comparative study of molecular typing systems, Wong & Lin (2001) compared three 
PCR methods for subspecies typing V parahaemolyticus that included ERIC- PCR, REP-
PCR and ITS-PCR. Forty strains representing a wide range of PFGE profiles were grouped 
into 27, 27 and 15 patterns with discrimination indexes of 0.98, 0.97 and 0.91 by ERIC-
PCR, REP-PCR and ITS-PCR respectively (Wong & Lin, 2001). In another study, PFGE 
was shown to be a more discriminatory method than BOX-PCR although both methods 
were able to distinguish between closely related strains of E. coli. However, neither of the 
methods used were effective in clustering E. coli strains according to the source of the 
organism (Cesaris et al., 2007). 
42 
2.7.9 Multi locus enzyme electrophoresis (MLEE) 
Multi locus enzyme electrophoresis (MLEE) is a technique that examines the 
electrophoretic mobility of a selection of metabolic enzymes. The variation in mobility is 
visualised by staining of gels to reveal specific enzyme activity and is attributed to 
isozymes or allozymes. MLEE is commonly used to study long-term epidemiology on a 
global scale where minor differences between related strains are not required. 
Farfan et al. (2000) used MLEE to study genetic relationships between a diverse group of 
107 clinical and environmental isolates of V cholerae to determine allelic variation in IS 
housekeeping enzyme loci. They identified 99 electrophoretic types with a genotypic 
diversity (G) of 0.9872 for all samples. All IS enzyme loci studied were polymorphic, the 
number of alleles ranging from 2 to 7. The authors concluded that the 0139 and 01 El Tor 
isolates were genetically more related to each other than all the other sub-populations 
studied. 
Another study using 62 strains of V vu/nificus strains, placed the population into two 
divisions that were comparable to the two divisions obtained using RAPD (section 2.7.4) 
(Gutacker et al., 2003). The method did not show any significant clustering or association 
between distinct clones and as such its use is inappropriate for subtyping isolates from 
local outbreaks of infection. 
2.7.10 Multi locus sequence typing (MLST) 
Multi-locus sequence typing (MLST) is a nucleotide sequence based approach that was 
proposed in 1998, borrowing from the concepts of MLEE (Maiden et al., 1998). Instead of 
using the variation in electrophoretic mobility of a selection of enzymes to assess allelic 
genotypes, the variation of the gene sequences, is bioinformatically assessed for 
relatedness using software and database approaches. 
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In a recent finding using three housekeeping gene loci and three virulence gene loci, 
Kotetishvili et al., (2003) demonstrated a better discriminatory ability of MLST than PFGE 
and since then several workers have used MLST for subtyping of V cholerae (Lee et al., 
2006; Danin-Poleg et al., 2007). Using MLST sequence data from six housekeeping genes 
of V vulnificus, Cohen et al. (2007) were again able to subtype 94% of the isolates into the 
two distinct lineages commonly associated in this species. To date, ten housekeeping genes 
have been proposed for V vulnificus (Bisharat et al, 2007a; 2007b). Of these ten, five of 
these loci have also been adopted for the MLST typing of V parahaemolyticus with an 
additional two housekeeping loci, recA, dnaE and the variable gene ompK (Gonzalez-
Escalona et al., 2008). Using MLST of 100 isolates of V parahaemolyticus, three major 
clonal complexes and 62 sequence types were identified. Based on these initial studies it 
was concluded that V parahaemolyticus is genetically diverse exhibiting a semi-clonal 
population structure that is driven primarily by frequent recombination rather than 
mutation events (Gonzalez-Escalona et al., 2008). However, as with all MLST methods, it 
is considerably more resource intensive, expensive and impractical for typing a large 
number of V parahaemolyticus isolates from shellfish samples. 
2.7.11 Variable number tandem repeats PCR (VNTR-PCR) 
Short DNA sequence motifs that occur in specific regions of a genome where there are 
variations in the number of repeat units can provide a source of high genomic 
polymorphism are often termed variable number tandem repeats (VNTR), single sequence 
repeats (SSR) or 'multi locus variable number of tandem repeat analysis' (ML V A) (van 
Belkum, 1999; 2007). The number of repeat units that occur at a locus can vary between 
strains (and within strains) due to many reasons including slipped strand mispairing, 
deletions and insertions. VNTR analysis makes use of PCR primers complementary to the 
stable flanking sequences and polymorphisms in the numbers of repeat units are 
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detennined by agarose gel electrophoresis (van Belkum et al., 1998). In ML V A, the 
approach can be supported or extended by locus-specific DNA sequencing. 
VNTR has been used for a variety of applications including human genetics and bacterial 
epidemiological studies most notably in subtyping Mycobacterium spp. (Roring et al., 
2004). More recently, it has been applied to members of the Vibrioneacae; V. cholerae and 
V. vulnificus. Danin-Poleg et al. (2007) screened the V. cholerae genome sequence to 
reveal thousands of SSR tracts with an average frequency of one SSR every I 52 bp. Using 
32 strains of V. cholerae that represented both clinical and environmental isolates, the 
workers tested for polymorphism in SSR loci with two methods including polymorphism 
of SSR tracts longer than 12 bp and mononucleotide repeats as assessed by sequencing. 
Phylogenetic analysis of combined data was able to discriminate between the clinical 01 
and 0139 serogroups and environmental isolates. This ability to discriminate between all 
but three clinical and environmental isolates from a total of 45 strains V. cholerae was also 
demonstrated (Danin-Poleg et al., 2007). 
Unlike the various other PCR methods previously described, VNTR regions are sequence 
specific for each bacterial species and may occur at only a single locus. Whilst VNTRs 
have been widely used on variety of applications, until recently, there had been no reports 
of the technique applied to V parahaemolyticus. Kimura et al. (2008) recently showed 
MLVA to have high resolution and reproducibility for typing of V parahaemolyticus 
03:K6 that were clonally related. In 28 pandemic V. parahaemolyticus 03:K6 isolates 
from human cases, ML V A produced 28 distinct VNTR patterns at eight loci (Kimura et al. 
2008) and differentiated a further six environmental 03:K6 isolates that apparently showed 
the same PFGE pattern. However, the parameters that were used to obtain the PFGE 
clusters were unclear, and three clinical isolates were untypeable by PFGE. As with 
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Chapter Three 
GENERAL MATERIALS AND METHODS 
3.1 Chemicals and reagents 
Unless otherwise stated all general laboratory chemicals were purchased from Amersham 
Biosciences, Bio-Rad Laboratories, Invitrogen, Them10-Fisher Scientific, or Sigma-
Aidrich, and, if possible, were of molecular biology grade. All bacteriological culture 
media was obtained from Oxoid and PCR related reagents and restriction enzymes were 
obtained from Roche Biosciences. Recipes for all of the buffers that were used and the 
suppliers' details are outlined in Appendix I. Details of specific reagents can be found in 
the Materials and Methods section of individual chapters. 
3.2 Bacteriology 
3.2.1 Isolates of V. parallaemolyticus 
The designation codes of V parahaemolylicus obtained from various locations between 
2003 and 2006 and related organisms used in this study together with their countries of 
origin and source of isolation where known, and PCR data for tdh, trh and toxR where 
available are listed in Table 3.1. A total of 86 different isolates of V parahaemolyticus and 
closely related members of the Vibrionaecae were used for various typing procedures. 
Unless otherwise stated, the isolates were held as 50% glycerol stocks ( -70°) or on 2% 
Marine Salts Agar (MSA) in the University of Plymouth culture collection. A selection of 
biochemical tests and growth characteristics on several bacteriological media were 
perfonned regularly to confinn identity and purity of the cultures. Together with PCR and 
hybridisation analysis, molecular typing was performed on isolates as appropriate for 
which further details are provided in each chapter. These techniques included the analysis 
of one or more of the following: pulsed field gel electrophoresis (Chapter 5), l6S-23S and 
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23S-5S rRNA intergenic spacer analysis (Chapter 6), tDNA intergenic length 
polymorphism analysis (chapter 7) and randomly amplified polymorphic DNA (chapter 8). 
The characterisation of V parahaemolyticus was the first of its kind in the UK and 
sourcing of clinical isolates from UK bacterial culture collections proved to be very 
difficult. Where possible, clinical isolates were sought from other countries and this study 
represents a preliminary study to assess the feasibility of molecular typing techniques to 
determine clinical and environmental isolates of V parahaemolyticus. 
3.2.2 Culture and growth of V. parallaemolyticus 
All V parahaemolyticus isolates were recovered from 50% glycerol stocks or grown from 
MSA slopes stored at room temperature in the dark. Isolates were cultured for 8 to 18 
hours (depending on use) at 37°C in either 15 ml volumes of tryptone soya broth (TSB) 
with a final NaCI concentration of 3%, or MSA with a fmal salt concentration of 2%, 
shaking in a water bath (Ciifton NE5-28D) at 70 rpm. 
3.2.3 Culture and growth of additional bacterial species 
Bacterial isolates other than V parahaemolyticus that were used in this study are listed in 
Table 2.3 together with growth medium. All halophilic Vibrio spp. were grown in TSB and 
MSA supplemented with the appropriate amount of NaCI. Escherichia coli was grown on 
Luria-Bertani (LB) medium overnight at 37°C. 
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Table 3.1: Description of V. parallaemolylicus and their genotypes, where known, that were used in this 
study. The Strain ID is used throughout the study. 
Strain 
ID 
1902 
CEFAS 
Rderence 
V05/00I 
VPI0884 V05/002 
VPI0885 VPI0885 
219 
220 
221 
222 
223 
224 
225 
226 
227 
228 
1022/4 
1024/5 
1021/5 
1022/10 
1023/1 
1023/2 
1023/3 
1103/9 
2053 
2436 
5421 
6134 
6316(3) 
Vibl 
Vib2 
Vib3 
Vib5 
Vib6 
Vib7 
Vib8 
Vib9 
VibiO 
VPI 
VP2 
VP3 
VP4 
VPS 
VP6 
VP7 
VP8 
VP9 
VPIO 
VOS/009 
V05/0IO 
VOS/011 
VOS/012 
VOS/013 
VOS/014 
VOS/015 
VOS/016 
VOS/017 
V05/018 
V05/020 
V05/021 
VP 102115 
VPI022/IO 
VP 102311 
VP 102312 
VP 1023/3 
VP 1103/9 
VP 2053 
VP 2346 
VP 5421 
VP 6134 
VP 6136 
Vib I 
Vib2 
Vib3 
Vib 5 
Vib6 
Vib 7 
Vib 8 
Vib9 
Vib 10 
VP I 
V05/022 
VOS/023 
VP4 
VP 5 
VP6 
V05/024 
V05/025 
V05/026 
V05/027 
tnslitute(l) 
CEFAS 
CEFAS 
NSVS 
NSVS 
NSVS 
NSVS 
NSVS 
NSVS 
NSVS 
NSVS 
NSVS 
NSVS 
CEFAS 
CEFAS 
CEFAS 
CEFAS 
CEFAS 
CEFAS 
CEFAS 
CEFAS 
KUMS 
KUMS 
KUMS 
KUMS 
KUMS 
CEFAS 
CEFAS 
CEFAS 
CEFAS 
CEFAS 
CEFAS 
CEFAS 
CEFAS 
CEFAS 
Location 
PHLS, UK 
PHLS, UK 
Oslo, Norway 
Oslo, Norway 
Oslo, Norway 
Oslo, Norway 
Oslo, Norway 
Oslo, Norway 
Oslo, Norway 
Oslo, Norway 
Oslo, Norway 
Oslo, Norway 
Galicia, Spain 
Galicia, Spain 
Galicia, Spain 
Galicia, Spain 
Golicia, Spain 
Galicia, Spain 
Galicia, Spain 
Galicia, Spain 
Kyoto, Japan 
Kyoto, Japan 
Kyoto, Japan 
Kyoto, Japan 
Kyoto, Japan 
Southampton, PHL 
Southampton, PHL 
Southan1pton, PHL 
Southan1pton, PHL 
Southampton, PHL 
Southampton, PHL 
Southampton, PHL 
Southampton, PHL 
Southampton, PHL 
Southan1pton, PHL 
Southampton, UK 
Southampton, UK 
Southan1pton, UK 
Southampton, UK 
Southampton, UK 
Southampton, UK 
Southampton, UK 
Southampton, UK 
Southampton, UK 
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Environmental/Clinical/ PCR (2) Ure 
Reference strain toxR tdlr trh 
NCIMB Reference Strain 
NCTC Reference Strain 
NCTC Reference Strain 
Clinical 
Clinical 
Clinical 
Clinical 
Clinical 
Clinical 
Clinical 
Clinical 
Clinical 
Clinical 
Environmental 
Environmental 
Environmental 
Environmental 
Environmental 
Environmental 
Environmental 
Environmental 
Clinical 
Clinical 
Clinical 
Clinical 
Clinical 
Environmental 
Environmental 
Environmental 
Environmental 
Environmen!al 
Environmental 
Environmental 
Environmental 
Environmental 
Environmental 
Environmental 
Environmental 
Environmental 
Environmental 
Environrnenlal 
Environmental 
Environmental 
Environmental 
Environmental 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ + 
+ (+) 
+ 
+ + + 
+ 
+ 
+ 
(+) + 
+ 
+ + + 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ + 
+ + 
+ + 
+ + 
Table 3.1: COIII. 
Strain CEFAS En•ironmentai/Ciiniral/ PCR(2) Ure 
ID Reference lnslitutejl) Location Reference strain toxR tdll trh 
E154482 VP E154482 PHLS Unknown Clinical + + 
El55855 VP El55855 PHLS Unknown Clinical + + 
+ + 
El68143 VP E168143 PHLS Unknown Clinical 
VP F3305 Clinical + + + + 
VP331 VP 02/331 Holes Bay En•ironmental (G) + 
DOM Atlantic + 
VP345 VOS/028 CEFAS Shellfish, UK En•ironmental (G) 
VP346 VP 021346 Dom Fota Farm En•ironmental (G) + 
VP349 VOS/029 CEFAS Holes Bay, UK En•ironmental (G) + + 
VP350 VOS/030 CEFAS Arne, UK En•ironmental (G) + + + 
VP361 VP 02/361 DOM Fota Farm En•ironmental (G) 
DOM Atlantic + + 
VP377 VP 02/377 Shellfish Environmental (G) 
VP378 VP02/378 DOM Fota Fann Environmental (G) + 
VP416 VP 01/416 Holes Bay Environmental (G) + + 
VP491 VOS/031 CEFAS Weymouth, UK Environmental (M) + 
VP939 VP 02/939 Coedcanlas spit Environmental (E) + 
VPIECI VOS/032 CEFAS Portland, UK Environmental (P) + + 
VPSCI VP 02/SCI Portland Area Environmental (S) 
(+) Very faint amplicon in PCR 
(I) Isolates obtained from the following institutions: 
Centre for Environment, Fisheries and Aquaculture Science (CEF AS) 
Health Protection Agency (HPA), formerly Public Health Laboratory Service, (PHLS) 
Kyoto University Medical School (KUMS) 
Norwegian School of Veterinary Science (NSVS) 
(2) PCR for V. parahaemo/yticus species specific toxR, and virulence tdh and trh genes (Table 3.2) 
Ure: Urease test. Data provided by S. Wagley, CEFAS Weymouth Laboratories. 
(3) Identity of isolate 6316 as V. parahaemolyticus uncertain: Chapters 6 and 7. 
Source of environmental isolates (where known) from following species: 
G: Crassostrea gig as (Pacific oyster), M: Pecten maximus (Great scallop), S: Maja squinado 
(Common spider crab), P: Cancer pagurus (edible crab}, E: Mytilus edu/is (blue mussel) 
Table 3.2: Sequences of previously described PCR primers for toxR, and putative 
V .parallaemolyticus virulence genes tdlr and tr/r 
Target gene PCR primers jS' to l') Reference 
F: GTCITCTGACGCAATCGITG Kim et al .. (1999) lo.TR R:ATACGAGTGGITGCTGTCATG 
F:CCACTACCACTCTCATATGC Tada et al., (1992) tdh R:GGTACTAAATGGCTGACATC 
F: GGCTCAAAATGGITAAGCG Tadaetal., (1992) I rh R:CATITCCGCTCTCATATGC 
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Table 3.3: Description of additional bacterial strains, DNA, and their genotypes, where known, that 
were used in this study 
Environmental/Clinical/ PCR (2) Ure 
StraioiD Institute !I! Location S2ecies I DNA Rererence strain toxR 
BL21 Amersham £.coli DNA LyophilisedControl DNA 
Cl a Amersham £.coli DNA LyophilisedControl DNA 
ST5 CEFAS Salmonella tyhimurium Environments] 
PM5 CEFAS Proteus mirabilis Environmental 
PAl CEFAS P. aeruginosa Environmental + 
KA5 CEFAS Klebsiella aerogenes Environmental 
LD365 CEFAS Lis/one/la damsela Environmental 
2046 CEFAS PHLS, UK V. vulnificus NCTC Reference 
11327 CEFAS PHLS, UK V. j/uvia/is NCTC Reference 
VOS/005 CEFAS PHLS, UK V. mimicus NCTC Reference 
VOS/006 CEFAS PHLS, UK V. lrollisae NCTC Reference 
VOS/007 CEFAS PHLS, UK V. algino/yticus NCTC Reference 
8042 CEFAS PHLS, UK V. clrolerae NCTC Reference 
CMI04 UoP V. anguil/arum Environmental 
VCI Southampton V. clrolerae Environmental 
VC2 Southampton V. c/rolerae Enviromnental 
VC3 Southampton V. cholerae Environmental 
VC4 Southampton V. cho/erae Environmental 
VC5 Southampton V. cho/erae Environmental 
Vib4(3) Southampton Unspeciated Environmental + 
2341 Kyoto, Japan V. alginolyricrrs Clinical 
VA430 River Exe V. alginolyticus Environmental 
VF430 V. jluvialis Environmental 
VM499 DOM Fota V. mimicus Environmental 
VCBADOI V. cholerae Environmental 
VVII067 CEFAS V. vulnificus Environmental 
KIDBBVV CEFAS V. vulnificus Environmental 
(I) Isolates obtained from the following institutions: 
Centre for Environment, Fisheries and Aquaculture Science (CEF AS) 
Health Protection Agency, formerly Public Health Laboratory Service, (PI-lLS) 
Kyoto University Medical School (KUMS) 
University of Plymouth Culture Collection (UoP) 
Amersham Biosciences: Lyophilised DNA 
tdlr trlr 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
(2) PCR for V. parahaemolyticus species specific toxR, and virulence tdh and trh genes (Table 3.2) 
Ure: Urease test. PCR data provided by S. Wagley, CEFAS Weymouth Laboratories. 
(3) Isolate Vib4, together with Vib I - Vib I 0 (Table 3 .I) originally obtained as a collection of 
unspeciated isolates. Whereas Vibl- Vib3 and Vib5 to VibiO were later confirmed to be V. 
parahaemolyticus, Vib4 remained unspeciated 
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3.3 Bacterial genomic DNA extraction 
3.3.1 CeU lysis and protein precipitation 
Genomic DNA was isolated from V parahaemolyticus and other bacterial species using 
the 'Puregene D-6000 DNA isolation Kit' according to the manufacturer's instructions for 
Gram-negative bacteria (Gentra Systems Inc., 'DNA Isolation Kit Instruction Manual', 
pages 54-57). A I Oml overnight culture of the organism was placed into a 15ml Falcon 
tube, centrifuged (1000 x g, 10min, 4°C) and the cell pellet resuspended in 3ml cell lysis 
solution with gentle pipetting. Samples were incubated at 80°C for 5 min to lyse cells. 
Rnase A solution (15!11) was then added to the cell lysate before incubating the samples at 
37°C for 1 hour. Following this, samples were cooled to room temperature (20°C) and 1 ml 
of protein precipitation solution added to the cell lysate and tubes vortexed vigorously at 
high speed for 20 seconds to mix the protein precipitation solution evenly with the cell 
lysate. The samples were kept on ice for 5 min before being centrifuged (2000 x g, 10 min, 
4oC). 
3.3.2 DNA precipitation and hydration 
The supematant containing the DNA was poured into a clean 15 ml centrifuge tube 
containing a volume of isopropanol (3 ml) and mixed by inverting the tubes several times 
to precipitate the DNA followed by centrifugation (2000 x g, 3 min, RT). The supematant 
was discarded and the tubes left to drain over clean absorbent paper. Ethanol (70%, 3 ml) 
was used to wash the pellet of DNA before re-centrifugation (2000 x g, lmin, RT). Again, 
the supematant was discarded, tubes drained and allowed to air dry for an hour. An 
appropriate volume (50 - I 00 111) of DNA hydration solution (containing TE buffer) was 
added, depending on the amount of DNA visible upon precipitation, to dissolve the DNA. 
Samples were centrifuged briefly, transferred to 1.5ml microfuge tubes and incubated for 1 
hour at 65° to rehydrate the DNA. Samples were mixed and briefly centrifuged again 
before storage at -20°C. 
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3.4 DNA quantification 
The quality and quantity of genomic DNA was established by agarose gel electrophoresis 
(Section 3.8). Images of each agarose gel were captured with a gel documentation system 
(UViTec, UK) and the DNA concentration was estimated for each isolate by comparison 
with a range of the following known amounts of 'A DNA standards: 0.552 11g, 0.276 11g, 
0.138 11g and 0.069 11g using UV photo software (UViTec, UK). Genomic DNA was also 
quantified with a UV spectrophotomer (NanoDrop 100). 
3.5 Primer design for PCR 
Unless stated otherwise, primers for PCR reactions were designed using the aid of DNAsis 
for Windows software (Hitachi) and Amplify based on a Mac platform (Engels, 1993). 
Primers consisting of24 bases were generated on the basis of a 50% G+C ratio and relative 
proximity to the desired target sequence. The presence of 2-3 guanine or cytosine bases at 
the 3' end of the primer, a lack of secondary structure and primer-dimer formation was 
assessed using AmplifY. Primers were synthesised by Sigma-Genosys. 
3.5.1 Other PCR primers 
Primers used for detection of V parahaemolyticus virulence genes, tdh, trh and toxR have 
been described previously, (Tada et al., 1992; Kim et al., 1999) (Table 3.2). Other primers 
used in the current work are described in detail in individual chapter and summarised in 
Table 3.4. 
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Table 3.4: PCR primers used in this study. Specific details are provided in each chapter. 
Target regions/ Designation Sequence (5' to 3') Reference 
Method 
ITS I VINTF TGGGGTGAAGTCGTAACAAGG Maeda et al., 2000 
VINTR TCCTTCATCGCCTCTGACTG Chapter 6 
ITS2 S2F CTAATTGCCCGTGAGGCTTA This st11dy, 
S2R GAGTCAGGTGGGTCCAAAAC Chapter 6 
IONA spacer TJA GGGGGTTCGAATTCCCGCCGGCCCCA Welsh& 
TJB AGGTCGCGGGTTCGAATCC McClelland, 199Ia; 
TSA AGTCCGGTGCTCTAACCAACTGAG 1992 
TSB AATGCTCTACCAACTGAACT Chapter 7 
RAPD PI GGTGCGGGAA 
P2 GTTTCGCTCC Amersham 
P3 GTAGACCCGT Biosciences 
PS AACGCGCAAC Chapter 8 
------
-- - - -
TTSSI VPI662F TCACCGCTGGTATTATCGTTACGC 
VPI662R GAGATACAACGCGCGTCTTACTCT 
VPI680F GCCGAAGCGTATCATCATCAACTC 
VPI680R CACAGAGCTTACACCAAACGTACC 
VPI696F ATTGCTTCGGTATTGAGCCGTGTG Makino et al., 2003 VPI696R AACTCTGACCACTGCCCAATGTGA This st11dy 
TTSS2 VPAI321F GGTTAGTGAATCCAACCAAACCGC 
Chapter 9 
VPAI321R TTGCCGTGCATGTCATACAACCAG 
VPAI339F GACACTCGCTGTTGTTCTCAGGTA 
VPAI339R GTAAGCGCGTGATGTTAGCTCTTC 
VPAI355F GGCATGTGGTGTCTATTTGACACG 
VPAI355R TACGACAACTGCAGGTAGTCCAAG 
3.6 Standard Polymerase Chain Reaction (PCR) 
All PCR reactions were prepared within a PCR cabinet and performed with either a MWG 
Primus 96 Plus (MWG Biotech) or a Perkin Elmer (TCI) thermal cycler and based on a 
standard reaction mixture as follows. Each reaction mixture contained 1 unit (U) of Taq 
polymerase (Roche), reaction buffer containing 1.5mM MgCb (Roche), 24 pmol of each 
primer, each deoxynucleoside triphosphate (dNTP) at a concentration of 0.2mM, between 
2 - l 0 ng of bacterial DNA and the reaction volume was made up to 25 J.ll or 50 fll using 
molecular biology grade water (Sigma). Negative controls were set up in exactly the same 
way except the addition of DNA template was replaced with an equivalent volume of 
water. Reactions that took place in the Perkin-Elmer thermal cycler were overlaid with 
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mineral oil, due to the absence of a heated lid. Various cycling conditions were used as 
described elsewhere. Specific details are provided in each individual chapter. 
3. 7 PCR product purification 
PCR products were purified using the 'High Pure PCR Product Purification Kit' (Roche 
Applied Science) according to the manufacturer's instructions. Details of the individual 
solutions included in this kit can be found in Appendix I. After the PCR reaction was 
complete the final volume of the reaction mixture was adjusted with TE buffer to I 00 J.d. 
This was transferred to a clean 1.5ml microcentrifuge tube containing 500 ~-tl Binding 
Buffer (containing guanidine thiocyanate) and mixed thoroughly. The mixture was 
centrifuged (13,000 x g, 60s, RT), on a column (containing the manufacturer's filter) and 
flow through solution removed. The column filter tube containing PCR DNA was washed 
firstly with 500 ~-tl of Wash Buffer by centrifugation (13,000 x g, 60 s, RT) and secondly 
with 200 ~-tl of Wash Buffer (13,000 x g, 60s, RT). The filter tube was reconnected to a 
fresh 1.5ml microcentrifuge tube and an appropriate volume (50 ~-tl - I 00 ~-tO of Elution 
Buffer added to the column before centrifugation (13,000 x g, 60s, RT) to elute the DNA. 
This DNA was quantified using the procedures in sections 3.4 and 3.8. 
3.8 Agarose Gel Electrophoresis 
Depending upon the application, agarose gel electrophoresis was performed using 0.8%- 2 
% agarose made with I x TBE buffer. Three sizes of agarose gel were used, 30 ml, 60 ml 
or 250 ml volume (equating to approximately 50 x 100 mm, 80 x 100 mm and 200 x 200 
mm agarose slabs). Agarose gels of 250 ml were electrophoresed at 90V for 6 h, while 60 
ml gels were run for 90 min at 120V. Gels of 30 ml were run at 75V for between 20 - 60 
min depending on the expected fragment sizes. A suitable volume of 6x gel loading 
solution (Bromophenol Blue I Glycerol, Appendix 1) was added to all san1ples before 
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loading the gels. The sample volumes and concentrations varied according to each analysis 
and are stated in the Material and Methods section of each chapter. The sizes of the DNA 
bands that were resolved on agarose gels were estimated by comparison with either 100 bp, 
I kb standards (0.3 J.tg) or f... ladders and these are detailed in Appendix I. Following 
electrophoresis, the DNA bands were stained by immersing the gel for 20 min in a solution 
containing 1 J.tg of ethidium bromide (EtBr) per m! of TE buffer followed by 10 min de-
stain in distilled water to remove any unbound EtBr. The stained bands were visualised 
with UV light (309 nm) using a trans-illuminator and gels were recorded as digital TIFF 
images using a gel documentation system (UVI-Tech) 
3.9 Restriction enzyme digests of genomic DNA 
Various restriction enzymes purchased from Roche Applied Science were used for several 
applications. Usually, between 0.2 - 2.0 J,tg DNA was incubated with 10-20 units of 
enzyme, using the buffer supplied by the manufacturer. Digests were incubated for various 
periods up to overnight, at 37°C or 50°C, depending on the enzyme to ensure appropriate 
digestion. 
3.10 Analysis of banding profiles 
Banding patterns were analysed with the aid of BioNumerics (Applied Maths, Ghent, 
Belgium). Generally, the bands from each lane were subjected to curve calculations and 
analysis to exclude background noise from PCR reactions. The tracks were then 
normalised using two external reference positions that consisted of 1 OObp molecular 
weight markers on either side of the gel, and an internal reference; a common band that 
appeared in several lanes, as identified by visual inspection. Dendrograms calculated by 
the unweighted pair group method by arithmetic averaging (UPGMA) algorithm using a 
Pearson product-moment correlation coefficient or Dice coefficient, as appropriate to 
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1obtain the ·most reliable •Clustering patterns~ BioNumerics. po"sition_ toleran9e, s~t}in~s; 
generally. Wet(;! (h)%, optimisation,, ar position ·tolerance of 5% of get. andi i~oring· faint 
bands. Clusters ·were rdetermined ibased on visual inspection of deild!'ogr@i• ahalysi!), 
Spedfic detail~ .a:re giv.en in ~acil chapter. 
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Chapter 4 
BIOCHEMICAL, GROWTH AND SEROLOGICAL 
VARIATION AMONGST VIBRIOPARAHAEMOLYTICUS 
4.1 Introduction 
Bacteria have traditionally been characterised using various phenotypic procedures that 
include biochemical properties, antimicrobial sensitivity tests, growth characteristics on 
selective media, and motility. Biochemical profiling (or biotyping) has widely been used to 
identify V parahaemolyticus at the species level. In particular, API 20E is a standardised 
system, used for identifying members of the Vibrionaeceae. Up to 21 differential 
characteristics have been described which show considerable variation amongst Vibrio 
spp., and in many cases resistance to antibiotics and di-isopropyl pteridine phosphate 
(0/129) has been used to identify V parahaemolyticus from other members of this genus 
(Baumann, & Schubert, 1984; Elliot et al., 1995). 
Using the API 20E system Martinez-Utarza and colleagues (2006) showed that clinical 
isolates of V parahaemolyticus were correctly identified using a 0.85% NaCl diluent as 
specified by the manufacturer. However, environmental isolates were more correctly 
identified with a 2% NaCl diluent than the standard concentration. Clinical isolates grown 
on a 2% NaCl diluent showed non-specific profiles. Furthermore, differences in citrate 
(CIT), amygdalin (AMY), gelatine (GEL) and arabinose (ARA) utilisation between the 
two groups of strains suggest wide biochemical diversity amongst V. parahaemolyticus. 
Environmental isolates grown in vitro have been shown to exhibit characteristics different 
from clinical and established laboratory strains, that include less growth, induction of a 
viable but non-culturable (VBNC) state in certain conditions and excessive polysaccharide 
production. There have been few published reports into the study of growth characteristics 
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amongst clinical and environmental isolates. Considering that clinical and environmental 
isolates show enhanced biochemical fitness at different salinities of 0.85% and 2% 
respectively, little comparison has been made of these two heterogenic groups of isolates. 
To assess phenotypic traits amongst members of clinical and environmental isolates of V 
parahaemolyticus, standard identification tests including Gram staining and oxidase tests 
were performed throughout the course of study. Of these, test results for cytochrome 
oxidase have been shown to vary amongst V parahaemolyticus (Twedt et al., 1969) and 
the absolute requirement for Na + prompted some NaCl limiting growth tests. Early work 
also suggested a loss of viability of some cells stored in glycerol and hence viability of 
storage at -20°C was periodically monitored. These simple tests allowed monitoring of 
purity, viability, and growth characteristics on the most popular media used to cultivate V 
parahaemolyticus. Growth was also assessed on Wagatsurna agar (WA), used principally 
to detect haemolysis attributed to TDH production. Finally, serotype variation amongst 
clinical and environmental isolates was investigated in collaboration with CEF AS 
Laboratories, Weymouth, UK. 
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4.2 Materials and Methods 
4.2.1 Biochemical tests 
Bacteria used in this study were Gram-stained according to standard procedures. The 
oxidase test was performed with oxidase strips (Fiuka). Reference strains were used as 
appropriate. A full set of API 20E biochemical characterisation was performed in 
association with colleagues at CEFAS, Weymouth, UK. 
4.2.2 Growth and survival characteristics 
Growth of V parahaemolyticus was assessed using several solid and broth media including 
Marine Broth (Difco Laboratories), tryptic soy broth (TSB), Wagatsuma agar (WA) and 
thiosulphate citrate bile salts (TCBS) agar (Oxoid). Colony morphology was examined and 
recorded and growth tests carried out. Briefly, growth of 20 clinical and 20 environmental 
isolates was monitored in broth at 0.5% and 3.0% NaCI. A 0.5% NaCI is the standard 
concentration of NaCI in TSB (Oxoid) whereas a 3% NaCI is widely employed for the 
routine culturing of V parahaemolyticus. A 50 1-11 volume of an overnight culture grown in 
TSB (3% NaCI) was used to inoculate 20 ml of fresh TSB (3% NaCI) in a shaking water 
bath (30°C) and growth rates were determined by monitoring absorbance at 600nm. The 
average growth rates of clinical and environmental isolates were determined and means 
tested for statistical significance with a two sample /-test (NCSS software). 
Assessment of viability from cold storage was made by inoculating 50!-11 of 50% glycerol 
stock stored at -20°C into I Oml of TSB (3% NaCI), after I, 2 and 3 month intervals since 
initial preparation of stock culture. Cultures were grown overnight and 201-11 directly streak 
plated onto TCBS. Viability was monitored during the first three months of setting up 
glycerol stocks. 
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4.2.3 Thermostable Direct Haemolysin (TDH) phenotype- 'Kanagawa test' 
Wagatsuma agar (W A) was prepared using fresh rabbit blood in heparin using the methods 
described in the FDA guidelines (Appendix 1). Briefly, fresh (within 24 h of drawing) 
rabbit blood was mixed with equal volume of physiological saline and centrifuged at 4000 
x gat 4°C for 15 min. Supernatant was removed and the blood cells washed a further two 
times. After the third wash, supernatant was poured off and cells resuspended to original 
volume with fresh saline. Blood was used at 5% v/v with remaining agar mixture that had 
been steam sterilised and cooled to 50°C before use. Dried (30°C, 30 min) Wagatsuma 
agar plates were streak or spot plated using 5, 10 and 20 ~-tl of overnight grown cultures of 
V. parahaemolyticus. To determine whether haemolysis was solely a result of bacterial 
growth on W A or heat stable haemolysin present in broth, the supernatant of the overnight 
grown cultures was heated to l00°C for 10 m in and spot plated in 5, 10 and 20 ~-tl W A 
overnight at 37°C. 
4.2.4 Determination of haemolytic activity levels 
Quantifying relative amounts of haemolytic activity between several strains was attempted 
using a modification to a method by Yoh et at, ( 1986). This method was used to potentially 
assess the uncertain P-haemolytic phenotypes on Wagatsuma agar. Briefly, one ml 
supernatant volumes of overnight cultures of test bacteria containing crude TDH were 
heated to l00°C for 10 min. A 50~-tl volume of each of the supernatants were transferred 
separately to a round bottomed microtitre plate followed by the addition of 50 ~-tl PBS 
containing 20 mM CaCh and rabbit erythrocytes at a final concentration of2% v/v. After 3 
hours at 37°C the assay was performed using a microtitre plate reader (Optimax Tunable) 
set to As4o using no-lysis and full lysis as relative controls. 
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4.2.5 K and 0 antigenic variants (Serotyping) 
V parahaemolyticus was serotyped for somatic (0) and capsular (K) antigens using a 
commercially available serotyping kit from Denka, Seiken Corp, Japan. using a polyvalent 
and monovalent anti-sera combination according to the scheme outlined in Table 4.1 and 
4.2. This work was carried out in collaboration with colleagues at CEFAS Weymouth 
laboratory. 
The K serotype was determined from the polyvalent antiserum I to IX (Table 4. 1) using 
some modifications from the manufacturer's guidelines. Test bacteria were grown 
overnight on TSA supplemented with 3% NaCI and fresh colonies were densely suspended 
in 500 Jll 3% saline. A double-welled slide, each well containing 20 Jll of the polyvalent 
serum was used; to one well 20 Jll of test bacteria was added and the other PBS (negative 
control). The mixture was stirred with the pipette tip and the slide tilted around to facilitate 
agglutination which was seen as the formation of a cloudy, granular precipitate. Only 
strong agglutination that occurred within one minute was considered a positive reaction. 
Once a polyvalent antiserum had been ascertained, the procedure was repeated with 
monovalent sera until a positive agglutination was achieved. Where no agglutinations took 
place, a new type of K antigen was presumed and was indicated by K -untypable or KUT. 
Overnight cultured test bacteria as described above were suspended in 3% saline at an 
approximate concentration of 10 mg/ml. Glycerine at 5% w/v was used in the mixture to 
prevent spontaneous agglutination of V parahaemolyticus. Cells were heat-lysed by 
autoclaving at 121 oc for 15 minutes and centrifuged for 10 mins. The supernatant was 
discarded and the sediment used for the agglutination test. When the K type had previously 
been identified, the antigenic scheme in Table 4.2 was used to test for serotype. If the 0 
antigen corresponding to the K type as shown in Table 4.2 did not agglutinate, the 
remaining 0 serum was tested. 
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Table 4.1: Polyvalent and monovalent antisera containing agglutinins 
specific to K type. Each polyvalent antisera contained a mixture of 7 
agglutinins. A positive agglutination in the polyvalent sera served to narrow 
down and test for the monovalent K antigen (Denka Seiken Corp.) 
Pol~valent K antiserum K agglutinins (lresent 
3 4 5 6 7 8 
11 9 10 11 12 13 15 17 
Ill 18 19 20 21 22 23 24 
IV 25 26 28 29 30 31 32 
V 33 34 36 37 38 39 40 
VI 41 42 42 44 45 46 47 
VII 48 49 50 51 52 53 54 
VIII 55 56 57 58 59 60 61 
IX 63 64 65 66 67 68 69 
70 71 
Table 4.2: Antigenic scheme of V. parallaemolyticus 0 groups and K serotypes. K types that have 
been shown to correspond to 0 antigens to facilitate serotyping (Denka Seiken Corp.) 
0-antigen Grou(l K ~(le 1 
25 26 32 38 41 56 58 64 69 
2 J 28 
3 4 5 6 7 29 30 31 33 37 43 45 48 54 57 58 59 65 
4 4 8 9 10 11 12 13 34 42 49 53 55 63 67 68 
15 17 30 47 60 61 68 
6 18 46 
7 19 52 
8 20 21 22 39 70 
9 23 44 
10 19 24 52 66 71 
11 36 40 50 51 61 
1 Note: The antigenic scheme by Denka Seiken is different to the first established by Sakazaki et al., ( 1963) 
and later revised versions (Hugh & Feeley, 1972; Kaysner & DePaola, 2004) 
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4.3 Results 
4.3.1 Biochemical tests 
Results obtained from 63 isolates of V parahaemolyticus and various reference strains 
show Gram negative and cytochrome oxidase positive strains although 4 isolates (VPS, 
VP349, VP377 and VP378) showed weak blue/purple colouration of oxidase test strips 
even after repeat testing. Whilst all V alginolyticus and V cholerae isolates were positive 
for acid production upon sucrose utilisation as identified on TCBS agar, all V 
parahaemolyticus isolates were negative (section 4.3.4). Isolates were confirmed as V 
parahaemolyticus by colleagues in CEF AS based on API galleries (BioMerieux) and if 
they met the following criteria: positive for oxidase, negative for Voges Proskauer and 
Ortho-nitrophenyi-~-D-galactopyranoside (ONPG). 
4.3.2 Growth rates of V. para haemolytic us by reduction of Na + 
Doubling times generated from growth curves of a selection of clinical and environmental 
isolates are summarised in Figure 4.1. The average doubling time (n = 20, including two 
references strains) for clinical isolates at a NaCI concentration of 3.0% and 0.5% were 21.1 
min and 27.2 min, respectively representing a 29% increase in doubling time at the lower 
NaCI concentration. The average doubling time for environmental isolates at the same 
NaCl concentrations were 22.2 min and 31.1 min respectively, the latter this time 
representing a 40% increase in doubling time upon decreasing NaCI concentration (Fig. 
4.1 ). A comparison between clinical and environmental isolates showed that at a lower Na+ 
level, environmental isolates showed more variability in growth times with less growth, as 
represented by a mean doubling time significantly higher (p < 0.00 I) than that of clinical 
isolates (Fig. 4.1) in t-test analysis (Appendix II). 
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Doubling times (min) 
Clinical Environmental 
NaCI (0.5%): 27.25 ± 0.62 3 1.1 ± 1.14 
NaCI (3 .0%): 2 1.10 ± 0.7 1 22.2± 0.81 
40.0 E 
c 
--.. 
E 
c 
E 30.0 c - -._.. 
Cl) 
Q) 
E 
+=i 
0> 
c 
·-
..c 20.0 :::J 
0 
0 
10.0 
0.5 3.0 
NaCI (%) 
Figure 4.1: Growth rate phenotypes of clinical (C) and environmental (E) isolates of 
V. parallaemolyticus at 0.5 and 3.0% NaCI. The average times and error values are 
indicated above. Each box-and-whisker plot summarises 20 isolates grown at 30°C. 
Maximum and minimum doubling times outside of the inter-quartile range are indicated by 
error bars. Average growth rates of clinical isolates were significantly higher (p < 0.001 in 
!-test) than the selected environmental isolates at 0.5 % NaCl (NCSS software). 
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4.3.3 Culturability of V. parahaemolyticus isolates from -20°C 
Viability of 50% glycerol stock cultures was monitored for a total of 59 isolates and this 
showed 28 (47%) of V. parahaemolyticus cultures were not culturable after a month of 
storage at -20°C. After another month, a further 10 (17%) isolates could not be cultured 
using the overnight method adopted, followed by another 5 (8%) on the third month. Out 
of 59 cultures, 73% of the cultures were not culturable by the third month. This included 
18 clinical and 25 environmental isolates representing 100% of total clinical and 61% of 
total environmental isolates respectively (Table 4.3). 
4.3.4 General growth characteristics on selective and non-selective media 
Isolates of V. parahaemolyticus and related organisms (section 3.2.3) were grown on four 
bacteriological media and growth levels scored and recorded (Appendix II). Most 
organisms grew on all media at varying intensities over a period of 18 h at 37°C. V. 
parahaemolyticus grew well on both MSA and 3% NaCl TSA with more pronounced 
growth and larger sized colonies on MSA. Colonies appeared circular on TSA whereas 
growth on MSA was less raised and generally opaque, although this varied amongst 
members of the genus. V. cholerae colonies were generally more translucent on MSA and 
TSA. Growth on a more selective media, TCBS, usually used for isolation and 
confirmation purposes, generally showed less growth than MSA or TSA, yet distinct 
colonies of various green intensities were observed (Fig. 4.2). Unusually, amongst the V. 
parahaemolyticus cultures one clinical isolate, 6316, grew remarkably small colonies on 
all four types of media tested. V. cholerae isolates showed distinct yellow colonies upon 
acid production with sucrose fermentation as did V. alginolyticus isolates used in the study. 
The production of acid alters the pH and is indicated by the dyes bromothymol blue and 
thymol blue. The colour reverted to green within a few days. 
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Table 4.3: Serotypes and selected phenotypes of V. paralraemolytlcus isolates. 
Phenotypes Genotypes' 
Serotype' Culturability' 
Environmental/Clinical/ From -2o•c Beta- Urease tdh+ trh+ 
Isolate Reference strain haemollsls' 
1902 NCIMB Reference OI:KI + 
VPI0884 NCTC Reference 03:K4 +++ + 
VPI0885 NCTC Reference 02: K3 ND ND ND 
219 Clinical 06:KUT 0 
OJ:K6 ++ + 220 Clinical 
221 Clinical Oi:KUT 0 + 
(+) 
222 Clinical 03:K6 0 ++ + 
223 Clinical 03:K6 2 
++ + + 
Clinical 04:K9 0 + + + (+) 224 
225 Clinical 03:KUT 0 +++ + 
03:KUT 0 ++ + 226 Clinical 
227 Clinical 05:K68 +++ + 
228 Clinical OII:KUT + (+) 
1022/4 Environmental 03:K37 2 
I 024/5 Environmental OJ:KUT 0 + 
I 02115 Environmental 02:KUT 0 
1022110 Environmental Oii:KUT + 
102311 Environmenlal OI:K32 0 + 
102312 Environmental ND 0 ND 
1023/3 Environmental ND + 
1103/9 Environmental OI:KI + 
2053 Clinical 03:K6 0 + + 
2436 Clinical 06:KI8 0 ++ + + + 
Clinical 03:K6 0 + 5421 
6134 Clinical 04:KI2 +++ + 
6316 Clinical 03:K6 ++ + 
Vib I Environmental OI:K32 0 
Vib2 Environmental OI:K32 0 + 
Vib3 Environmental Oi:K32 2 + 
Vib4 Environmental OI:K32 3 
Vib 5 Environmental OI:K32 0 + 
Vib6 Environmental ND 3 + 
Vib 7 Environmental ND 3 + 
Vib8 Environmental ND 3 
Vib9 Environmental ND 3 + 
Vib 10 Environmental ND 3 + + 
VPI Environmental OI:K33 0 + 
ND 0 + VP2 Environmental 
ND 0 + + VP3 Environmental 
VP4 Environmental OI:K33 3 
VP 5 Environmental Oi:K33 3 ND 
VP6 Environmental 02:K28 3 + 
VP7 Environmental ND 0 + + + 
ND 0 + + + VP8 Environmental 
VP9 Environmental ND 3 + 
+ + 
ND + + + VPIO Environmental 
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Table 4.3: cont. 
Phenotypes Genotypes 
Serotype' Culturability1 
Environmental/Clinical/ From -20°C Beta- Urease tdh+ /rh+ 
Isolate Reference strain haemoll:sis3 
OI:KI 2 + + E154482 Clinical 
El55855 Clinical 03:K6 0 +++ + 
El68143 Clinical 03:K6 0 + + 
VP F3305 Clinical OI:K69 ND ND + + + 
VP331 Environmental ND 3 
ND 3 + + VP345 Environmental 
VP346 Environmental OI:KUT 
VP349 Environmental ND 2 + + 
VP350 Environmental ND 0 + + 
Environmental OI:KUT 0 + VP361 
VP377 Environmental 04:KUT 3 + 
VP378 Environmental 06:Kl8 3 
VP416 Environmental 04:KUT 0 +++ + 
VP491 Environmental ND 0 + 
VP939 Environmental 08:KUT 0 + 
VPECI Environmental ND 3 + 
VPSCI Environmental 08:KUT 3 
NO: Not detennined 
1 Serotyping perfonned in collaboration with colleagues at CEF AS. 
KUT: Untypeable K antigen 
2 Culturability scores are: 
0 and I for non-viability and viability on the first month. 
2 indicates viability in the second month respectively. Viability on month 3 is recorded as 3 
3 Levels of P-haemolysis was monitored at I 8 hours and scored as,+++ High,++ Medium, 
+Low/uncertain,- No visible haemolysis. P-haemolysis is resultant phenotype of gene tdh expression. 
4 Potentially virulent genes: tdh and trh encoding for thermostable direct haemolysin and related haemolysin 
respectively. 
( +) Weak amplification bands 
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A 
Figure 4.1: Representative growth of V. ptut~hllemo/ydcus clinical oolate 1436 (plate A) and 
environmental isolate VP4 (plate B) on TCBS agar after 18 hours at 37°C. There were no obvious 
growth characteristics differentiating isolates of V. parahaemolyticus on TCBS agar. 
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c 
Figure 4.3: Esopolysaccbaride production amongst two environmental isolates or V. partlhaemolyticus, 
VPECl (A), VPSCI (B) and swarming phenotype or V. a/glnolyticus, V A430 (C). Isolates were grown on 
Wagatsuma agar for 18 hours at 37°C. 
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Growth on Wagatsuma agar (WA), principally used to test for Kanagawa haemolysin 
TDH, showed much variation as well as an unusual amount of exopolysaccharide 
production for two environmental isolates, VPSC I and VP EC I, (Fig. 4.3). Of significance 
is that six isolates showed poor growth including NClMB type strain 1902, clinical strain 
6316, and four environmental isolates 1022/4, Vib4, VP350 and VP361. With the 
exception of these isolates, there appeared no obvious or distinct growth characteristics on 
selective or non-selective media. 
4.3.5 Beta-haemolysis and clinical phenotypes 
Varying degrees of haemolysis were demonstrated by isolates of V. parahaemolylicus and 
related species as indicated on Table 4.3 and in Fig. 4.4. In many cases, it was not possible 
to ascertain whether haemolysis had actually occurred as the zone around the colony was 
not characteristic of a clear P-haemolysis phenotype. Of the distinct haemolytic phenotype, 
all of the isolates except clinical strain 6316 were positive for tdh. In some cases of P-
haemolysis, there appeared a secondary zone of haemolysis (Fig. 4.5) but without a green 
pigmentation (characteristic of a-haemolysis). This secondary zone appeared similar to the 
zone induced by heat treated ECPs (Fig. 4.6) and was only present in isolates that appeared 
to be the most haemolytic (Table 4.3). 
Out of 27 tdh positive V. parahaemolyticus isolates, 12 (44%) showed distinct P-
haemolysis, I 0 (37%) isolates showed some signs of haemolysis, but remained 
unconfirmed, and a further five (19%) isolates did not exhibit any visible haemolytic 
activity (Table 4.3). Of these five strains, one was from a clinical isolate (5421) and four 
(Vib7, Vib9, VP350 and VPECl) were environmental. The use of a spectrophotometer to 
assay haemolytic levels for uncertain P-haemolytic phenotypes proved to be inconclusive 
with the method described (Fig. 4.7). 
71 
Figure 4.4: Variation in P-haemolytit levels of rabbit erythrocytes on Wagatsuma agar after 18 boun 
at 37°C. Kanagawa positive strains are isolates of V. parahaemo/yticus that express haemolysin TDH and 
exhibit various degrees ofp-haemolysis (plates B-D, scored+, ++,+++ respectively) from the control plate 
A(-). Plate E shows clinical tdh+ isolate with an uncertain haemolytic phenotype. 
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A 
Primary zone: 
!}-haemolysis (Jmm) --+--
Secondary zone: 
incomplete haemolysis 
(7mm) 
8 
Figure 4.5: Zones of haemolysis in cllnkal and environmental isolates of Jl. parahaemo/ytlcus. A 
primary zone off}-haemolysis is followed by a larger zone of secondary incomplete (alpha) haemolysis 
in NCTC clinical reference strain VP I 0884 (A). Inoculum spot volumes of 5, I 0 and 25~tl of overnight 
TSB cultures of V. parahaemolyticus supplemented with 3% NaCI. Image B shows (}-haemolysis 
attributed to an environmental strain, VP416, isolated from Crassostrea gigas in comparison with a non-
haemolytic environmental isolate. 
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Figure 4.6: Zones of partial haemolysis attribated to TDH from thermostable ECP. Supematant of 
overnight V. parahaemo/yticus ,(isolate 6134) culture was heat-treated and spot inoculated with 5 (Q4), 
10 (Q3) and 20 ~I (Q2). Arrows indicate diameter of partially haemolysed zone. First quadrant (Ql), 
shows growth and both primary and secondary zones of haemolysis from unheated supematant. 
Haemolysin 
+ 50% 25% 15% 5% 0% 
Isolate 
6134 
VP10884 
VP2 
PBS 
Figure 4.7: Haemolytic activity of V. parahaemolyticMs. Lane 1, Control (equal volume H20 and RBC; 
Lanes 2-5; decreasing concentration ofhaemolysin (heat treated ECP); Lane 6, negative control (PBS & 
RBC). Varying haemolysin concentration had no apparent significant haemolytic effect on rabbit 
erythrocytes at 3 hours. 
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In addition to V. parahaemolyticus, there were three isolates of different species: V. 
cholerae (V CS), V. alginolyticus (V A430) and V. mimicus (VM499) that possessed gene 
tdh but exhibited no haemolysis (data not shown). Data available on the presence of the trh 
gene (Table 4.3) showed no association with haemolytic activity on Wagatsuma agar. 
Based on the current data, there did not appear to be a link between urease activity and the 
presence of the trh gene in V. parahaemolyticus, as both urease positive and negative 
isolates were present with and without the gene trh (Table 4.3). 
4.3.6 Variation in 0 and K serotypes amongst V. parallaemolyticus 
Of the 44 isolates of V. parahaemolyticus serotyped, a total of 20 different O:K serotypes 
were found amongst the 19 clinical, 22 environmental and three reference strains studied 
(Table 4.3). Amongst these isolates, six had previously been characterised as 03:K6 and 
were effectively used as controls and included three Norwegian and three Japanese 
isolates. In total, there were eight different 0-types, 13 different K-types and 22 of the 
environmental isolates were K untypeable (KUT). Serotype 01 appeared the most common 
(36%) amongst all the isolates tested and was found mainly amongst the environmental 
group. Similarly, serotype 03 was the most common 0-antigen in the clinical group (Table 
4.3). Other than these two serotypes, and a larger proportion of environmental untypeable 
K types, there were no apparent association of 0- or K- serotypes with clinical or 
environmental isolates. Of significance, was the identification of two UK clinical isolates 
(E155855 & E168143) that were of the same 03:K6 serotype associated with the pandemic 
genotypes. 
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4.4 Discussion 
Table 4.4: Distribution of 0-antigens in Isolates of V. parallaemolyticus. 
Reference strains not included in the table. A total of eight out of 13 0-types were 
identified. 
0- Serogroup 
01 
02 
03 
04 
05 
06 
08 
011 
Clinical 
3 
0 
10 
2 
I 
2 
0 
I 
No of isolates 
Environmental 
12 
2 
2 
2 
0 
I 
2 
I 
4.4.1 General growth and biochemical properties 
Several methods were used to study the biochemical and physical growth properties of V 
parahaemolyticus with the aim of assessing any differences between clinical and 
environmental isolates. Despite the relatively small number of isolates that were available, 
the strains used in the study show variation in physical growth, haemolytic and serological 
properties. Initial confirmatory biochemical test results were consistent with the typical 
characteristics of V parahaemolyticus (Gram negative, oxidase positive and motile). 
Isolates received were routinely tested for purity and assessed using these methods. 
Growth on several media routinely used in the isolation and characterisation of V 
parahaemolyticus were adequate for the purposes used, although some strains (e.g., 6316 
and 6134) did not grow well and others (e.g., VPECl and VPSCl) showed atypical growth 
on selected media. However, these characteristics were present in only a limited number of 
isolates. Based on these growth observations, there were no obvious differences between 
clinical and environmental isolates that would allow differentiation. 
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4.4.2 Growth of V. parahaemolyticus in reduced salinities 
Salt tolerance has been used by several workers to differentiate Vibrio spp. (Beuchat, 1973; 
Palasuntheram, 1981) and to assess properties within V parahaemolyticus (Twedt et al., 
1969). To the author's knowledge, there did not appear any published studies that 
compared growth rates between clinical and environmental isolates of V 
parahaemolyticus. As isolates were cultured throughout the course of this present study 
with 3% NaCl, it was of interest to assess if a reduction in NaCl would affect growth of 
clinical and environmental isolates. On the basis of this present limited study, it was shown 
that environmental isolates grew at more variable growth rates at both 0.5 and 3.0% NaCl 
than clinical isolates. However, at the reduced Na+ level, a significantly larger proportion 
of environmental isolates grew slower than clinical isolates and may indicate 
environmental isolates are less suited for growth at reduced salinities. It would thus appear 
that clinical and environmental isolates of V parahaemolyticus do not differentially exploit 
excess Na + (e.g. 3% NaCl) for growth when it is freely available. For the purposes of 
experiments that involved culturing of V parahaemolyticus isolates (e.g. tests for 
Kanagawa haemolysin), it would seem culturing at the higher NaCl concentration is more 
appropriate as this did not favour the growth of clinical or environmental isolates. 
Recent work by Martinez-Urtaza and colleagues described how clinical and environmental 
isolates were better identified according to the API 20E profile using two different NaCl 
concentrations (Martinez-Urtaza et al., 2006). In addition to environmental and clinical 
isolates showing significant differences in biochemical tests, clinical isolates were 
correctly identified according to the API 20E profile using 0.85% NaCl diluent, but they 
presented nonspecific profiles with 2% NaCl diluent. In contrast, the use of a 2% NaCl 
diluent facilitated correct identification of the environmental isolates. The findings from 
the present study supports the work by Martinez-Urtaza and colleagues by providing 
evidence of better growth of clinical isolates at a lower NaCl concentration and thus a 
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possible explanation of more accurate API 20E profiles. Further analysis of growth rates at 
different NaCI concentrations would be necessary to validate these findings. 
4.4.3 Culturability of cells from cold storage at -20°C 
Cold temperatures have been known to induce a viable but non-culturable VBNC state in 
V. parahaemolyticus and several other species (Baffone et al., 2003). Stock glycerol 
cultures were prepared using a standard method (Sambrook et al., 1989) and cells 
monitored for survival over three months. Of some significance is that within the first 
month, 50% of clinical and 41% of clinical strains became non-culturable. A somewhat 
similar finding was made by Jiang and Chai ( 1996) who showed that an environmental, 
Kanagawa negative strain took longer to achieve non-culturability than a Kanagawa 
positive one. Upon observing decline of culturable cells, it was decided to keep some 
remaining samples of stock culture at -20°C and monitored for culturability or viability to 
assess any difference amongst the V. parahaemolyticus strains. Although tests specifically 
for the VBNC state of cells were not carried out here, work by Johnston and Brown (2002) 
showed V. parahaemolyticus was not inactivated at -20°C and therefore it is speculated 
that the V. parahaemolyticus strains may have entered a VBNC state. Others have shown 
various degrees of resuscitation of VBNC cells by treatment with catalase or sodium 
pyruvate (Mizunoe et al., 2000) and that resuscitation was dependent on the age of the 
culture and strain dependent (Wong & Wang, 2004) although this approach was not taken 
here. 
4.4.4 Beta-haemolysis attributed to thermostable direct haemolysin (TDH) 
Haemolysis on Wagatsuma agar (WA) was demonstrated by various strains of V. 
parahaemolyticus. This ~-haemolysis phenotype of TDH is widely described as a marker 
for virulent strains of V. parahaemolyticus although haemolysis levels varied considerably 
amongst tdh gene positive strains tested. Of immediate interest is an environmental isolate, 
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VP416, recovered from oyster (C. gigas), off the Dorset coast which demonstrated 
remarkably strong ~-haemolytic activity (Fig 3.3), appearing more haemolytic than 
clinically acquired isolates expressing the haemolysin TDH. As clinical isolates must 
originate from environmental samples, it questions whether V parahaemolylicus TDH is 
expressed in C. gigas. To date, there appears little information on oyster physiology and 
immune status upon levels of potentially pathogenic V parahaemolyticus. 
Of the clinical isolates used in the study, approximately 55% exhibited ~-haemolysis; a 
significantly larger proportion than that previously described amongst clinical isolates 
(Kelly & Stroh 1989). However, four tdh+ clinical strains (PCR data: Table 3.I) showed 
an uncertain ~-haemolytic phenotype and such findings have also been described by others 
(Nair et al., I985). Therefore, in an attempt to quantify levels of haemolysis, three strains 
that gave distinct phenotypes (Fig. 4.4) were assessed to see whether it was possible to 
assay for haemolytic activity using a simple spot plating and microtitre assay method. 
Previous reports have shown that TDH is able to retain 70% of its haemolytic properties 
after treatment at I 00°C for I 0 m in (Nishibuchi & Kaper, 1995) and thus it was thought it 
may be possible to obtain relative haemolysis levels that may be used to characterise those 
isolates that visually showed uncertain haemolytics levels. However, both the spot plating 
method and the microtitre method were unable to generate discernable figures of 
haemolytic levels. It would appear that without concentrating TDH, a significant 
haemolytic reaction would not be able to be determined with a microtitre assay. Spot 
plating a higher volume of ECP containing TDH on Wagatsuma agar did not show any 
significant haemolysis either. ELISA methods have been used to quantify TDH levels 
(Honda et al., I985; Yoh et al., 1995) but the difficulties and costs associated in obtaining 
purified TDH products mean it is not a feasbilbe option at present for rapid quantification 
ofTDH amongst isolates. 
79 
The large variation m TDH expressed amongst tdh+ isolates (Kelly & Stroh 1989; 
Nishibuchi & Kaper, 1990) adds to the uncertainty of the significance of finding tdh+ in 
environmental isolates. For example, several clinical isolates did not exhibit clear 
haemolysis, one being distinctly negative (5421 ), and a further two isolates that were 
haemolytic, showed poor growth on W A. Additionally, false positive haemolytic reactions 
can occur due to pH changes around the colonies, fragility of erythrocytes or haemolysins 
other than TDH (Nair et al., 1985). Such inconsistencies in the use of W A suggest it may 
not be a reliable method for screening environmental isolates of V parahaemolyticus for 
TDH. Despite the present findings, some workers have employed the Kanagawa test for 
confirmatory purposes. Cabrera-Garcia et al., (2004) identified four tdh+ isolates amongst 
46 environmental samples of V parahaemolyticus and all four isolates were shown to be 
Kanagawa positive. However, Kanagawa tests are not routinely performed and the use of 
W A may be hindered by the availability of fresh human or rabbit blood as recommended in 
the FDA guidelines (Kaysner & Depaola, 2004). 
In order to study actual expression of tdh genes, the use of reverse transcriptase RT-PCR 
can address the issue of estimating TDH production by monitoring mRNA levels. 
However, putative virulence genes tdh and trh have been reported not to be expressed as 
well as housekeeping genes under certain conditions (Coutard et al., 2005; 2007). Others 
have used a transcription-reverse transcription concerted (TRC) method to quantify tdh and 
trh mRNA transcripts (Masuda et al., 2004; Nakaguchi et al., 2004), but it appears few 
workers who employ tdh and trh gene detection protocols in V parahaemolyticus actually 
studied the expression of these genes. Future developments on these methods and gene 
expression studies are necessary, and may provide more reliable indications as to whether 
the tdh or trh genes in environmental isolates are active and the degrees to which they are 
expressed. 
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4.4.5 Urease production and TDH-related haemolysin (TRH) 
The correlation of urease production with pathogenic isolates and more importantly lrh+ 
has been reported in several studies (Suthienkul et al., 1995; Okuda et al., 1997b; Iida et 
al., 1997). Data obtained from previous studies on the strains tested show only five strains 
that are trh+ and urease positive. The trh primers used were based on consensus regions of 
I rh I and trh2 and are therefore reliable indicators of /rh (Tada et al., 1992). A further eight 
strains, seven of which were environmental, were shown to be positive for trh yet did not 
show urease activity. Similarly, three isolates that expressed the urease phenotype lacked 
the trh genes. Consequently, there is insufficient evidence in this study to support 
published data that urease production is a reliable indicator for pathogenic strains. 
4.4.6 Serotyping 
Serotyping is important in distinguishing the small number of strains that actually cause 
disease in a large number of species including E. coli, V cholerae and Salmonella (reviews 
by Stenutz, et al., 2006; Nair, 1996; Kingsley & Baumler, 2000). The finding of a 
heterogeneous population of 0 and K antigens whilst serotyping V parahaemolyticus 
demonstrates the wide diversity of isolates present in the study. A large number of isolates 
that were not K-typeable (KUT) accounted equally for approximately a fifth of the clinical 
and environmental isolates. The total number of different serovars ( 13 and 16 in clinical 
and environmental isolates respectively) have only two common serotypes 01 :K1 and 
06:K18, and other than the 03:K6 isolates amongst clinical isolates, there appear no 
correlation amongst the two groups of isolates. Additional environmental V 
parahaemolyticus isolates that were serotyped do not show a predominant serotype 
amongst UK acquired environmental strains (Pers. Comm. S. Wagley, 2007). 
The difficulty of being able to differentiate V parahaemolyticus by this method is 
hampered because the manufacturers of the test sera (Denka Seiken, Japan) have stated that 
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the determination of K antigens can be affected by the presence of certain 0 antigens and 
similarly the agglutination ofO type can be inhibited by K antigens. 
Of all methods studied, the growth levels in different NaCI concentrations have been of 
most interest. The difficulty in assessing haemolytic levels of tdh expression need to be 
addressed if the haemolytic phenotype is to be used successfully. Although biochemical 
and physical growth characteristics have been explored, the relationships and ability to 
differentiate between clinical and environmental isolates using these approaches can be 
long and often difficult to interpret. Larger sample numbers and greater number of methods 
are required to help assess feasibility of biochemical, growth and serological 
characterisation. The next few chapters explore the use of molecular methods in 
characterising V parahaemolyticus. 
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Chapter 5 
USE OF PULSED-FIELD GEL ELECTROPHORESIS 
TO SHOW CLONAL RELATIONSHIPS AMONGST 
VIBRIO PARAHAEMOLYTICUS ISOLATES 
5.1 Introduction 
Pulsed-field gel electrophoresis (PFGE) is based on the observation that during continuous 
field electrophoresis, DNA above 30-50 kb migrates with the same mobility regardless of 
size. If the DNA is forced to change direction during electrophoresis, different sized 
fragments begin to separate from each other. PFGE thus allows separation of larger pieces 
of DNA than conventional agarose gel electrophoresis, and in recent years it has been used 
extensively to sub-type bacterial species, and is widely regarded as the method of choice 
for typing nosocomial and community acquired pathogens (Tenover et al., 1995). PFGE 
has been shown to be more discriminating than other molecular methods of typing for 
many species of bacteria and with V parahaemolyticus it has been reported to have the 
highest discrimination index of a single typing method when compared with several other 
methods including ERIC-PCR, and an RFLP method based on the Fla locus (Marshall et 
al., 1999). 
Intact genomic DNA is digested with an infrequently cutting restriction enzyme and the 
resulting DNA fragments are separated in agarose gels using highly specialised equipment 
to switch the direction of the current for different time periods. This allows the separation 
of DNA fragments sized between 50kb and l 0 M b. In practice, whole bacterial cells are 
suspended in molten agarose in small plug moulds. The solidified plug containing a known 
number of bacterial cells is then treated to lyse the cells in situ and remove interfering 
constituent proteins. The resultant linearised DNA fragments are then separated by PFGE. 
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Differences in the number and sizes of fragments after separation are due to variation in 
the positions and frequency of restriction sites on the genome (Tenover et al., 1995). 
PFGE has also been used for macro restriction analysis to study entire bacterial genomes. 
The ability to separate large DNA fragments has enabled the identification of multiple and 
linear chromosomes as well as genomic reorganisation caused by duplication, mutation, 
insertion or deletion. Indeed, this technique has been used to unravel the complex genomic 
structure of several bacterial genomes and produce detailed physical maps, including that 
of Vibrio parahaemolyticus (Fonstein & Haselkom, 1995; Kolsto, 1997; Tagomori et al., 
2002; Y amaichi et al., 1999;) 
The use ofPFGE for subtyping V parahaemolyticus was first reported in 1996 by Wong et 
al., ( 1996) and since then, several workers have developed various protocols for the 
application of PFGE for genomic typing of V parahaemolyticus based on the initial 
procedures of Cantor et al., (Bag et al., 1999; Chowdhury et al., 2000a; 2004a; Lu et al., 
2000; Cantor et al., 1988; Wong et al., 1996). However, variations in the use of restriction 
enzymes (Notl, Sfil and Apal), pulse switch times, equipment and other parameters mean 
that PFGE patterns produced by different laboratories are not readily comparable. 
Moreover, in many cases variation in the degree of DNA degradation has hampered the use 
of PFGE sub-typing methods (Marshall et al., 1999). 
The current study was initially based on the procedures described in the BioRad PFGE Kit 
(2001) using the electrophoresis and pulse settings of Wong et al., (2000) for V 
parahaemolyticus. Upon the observation of large degrees of DNA degradation, several 
modifications were made. This work was carried out to: 
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(i) compare V parahaemo/yticus UK isolates with each other and with isolates 
obtained from other countries, 
(ii) to assess existing methods for PFGE of V parahaemo/yticus for the ability to 
differentiate clinical (virulent) and environmental (mostly avirulent) V 
parahaemolyticus, and 
(iii) to establish a benchmark method using PFGE (described as the "gold standard" 
by Streulens, 1998) to which other molecular typing systems could be 
compared. 
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5.2 Materials and Methods 
5.2.1 Preparation of V. paralzaemolyticus plugs 
V parahaemolyticus cells grown in Marine Broth were harvested at OD600 of between 0.8 
and 1.0 corresponding to a cell density of between l 07 - 108 cells/m I. Where possible, all 
reagents used were of PFGE quality from BioRad. Details of the buffers used in this 
section are in outlined in Appendix I. V parahaemolyticus cells were embedded into 
agarose plugs using the method as described in the "CHEF Genomic DNA Plug Kits 
Instruction Manual" (CHEF Genomic DNA Pulsed Field Electrophoresis Systems -
Instruction Manual and Applications guide, BioRad). V parahaemolyticus cell density was 
established using a haemocytometer; contrast obtained by staining cells with Gram Crystal 
Violet. A volume corresponding to 5 x 107 bacteria was centrifuged (13, 000 x g, for 3 
min, RT) and the supematant discarded. Cells were washed twice with 500J.ll of cell 
suspension buffer (CSB), and then re-suspended in 250J.ll of CSB and equilibrated to 50°C. 
Alternatively, 1.25ml from an overnight culture grown in TSB (3% NaCI) was harvested 
by centrifugation (without cell counting) and resuspended in 250J.ll of buffer containing 
lOmM Tris, lOOmM EDTA and lmM NaCI (pH 8.0) (Wong et al., 1996). Next a 250J.ll 
volume of molten solution of2% (w/v) 'Pulsed-field CleanCut agarose' (50°C) was added 
and mixed gently. The mixture was transferred into 1 OOJ.ll disposable plug moulds and left 
to solidify at 4°C for 15 mins. Plugs were also prepared with the same method for selected 
isolates of V cholerae. 
5.2.2 Bacterial cell lysis and de-proteination 
Solidified plugs were removed from plug moulds and transferred to sterile plastic 
disposable bottles containing 50J.ll Lysozyme stock and 1.25ml of Lysozyme Buffer for 
each 500J.ll of agarose plugs. Plugs were incubated for 2 hours at 37°C, after which the 
lysozyme solution was discarded and the plugs were washed briefly with 1 Oml sterile 
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water. Plugs were then incubated for 24 h with a proteolytic solution containing 1.25ml of 
Proteinase K Reaction Buffer and 501J.I Proteinase K stock per 5001J.I agarose plugs at 50°C 
without agitation. Afterwards, proteinase K solution was removed and the plugs washed 
four times in lx Wash Buffer, 1 hour each wash at room temperature with gentle agitation. 
For each plug 1ml of 1x Wash Buffer was used. During the third wash a final 
concentration of 1 mM PMSF was used to inactivate residual Proteinase K. If undigested 
DNA plugs were required, then no further procedures were performed and the plugs were 
stored at 4°C. 
5.2.3 Restriction endonuclease digestion of agarose plugs 
Prior to restriction digestion, plugs were cut (4 x 9 x 1.2 mm approx) and washed for I 
hour in 1ml O.lx Wash Buffer per 100 111 plug in a 1.5 ml microfuge tube. This was 
followed by a second wash (30 m in) using 300 Ill of 0.1 x Wash Buffer. Wash Buffer 
solution was removed and I 001J.I of the appropriate restriction enzyme buffer added and 
left at 4°C for 30 min. Restriction enzyme buffer was removed and replaced with fresh 
restriction enzyme buffer and 20U of the enzyme. The contents were gently mixed and 
incubated overnight at the appropriate temperature. 
5.2.4 Agarose gels and running conditions 
Agarose gels were cast using pulsed-field certified agarose in BioRad's gel casting kit and 
run at 14°C using a CHEF DR-II machine, incorporating a cooling system and buffer 
pump. Agarose gel concentration, switch times, running conditions and other parameters 
were initially based on work by Wong et al., (2000) and modified as appropriate and are 
included in the legends of each figure. Following electrophoresis, all PFGE gels were 
immersed for 30 min in 250 ml of ethidium bromide solution at 1 jlg/ml to facilitate 
visualisation of DNA under UV illumination. 
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5.2.5 Standards and control organisms 
A commercially available A standard was used (Bio-Rad Laboratories) to size fragments 
throughout the experiments. These 48.5 kb concatemers were preparations of A cl85sam7 
ranging between approximately 0.05 and 1 mb in size. Saccharomyces cerevisiae and 
Schizosaccharomyces pombe standards supplied by BioRad were used as controls and size 
markers. V parahaemolyticus NCIMB reference strain 1902 was used to optimise 
conditions. Internal controls (DNA of same isolates) were placed at various gel lanes to 
assist data analysis. 
5.2.6 Data analysis and dendrogram construction 
DNA bands were initially compared by visual inspection and interpreted according to 
Tenover et al., ( 1995). Based on the number of DNA fragments that exhibited different 
pulse patterns, the isolates were considered to be indistinguishable (identical pulse 
patterns), closely related (two to three fragments with different patterns), or possibly 
related (four to six fragments with different patterns). If more than six DNA fragments 
exhibited a different migration pattern, the isolates were considered to be unrelated. A 
dendrogram showing relationships amongst the clinical and environmental isolates of V 
parahaemolyticus that appeared typeable were generated using BioNumerics Software 
with modules for Fingerprints and Cluster Analysis (version 5.1, Applied Maths, Belgium) 
as described in section 3.1 0, with data normalised using internal (same isolates placed at 
different gel lanes) and external controls (A ladders). Dendrogram was calculated by the 
unweighted pair group method by arithmetic averaging (UPGMA) algorithm using the 
Dice coefficient. BioNumerics position tolerance settings were 5% optimisation, a position 
tolerance of 2% with all visible bands scored. Pulse Types (PTs) were assigned at a cut off 
point of 88% similarity value that was based on visual inspection of identical and closely 
related isolates as described above. 
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5.3 Results 
5.3.1 PFGE of V. parallaemolyticus 
PFGE was perfonned on a total of 61 isolates of V parahaemo/yticus and 11 related 
species using restriction enzymes Noti and to a lesser extent with Sjil. The data reflect the 
wide genetic heterogeneity amongst the isolates used in the study (Figs. 5.1 to 5.8) and 
many isolates were untypeable due to excessive amount of DNA degradation. In total, 13 
of the environmental isolates and one clinical isolate were not typeable using the methods 
described. Using the BioRad method, visible PFGE bands were present at cell densities 
greater than 108 cells and various degrees of DNA degradation, including that of controls, 
S. cerevisiae and S. pombe visible throughout the gels (Figs. 5.1 & 5.2). 
5.3.2 PFGE of V. cllolerae 
V cho/erae plugs prepared using the same methods, were digested with both Sjil and Notl. 
Using the same electrophoretic parameters as those used with V. parahaemolyticus. V 
cholerae showed distinct banding profiles (Fig. 5.2). Only two strains of V cholerae, VC1 
and VC BAD01 could be typed and subsequently used for comparative purposes. Noti 
digested plugs of V. cholerae (VC4 & VC1) showed up to five common bands in a total of 
approximately 15 bands with V parahaemolyticus (Figs. 5.2 & 5.8). 
5.3.3 Sfil digested restriction profiles of V. para haemolytic us 
Up to 14 bands were visible with NCIMB type strain 1902 that ranged in size between 50 
kb and 430 kb. A larger, unresolved, faint band (>600kb) and several smaller bands 
(<48.5kb), although visible, were very faint amongst other widely distributed sizes of 
restriction fragments (Figs. 5.2 & 5.3). The appearance of these faint bands with Sjii 
digestion in comparison with Notl restriction bands initially favoured the use of a Notl 
restriction profiling and therefore Notl was used on the entire collection of V 
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parahaemolyticus isolates available. Isolates that were not typeable usmg Noli also 
appeared untypeable using Sjil. 
5.3.4 Notl digested restriction patterns of V. parahaemolyticus 
Noli digested PFGE profiles showed between 11 - 18 bands that ranged in size between 30 
kb to greater than 600 kb and was therefore selected for use on the entire collection of 
isolates available. Of the 47 typeable isolates, i.e. those that showed visible bands even 
within DNA smearing, 19 were of clinical origin (including two reference strains) and 28 
were environmentally acquired strains. These represent 95% and 68% typeability of 
clinical and environmental isolates respectively using the methods described. 
Environmental isolates used in the study showed a wide variation in banding profiles and 
included many unique restriction patterns. For example, at least seven environmental 
isolates were single members of their own Pulse Types (PT) and could not be grouped 
based on common bands (Figs. 5.5 - 5.1 0). The environmental isolates (n=28) were 
identified as 17 unique PFGE Types found distributed throughout dendrogram (Fig. 5.11). 
Seven of these groups consisted of between two to four isolates per Pulse Type that was 
usually from the same source of origin. For example, Vibl, Vib2 and Vib3, all of serotype 
OI:K32 from Southampton appeared to be clonally related as did Vib7 to VibiO (Figs. 5.8 
& 5.9). Similarly, the homology ofVPEC1 and VPSCI (Fig. 5. 11) could be attributed to 
the same source of isolation (Portland, Dorset). However, between all the environmental 
groups, although several bands were common, there was no band that was universally 
present amongst all the strains, thus reflecting a true heterogeneous population of V 
parahaemolylicus in this study (Fig. 5.11 ). 
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PFGE profiles generated by clinical strains of Pulse Types 18 to 22 exhibited the most 
similar banding patterns with at least 8 common bands out of approximately 1S bands 
(>80% similarity) (Figs. S.4- S.8 & S.10). This group of 10 isolates (Fig. S.1l) fell into 
one hierarchical cluster and included two strains obtained from the UK that had almost 
identical PFGE profiles to strains from Japan and Norway. These clinical isolates were of 
serovars 03:K6, 03:KUT and OS:K68 and were all positive for tdh and did not contain trh 
genes. Clinical isolates that were in Pulse Types IS and 22, however, contained trh only 
strains. Additionally, an environmentally acquired tdh positive strain (VP416) showed a 
near identical match to a clinical Japanese strain, 6134. Norwegian isolate 221 showed the 
least number of bands amongst the clinical isolates with 11 fragments that were widely 
dispersed in fragment sizes and was thus used as a size marker for dendrogram analysis. 
5.3.5 Dendrogram analysis of Notl restriction PFGE patterns 
Cluster analysis based on UPGMA and a cut off point at 88% banding similarity, as 
generated using BioNumerics, the isolates used in the study were grouped into a total of 30 
Not I restriction PTs (Fig. S.I1 ). Of these types, only one type, (PT 09) had a mixture of 
both an environmental and clinical strain in the group at 88% similarity. Isolate VP416, a 
UK shellfish acquired, Kanagawa positive strain matched the profile of a Japanese 
clinically sourced Kanagawa positive strain. Other environmental isolates were also 
grouped with clinical isolates but appeared to be more distant (<88% similarity) on the 
dendrogram. Seven clinical isolates, (PTs 02, 06, 1S, 19, 24, 2S & 27) consisted of unique 
PFGE types and included the UK reference strain, 1902 (Fig. S.11). Other than these 
strains, the clinical isolates used in the study generally clustered into one group of the 
dendrogram (PTs 18 - 22) with distinct clonality in PT 18. The environmental isolates 
exhibiting clonality were clustered in PTs 03 (Vibl - Vib3), 04 (Vib7-Vib10), OS (VPEC1 
& VPSC 1), 10 (VP1, VP2 & VibS), 12 (VP4 & VPS) and 30 (VP6 & VP7) although 
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Figure 5.1: PFGE proftles of restriction Notldigested and undigested V. parahaemolyticus of 
various cell densities and treatments using BioRad method. Lanes 1- 12 are NCIMB type 
strain 1902 treated with (Lanes l -6) and without (Lanes 7-12) PMSF. Lanes I, 2, 7 & 8 correspond 
to 108 cells; lanes 3, 4, 9 & 10 correspond to 107 cells; lanes 5, 6, 11 & 12 correspond to 106 cells; 
lane 13: S. cerevisiae; lane 14: S. pombe; lanes 15 & 16: undigested 1902; lanes 17 & 18: 
environmental isolate Vib 3; M: A. ladders size indicated by arrows. Gel prepared with l% agarose, 
0.5xTBE and run under the following conditions: 20 min pulse, at 65 volts (1 .9v/cm), for 18 h. 
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Figure 5.2: PFGE profiles of Notlaod Sfil digested environmental isolate V. parahaemolyticus 
VPl and V. cholerae isolate VC4 with cell densities of 1 09(A), 5x 108 (B) and 108 cells (C). 
Lanes 1 -7, 14 & 15: isolate VP1 ; lanes 8 -13, 17 & 18: isolate VC4. Not1 digested are indicated 
by Nand Sfil digested indicated by S above. Lanes 14 to 18 represent plugs prepared as replicates. 
M: A. ladders, sizes indicated by arrows. Gel prepared with 1% agarosc, 0.5xTBE and run under the 
following conditions: 20 rnin pulse at 65 volts (1.9v/cm), for 20 h. 
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Figure 5.3: PFGE profiles of Clal, Notl and Sftl restriction digested V. parahaemolyticus 
NCIMB type strain1902 with and without PMSF treatment and modification of method 
based on Wong et al. (2000). Lanes l - 6: Clal digests with (lanes 3 & 4) and without (lanes l & 
2) PMSF. Lanes 5 & 6 correspond to doubling restriction enzyme concentration (30u). Lanes 7 -
10: Notl digests with (lanes 9 & 10) and without (lanes 7 & 8) PMSF treatment. Lanes 11 - 14: S.ftl 
digests with (lanes 13 & 14) and without (lanes 11 & 12) PMSF. S. cerevisiae digested with Not I 
treated with (lane 16) and without (lane 17) PMSF. Lane 18: undigested VP1902. M: A. ladders 
indicated by arrows. Gel prepared with 1% agarose, 0.5xTBE and run under the following 
conditions: 20 min pulse, at 65 volts (1.9v/cm), for 18 h. 
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Figure 5.4: Comparison of PFGE proft.les of Notl restriction digested V. parahaemolyticus 
clinical and environmental isolates. Lanes 1-6 correspond to the following isolates: VP2a, VP2b, 
El54482a, El54482b, Vib 6a and Vib6b respectively. Letters a & b indicate OD600 of0.4 and 0.5 
respectively after overnight growth in TSB. Lanes 8 - I 0 correspond to isolates VP2, VP7 and Vib 
6 respectively, prepared with plugs that were 7 days old. M: /...ladders indicated by arrows. Gel 
prepared with I% agarose, 0 .5xTBE and run under the following conditions: 20 min pulse, at 65 
volts (1 .9v/cm), for 20 h. 
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Figure 5.5: Comparison of PFGE proftles of Notl restriction digested V. parahaemolyticus 
clinical and environmental isolates of UK origin. Lanes 1-l 0 correspond to the following 
isolates: VP3a, VP3b, VP6a, VP6b, VP7a, VP7b, El55855a, El68143a, El68143b and El55855b 
respectively. Letters a and b indicate OD60o of0.4 and 0.5 respectively after overnight growth in 
TSB. M : /. ladders indicated by arrows. Gel prepared with 1% agarose, 0.5xTBE and run under the 
following conditions: 20 min pulse, at 65 volts (1.9v/cm), for 20 h 
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Figure 5.6: Comparison of PFGE profiles of Not1 restriction digested V. parahaemolyticus 
clinical and environmental isolates from UK, Spain and Japan. Lanes 1-18 correspond to the 
following isolate designations: VP1 , VP2, VP3, VP4, VP7b, Vib3, 1022/4, 2053x, 2053, 2436, 
5421, 6134, 63 16, E154482, El55855a, El68143a, El68143b and VP10884 respectively. Letters a 
and b (after isolate numbers) indicate 00600 of0.4 and 0.5 respectively after overnight growth in 
TSB. M: A. ladders with selected sizes indicated by arrows. Gel prepared with 1% agarose, 
0.5xTBE and run under the following conditions: 20 min pulse, at 65 volts (1 .9v/cm), for 20 h 
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Figure 5. 7: Comparison of PFGE proftles of Notl restriction digested V. parahaemolyticus 
clinical and environmental isolates from UK and Japan. Lanes 1-17 correspond to the following 
isolate designations: Vibl , VP10884, 6316, VPl , VP2, VP3, VP4, VP7, Vib3, 1022/4, 2053, 2436, 
5421,6134, 6316 and El54482 respectively. Lane 18: NCTC type strain VP10884. M: I.. ladders 
with selected sizes indicated by arrows. Gel prepared with l% agarose, 0.5xTBE and run under the 
following conditions: 20 rnin pulse, at 65 volts (1.9v/cm), for 20 h 
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Figure 5.8: PFGE profiles of Notl digested UK environmental and UK clinical strains of V. 
parahaemolyticus. Lanes 1-18 correspond to the following isolate designations: VPl, VP2, VP3, 
VP4, VP6, VP7, VP8, VP9, VPlO, Vib3, Vib5, Vibl, Vib2, 1103/9, E154482, El55855, El68143 
and VCl respectively. Lane 14 is a Spanish isolate of V parahaemolyticus and lane 18 corresponds 
to V cho/erae. M: I. ladders with selected sizes indicated by arrows. Gel prepared with I% agarose, 
0.5xTBE and run under the following conditions: 20 min pulse, at 65 volts (1.9v/cm), for 20 h 
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Figure 5.9: PFGE profiles of Notl digested environmental isolates of V. parahaemolyticus and 
other Vibrio species. Lanes l-18 correspond to the following isolate designations: Vib2, Vib3, 
Vib5, Vib6, Vib7, Vib8, Vib9, Vib10, 1022/4, 1022/10, VP350, VP5, VP378, VP416, 219, 220, 
VCBAD01 and VM499 respectively. Lanes 15 & 16 correspond to Norwegian clinical isolates of 
V parahaemolyticus. Lanes 17 & 18 correspond to V cholerae and V mimicus respectively. M: A. 
Ladders with selected sizes indicated by arrows. Gel prepared with 1% agarose, 0.5xTBE and run 
under the following conditions: 20 min pulse, at 65 volts (1 . 9v/cm), for 20 h 
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Figure 5.10: Comparison of Notl digested Norwegian clinical and UK environmental isolates 
of V. parahaemolyticus. Lanes 1-18 correspond to the following isolate designations: 219, 219*, 
221 , 221 *, 222, 222*, 223, 224, 225,226,227, 228, VP350, VP350, VP416, VP416, VPl and VPl 
(undigested) respectively (duplicates are indicated with *). Lanes 15 & 16 correspond to 
Norwegian clinical isolates of V parahaemolyticus. M: A ladders with selected sizes indicated by 
arrows. Gel prepared with l% agarose, 0.5xTBE and run under the following conditions: 20 min 
pulse, at 65 volts ( l . 9v/cm), for 20 h 
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% Similarity Isolate Location Source Pulse Type 
0.53 0.24 0.05 (PT) 
~ 
1022/10 Spain Environ menta I 01 
228 Norway Oinical 02 
Vib1 Sou1hampton, UK Environmental 03 
Vib2 Sou1hampton, UK Environmental 03 
Vib3 Sou1hampton, UK Environmental 03 
Vib8 Sou1hampton, UK Environmental 04 
Vib9 Sou1hampton, UK Environmental 04 
Vib7 Sou1hampton, UK Environmental 04 
Vib10 Sou1hampton, UK Environmental 04 
VPEC1 Dorset, UK Environmental 05 
VPSC1 Dor.;el UK Environmental 05 
2436 Japan Oinical 06 
VP1 0884 PI-I.S, UK NCTC Reference Strain 07 
-~- _ ~~~15.. ___ -~vi_ro_!!"l_en_ta.!_ ___ -~ _ 
6134 Japan Oinical 09 I 
VP416 Dorset, UK Environmental 09 
1 
--------------- -----------1 Vib5 Sou1hampton, UK Environmental 10 
VP2 Sou1hampton, UK Environmental 10 
VP1 Sou1hampton, UK Environmental 10 
VP3 Sou1hampton, UK Environmental 11 
VP4 Sou1hampton, UK Environmental 12 
VP5 Sou1hampton, UK Environmental 12 
110319 Spain Environmental 13 
VP378 Dorset, UK Environmental 14 
-------------------------, E154482 PI-I.S, UK Oinical 15 1 
__ ~~ __ ~~a~~!!, !,!K __ ~~ro.!'~~taJ. ____ 12 _1 
6316 Japan O inical 17 
-------------------------~ E155855 PHLS, UK Oimcal 18 1 
E168143 PHLS, UK Oinical 18 I 
2053 Japan Oinical 18 
_ ,!2~ - --~'!"'! __ - -- _?~i~l_ - -- - __ !B_ ! 
226 Norway Oinical 19 
227 Norway Oinical 20 
5421 Japan Oinical 20 
221 Norway O inical 20 
220 Norway Oinical 21 
222 Norway Oinical 22 
1022/4 Spain Environmental 23 
VP939 Dorset, UK En111ronmental 23 
224 Norway Oinical 24 
1902 PI-I.S, UK NCIMB Reference Strain 25 
VP10 Sou1hampton, UK Environmental 26 
219 Norway Oinical 27 
VP8 Sou1hampton, UK Environmental 28 
VP9 Sou1hampton, UK Environmental 29 
VP6 Sou1hampton, UK Environmental 30 
VP7 Sou1hampton, UK Environmental 30 
Figure 5.11: UPGMA dendrogram of clinical and environmental isolates of V. parahaemolyticus. A 
total of 47 isolates were typeable by PFGE. Clusters (Pulse Types) created are based on a 88% similarity 
value indicated by the blue line. Red dotted area indicate two isolates from UK with clonal relatedoess with 
Japanese and Norwegian 03 :K6 isolates. Environmental isolates sharing similar proftles to clinical isolates 
are highlighted in green and blue. Scale above banding profiles indicates approximate sizes (Mb ). 
BioNumerics, Applied Maths, Belgium. 
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5.4. Discussion 
This study looked at the variation in banding patterns of Notl digested PFGE profiles 
amongst clinical and environmental isolates of V parahaemolyticus. The technique of 
PFGE has gained increasing popularity and is currently the most widely employed typing 
method for V parahaemolyticus with recent reports of standardised procedures (Wong et 
al., 2007; Parsons et al., 2007; Kam et al., 2008). The present work described, was 
conducted in 2004 to establish initial relationships between the isolates used using 
modifications to the BioRad PFGE method and to assess whether PFGE could distinguish 
pathogenic from non- pathogenic isolates. It was hoped that PFGE would serve as a 
benchmark subtyping method to compare clusters obtained with additional typing systems. 
5.4.1 Clustering of clinical isolates 
PFGE analysis showed a large genomic variation amongst clinical and environmental 
isolates with Pulse Types 18 - 22 showing the highest similarities of all the strains. Out of 
I 0 clinical isolates that exhibited similar banding profiles, seven were of 03:K6 serotype, 
one of 05:K68 serotype and two were K untypeable (KUT). Within the homogeneous 
03:K6 group of isolates, PFGE demonstrated the sensitivity to discriminate with the 
presence or absence of between two to three bands. A Norwegian isolate of serotype 
Ol:KUT, believed to be one of the pandemic group, showed a similar banding profile 
(>88% similarity) to 03:K6 strains (Figure 5.11), consistent with previous work 
demonstrating clonal relationships of pandemic serotypes (Chowdhury et al., 2000b; 
Matsumoto et al., 2000; Okura et a/, 2003). The finding of UK acquired isolates to possess 
almost identical banding patterns to pandemic 03:K6 isolates from Japan and Norway 
demonstrated for the first time the presence of clonally related, more virulent pandemic 
isolates in the UK. These isolates were obtained from travellers arriving from India and 
Thailand, so it appears that infection of V parahaemolyticus due to 03:K6 due to 
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consumption of indigenous shellfish in the UK have not yet been identified or tested for. 
This highlights inadequate surveillance measures of pathogenic V parahaemolyticus in the 
UK that may partially be due to low numbers of sporadic V parahaemolyticus infections in 
the UK, most of which are attributed to travel related cases, (Anon, 2006) and the self-
limiting nature of the infection. 
Although some clinical isolates were grouped regardless of geographical origins, others 
such as El54482 and the NCIMB reference strain, 1902, with Pulse Types 22 and 23 
respectively, showed less relatedness, even though they were of the same 01 :KI serotype. 
An additional strain, environmental Spanish isolate, 1103/9 with the same 01 :K I serotype, 
showed yet a different Pulse Type to types 22 and 23 thereby PFGE, in this instance, was 
clearly able to discriminate isolates within the same serotype. 
Typically, molecular differentiation is used to characterise strains that are phenotypically, 
biochemically or serotypically similar as described. In this study however, it was also 
found that within the same Pulse Field type, different serotypes were present, such as the 
presence of a 05: K68 strain amongst clinical strains of 03:K6 and also the presence of 
two serotypes in an environmental cluster, Pulse Type 05. This phenomenon was also 
described by Martinez-Urtaza et al. who showed different serotypes from the same area in 
Spain were included in the same PFGE cluster (Martinez-Urtaza et al., 2004), thereby 
reinforcing the need for careful interpretation of data and the use of additional molecular 
characterisation to determine accurate relationships between isolates. 
5.4.2 Environmental isolates showing homology to clinical isolates 
PFGE was able to group two environmentally acquired strains with known clinical strains 
as demonstrated by Pulse Types 09, 15 and 16. An environmental isolate, VP416 that was 
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previously identified as a Kanagawa positive haemolytic strain, showed remarkably similar 
banding profiles (>94%) to a Japanese clinical isolate (6134) with serotypes 04:KUT and 
04:K12 respectively. As isolate VP416 was obtained from an oyster sample from the south 
coast of UK in 2001, this finding may provide some evidence of the inter-continental 
spread of virulent strains of V parahaemolyticus amongst coastal waters, and thus 
highlights the need for increased surveillance of shellfish samples in the UK. 
In addition to isolate 6134, an environmental isolate Vib6, from Southampton, UK, also 
exhibited some homology to a trh positive clinical isolate, El54482. With a total of 17 
bands, the isolates shared 14 common bands with >86% dendrogram similarity value (Fig. 
5.11 ). As E 154482 was isolated from a travel related gastroenteritis incident arriving from 
Thailand, the similarities of PFGE profiles to that of Vib6 may suggest the presence of UK 
environmental reservoirs of V parahaemolyticus that may have originated from South East 
Asia. PFGE data with a different restriction enzyme would provide more conclusive 
information regarding the relatedness of these two environmental isolates used in the 
study. Additional sub-typing methods (chapters 6 to 8) explore these intra-species 
relationships further. 
5.4.3 Typeability with PFGE 
In this study, a large degree of DNA degradation was evident throughout the experiments. 
It was found that the use of both turbidity measurements and cell density counts to estimate 
DNA concentration, and the use of chloramphenicol to inhibit replication, as used by the 
BioRad method, was not deemed necessary. This reduced preparation time and DNA 
degradation. The method by Wong et al., (1996) that simply used a volume of an overnight 
culture of V parahaemo/yticus was implemented; whereby the harvested cells were 
washed in buffer containing l OmM Tris, I OOmM EDT A and 1 mM NaCI (pH 8.0). This 
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buffer replaced the Cell Suspension Buffer (CSB) as supplied in the BioRad PFGE kit, the 
content of which remains publicaly unknown. Interestingly, the same isolates that were not 
typeable with Notl restriction were also not typeable with Sjil restriction. Untypeability of 
environmental V parahaemolyticus strains has widely been documented by several others 
including Marshall et al. (1999) and Yeung et al. (2002). Marshal! et al. reported 77% 
typeability amongst clinical isolates whereas Y eung et al. found only a single isolate 
untypeable amongst clonally related 03:K6 isolates. 
The lengthy PFGE process described in the present work required numerous procedures 
that required several days to complete. Preparation of plugs and their treatment inevitably 
introduced DNase in addition to residual nuclease activity which may not have been 
adequately deactivated using the methods described. Once plugs were prepared it was 
found that they only remained stable for a few days therefore suggesting that meaningful 
comparisons could only be made using freshly prepared plugs. 
Recently, a number of workers have employed the 'One Day Standardised Laboratory 
Protocol for Molecular Subtyping of Non-typhoidal Salmonella by PFGE' (Pulse-Net; 
Centers for Disease Control, Atlanta, Ga) procedures for PFGE typing of V 
parahaemolyticus (Martinez-Urtaza et al., 2004). This method differs mainly in that an 
overnight culture grown on solid plate media is directly transferred to cell suspension 
buffer and OD adjusted to 0.48 to 0.52 before cell lysis. Immediate cell lysis with 
proteinase K is followed by addition of molten agarose, premixed with SOS, to prepare the 
plugs. In a parallel study by colleagues elsewhere, this method correctly grouped the two 
UK 03:K6 strains (E155855 and E168143) with clonally derived pandemic isolates from 
Japan, Spain, Korea and Laos (Wagley et al., 2008). However, whereas the authors showed 
clinical isolates 2053 and 5421 in the same cluster, the BioRad method used in this study 
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identified them in two different pulse types (18 and 20 for isolates 2053 and 5421 
respectively) at an approximately 84% similarity level. Clearly, there is an essential 
requirement for standardised procedures for data acquisition and analysis for the PFGE of 
V parahaemolyticus to enable the meaningful exchange of inter-laboratory results. 
5.4.4 Standardisation of PFGE 
Despite a large degree of untypeability in the current study, PFGE has gained increasing 
popularity over recent years and these methods have so far yielded an increase in 
typeability. However, there do not appear to be many reports of this method being used 
extensively on environmental strains of V parahaemolyticus, as it has been shown that 
these are more likely to be untypeable (this work; Marshall et al., 1999). More recently, the 
CDC PulseNet have put forward a standardised protocol for the PFGE of V 
parahaemolyticus (Parsons et al., 2007). In a multicenter evaluation of this method, that 
incorporated 36 well characterised strains of various serotypes from different geographical 
regions, a high discriminatory power (34 Pulse Types in 36 strains) and typeability was 
shown. The study involved clinical and environmental strains. However, there was no 
mention of methods of data analysis and an increasing number of bands (markers) with the 
addition of new strains can induce errors that are compounded exponentially thereby 
reducing the robustness of PFGE (Call et al., 2008). It remains to be seen whether this 
method, or others (Wong et al., 2007; Kam et al., 2008) that have recently been described, 
will gain widespread acceptance and increased typeability of environmental strains of V 
parahaemolyticus. Ideally, a protocol that would employ the same methods and pulse 
conditions to type other related organisms found in the same environment would be more 
beneficial. As the CDC PulseNet protocol was based on the procedures of V cholerae and 
E. coli 0157:H7 typing, it would seem likely that V cholerae could also be typed. 
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5.4.5 Conclusion 
To date, there has been very limited published data on the detection and prevalence of V 
parahaemolyticus in the UK. This chapter presents the first known study of the 
characterisation of UK isolates, using modifications to a protocol initially based on 
commercially available PFGE kits (BioRad Laboratories). Due to the nature of the clinical 
symptoms of V parahaemolyticus infection, together with the difficulty in correctly 
identifying the organism, it is probable that clinical cases are currently under reported or 
misdiagnosed with other self-limiting gastroenteritis related illnesses. 
This chapter described the use of PFGE in assessing the relationships between clinically 
and environmentally acquired isolates of V parahaemolyticus. It was found that two UK 
isolates from gastroenteritis cases were closely related to those of Japan and Norway as 
demonstrated by PFGE profiles as well as belonging to the same 03:K6 serotype. The 
03:K6 serotype is widely considered a clonally derived, pandemic strain responsible for 
disease worldwide (Hara-Kudo et al., 2003; Matsumoto et al., 2000; Martinez-Urtaza et 
al., 2005). This together with the finding of a non pandemic, 04:KUT isolate amongst C. 
gigas in British coastal waters that showed almost identical PFGE profile to a Japanese 
clinical isolate and presents additional evidence of clinically significant V 
parahaemolyticus in the UK and the importance of reliable typing systems for pathogenic 
isolates. Using PFGE, only 47 isolates could be characterised representing 77% of the total 
number of isolates. This, together with the long time required to process samples, as only 
a limited number of samples can be processed at any one time, adds to the difficulty in the 
routine use of PFGE for surveillance and epidemiological purposes. Clearly, more 
appropriate rapid, robust methods are required to screen large numbers of environmental 
and shellfish samples to differentiate potentially pathogenic isolates, that can then be 
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Chapter 6 
DIFFERENTIATION OF VIBRIO PARAHAEMOLYTICUS 
ISOLATES BASED ON LENGTH POL YMORPHISMS 
OF THE 16S- 23S INTERNAL 
TRANSCRIBED SPACER (ITS) REGION 
6.1 Introduction 
Ribosomal RNA (rRNA) operons can be found in all species of bacteria with the genes 
usually arranged in a defined order (l6S-23S-SS), often with several copies distributed 
throughout the genome. These highly conserved regions make them ideal for the 
classification, identification and typing of isolates (Abed et al., 199S; Tilsala-Timisjarvi et 
al., 2001; Dingman, 2004). Both the 16S rRNA gene and SS rRNA gene have been used to 
establish phylogenetic relationships between a wide variety of organisms (Gazumyan et 
al., 1994; Yoon et al., 1997; Maiwald et al., 2000). The internal transcribed spacer (ITS!) 
region between 16S and 23S genes shows the most variation, both in length and sequence 
(Gurtler & Stanisich 1996; Dennis et al., 1998; Perez-Luz et al., 2002; Wojciech et al., 
2004; Dillon et al., 200S) and this variation can be used for distinguishing between closely 
related bacterial species and, sometimes, between strains (Gurtler & Stanisich 1996; 
Leblond-Bourget et al., 1996; Daffonchio et al., 2006). In addition to this ITS1 region, the 
spacer region between the 23S and SS (ITS2) may be useful for designing species-specific 
probes and establishing relationships between closely related species (Ji et al., 1994; Nour 
et al., 1998). 
Sequence information of a number of V parahaemo/yticus isolates has revealed that they 
possess up to 11 copies of the rRNA operon (rrn) each having identical 16S rRNA genes 
(rrs) but with 6 spacer classes differing in size with either I, 2 or 3 copies of each class, 
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(Makino et al., 2003; Gonzalez-Escalona et al., 2005b). However, a type strain isolated in 
1951, varied in two of the spacer classes; one was found to be 45 bp larger and the other 15 
bp larger containing genes for tRNA Ala and tRNA Glu (Maeda et al., 2000). A preliminary 
analysis of the spacers, demonstrated on a few clinical isolates by Gonzalez-Escalona and 
colleagues, differentiated clinical isolates of V. parahaemolyticus ITS l spacers into four 
groups based on two spacer classes (Gonzalez-Escalona et al., 2006a). By sequencing two 
clinical isolates, VpAQ and Vpl, it was further found that ITSl regions of 40bp and 
208bp, close to the l6S and 23S genes respectively, were conserved in three clinical 
isolates of V. parahaemo/yticus. Despite these structural similarities and variation in spacer 
classes, little is known about intra-species relationships between clinical and 
environmental isolates based on ITS l regions. There are currently no published data 
assessing the feasibility of typing V. parahaemolyticus based on variation of the ITS 1 and 
ITS2 regions or addressing its significance as an epidemiological typing tool with this 
organism. 
This chapter applies the use of consensus primer pairs for amplifying ITSl regions. ITS2 
regions were also amplified with primers developed using existing sequence information of 
V parahaemolyticus (Mak.ino et al., 2003) described in section 3.5. This chapter describes 
the: 
i) molecular typing of V parahaemolyticus based upon PCR amplification of ITS 
l and 2 regions 
ii) the usefulness of ITS typing as a molecular typing tool for V parahaemolyticus 
isolates 
iii) evaluation of the ability to discriminate clinical and environmental isolates of V. 
parahaemolyticus based on ITS I typing. 
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6.2 Materials and Methods 
6.2.1 Primers for amplification of ITS regions 
Primers VINTF (5'-TGGGGTGAAGTCGTAACAAGG-3') from 16S rRNA 
corresponding to E coli l6S positions 1485 to 1505 and VINTR (5'-
TCCTTCATCGCCTCTGACTG-3') from E. coli 23S positions 37 to 56 were used to 
amplify ITS l regions (Maeda et al., 2000). E. coli 16S is notably larger than V. 
parahaemolyticus l6S: !54! bp compared to 147lbp (Brosius et al., 1978; Makino et al., 
2003) and primer VINTF is complementary to a conserved region (section 6.4.4; 
Gonzalez-Escalona et al., 2006a) outside of V. parahaemolyticus 16S (Fig. 6.1 ). Primers 
for ITS2 were designed based on conserved 23S and 5S regions that flanked the ITS2 
region of V. parahaemolyticus (Makino et al., 2003) as described in section 3.5 (Fig. 6.1). 
ITS2 primer sequences were designated S2F, 5'-CTAATTGCCCGTGAGGCTTA-3' and 
S2R, 5'-GAGTCAGGTGGGTCCAAAAC-3 for forward and reverse primers respectively. 
V!NTF 
.. 
ITS2 SS 
16S (1471bp) 
8! ~obpJ 
ITS;------~~ ===========(=28=29_3 ls,-b_p=)===========~rc 
+-
VlNTR 
+-
S2R 
Figure 6.1: Schematic representation of the V. paralraemolyticus rRNA operon (rmA), ITS regions and 
primers used in the study. Sizes are based on clinical isolate RIMD221 0633 (Makino el al., 2003). Primer 
VINTF is complementary to a conserved region in V. parahaemolylicus ITS I. 
6.2.2 Amplification of ITS I and ITS2 regions 
PCR amplifications were performed as described in section 3.6 using an MWG thermo 
cycler (Primus 96 Plus). Conditions were optimised with the following modifications: 
reactions were performed in 55 J..ll volumes and contained 20 ng of genomic DNA and 25 
pmol of each forward and reverse primer. Each reaction mixture contained I U of Taq 
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polymerase (Roche), 1 x reaction buffer containing l.SmM MgCh (Roche) and each 
deoxynucleoside triphosphate (dNTP) at a final concentration of 0.2mM .. 
The final cycling conditions for the ITS-PCR were as follows: an initial denaturation step 
at 94°C for 2 minutes followed by 30 cycles of94°C for 60 sec, 62°C for 45 sec, and 72°C 
for 90 sec and a final extension at 72°C for 5 min. Cycling conditions were optimised by 
performing PCR reactions at different annealing temperatures and with genomic DNA of 
three strains; type strain NCIMB 1902, Japanese clinical isolate 2053, and Spanish 
environmental isolate 1023/1, and PCR performed on a total of 56 isolates of V 
parahaemolyticus including a number of replicates. Additional species that were examined 
included, V cholerae, V vulnificus, V mimicus and several members of non-Vibrio spp. 
All PCR products were analysed and compared by electrophoresis of 12 J.ll of each reaction 
mixture in 2% agarose gels as described in section 3.8. 
6.2.3 Data analysis and dendrogram construction 
Amplicons generated with primers VINTR and VINTF were scored both empirically by 
means of visual inspection and by software analysis. Isolates were grouped according to 
fingerprint pattern types and also by using a curve based correlation coefficient and a band 
based Dice coefficent with BioNumerics as described in section 3. The parameters that 
were varied in BioNumerics during the identification of bands were "minimum profiling" 
(used to identify bands based on the elevation of densitometric peaks relative to the highest 
peak on the pattern), "minimum area" (used to identify bands on the area of densitometric 
features relative to the total area of the pattern) and "shoulder sensitivity" an option that 
allows identification of doublet bands where the curve appears as a "shoulder" to another 
band. BioNumerics optimisation, position tolerance settings and percentage similarity cut 
off points were altered in small increments until clusters resembling similar banding 
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profiles were achieved. A final position of 93% similarity was used for the dendrogram 
and ITS I groupings. 
6.3 Results 
6.3.1 Consensus primers for ITSl regions 
Primers described by Maeda et al. (2000) were tested at PCR annealing temperatures of 62 
- 68°C on two isolates of V. parahaemolyticus, NCIMB type strain 1902 and 
environmental isolate 1023/1 (Fig. 6.2). Bands of varying intensities were identified on the 
fingerprint pattern with more bright bands indicative of multiple ITS I regions of similar 
sizes present in V. parahaemolyticus (Section 6.4.5). It was found that varying the 
temperatures within these ranges did not significantly alter the banding profiles with higher 
annealing temperatures resulting in decreased yield of PCR products (Fig. 6.2). Increasing 
the annealing temperature reduced backgrow1d PCR noise but also reduced the intensity of 
amplicons generated (Fig. 6.2). However, increasing template and primer concentrations, 
from 10 to 20 ng and I 0 to 50 pmols respectively, was shown to specifically increase the 
amplification of the 390 and 635 bp spacer regions (Fig. 6.2, Plate A, lanes 6-8) and was 
used to help deduce optimised reaction conditions (section 6.2.2). However, increasing 
primers and templates did not increase the intensity of the two larger amplicons of 
approximately 790 and 810 bps. Faint bands above 790 bps were ignored from 
BioNumerics analysis. 
6.3.2 PCR of 238-SS (ITS2) intergenic spacer regions 
Primers that were designed based on published 23S and SS sequences of V. 
parahaemolyticus amplified a single unambiguous band of approximately 150bp in UK 
type strain 1902, Spanish environmental isolate 102311 and clinical isolate 2053 (Fig. 6.3). 
Amplicons from all three isolates appeared consistent in size reflecting an ITS2 region of 
approximately 90 bp (without primer regions). 
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6.3.3 PCR of 16S-23S (ITSl) intergenic spacer regions of V. paraltaemolyticus 
PCR with primers VINTF and VINTR flanking the 16S-23S rRNA regions was carried out 
on 56 strains of V parahaemolyticus (Figs. 6.4 to 6.8). Between four and eight bands were 
amplified with two distinct markers of approximately 390 and 635 bps that distinguished 
all but one isolate (6316) of V parahaemolyticus from all the other species (Fig. 6.9). With 
the exception of isolate 6316, these two amplicons appeared of similar size in all of the 
remaining isolates tested (section 6.3 .4; Fig 6.11) with some apparent variability in size of 
the 390 bp amplicon amongst the environmental isolates (Figs 6.4 & 6.8). Isolate 6316 was 
characterised by a unique profile and did not match any of the other Vibrio spp. tested by 
ITS 1-PCR. In addition to the 390 and 635 bps bands, a further three bands of 
approximately 640, 790 and 81 0 bps were present in most of the isolates, with the larger 
sizes of bands generally appearing more faint. A further four bands, (between 390 and 640 
bps, Fig. 6.1 0) some faint, were found distributed in some of the isolates. Based on general 
banding profiles, there appeared no obvious correlation of banding patterns with the source 
or the location of the isolates. 
6.3.4 Reproducibility ofiTSl-PCR banding profiles 
A comparison of repeated ITS 1 fingerprint profiles (Figs. 6.4 - 6.8, isolates underlined) 
demonstrated the degree of reproducibility of the ITS-PCR technique. A total of 17 
arbitrarily chosen isolates, that included three non Vibrio spp. were subjected to repeat 
ITS 1-PCR and gel runs. Five UK clinical isolates in Figure 6.6 (Lanes 16 - 20) amplified 
the same bands as Figure 6.5 (Lanes 12 - 14, 16 & 18). However, banding patterns, in 
common with the rest of the isolates on the gel, appeared more intense with more 
background PCR noise in Figure 6.6. Similarly, eight environmental isolates (Figs. 6.5, 6. 7 
& 6.8, underlined) showed reproducibility of the two main amplicons. However, 
identification of faint bands appeared problematic in some isolates and in some of the 
repeats performed faint bands could not be identified at all. For example, initial 
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experiments with NCIMB reference strain 1902, (Fig 6.2, Plate A, 62°C) identified two 
faint bands between 500 and 600 bps, both bands were absent in Figure 6.4 (Lane2) and 
only one present in Figure 6.6 (Lane 20). A full comparison of the bands produced in 
repeat analysis is shown in Table 6.1. Of the total 17 repeats, a number of the faint bands 
could not be ascertained in at least five isolates including 1902, VP491, VP939, VPEC1 
and VPSC1 (Table 6.1). 
6.3.5 ITSl PCR in Vibrio species 
The 16S-23S rRNA spacers in Vibrio species varied amongst members of the genera tested 
(Figs. 6.3, 6.4, 6.5 & 6.7). Using the same consensus primers, up to seven bands of various 
intensities were present. Amongst the six known Vibrio spp. tested, V. cholerae shared a 
common band of approximately 635 bp with V. parahaemolyticus that was present in all 
six isolates including V. cholerae NCTC type strain 8042 (Fig. 6.8). An unspeciated Vibrio 
sp., Vib4 (Table 3.3), showed a profile matching that of Listonella damsela. LD365 (Fig. 
6.5) Based on initial ITS 1-PCR, L. damsel a appeared more closely related to V. vulnificus 
than V. cholerae or V. parahaemolyticus, although a larger number of isolates and 
sequence analysis would be required to verify ITS 1-PCR homologies between these 
species. Based on a limited number of isolates, the PCR developed was able to distinguish 
between all six Vibrio spp. and five non-vibrios (Fig. 6.9). 
6.3.6 Dendrogram analysis and differentiation of V. parallaemolyticus isolates 
Dendrogram analysis employing a curve based correlation coefficient was used to cluster 
V. parahaemolyticus into thirteen groups (A - M) at a 93% similarity value (Fig. 6.11 ). 
These groups appeared to be based on the positions and intensities of the two more 
prominent bands (approximately 390 and 635 bps) with faint bands largely unaccounted 
for (Fig. 6.11 ). 
117 
ITS types A and B consisted of a single clinical isolate, clustered with two environmental 
ones and a reference strain, NCIMB 1902. Isolates of these two groups appeared similar in 
banding profiles to those of Group C. This group, ITS-C appeared the largest with a 
mixture of both 32 clinical and environmental isolates and appeared closely related with 
VP346 (ITS Type D); the isolate differentiated based on the presence of two distinct bands 
between 390 and 500 bps (Fig 6. 7). Most of the clinical isolates were found clustered in 
one of two groups amongst ITS-C with two bands around 640bp appearing as 'doublets' in 
comparison with environmental isolates of the same group (Figs. 6.6 & 6.11). Furthermore, 
two faint bands between 390 and 635 bp appeared variable amongst the 13 ITS Types. For 
example the 540 bp amplicon (Fig 6.1 0) was present in 14 out of 17 of clinical isolates 
whereas this amplicon could be identified anywhere in between 13 to 20 of 36 
environmental isolates and thus highlighting variability in banding intensities (Section 
6.3.4). 
Other than isolate 6316 and reference strain VP I 0884, the remaining ITS Types, E-L, did 
not contain a mixture of both clinical and environmental isolates in any of the groups (Fig. 
6.11 ). The most significant variation was found in the amplification of multiple ITS 1 
spacers of various lengths that were not identified in any of the clinical ITS types. In 
addition to the 390 bp amp! icon, four environmental isolates, VP346, VP939, VPEC 1 and 
VPSC I, amplified two other spacer regions of approximately 425 and 450 bps (Figs. 6.4 & 
6.7). In all four isolates the 390 bp fragment was present, but was of reduced intensity. 
Several other isolates also exhibited a 415 amplicon, but appeared faint and unaccounted 
for in the dendrogram. Environmental isolates also differed by the variable size of the main 
spacers found in V parahaemolyticus. These were clustered together in ITS groups E, G 
and H (Fig. 6.11 ). In addition to the new spacer types and intensity of some of the 
amplicons, length polymorphisms in the '390 bp' amplicon were observed. For example, 
isolates of E, G and H groups showed smaller amp! icons than typically found in the other 
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groups {Fig, :6.1111} Similar iiength ipdlyrnmphisrns. in 'spacers were also; identified in 
environmental I isolates of IV iparahaemolyil'cus. 8linical :isolates~ in genenil, appeared ,more. 
homogeneous in: bilfidiiig profiles~ 
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Figure 6.3: PCR amplification of ITS2 regions of V. parahaemolyticus using primers designed for 
conserved 23S and 5S regions. Lanes l - 3 correspond to NClMB type slrain 1902, lanes 4- 6; Spanish 
isolate 1023/1, lanes 7- 9; Japanese isolate 2053 with decreasing template DNA concentrations of 20ng, 
lOng and 5ng respectively. Lane M: 1 OObp ladders, sized of selected markers indicated by arrows on the 
right. 
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Figure 6.4: PCR amplification of ITS I regions from clinical (C) and environmental (E) isolates of V. 
parahaemolyticus and other species (unmarked) using primers VINTF and VINTR. Lanes I - 20 
correspond to the following isolates:- 1: E. coli Cla; 2: 1902 Reference strain; 3: 2053; 4: 2436; 5: 5421 ; 6: 
6 134; 7: 6316; 8: V alginolyticus V A234 L; 9: Vib3; 10: Vib5; 11 : VP416; 12: VP491 ; 13: VP939; 14: 
VPECl; 15: VPSCl; 16: V anguillarum CM104; 17: S. typhimurium ST5; 18: K. aerogenes KA5; 19: P. 
aen1ginosa PA 1; 20: E. coli BL2l. Lane M: 1 OObp ladders, size of selected markers indicated by arrows on 
the right 
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Figure 6.5: ITSl fmgerprinting patterns of cUnical (C) and environmental (E) isolates of V. 
parahaenwlyticus and related species (unmarked) using primers VINTF and VINTR. Lanes I - 20 
correspond to the following isolates:- 1: Negative control; 2: VP10; 3: Vjluvialis 11327; 4: Vibl; 5: Vib2; 6: 
Vib3; 7: Vib4 (unspeciated Vibrio sp.); 8: Vib5; 9: Vib6; 10: Vib7; 11: Vib8; 12: Vib10; 13: V vulnificus 
KiDbW; 14: V vulnificus Wll067; 15: Listonella damsela LD365; 16: E154482; 17: El55855; 18: 
El68143; 19: 2436; 20: 6134. Isolates underlined are repeat PCRs. Lane M: lOObp ladders, size of selected 
markers indicated by arrows on the right 
Norway Japan R 
Figure 6.6: Comparison of ITSl fmgerprinting patterns of clinical isolates of V. parahaemolyticus from 
Norway, UK and Japan using primers VINTF and VINTR. Lanes l - 20 correspond to the following 
isolates:- I: Negative control; 2: 219; 3: 220; 4: 221 ; 5: 222; 6: 223; 7: 224; 8: 225; 9: 226; 10: 227; 11 : 228; 
12: E 154482;13: E155855; 14: E168143; 15: 2053; 16: 2436; 17: 5421; 18: 6134; 19: 6316; 20:1902 
Reference strain (R). Isolates underlined are repeat PCRs. Lane M: lOObp ladders, size of selected markers 
indicated by arrows on the right. 
122 
UK Spain UK 
~ 
M 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 M 
Figure 6.7: Comparison of ITSl fingerprinting patterns of environmental isolates of V. 
parahaemolyticus from UK and Spain. Lanes 1 - 20 correspond to the following isolates:- l: Negative 
control; 2: VP1 ; 3: VP2; 4: VP3; 5: VP4; 6 : VP6; 7: VP7; 8: VP8; 9: VP9; 10: VP10; 11: 1021/5; 12: 
1022/10; 13: 1023/l ; 14: 1023/3; 15: 1024/5; 16: 1103/9;17: VP331 ; 18: VP345; 19: VP346; 20: VP349. 
Isolate underlined represents a repeat PCR Lane M: lOObp ladders, size of selected markers indicated by 
arrows on the right 
V. parahaemolyticus V. cholerae 
M 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 M 
Figure 6.8: Comparison of ITSl fmgerprinting patterns of environmental isolates of V. 
parahaemolyticus, V. cholerae and other species. Lanes 1 -20 correspond to the following isolates:- 1: 
VP350; 2: VP36L; 3: VP377; 4: VP378; 5: VP416; 6: VP491; 7: VP939; 8: VPECI; 9: VPSC1 ; 10: VP10884 
(Type Strain); Ll: V. cholerae Reference Strain 8042; 12: VCI ; 13: VC2; 14: VC3; 15: VC4; 16: VC5; L 7: 
Proteus mirabilis PM5; 18: S typhimurium ST5; 19: K aerogenes KA5; 20: P. aeruginosa PAl. Isolates 
underlined are repeat PCRs. Lane M: 100bp ladders, size of selected markers indicated by arrows on the 
right. 
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Table 6.1: Reproducibility of ITSI-PCR bands in repeat tests. Tests I and 2 refer to independent ITS-
PCR and gel runs. Uncertain band numbers are hyphenated. Corresponding band numbers in two repeats are 
indicated in bold. The 390 and 635 bp bands were present in all 14 isolates of V. parahaemolylicus in both 
tests. Discrepancies in the number of bands were also the result of inconsistencies in gel running conditions. 
Isolate No. of bands References 
Test I Test 2 Figures: Lanes 
V. f!.Orahaemol}!,ticus: 
1902 (Type Strain) 2-3 5 6.4: 2 & 6.6: 20 
Vib3 4-5 5 6.4: 9 & 6.5: 6 
Vib5 4-5 5 6.4: 10 & 6.5: 8 
V PlO 3 3 6.5: 2 & 6.7: 10 
VP416 3 4 6.4: 11 & 6.8: 5 
VP491 2-3 4 6.4: 12 & 6.8: 6 
VP939 3-5 7 6.4: 13 & 6.8: 7 
VPECI 4-5 6-8 6.4: 14 & 6.8: 8 
VPSCI 4-5 6-8 6.4: 15 & 6.8: 9 
El54482 5 5 6.5: 16 & 6.6: 12 
El55855 5 5 6.5: 17 & 6.6: 13 
El68143 5 5-6 6.5: 18 & 6.6: 14 
2436 5 5-6 6.5: 19 & 6.6: 16 
6134 4 3-4 6.5: 20 & 6.6:18 
Other species 
S. lypimurium, ST5 2 2 6.4: 17 & 6.8: 18 
K. aerogenes, KAS 4 4 6.4: 18 & 6.8: 19 
P. aeruginosa, PAl 2-3 2-3 6.4: 19 & 6.8: 20 
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% Similarity 
810bp 635bp 390bp Isolate Species 
2053 V. parahaemolyticus 
6134 V. parahaemo/yticus 
E154482 V. parahaemo/yticus 
1023/1 V. parahaemo/yticus 
VP7 V. parahaemo/yticus 
VP331 V. parahaemolyticus 
VP346 V. parahaemo/yticus 
1902 V. parahaemo/yticus 
219 V. parahaemo/yticus 
VP10884 V. parahaemo/yticus 
VP416 V. parahaemo/yticus 
8042 V. cholerae 
11327 V. fluvia/is 
VanCM104 V. anguillarum 
KA5 Klebsiella aerogenes 
LD365 Ustonella damsela 
W11067 V. vulnificus 
BL21 E. coli 
PA1 P. aeruginosa 
ST5 S. typhimurium 
Figure 6.9: Comparison of ITS-PCR to differentiate representative V. parahaemolyticus from other 
members of Vibrio spp., and related bacteria. Arrow indicates a 390 bp spacer unique to V 
parahaemolyticus 
635 
390 
2 3 
790 
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f- 810 bp 
f- 640 bp 
f- 590 bp 
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f- 390 bp 
Figure 6.10: Length variations of 16S-23S (ITS I) spacers found in clinical and environmental V. 
parahaemolyticus. Lanes 1 & 3: bands found only in V parahaemolyticus with bands of Lane 1 as the 
predominant markers for the species. Lanes 3, 4, 5, 6 & 9: Bands found in some isolates of V 
parahaemolyticus. Bands above 790 bp were ignored. Data normalised in BioNumerics with internal and 
external reference positions with approximate sizes of bands (bp) indicated by arrow and below each lane. 
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% Similarity Isolate Location Source ITS 
81 Obp 635bp 390bp Types 
~ ~ ~ !' 
VP1 Salllllfi'CliCil. UK Emlra1rn<rill A 
VP349 Oorsel, UK Enworvn<rolll A 
1902 PHLS, UK NCIMB Ref.,.ence Slnlin A 
2 19 Noway Clillcol B 
1022110 Slain Emlra1rn<rill c 
102311 Spoln Emlra1rn<rill c 
110319 Spoln Emlra1rn<rill c 
VfT7 Salllltf1lliC11, UK Emlra1rn<rill c 
1023/J Spoln Emlra1rn<rill c 
VP10 Sallhanl>lm . UK ErMronmenlll c 
VP9 Salthlnl>ICil. UK Emlra1rn<rill c 
102115 Spoln ErMrc:rmentll c 
102415 Spoln ErMronmenlll c 
224 Norwty Clillc:al c 
227 Norwty Clillc:al c 
225 Noway Clillcal c 
226 Noway C*>lc:al c 
228 Norwty Clili<al c 
E154482 PH.S. UK Clillcol c 
E155855 PHlS, UK Clilk:al c 
2436 J- CIOIIall c 
5421 ~ Clillcol c 
E168143 PH.S. UK Cli'llcol c 
2053 ~ Clillcol c 
VP4 SalihanlJICil, UK En~ Ill c 
Vl'6 Salihanl>~Cil , UK ErMronmenlll c 
Vl'8 SalihanlJICil. UK ErMronmenlal c 
VP2 Sal!MirPCil. UK ErMronmenlll c 
VP3 SalihanlJICil, UK ~ronmenlll c 
6134 J- Clillc:al c 
VP331 Dorset. UK Em4rorvne'llal c 
VP345 Oorsel. UK EnWcrvn<ntal c 
220 Noway Cli'li<al c 
221 Noway Clillcol c 
222 Noway Clillall c 
223 N<lrwll' Cli'llcol c 
VP346 Oorsel, UK Emlra1rn<rill 0 
VP378 0orse1. UK Em4rorvn<ntll E 
VP416 Oorsel, UK EmAronmentll E 
VPJn Oorsel, UK Enwmmenlll E 
VP36 1 Dorset, UK EnWavnenlll F 
VP491 Oorsel, UK En-11 G 
VP108&4 PH.S. UK NCTC Ref.,.ence SlrUl H 
VP939 0orse1. UK Emlra1rn<rial H 
VPB::1 Oorsei. UK ErMronmenlll H 
VPSC1 0orse1. UK EnWaumr>tll H 
Vib10 Sal!MirPCil. UK EnWonmenlll 
Vib7 Solll'llnlltCil. UK EnWonmenlll 
Vlb8 Sollllln1iC11. UK ErMronmenlll 
Vib2 Solilltf1lllm, UK EnWonmenlll J 
WJ6 SolihanlJICil, UK EmAronmental J 
Vib1 Solllltf1lliC11, UK Emlra1rn<rill K 
Vib3 Solllltf1lliC11, UK ErMronmenlal K 
WJ6 Solllllfi'CliCil, UK EnWonmenlll K 
VP350 Oorsel, UK Em4ronmon111 L 
6316 J- Oinlcal M 
Figure 6.11: ITSl-PCR banding proftles from 56 isolates of V. parahaemolyticus used in tbe study. The 
dendrogram was generated using BioNumerics and a densitometric curve based analysis with groups 
determined as shown with a dotted line at 93% similarity. Groupings (A - M) resulted from bias of 
predominant (darker) bands over faint bands. Based on this study, the identity of isolate 63 16 is questioned. 
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6.4 Discussion 
Both the length and the sequence of the ITS region separating the 16S and 23S rRNA 
genes are increasingly used to assess relationships in bacterial population studies 
(Daffonchio et al., 2006; Stewart & Cavanaugh, 2007). This chapter assessed the 
feasibility of ITS length polymorphisms as a simple method for sub-typing V 
parahaemolyticus based on consensus 16S and 23S primers. The 56 isolates used in the 
study were assigned to 13 ITS Types, of which all but two clinical isolates fell into a single 
ITS Type that included an isolate (6316) initially identified as V parahaemo/yticus, the 
identity of which became questionable after ITS 1-PCR analysis. Environmental isolates 
appeared more variable and were found included in all but two ITS Types thereby 
providing a simple and efficient means of differentiating isolates of V parahaemolyticus. 
ITS 1-PCR was thus shown to be a quick and reliable way of inter and intra-species 
differentiation of V parahaemolyticus. The following discussion addresses some of the 
issues with the ITS 1-PCR technique and highlights some further work in this area of study. 
6.4.1 Primers used in the study 
The consensus primers used in the present study (Maeda et al., 2000) were shown to be of 
identical complementary match to V parahaemo/yticus regions based on BLAST 
comparisons at all 11 operon sites of the V parahaemolyticus genome based on strain 
RIMD 2210633 (Makino et al., 2003). Expected amplicon sizes for the sequenced strain 
are shown in Table 6.2. Based on these primers VINTF and VINTR successfully amplified 
up to eight bands despite the various degrees of background PCR noise that was present. 
Several approaches were taken to optimise reaction conditions and minimise the 
background PCR noise that was expected from the use of consensus primers in amplifying 
a number of products in a single PCR reaction. Bands of various intensities were produced 
implying either a favoured amplification of certain regions due to base mismatch in others 
or, as in this case, the presence of multiple amplicons of the same size (section 6.4.4). 
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6.4.2 ITSl-PCR banding patterns 
V. parahaemolyticus isolates used in the study were categorised into 13 groups based on a 
similarity score of 93% in dendrogram analysis. This point was selected as it differentiated 
isolate VP346 (ITS-D) from ITS-C, with three distinct bands less than 450bp that clearly 
distinguished this isolate from others. Despite this prominence, there was only a marginal 
difference in BioNumerics cluster analysis of less than 1% between VP346 and ITS-C. 
However, by using a 93% dendrogram similarity, other isolates that appeared visually 
similar were differentiated into their own types. For example, isolates in ITS groups A and 
B appeared similar to those of group C but it is likely that gel intensities and backgrowtd 
subtraction used in BioNumerics would have had some impact on reducing actual band 
intensities and thereby affecting calculations in the BioNumerics curve based analysis 
method. It is noteworthy that all four profiles of groups A and B, were from the 
furthermost lanes of gels where the UV illumination and the lightening system of gel 
photography may not have been optimal and hence background processing methods in 
BioNumerics may have incorrectly grouped similar banding isolates in separate clusters. 
This error is likely to be more apparent in techniques such as ITS 1-PCR as the analysis 
method is reliant on the discrimination based only on a few prominent bands. RAPD 
analysis (Chapter 8) explores whether a more complex banding pattern can minimise any 
such errors. 
Faint bands appeared largely unaccounted for in dendrogram analysis. Isolates in ITS-C 
could be visually identified as at least 4 banding types based on the presence of a 'doublet', 
and the presence or absence of faint bands between the 390 and 63Sbps. However, 
verification of these doublets would require more reliable size determination by use of 
acrylamide gels, or more accurately with the use of a DNA sequencer. The presence of 
these bands, were variable in some of the repeat tests and identification remained 
subjective. Despite this, and as isolates of ITS-C were from two gels (Figs. 6.6 & 6.7), the 
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grouping illustrates some degree of comparability between two independently run ITS 1-
PCR experiments. However, environmental isolates of ITS-I, 1 and K that showed similar 
banding profiles to clinical isolates of ITS-C were distinguished into their own groups. 
This highlights a further factor for consideration when comparing different gels: bands that 
appeared apparently the same by visual inspection were grouped differently on the 
dendrogram. To what extent this could be attributed to BioNumerics' inaccuracy in 
normalisation of gels or to the ITS 1-PCR technique itself remains uncertain. For example 
longer gel runs may have been able to better resolve small differences in amplicon sizes. 
Inherently, the ITS-PCR method, as with most other PCR typing methods, contains 
variables such as temperature control and buffer quality that are difficult to control, some 
of which are discussed in section 6.4.3. To enable more accurate comparisons in 
BioNumerics, isolates should be randomly distributed amongst the gels together with an 
internal reference for gel normalisation to verify ITS 1-PCR as a useful typing method. 
6.4.3 Properties of the ITSl-PCR system 
ITS1-PCR was shown to be a simple method of typing V parahaemolyticus throughout the 
study where all isolates of V parahaemolyticus appeared typeable. In some cases, 
individual agarose gels appeared unresolved (e.g. Figs. 6.4 & 6.8) and these are likely to be 
due to agarose gel running conditions and may reflect the age of buffers employed. A 
concentration of 2% ( w/v) agarose gels was used to achieve higher resolution of bands and 
thus increased gel running times and higher buffer temperatures may be partially 
responsible for these effects. To overcome such issues and to resolve bands which 
essentially all lay within a 400 bp region, other workers have employed polyacrylamide 
gels and have targeted more variable regions (section 6.4.4) within the ITS 1 domain to 
obtain smaller amplicons (Maeda et a/, 2000; Gonzalez-Escalona et al., 2006). 
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Perhaps the most significant criticism related to the ITS 1-PCR system is also the attribute 
that would most favour its use. Multiple ITS I regions of the same length, especially likely 
in strains possessing a large number of rRNA operons, may be difficult to distinguish and 
thus be unaccounted for, leading to bias in interpretation and phylogenetic groupings 
(Boyer et al., 2001). For example, the dendrogram presented in this present work clearly 
shows a bias in favour of the position of the more intense bands with weaker bands largely 
ignored (Fig. 6.11 ). Although this may be useful in its own right, as it highlights the 
significance of two, three or more copies of the ITS I spacer, it may not necessarily reflect 
true diversity of single copy spacers that may exhibit greater variability and thus more 
useful for a dendrogram based analysis. 
To overcome the bias generated by BioNumerics, several parameters (section 6.2.3) were 
altered for dendrogram construction to obtain reliable groups that corresponded with 
similar banding profiles. A 'band based' Dice coefficient was also employed but failed to 
adequately group similar isolates together, most likely due to the close proximity of the 
bands. A recent study that assessed BioNumerics parameters for optimal correspondence of 
E. coli strains showed that a curve based method was found to be more robust and reliable 
than the 'band based' banding profiles in REP-PCR (Goldberg et al., 2006). Clearly, 
further work optimising parameters would be necessary for more accurate software based 
analysis. The findings from these experiments highlight the need for careful empirical 
assessment of groupings that are automatically generated from software based analysis. 
6.4.4 Sequence based analysis of ITSl 
Due to the relative large copy number of the rRNA operons present in V parahaemolyticus 
and the presence of multiple ITS I of the same size, sequence analysis of spacer regions 
was not pursued in the present study. Clearly, the source of the ITS! variation present in 
some of the isolates have not been established. The 11 copies of the 16S genes of the 
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sequenced strain, RIMD 2210633, have been shown to possess identical nucleotide 
sequences (Makino et al., 2003). The design of operon specific primers would therefore 
involve initial 'Long PCR' followed by primers targeted to the conserved sequences, 
flanking ITS 1 regions. Gonzalez-Escalona et al. (2006a) demonstrated that conserved 
regions of 40 bp and 209 bp, flanking the 16S and 23S regions respectively, were present 
in the ITS1 of V parahaemolyticus (Fig. 6.12). Therefore, cloning and sequence analysis 
of a smaller region may help to establish further relationships between clinical and 
environmental isolates of V parahaemolyticus. The findings in the present study show that 
the 540 and 590 bp amplicons exhibit the greatest variability in size, and thus one or both 
of these ITS 1 regions may provide a source for genetic heterogeneity. 
6.4.5 ITSl spacer classes in V. paralraemolyticus 
The presence of multiple rRNA operons in the same genome have been widely 
documented in a large number of species including E. coli, Salmonella, V cholerae and 
V vulnificus (Boyer et al., 200 I; Chun et al., 2002; Gonzalez-Escalona et al., 2006a). Up to 
14 rRNA operons in psychrotolerant strains of Bacillus cereus have recently been reported 
(Candelon et al., 2004) with operon numbers of seven commonly found in bacteria. 
However, approximately 40% of bacterial species are believed to have just one or two 
copies of the rRNA operons (Acinas et al., 2004) and in such instances it is unlikely that 
length polymorphisms identified with ITS 1-PCR would serve as a useful tool for sub-
typing. 
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Figure 6.12: Schematic representation of the ITS I conserved regions in V. parahaemolyticus. Up to six 
spacer classes between 277 and 706 bps identified possessing genes for up to four tRNA (Table 6.2; Maeda 
et al. , 2000; Gonzalez-Escalona et al., 2006a). 
Table 6.2: Comparison of spacer classes identified in different V. paralwemolyticus, Variations in spacer 
sizes (a- c) based on four sequenced clinical strains that may be used to discriminate isolates are underlined. 
Column d shows approximate sizes based on current study. 
ITSI Spacer tRNA genes found in ITSI region ITS I S(!acer sizes {bf!) 
C lass a b c d 
0 None 277 278,278 278 268-278 
E Glu (UUC) 475 476, 461 lli 428-478 
lA Ile(GAU), Ala(UGC) 523 524, 524 524 523 
AE Ala(GGC), Glu(UUC) 54 1 542,542 527 528 
EKV Glu(UUC), Lys(UUU), Vai(UAC) 668 669, 669 669 678 
EKAV Glu(UUC), Lys(UUU), Ala(UGC), Vai(UAC) 705 706, 706 706 698 
a Based on Maeda et al., 2000 
b Based on two isolates, type strain ATCC 17802(Aq and RJMD 22 10856 (Gonzalez-Escalona, et a/, 2006) 
c Based on clinical strain RM1D 22 10633 (Makino et a/, 2003) 
dEstimated sizes aud li kely class assigned based on this study (band sizes minus 11 2 bp) 
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Based on the present limited study, it is most likely that the intensity of some of the bands 
(390 and 635 bps) are due to multiple copies of the same ITS spacer found in V 
parahaemolyticus (Maeda et al., 2000; Makino et al., 2003; Gonzalez-Escalona et al., 
2005b, 2006a) although sequence analysis of representative strains would be required to 
confirm these findings. 
Studies on the structural variation of the 16S-23S spacer regions of V parahaemolyticus 
have identified six spacer classes based on different tRNA gene compositions (Table 6.2). 
These classes were based on four clinical strains two of which were of the pandemic 
03:K6 serovar that are widely regarded to be clonally related (Matsumoto et al, 2000; 
Chowdhury et al., 2000b ). Furthermore, ITS I lengths between all four strains were in close 
agreement with each other (Table 6.2) with the lengths of spacers supporting the current 
study with 55 isolates of V parahaemolyticus. Present work has demonstrated that clinical 
isolates do not exhibit significant ITS 1 length heterogeneity in repeated PCR analysis and 
thus the varying banding intensities offer further evidence to support the case for multiple 
amplicons. Additionally, pandemic 03:K6 isolates that were used in the current study 
show identical banding profiles to other clinical and environmental isolates. Based on these 
findings, ITS1 lengths (at least of the clinical isolates used in the study) correspond 
favourably to those of sequenced strains. These lengths take into account a subtraction of 
112 bps corresponding to the primer positions near the 16S and on the 23S regions (Table 
6.2). Based on these initial assumptions, it seems likely that the ITS I Spacer Classes 0 
(possessing no tRNA genes) and lA (possessing genes tRNA11e and tRNAA1") present in 
three and two copies respectively, in the sequenced strains are commonly found in V 
parahaemolyticus. However the significance of having multiple copies of certain classes of 
operons remains unclear. Based on band intensities, it is probable that some environmental 
isolates may possess variations in operon copy number, a phenomenon suggested by others 
in B. cereus (Candelon et al., 2004, Clostridium difficile (Sadeghifard et al., 2006) and 
133 
Acinetobacter spp. (Maslunka, et al., 2006). The present data also suggest that Spacer 
Class E, possessing a single tRNA 01" gene, was the most variable of regions supporting 
previous work showing that indels near the tRNA 01" gene was responsible for ITS 1 spacer 
variation (Gonzalez-Escalona et al., 2006). The presence of one, two or both bands (540 
and 590 bps) in some of the isolates in the current work suggest that some isolates may 
possess two copies of this spacer, rather than just the one identified in previous studies 
(Makino et a/, 2003, Gonzalez-Escalona et al., 2006a). The presence of these two bands 
may also correlate with the two rrs classes identified in V parahaemolyticus (Moreno et 
al., 2002; Harth et al., 2007). Clearly, further work and sequence analysis would be 
required to verify any of these claims and establish the significance of these two bands and 
spacer classes to the virulence of V parahaemolyticus. 
This work has shown that multiple rRNA operons present in the V parahaemolyticus 
genome can be exploited for the sub-typing of this organism using a simple PCR reaction. 
The primers used in the study identified additional ITS 1 spacers in environmental isolates 
that previously had not been reported. The main ITS 1 spacers (i.e. the more intense bands) 
consisting of multiple ITS 1 regions offered a quick method to differentiate V 
parahaemolyticus from other members of the aquatic environment but clinical isolates in 
general appeared indistinguishable from environmental strains with ITSl-PCR. 
Nonetheless, a previous study has shown that ITS spacers can be resolved directly from 
bacteriallysates without the need for further DNA purification (Gonzalez et al., 2003) thus 
favouring ITS-PCR for V parahaemolyticus. The large numbers of genes for tRNA 
molecules present within the ITS I spacer regions also suggest that a similar method may 
be employed to identify length polymorphisms in V parahaemolyticus and is explored 
further in the next chapter. 
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Chapter 7 
DNA PROFILING OF VIBRIO PARAHAEMOLYTICUS 
ISOLATES USING tDNA-PCR TO GIVE 
INTERGENIC LENGTH POLYMORPHISMS (ILPs) 
7.1 Introduction 
The genes for tRNA can be found arranged in clusters distributed throughout the bacterial 
genome often within multiple tandem repeat units. The order and arrangement of these 
genes is highly conserved, whereas the intergenic spacer regions between them can vary 
considerably, being prone to the insertion of mobile genetic elements such as insertion 
sequences (IS), transposons, bacteriophages and genomic islands (Gurtler & Mayall, 
2001). Length polymorphisms between adjacently primed tDNA sequences have been 
used to assess the degree of relatedness in a wide range of bacterial species and sub 
species. The PCR amplification of tDNA intergenic length polymorphisms (tDNA-ILPs) 
can be achieved by employing consensus primers, or specifically designed primers that are 
annealed at low stringency. Welsh and McClelland developed a set of consensus tRNA 
gene primers designed to face outwards from the end of the tRNA genes that have been 
shown to amplify a tDNA-PCR fingerprint that is determined by the arrangement oftRNA 
genes on the bacterial genome (Welsh & McClelland, 199la; McClelland et al, 1992). 
This technique has been successfully applied to distinguish at the species and subspecies 
level in a wide group of bacteria including Renibacterium salmoninarum (Alexander et al., 
2001 ), Streptococcus (McCielland et a/, 1992; Zschock et al., 2005), Staphylococcus 
(Welsh & McCielland, 1992; Maes et al., 1997), Acinetobacter (Ehrenstein et al., 1996) 
and more recently in Klebsiella pneumoniae (Lopes et al., 2007) 
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Genome sequence information for V parahaemolyticus has shown the organism to possess 
up to 126 tRNA genes distributed between the two chromosomes in comparison to 11 
rRNA operons (Makino et al., 2003; Gonzalez-Escalona et al., 200Sb). Thus, the 
successful application of consensus primers targeted to the tRNA regions of the V 
parahaemolyticus genome has a greater banding pattern potential than 16S-23S ITS 1-PCR 
(Chapter 6) to show intra-genomic variation, and hence provide a simple and rapid means 
of typing of this organism. The primers developed by Welsh and McClelland were based 
on I) at least a perfect match in five bases between the 3' end of the primer and many 
tRNA genes and 2) extensive homology in the rest of the primer with a number of different 
tRNA genes from a wide variety of sources (Welsh & McCielland, 1991a). The recent use 
of these consensus primers with Klebsiella spp. revealed different tRNA arrangements and 
highlighted intraspecies heterogeneity (Lopes et al., 2007). Considering the ease of use and 
simplicity, this method could show high efficiency for the typing of V parahaemolyticus. 
This chapter describes the use of consensus primers developed by Welsh and McClelland 
and the development of a PCR method to assess the differentiation of V parahaemolyticus. 
Thus the following were investigated: 
i) molecular typing of V parahaemolyticus based upon PCR amplification of 
tRNA spacer regions 
ii) comparative analysis of different sets of consensus primers described by Welsh 
and McClelland (1991) with V parahaemolyticus 
iii) the usefulness of tRNA-PCR ILPs typing as a molecular typing tool in V 
parahaemolyticus and 
iv) an evaluation of the ability to discriminate clinical and environmental (that may 
also be pathogenic) isolates of V parahaemolyticus based on tDNA-PCR ILPs 
typing. 
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7.2 Materials and Methods 
7.2.1 tDNA primer screening with V. para/raemolyticus 
Primers T3A, T3B, T5A and T5B (Table 7.1) were initially screened in all 6 pair wise 
combinations on a panel of strains that included NCTC reference strain VPI 0884 and 
clinical and environmental isolates, in accordance with the published protocols (Welsh & 
McClelland 1991, 1992; Clementino et a/, 2001) and reaction conditions optimised for use 
with V parahaemolyticus genomic DNA. 
Table 7.1: Description or consensus tDNA primers used in this study 
Primers Sequence Reference 
T3A 
T5A 
5'-GGGGGTTCGAA TTCCCGCCGGCCCCA-3' } 
5'-AGTCCGGTGCTCTAACCAACTGAG-3 Welsh & McCielland, 1991a 
T58 5'-AA TGCTCTACCAACTGAACT-3' 
McCielland et al., 1992 
T38 5'-AGGTCGCGGGTTCGAA TCC-3' 
7.2.2 PCR amplification of tDNA intergenic spacer regions using consensus primers 
The tDNA-PCR reactions were performed with DNA extracted from 56 isolates of V 
parahaemo/yticus and a further ten species that included other members of Vibrionaceae, 
Listonella spp., Klebsiella spp., and E. coli. Of the six primer sets, three were used to 
deduce fingerprinting profiles for all 69 isolates studied, viz. primer set I (T3A/T5A), 
primer set 3 (T3B/T5A) and primer set 5 (T3A/T3B); fingerprints were designated tDI, 
tD2 and tD3 respectively. 
Reactions were performed using a 50 111 mixture containing 1 U of Taq polymerase and 
reaction buffer with 1.5 mM MgCh (Roche ), 20 pmol of each tRNA gene primer (Sigma), 
0.2 mM deoxynucleoside triphosphates, and 20 ng of bacterial DNA. PCR amplification 
was facilitated in a DNA thermal cycler (Model: Primus 96, MWG Biotech). The reaction 
137 
mixture was incubated at 94 oc for 2 m in, and then subjected to 40 cycles of 94 oc for 30 s, 
50°C for 30 s, and 72°C for 2 min and a final cycle of 94°C for 30 s, 50°C for 30 s, and 
72°C for I 0 min. The amplification products were visualised after electrophoresis and 
banding profiles compared on 2% agarose gels. Banding profiles were also compared for 
reproducibility from two independent experiments. 
7.2.3 Dendrogram analysis of tDNA-PCR 
Dendrograms showing the relationships between isolates of V parahaemolyticus were 
generated using BioNumerics Software with modules for Fingerprints and Cluster Analysis 
(version 5.1, Applied Maths, Ghent, Belgium). All banding patterns for the three consensus 
primer sets were used for the cluster analysis of 56 isolates of V parahaemolyticus. The 
bands from each lane were subjected to curve calculations and analysis to exclude 
background noise from PCR reactions. The tracks were then normalised using two external 
reference positions that consisted of 50 bp molecular weight markers on either side of the 
gel and a common band that appeared in several lanes as an internal reference. Up to nine 
bands per lane, many of which were also common between isolates, were scored according 
to their presence or absence within the I 00 to 800 bp range only. Dendrograms calculated 
by the unweighted pair group method by arithmetic averaging (UPGMA) algorithm using 
both band matching coefficients (Dice) and curve matching correlation coefficients 
(Pearson product-moment correlation) were used as appropriate to obtain the most reliable 
clustering patterns. A dendrogram that combined the data for all three fingerprint sets was 
also constructed. BioNumerics position tolerance settings were 0.5% optimisation, a 
position tolerance of 5% of gel and ignoring faint bands. 
7.2.4 Concordance between tDNA fingerprint types 
The concordance between tO I, tD2 and tD3 fingerprint types were determined using 
BioNurnerics by comparing the values from the similarity matrices of the typing methods 
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7.3 Results 
7.3.1 Consensus tDNA primer combinations 
All six combinations of the four primers described by Welsh and McClelland were used on 
a test panel consisting of three clinical and three environmental isolates of V 
parahaemolyticus. These primers were designed to amplify the intergenic spacer region 
from the 5' and 3' ends of tRNA genes and were selected based on the successful 
amplification of the most number of bands that were widely spread in fragment size (Fig 
7.1). Primer pairs T3B/TSB and T3A/T5B showed a similar banding profile to T3B/T5A 
and T3A/T5A respectively, but fewer bands. Similarly, primers T5AIT5B showed a 
maximum of three bands amongst the six panel strains and therefore the remaining three 
primer pairs T3AIT5A, T3B/T5A and T3A/T3B were selected to investigate their ability to 
produce reproducible IONA fingerprinting patterns and assess the ability to subtype 
clinical and environmental isolates of V parahaemolyticus. 
7.3.2 tDNA-PCR subtyping based on primers TJA and TSA (tDl) 
The use of primers T3A/T5A (tO I) produced fingerprints that included four major bands 
of approximately 205, 355, 410 and 740 bp in most of the isolates of V parahaemolyticus. 
Additional bands were present but appeared faint and were excluded from the analysis. 
Most of the differences in fingerprinting profiles were based on small but significant 
differences in the relative sizes of fragments that were amplified (Figs. 7.2 and Fig. 7.3). 
Using UPGMA cluster analyses on V parahaemolyticus is was possible to group the 56 
isolates of V parahaemolyticus into seven clusters at a 90% similarity value, labelled tDl-
A to tDl-0 (Fig. 7.3). Cluster tDI-A was the largest (25 isolates in fingerprint type tDl) 
but unable to differentiate three clinical UK isolates from the remaining 22 environmental 
isolates. Similarly, two Japanese clinical strains were grouped with 7 environmental 
isolates in cluster tD 1-C. However, cluster tO 1-D consisted entirely of 13 clinical isolates 
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that included all I 0 isolates from Norway, two from Japan and a UK clinical reference 
strain. Although these isolates were from three different locations, all 13 isolates were 
grouped into a single cluster that included isolates of diverse serotypes and Pulse Types 
(section 5.3.5). Cluster tD 1-F contained five isolates of environmental origin and from the 
same geographical region. Isolates Vib8 and 6316 could not be grouped into any clusters; 
therefore, in this study they are the single representatives of two other groups tD 1-E and 
tDI-G respectively (Fig. 7.3). As with Chapter 6, together with fingerprint types tD2 and 
tD3, the identity of isolate 6316 as V parahaemolyticus remained questionable. 
7.3.3 tDNA-PCR subtyping based on primers T38 and TSA (tD2) 
Fingerprints produced by the primers T3B/TSA (tD2) showed a maJor band of 
approximately 370 bp that was present in all but one isolate (6316) of V parahaemolyticus 
(Fig. 7.4 ). A further nine bands of less intensity ranging in size between I 00 and 500 bp 
were also present in most of the isolates and could be used to distinguish V 
parahaemolyticus into 8 types (Fig. 7.4: E). However, as with primers T3AITSA, faint 
bands were excluded in the BioNumerics cluster analysis (Fig. 7.5). 
Cluster analysis at a similarity value of 95% enabled the 56 isolates of V 
parahaemolyticus to be grouped into 7 clusters (tD2-A to tD2-G). Cluster tD2-A was the 
largest accounting for 64% of the isolates but was unable to differentiate between a total of 
36 clinical and environmental isolates at 95% similarity (Fig. 7.5). Group tD2-B was the 
only group to consist of clinical isolates, both of which were from Norway. Clusters tD2-C 
and tD2-F both consisted of a mixture of clinical and environmental isolates, whereas tD2-
D and tD2-E contained environmental isolates only. 
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7.3.4 tDNA-PCR subtyping based on primers T3A and T3B (tD3) 
Primers T3A/T3B (tD3) amplified a maximum of nine visible amplicons with three major 
bands of approximately 240, 270 and 500 bp that were present in all but one isolate of V 
parahaemolyticus ( 6316). A distinct feature of tDNA-ILPs with these primers was that the 
sizes of all bands fell within a relatively short range of240-550 bp (Fig. 7.6). 
At a 95% similarity value, a UPGMA cluster analysis grouped the 56 isolates into 9 
clusters (tD3-A to tD3-I). Cluster tD3-B appeared the largest consisting of 26 clinical and 
environmental isolates (Fig. 7.7). Two other clusters (tD3-A and tD3-C) also consisted of 
mixed clinical and environmental isolates. Group tD3-D contained three clinical strains 
and NCTC UK reference strain, VP I 0884 (Fig. 7. 7). In addition, two clinical strains (219 
and E155855) were clustered with an otherwise predominantly environmental group of 
isolates in clusters B and C respectively. Three Norwegian clinical isolates that were 
previously grouped with other clinical isolates (based on fingerprint types tD l and tD2) 
from the same geographical region fell into a distinct cluster (tD3-D) of its own (Fig. 7.7). 
Furthermore, using primers T3A and T3B isolates VPSCI, 2053 6316 and 1021/5 
represented unique groups of their own. 
7.3.5 Comparative analysis of tDNA fingerprinting with different primers 
Using a curve based correlation coefficient to generate dendrograms for all three primer 
sets, it was possible to group isolates at relatively high similarity values of >90%. With 
dendrogram analysis the 56 isolates of V parahaemolyticus were grouped into seven, 
seven and nine clusters for the three fingerprint types, tDl, tD2 and tD3 respectively, as 
described above. With the exclusion of isolate 6316 that was distinguished into its own 
type with all three primer sets, the remaining 55 isolates showed similarities greater than 
66%, 93% and 83% in each of the fingerprint types tDI, tD2 and tD3 respectively (Figs. 
7.3, 7.5 & 7.7). Of the groups obtained, there appeared some concordance in groupings 
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amongst the three fingerprint types. For example, four Spanish isolates (1022110, 1023/1, 
1023/3 and 11 03/9) grouped in the first cluster of tD 1 and tD2 were also sub-grouped in 
t03-C but a further isolate (1021/S) was not identified as concordant. Likewise, whereas 
two isolates (VP349 & 20S3) from tD 1-B were found together, they were identified in 
separate groups in tD2 and tD3. Similar qualitative measures of concordance could be 
identified throughout the three fingerprint types. 
A comparison of the similarity matrices obtained from the three pnmer pairs was 
performed (Fig. 7.8). Three scatterplots representing all three comparisons demonstrated 
data skew towards high percentage similarity values whereas plots at the lower percentages 
were representative of distance relatedness of isolate 6316, the identity of which remained 
uncertain from typing experiments. A measure of concordance calculated with the Pearson 
product-moment correlation coefficient yielded congruence values of 69.9, 47.2 and 74.6 
percent for comparisons tD I /t02, tO llt03 and t02/t03 respectively (Fig. 7 .8). Linear 
regression models showed good data fit of 7S, 66 and 82% for the respective comparisons 
(Fig. 7.8) Therefore, fingerprint types tD2 and t03 were identified most concordant and 
tDl and t03 as the least concordant of the three comparisons. 
7.3.6 Combined dendrogram analysis of tDNA-PCR 
Fingerprints tO 1, tD2 and tD3 were combined as a composite data set (tD-combined) to 
assess whether better discrimination between V parahaemolytiocus isolates could be 
achieved (Fig. 7.9). At 9S% similarity, isolates were grouped into 12 clusters (tO-
combined A to L) of which five isolates (1 024/S, VP939, 2436, 20S3 & 6316) formed 
single members of their own clusters. With the identity of isolate 6316 questioned, the 
remaining SS isolates appeared >84.S% similar in combined dendrogram analysis. Cluster 
tO-combined -C grouped three clinical strains with environmental isolates from 
Southampton whereas Clusters 0, E, J and K consisted entirely of environmental isolates. 
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Group F clustered 12 clinical strains with NCTC reference strain V P 10884. The composite 
tD-combined data did not discriminate more than single tDNA primer pairs alone. tDI 
formed a larger number of groups at 95% similarity but groupings appeared to correspond 
largely to the isolates from the same gels. The combined data is evaluated for concordance 
with other typing systems in Chapter I 0. 
7.3.7 Reproducibility of tDNA-PCR 
A side-by-side comparison of six isolates of V. parahaemolyticus was performed to assess 
the reproducibility of the tDNA-PCR technique (Fig. 7.1 0) with all three sets of primers. A 
total of 18 comparisons of two repeats were analysed. Isolates from tDNA-PCR described 
in the reproducibility test were obtained from Figures 7.1 (20 pmols of primers), 7.2, 7.4 
and 7.6. 
Fingerprints appeared largely reproducible with regards to presence or absence of bright 
bands, but faint bands showed more variability (Fig. 7 .I 0). For example, in some of the 
repeats, faint bands could not always be ascertained, appeared absent or present in the 
repeat. Additionally, in some tests the brighter bands did not appear consistent between the 
two repeats (tD 1: I 021/5; tD3: 1021/5 & 2053). However, of the 18 comparisons, the main 
amplicons (4 in tDI, I in tD2 and 3 in tD3) could be identified in all but one comparison 
(Primer set tDI, isolate VP10884) (Fig. 7.1 0). 
7.3.8 tDNA-ILPs in other species 
Distinct fingerprint profiles were obtained for isolates of V. anguillarum, V. mimicus, V. 
fluvialis, V. cholerae, V. vulnificus, V. alginolyticus and L. damsela with PCR conditions 
optimised for V. parahaemolyticus in all fingerprint types (Figs. 7.2, 7.4 & 7.6). In all three 
fingerprint types isolate 6316, which had previously shown a unique fingerprint pattern, 
matched that of V. mimicus (Figs. 7.2, 7.4 & 7.6). Additionally, the profile of isolate Vib4 
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an unspeciated Vibrio sp., matched that of L. damsela (LD365). Furthermore, common 
amplicons were present in several Vibrio spp. For example, with primers T3B and TSA, V 
cholerae and V parahaemolyticus shared two common sized fragments of approximately 
200 and 470 bp (Fig 7.3). Similarly, V mimicus and V vulnificus shared common bands 
with V parahaemolyticus. Dendrogram analysis revealed the close tDNA-ILP similarities 
of V alginolyticus (2341) and V vulnificus (KIDBVV) with that of V parahaemolyticus 
(Fig. 7.11). The data showed a high degree of consistency of the tDNA-PCR technique in 
differentiating V parahaemolyticus at the species level. 
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Gel 2: Primer sets T3Bff5A and T3Bff5B 
M I 2 3 45 6 78 910 1112 1314151617181920M M21222324252627282930M 
Gel3: Primer sets T3Aff3B and T5Aff5B 
~700bp 
~350bp 
Figure 7.1: tDNA-PCR fingerprinting profiles with all 6 combinations of tDNA primers using a panel 
strain of 3 clinical and 3 environmental isolates. Lanes corresponding to the following isolates: 1-5: 
102115; 6-10: 2053; 11-1 5: Vibl ; 16-20: El55855; 2 1-25: VP350; 26-30: NCTC reference strain VPI0884. 
In each set of 5 lanes, the first two lanes correspond to I 0 pmol of primers, and the second two lanes 
correspond to 20 pmol of primers. Each lane alternates with the first and second primer set in Gels I, 2 and 3 
above. The fifth lane for each isolate is DNA only. Negative controls are marked with - and M corresponds 
to 50 bp molecular size markers: selected sizes are indicated on the right of each gel. 
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Figure 7.2: tONA-PCR fingerprints of 56 isolates of V. paraltaemolyticus and related spedes of clinical 
and environmental origin using primers T3A and TSA. Lane marked(-) is no DNA control and each lane 
is marked with the corresponding isolate at the top. NCIMB and NCTC reference strains for V. 
parahaemolyticus are 1902 and VP I 0884 respectively. Strains 11327 and 8042 are NCTC reference strains 
for V. vulnificus and V. cho/erae respectively. In each gel, 50 bp ladders were used, sizes of selected markers 
are indicated by arrows on the right 
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% Similarity 
730bp 4ll))p JS5bp 205bp 
I t I I 
Isolate Location So11rct tDl clusttr 
IIP3n 0cnot. UK EnWonmentll 
IIP378 Ocnat, UK En-tll 
VP350 0cnot. UK En-Ill 
VP416 Ocnat, UK En-tll 
111>3 ~•. EnWonmentll 
Vl>5 .. EnWonmentll 
VP4 SoulllaTc*Jn,. En-tll 
VP7 ~.. En-111 
VP2 ~en .. EnW'clnnw>tll 
IIP3 ~en •. EnWcnmonllf 
VP10 .. enwon ........ 
VPI ~.. EnWmmlnllf 
VP8 •. E.-111 A 
VP!I ~en .. Em4ronnwrt:ol 
VP8 SoulllaTc*Jn.. EnWcnmonllf 
1022/10 Spoin Em4ronnwrt:ol 
VP491 Ocnat, UK E,....,._lll 
102311 Spoin E~ 
102313 Spoin EnW'clnnw>llf 
110319 Spoin e.-111 
E154482 PHLS, UK c.1lcll 
PHLS, UK c.1lcll 
~- EnWonmentll 
 •. EnWonmonllf 
PHLS, UK c.1lcll 
E15585S 
\11)1 
\11)2 
El68143 
102115 
11102 
IIP346 
IIP349 
102415 
Vl>5 
\11)7 
Vl>10 
Spoin &Wmmontll }- B 
PHLS. UK NCIIIIB R-..:e S1roin 
Ocnat, UK ~
Ocnat, UK EnWon.,.,tll 
Spoin EnWonmonlll 
~ .. EnW<>nmenllf 
•. EnWonmontll 
~.-~
2053 J- Clinicol 
5421 J- c.1lcll 
VP939 Ocnat, UK EnWonmonllf 
226 ~ Clinicll 
227 ~ c.1lcll 
228 ~ c.1lcll 
VP101l84 PHLS, UK NCTC Rolorwnce StlWn 
221 ~ c.1lcll 
223 ~ c.1lcll 
220 
224 
225 
222 
8134 
219 
2438 
\11)8 
IIP345 
VP361 
IIP331 
VPEC1 
I/PSC1 
6316 
J- Clinicll 
~ •. EnWonnw!tll 
0cnot. UK En......,_tll 
0cnat. UK EnWonnwltll 
Ocnat, UK EnW<>nmentll 
Ocnat, UK EnW<>nmenllf 
Ocnat, UK EnWonnwllll 
J- c.1lcll 
c 
D 
Figure 7.3: Dendrogram based on UPGMA clustering or normalised tDNA-ILPs or V. 
parohaemolyticus obtained with primers T3A and TSA. At least 4 bands were present in all isolates 
(except 6316), varying in size and intensity. Clusters tDI-A to tDI-F are based on a 90% similarity score 
indicated by the dotted line. Scale above banding profiles indicates approximate sizes of amp I icons. 
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Figure 7.4: tDNA-PCR fingerprints of 56 isolates of V. parahaemolyticus and related species of clinical 
and environmental origin using primers TJB and T5A. Lane marked(-) is no DNA control and each lane 
is marked with the corresponding isolate at the top. NCIMB and NCTC reference strains for V. 
parahaemolyticus are 1902 and VP I 0884 respectively. Strains 11327 and 8042 are NCTC reference strains 
for V. vu/nificus and V. cho/erae respectively. ln each gel 50 bp ladders were used, sizes of selected markers 
are indicated by arrows on the right. Insert (E) shows the eight tD2 banding types identified using primers 
T3Bff5A. 
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liOiate Loattion Sotlrce 102 duster 
% Similarity 
4JOI>p J70bp JSSbp 20Sbp 
I I I I 
VP8 Soullla'npm, UK Envi'onmonlol 
VPil ~. UK EnWor'llW1Ial 
VP10 Soullla'npm, UK Envi'onmonlol 
VP8 Soullla'npm. UK Envi'onmonlol 
VP7 Soullla'npm, UK Envi'onmonlol 
VP1 SOUINr'f1llan, UK Envi'onmonlol 
VP4 Soullla'npm. UK Envi'onmonlol 
VP2 Soullla'npm, UK ~
VP3 Soullla'npm, UK Envi'onmonlol 
E154482 PHLS, UK Clnital 
102311 Splin Envi'onmonlol 
\IP34& OcrHI, UK Envi'onmonlol 
102313 Splin Envi'onmonlol 
102o4/5 Splin Envi'onmonlol 
110319 Splin ~
1022/10 Splin Envi'onmonlol 
225 ~ ~ 
22e N.._ Clnital A 227 ~ Clinic* 
5421 J- Clnital 
220 ~ Clilicll 
222 ~ Clnital 
223 ~ Cllnicol 
221 ~ Clinic* 
8134 J- Clnital 
228 ~ Clnital 
2438 J- Clnital 
VP1oe&l PHLS, UK NCTC R ...... S,.., 
Vl>1 ~.UK~ 
Vl>10 Soullla'npm, UK E~ 
Vl>3 Soullla'npm, UK ~
VI>& Soullla'npm, UK EnWormontal 
Vll6 ~. UK Envi'onmonlol 
Vl>7 UK EnWonmon1o1 
VI>& ~.UK~ 
Vl>2 . UK Emtruvnontol 
219 ~ Clnital }-B 224 ~ Clinic* 
E1551155 PHLS, UK 
= } E168143 PHLS, UK 102115 Splin EnW1wnontaf c 
1902 PHLS, UK NCIMB Rlforw1ce-
VP331 OcrHI, UK 
- }n VP345 OcrHI, UK En-VP381 OcrHI, UK ~ 
VPEC1 OcrHI, UK 
-VP491 Dcnol, UK E.......,_ 
}E VPil39 Dcnol, UK -VP349 Oone1, UK EnW1wnontaf VP350 OcrHI, UK -VP3n OcrHI, UK ErMronmonlol 
VP418 OcrHI, UK 
-VP378 OcrHI, UK EnYnwvnon111 
2053 J"*' Clnital }-F 
VPSCf OcrHI, UK 
-8318 J"*' Clinic* -G 
Figure 7.5: Dendrogram based on UPGMA clustering of normalised tDNA-lLPs of V. 
parahaemolyticus obtained with primers T3B and T5A. Up to eight bands were present in most isolates 
(except 6316), varying in size and intensity. Clusters A to G are based on a 95% similarity score indicated by 
the dotted line. Scale above banding profiles indicates approximate sizes of amplicons. 
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Figure 7.6: tDNA-PCR fingerprints of 56 isolates of V. parahaemolytlcus and related species of clinical 
and environmental origin using primers TJA and TJB. Lane marked(-) is no DNA control and each lane 
is marked with the corresponding isolate at the top. NCIMB and NCTC reference strains for V. 
parahaemolyticus are 1902 and VP10884 respectively. Strain 11327 and 8042 are NCTC reference strains for 
V. vulniflcus and V. cholerae respectively. In each gel 50 bp ladders were used, sizes of selected markers are 
indicated by arrows on the right. 
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Isolate Loutlon Souce tDl cluter 
% Similarity 
7llllp 41111p 24Sbp 
' ' ' f ~ 
IIP1 Soi.Chon1*>n. lJ( ~ }A IIP7 Soi.Chon1*>n. lJ( Elwlr-E1544. PHtS, Ul( c.,_ 
2QO ~ ~ 
E1881. PHtS, Ul( Clnk:ol 
IIPEC1 o.r-. Ul( ~ 
5421 ~ Clnk:ol 
8134 .-.. Clnk:ol 
m ~ Clnk:ol 
223 Nolwo\' c.-
225 ~ Clnk:ol 
220 ~ Clnk:ol 
221 ...._ Clnk:ol 
22oC ~ Clnk:ol 
IIP2 Soi.Chon1*>n' lJ( E-
IIP3 ~.lJ( 
-\/PI Soi.Chon1*>n. lJ( ~ B 
IIP8 -...... lJ( 
-IIP8 -......UI( ~ 
IIP4 -...... lJ( E-
21V Nolwo\' Clnk:ol 
1111>10 -...... lJ( f-
WJ5 -.-. lJ( EJMrortmnol 
Wlll -....,, UK ~
~ -....,, lJ( 
-111>7 --. lJ( 
-\/PlO Soi.Chon1*>n. lJ( 
-Vlb1 Soi.Chon1*>n. lJ( ~ 
V1b2 -....,, lJ( 
V1b3 Soi.Chon1*>n. lJ( 
-102311 Si>oln 
-102313 Si>oln 
-
-
o.r-. Ul( fiMr-
£1558. PHtS, lJ( Clnk:ol 
IIP34V D<nol, lJ( ~ 
IIP3T7 o.r-. Ul( 
-IIP418 o.r-. Ul( 
-IIP371 o.r-. Ul( Elwlr- c IIP4V1 D<nol, Ul( 
-IIP331 0or-. UK 
-IIP345 D<not, UK ~ 
IIO:W Si>oln 
-IIP3SO D<nol. Ul( ~ 
IIP361 D<nol, Ul( 
-1022/10 Si>oln ~ 
102415 Si>oln 
228 Nolwo\' 
Clnk:ol } 227 ...._ lnk:ol D 
228 ...._ 
=Rol--IIP1011. PHtS, Ul( 1/PSCI D<nol. Ul( 
-
-E 
2053 .-.. Clnk:ol -F 
11102 PHtS, Ul( :=::.,--}-a 
-
D<nol, lJ( 
102115 Spolft ~ -~-~ 
8318 .-.. Clnk:ol 
- I 
Figure 7.7: Dendrogram based on UPGMA clustering of normalised tDNA-ILPs of V. 
parahaemolyticus obtained with primen T3A and T38. Up to 10 bands were present in all isolates (except 
6316), varying in size and intensity. Clusters tD3-A to tD3-I are based on a 95% similarity score indicated by 
the dotted line. Scale above banding profiles indicates approximate sizes of amplicons. 
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Figure 7.8: Simi larity plots of tDNA-PCR fin gerprint types with three primer pairs. Congruence of 
fingerprint types tDI /tD2, tD I/tD3 and tD2/tD3 were 69.9%, 47.2% and 74.6% respectively. The linear 
regress ion corre lation, r, is a lso ca lculated and expressed as a percentage fit (BioNumerics, Applied Maths). 
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Isolate Location Source tO-combined 
% Similarity 
cluster 
' ' 
\! l! 
' ' 
¥ 
102415 Spain Environmental A 
VP939 Dorset, UK Environmental 8 
E154482 PHLS. UK Cfinical 
E155855 PHLS, UK Cfinical 
VP2 Soulhamplon, UK Environmental 
VP3 Soulh81l1J!on, UK Environmental 
VP4 Soulhamplon. UK Environmental 
VP6 Soulhamplon, UK Environmental 
VPB Soulhamplon. UK Environmenlal 
VP9 Soulhamplon, UK Environmenlal 
VP10 Soulhamplon, UK Envirorvnental c 
VP1 Soulhamplon, UK Envlronmenlal 
VP7 Soulh81l1J!on. UK E nllironmental 
Vib3 Soulhamplon, UK Environmental 
Vob5 Soulh8f1'lllon, UK Environmenlal 
Vob1 Soulhampton, UK Environmental 
Vib2 Soulhamplon, UK Environmental 
E168143 PHLS. UK Cinical 
VP346 Dorset. UK Environmental 
VP349 Dorset. UK Environmenlal 
VP350 Dorset, UK Environmental 
102311 Spain Environmental 
102313 Spain Environmental 
110319 Spain Environmental D 
102V10 Spain Environmental 
VP491 Dorset, UK Environmental 
VP377 DorseL UK Environmenlal 
VP378 Dorset. UK Environmental 
VP416 DorseL UK Environmental 
Vib6 Soulhamplon. UK Environmenlal }E Vib7 Soulhampton. UK Environmental Vib10 Soulh8f1'lllon, UK Environmental 
Vib8 Soulh8f1'lllon, UK Environmenlal 
222 Norway Clinical 
223 NO/Way Clinical 
220 NOIWay Clinical 
221 Norway Clinical 
224 Norway Clinical 
6134 Japan Clinical 
219 Norway Clinical F 
226 Norway Clinical 
227 Norway Clinical 
225 Norway Clinical 
228 Norway Clinical 
5421 Japan Clinical 
VP10884 PHLS. UK NCTC Reference Strain 
2436 Japan Clinical G 
102115 Spain Environmental } H 1902 PHLS, UK NCIMB Reference Strain 
2053 Japan Clinical 
VPEC1 Dorset. UK Environmenlal } VPSC1 Dorset, UK Environmental 
VP331 Dorset, UK Environmental } VP345 Dorset, UK Environmental K VP361 DorseL UK Environmenlal 
6316 Japan Clinical L 
Figure 7.9: Combined dendrogram of composite tDI , tD2 a nd tD3 fingerprint da ta. 12 clusters tO-
combined -A to L are based on a 95% similarity score indicated by the dotted line. 
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Primers T3AffSA (tDl): 
1 2 2 2 1 2 2 1 2 
E1S58SS VPJSO VPI0844 
Primers TJBffSA (tDl): 
2 1 2 2 2 2 2 
VPI0844 
Primers T3Aff38 (tD3): 
2 2 2 1 2 2 1 2 
1021/S EISS8SS VP3SO VPI0844 
Figure 7.10: Reproducibility of tDNA-PCR fingerprints from six isolates in repeat tests J and 2 with all 
three primer pairs. Arrows indicate common amplicon of approximately 355, 370 and 270 base pairs in 
fingerprint types tDI , tD2 and tD3 respectively and indicate relative migration ofbands on each gel. 
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Isolate Species Location Source 
730bp 410bp JSSbp 20Sbp 
I I I I 
11 
228 V . .,...-.,olyticut Notway Clilic* 
5421 V . .,..._olyticut Jopen Clilic* 
2053 V. peno-..otj4icla Jopen Clilic* 
E155855 V. ~olyticuo PHLS, UK Clinlcel 
\11)1 V. ~olyticut sout\lmpton, UK Enwonmental 
VP1 v . .,.,.-..olyticuo sout\lmpeon, UK EnW'Onmenlel 
1802 V. ~olyticut PHLS, UK NCIMB R-..oo S~ 
2438 V . .,_.-.,olyticuo Jopen Clilic* 
VP101!84 V. ~olyticut PHLS, UK NCTC Reterwnoo s...n 
102~ V. l*ai\Mmolyticuo Spaln EnWonn1-l 
VP345 V. ~olyticuo Do<wt, UK ErMronmenl81 
IIPSC1 V . .,_.,_,olyticuo Ootvt, UK EnW'Onmenlllt 
2341 V. olglnolytcua Jopen Clilic* 
KJOBVV V. wlnillal t ~UK EIMronmonlll 
VanCM1 04 v . • nguillerum Plymouth ErMronmonl81 
EA5 E. MrOgonel 
L.D365 L domMIM DorMt, UKUK EIMronmonlll 
\IC4 V. chol ..... Sou!hampton, UK ErMn>nmon181 
VC5 V choleree sout\lmpton, UK EIMronm-1 
VC3 V. chol.,.. sout\lmpton, UK EnWonn1onl81 
11042 V chol- PHLS, UK NCTC Relll.- Snin 
VC1 V. chol ..... sout\lmpeon, UK ErMronmonlal 
VC2 V chol.,_ sout\lmp!On, UK EnWnnmonlal 
EC5 E. coli 
I/M4119 V minlc&J• Oo<wl, UK EnWonn11t111al 
~_. . joO{. W11067 V. loUinillcut ~UK EnWonn1enlal 
Figure 7.11: Dendrogram showing relatedness based on UPGMA clustering of tDNA-ILPs of Jl. 
parahllemolyticus and 8 related species. tDNA consensus primers T3A and T5A were used and data 
analysed with a curve based Pearson product-moment correlation coefficient. 
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7.4 Discussion 
To the author's knowledge, this chapter is the fust study that assesses tDNA-ILP typing for 
V parahaemolyticus by comparing and evaluating the performance of three pairs of tDNA 
primers. The use of these primers provided a simple and largely reproducible PCR based 
approach to subtype clinical and environmental isolates of V parahaemolyticus. This 
created divisions between isolates that had previously been shown to be biochemically and 
serologically indistinguishable and where clinical and environmental isolates could not be 
grouped by other means (Chapters 4 and 6). The method developed was applied to a total 
of 36 environmental and 20 clinical isolates sourced from the UK, Spain, Norway and 
Japan as well as isolates from other species. Based on the present study, the identity of one 
clinical V parahaemolyticus isolate, 6316, remained questionable. 
The tRNA genes occur in multiple copies dispersed throughout the bacterial genome in 
most species. The shared sequence motifs of tRNA genes mean that the use of primers that 
contain consensus tRNA sequences in the PCR are likely to result in a number of 
characteristic PCR products (Welsh & McClelland, 199la). In the current study, the use of 
consensus primers enabled the subgrouping of V. parahaemolyticus isolates into distinct 
clusters based on a similarly score of greater than 90%. These groups, although not 
identical, fared well in concordance studies with correlation greater than 66%. 
7.4.1 Fingerprinting based on tDl, tD2 and tD3 
Up to four bright bands and a further five faint bands were common in most isolates with 
tDl and these are representative of the multiple copies of tRNA genes found within 
clusters, which in turn are arranged within tandem repeat units. These bands can be 
generated from both within and between these multiple repeat regions (Honeycutt et al, 
1995). Upon closer inspection, it can also be seen that variation lies mainly in the relative 
sizes of the fragments and intensity of some of the bands rather than in the presence or 
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absence of bands, except for one clinical isolate, 222. Here, two fajnt bands were absent 
altogether, suggesting the absence or sequence variation of primer binding sites present in 
all the other strains. The absence of such bands also highlights a major drawback in the use 
of consensus tDNA primers in producing a robust test. Whereas mismatches between 
primer and target sequence can give rise to variation evident by PCR, the same mismatches 
compromise the stability and hence the reproducibility of faint bands evident in some of 
the repeat tests. However, a trade-off between reasonably reproducible results and ease of 
use formed the basis of the present study. 
With the large degree of s imilarities in banding profiles (similarity value of 75% 
accounting for 89% of all isolates), it was decided to cluster tD 1 groups at 90% similarity 
values, resulting in large clusters and only seven divis ions but interestingly formed an 
entirely new clinical division that had previously not been clustered using PFGE. Of this 
group, four isolates were of the pandemic serotypes, 03 :K6 (isolates 220, 222 and 223) 
and 01 :KUT (isolate 22 1 ). Isolates of these serovars have repeatedly shown a high degree 
of clonality in previous studies (Okuda et al., 1997b; Chowdhury et al, 2000b; Matsumoto 
et al., 2000; Laohaprertthisan et al., 2003). Based on tDNA-PCR it appears that these 
clonally re lated groups fe ll within a group of 13 clinical isolates of diverse serovars 
forming a unique cluster. However, as all 13 isolates were from the same gel (Fig. 7.2: Gel 
B), careful interpretation is necessary to determine whether this grouping could be 
attributed to close banding similarities or due to the inability of BioNumerics to 
differentiate isolates on the same gel, especially at such hi gh similarity values. A further 
criticism of the method developed is the use of an internal marker based on common bands 
in a gel in the BioN umerics normalisation process. Additional external markers (i.e. 
molecular size markers within the gel) would have been preferable, but was omitted from 
the experimental design as the author was unaware at the time that data would be analysed 
in BioNumerics. These errors in experimental design need to be addressed in future studies 
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to validate such groupings. Nonetheless, a further two clonally related 0 3 :K6 isolates 
(5421, 2053, Table 4.3) from cluster tD 1-C showed a similar degree of relatedness to each 
other and were on the same gel, but failed to be clustered in tO 1-D. Group specific PCR 
(GS-PCR) markers for the post 1995 clonal pandemic strains (Bhuiyan et al. , 2002)., have 
been shown to be positive for eight out of the 13 isolates incJuding the two clinical isolates 
oftDl-B (Pers comm: S. Wagley). 
Environmental isolates of tO 1-F all originating from nearby oyster (Crassostrea gigas) 
samples showed similar profil es. However, two isolates VP49 1 and VP939, isolated from 
the same region but different sources: scallop (Pecten maximus) depuration and mussel 
(Mytilus edulis) samples respectively, were mapped differently in the dendrogram. The 
observation that isolate VP49 1 clustered with environmental isolates from Spain is 
particularly interesting since environmental strains of V parahaemoly ticus have been 
known to ex ist as genetically heterogeneous populations in comparison to clinical isolates 
(Chapter 5; Wong et al., 1999a; Martinez-Urtaza et al., 2004). Despite isolates being 
obtained from different geographical regions, intergenic regions, at least with primers T3A 
and T5A, between tRNA gene clusters appeared the same. 
Whereas dendrogram analysis seemed to have differentiated tO 1 isolates based on small 
differences in fragment sizes and banding intensity of four amplicons, primers for tD2 
produced eight unique fingerprint patterns but only a single intense band. As mentioned 
earlier, faint bands did not always appear consistent in repeat comparisons of isolates in 
tD2 and therefore it is presently not clear whether such band ing patterns could be used as 
reference types. It is also worthy of note that only two repeats were compared to assess the 
reproducibility of tDNA-PCR. Clearly, a further series of repeats, together with more 
accurate band sizing techniques would be necessary to substantiate the eight t02 types 
described. Additionally, by combining three or more repeats in BioNumerics to produce an 
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averaged curve based banding pattern, it may have been possible to reduce inconsistencies 
of band intensities and to overcome this drawback of the use of consensus primers. 
With large clusters based on high percentage similarities, empirical assessment of 
concordance in clusters between tD 1 and tD2 became difficult. It became apparent that 
although some isolates from the groups of two fingerprint types were concordant (as 
expected with such large clusters), others were not. A scatterplot comparing the values of 
percentage similarity between two fmgerprint types demonstrated the skew of data towards 
high matrix similarity figures. A congruence value approaching 70% between tO I and t02 
(regression = 75.0%) suggested a high degree of concordance between tDI and t02 
fmgerprint types; however, it is not known to what extent this could be attributed to 
isolates being placed on the same gel in each of the fingerprint types and fm1her 
emphasises the need for random distribution oftDNA-PCR products between agarose gels. 
It is of particular interest that the Norwegian isolates that had previously been grouped 
together, largely in one main group (clusters D and A for fingerprint types tO I and tD2 
respectively), was found split in two distinct groups (clusters B and D) suggesting some 
discrimination of clonally related isolates in t03 . Concordance studies of t03 with 
fingerprint types tDI and t02 provided some confirmatory results. Whereas tDI and tD3 
appeared the least congruent, fmgerprint types t02 and tD3 exhibited a greater degree of 
concordance. These results may reflect that greater variation in tD 1 and least variation in 
tD2 (55 V parahaemolyticus isolates showed > 66% similar in tDI , >92% similarity in 
t02 and >88% similarity in t03) could be partially responsible for the congruence values 
in the three fingerprint types. A combined dendrogran1 of composite data, as expected, 
produced a greater number of clusters at 95% similarity than tD2 or tD3, but failed to give 
more discrimination than tDl. Interestingly, in congruence tests (Chapter IO, Fig. I0.8) it 
appears that the composite data, tO-combined, is more congruent with tO I than t02 or 
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tD3 and thereby confirming primers T3A and T5A for better discrimination of V 
parahaemolyticus. 
7.4.2 Consensus and specific tDNA primers 
The primers designed by Welsh and McClelland were based on consensus tRNA sequences 
from a number of bacterial species (Welsh & McClelland, l991a, 1992). Preliminary work 
investigated the potential development and use of specific V parahaemolyticus tRNA 
primers. Based on availability of a single genome sequence, it was found that tDNA 
sequences between tRNAs for different amino acids varied considerably. Copies of the 
san1e tRNA genes were not found clustered adequately to yield an appropriate number and 
size of intragenomic length polymorphisms. BLAST analysis of consensus primer 
sequences designed by Welsh and McClelland identified significant homologies to the 
tRNA genes of V parahaemolyticus. Of the three primers (T3A, T3B and T5A) that were 
investigated by BLAST searches, three, six and ten tDNA sites were found to be 
homologous to the primers T3A, T3B and T5A respectively, with 12 to 17 bp homology 
and only a single bp mismatch. It is likely that those were the priming sites and it is 
therefore unlikely that the use of specific tDNA primers would have been able to further 
differentiate V parahaemolyticus. 
7.4.3 General considerations from tDNA-PCR typing 
This chapter has demonstrated that tDNA-PCR can serve as a reasonably discriminatory 
epidemiological typing method for V parahaemolyticus that is easy to execute and 
relatively cost effective. As the method is less time consuming than others such as 
ribotyping, tDNA-PCR could be implemented to screen a larger number of environmental 
samples. However, several important considerations need to be made. Firstly, as with other 
typing systems, the stability of the tDNA-PCR needs to be assessed. The stability of a 
typing system is defined as the ability to express constant markers over time and 
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generations, and the method should be stable for at least the time fran1e of the investigation 
(Struelens, 1998). Length polymorphisms of tRNA spacer regions may not necessarily be 
coding regions and hence their stability could be questioned (Burr et al., 1998). Other than 
identifying isolates in distinct clusters in independent fingerprinting experiments, this 
study has not fully assessed the stability of the tDNA-PCR technique over a period of time, 
and this should be explored iftDNA-PCR is to be implemented for routine monitoring. 
Reproducibility is a second factor for consideration. In fingerprint types tD 1, tD2 and t03, 
all but one isolate (6316) was clustered together at similarity coefficients of 67%, 92% and 
89% respectively. The presence of intense bands common to most isolates in repeat tests 
demonstrated a fairly good degree of reproducibility of this technique. An inter-laboratory 
study that incorporated capillary electrophoresis in the identification of Streptococcus spp 
also concluded reproducibility in tDNA-PCR (Baele et al., 200 l ). These findings are 
consistent with those of several other workers (Baele et al., 2000; De Gheldre et al., 2001; 
Clementino et al, 2001, Lopes et al., 2007). 
In addition to stability and reproducibility, the discriminatory powers of tRNA primer sets 
and typeability are of major importance. Clearly, the three sets of primers grouped isolates 
at different similarity coefficients and gave different groupings. Primer set tO 1 was most 
discriminatory and tD2 least discriminatory based on a few amplification products. Ease of 
data interpretation is another factor that is applicable with tDNA-PCR. Almost all typing 
experiments require the use of data analysis software. The large numbers of groups 
obtained are the result of sophisticated data manipulation, normalizations and curve 
calculations. Clearly, without the aid of such fingerprint analysis software, such groupings 
would not have been possible. 
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7.4.4 Typing of V. parahaemolyticus based on tDNA spacer regions 
As with 16S - 23S ITS-PCR (Chapter 6), tDNA-PCR discriminates between isolates by 
measuring molecular variation within defined regions, i.e. the tRNA gene spacer regions 
both between and within tRNA gene dusters. Up to nine an1plicons were generated using 
the various prin1er pairs, and in each case, variation was found mainly in the size and 
intensity of the bands produced, although the number of amplicons was the same in each 
fmgerprint type in most isolates. This could suggest that numbers of tRNA genes remain 
the same in most isolates. A total of 126 tRNA genes in V parahaemolyticus (in strain 
RIMD) is relatively high compared to that found in E. coli K 12, E. coli 0157 and S. 
typhimurium (86, 99 and 85 for the three strains respectively) and this may correlate with 
the comparatively high ribosomal operon number, reflecting V parahaemolyticus fast 
growth properties (Makino et al., 2003; Withers et al, 2006). However, from tDNA-PCR 
fmgerprint data alone, it was not possible to deduce possible variations in copy numbers of 
tRNA genes an1ongst V parahaemolyticus. As both methods of spacer regions analysis 
(tDNA-PCR and ITS-PCR) were looking at specific genomic region, it was logical to 
examine the isolates further, through a method which gives access to the entire genome. 
Although PFGE studies aimed to establish this, a lack of comprehensive typing data 
resulted in the development of a sensitive RAPD method described in Chapter 8. 
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Chapter 8 
RANDOMLY AMPLIFIED POLYMORPHIC DNA (RAPD) 
METHOD FOR DIFFERENTIATING 
VIBRIO PARAHAEMOLYTICUS 
8.1 Introduction 
Randomly amplified polymorphic DNA (RAPD) is a PCR based technique where short 
primers (usually 10-mers) of arbitrary sequence are used to generate an1plification products 
characteristic of the template DNA (Williams et al., 1990). The method is unique in that it 
requires no previous knowledge of the target genome sequence, requires only small 
quantities of template DNA, can be analysed with standard electrophoresis methods and be 
used for any organism. The simplicity of this arbitrarily primed PCR method (also known 
as AP-PCR) has enabled this technique to be adopted in a wide variety of applications such 
as determining parent-sibling connections (Hadrys et al, 1993), identification of genetic 
alterations in tumours (Dil-Afroze et al. , 1998) and the detection of UV induced 
genotoxicity (Atienzar et al. , 2000) . In bacteriology, RAPD analysis has been successfully 
used to differentiate between strains of a wide variety of species including Renibacterium 
salmoninarum (Grayson et al., 1999, 2000), Burkholderia pseudomal/ei (Leelayuwat et al., 
2000) and Vibrio vulnificus (Ryang et al., 1997). More recently, RAPD was used to 
differentiate clonally related V cholerae that could not be discriminated by ribotyping or 
PFGE (Pourshafie et al, 2007). 
Wong and colleagues (1999c) described the use of RAPD to establish relationships among 
308 clinical isolates of V parahaemolyticus from food poisoning outbreaks in Taiwan. A 
total of 41 polymorphic RAPD patterns were identified based on the presence of up to 10 
bands that were grouped into 16 types (Wong et al. , 1999c). Earlier work examined the 
genotypes of urease positive clinical strains of V parahaemolyticus (Okuda et al., 1997a), 
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demonstrating that RAPD was able to differentiate between 04:K12 serotypes and non-
04:K12 serotypes in a sample of eight clinical isolates. In a further report, the clonal 
relationship of 03 :K6 isolates from Calcutta and Japan was demonstrated with RAPD 
(Okuda et al., 1997b). Both of the studies by Okuda and colleagues used single primers PI 
and P2 and, as expected, clonally derived isolates yielded similar comparative results. 
However, both single primers produced a mere five major amplicons and several faint 
bands that were hardly discernable from background PCR noise (Okuda el al., 1997a, 
1997b). These primers, together with primers P3, P4, PS, P6 (Amersham Biosciences) 
were investigated by Maluping et al., (2005) who were only able to show a maximum of 
between 2 to 4 bands with primers P4 and P6 in environmentally acquired isolates and thus 
it was difficult to obtain sensitive discrimination of data. To date, there has been no 
attempt to assess the ability of a RAPD method to differentiate pathogenic isolates of V 
parahaemolyticus from environmentally acquired samples. 
Previous work that employed consensus ITS and tRNA gene primers showed up to eight 
distinct amplicons (Chapters 6 and 7 respectively) and enabled the grouping of isolates. 
However to further assess relatedness between isolates and to allow a greater probability 
for a possible discrimination in relationships, it was necessary to produce a more complex 
banding pattern. This chapter describes the use of combined RAPD primers that have been 
used in both bacteria (Mycoplasma spp., and E.coli), and plants (Brassica napus, and 
Hordeum spp.). Combined primers have been shown to demonstrate greater 
polymorphisms in banding than single primers alone (Hu et al., 1995; Reddy & Soliman, 
1997; Charlton et al., 1999; Hopkins & Hilton, 200 I). 
The following are investigated in this chapter: 
i) screening of commercially available RAPD pnmer patrs for complex and 
reliable banding patterns 
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ii) analY.sis of RA:PJil fingerprinting· in V parahaemolyticus based:on tw:o1 di'ffererit 
iprill11!t setf)'for co111parison and ,reliability ofCilit!t (J~oCillcedJ 
- . - --· 
·i}O: an. evaluation [of,the: ability ;to· discriminate clinlcal.and :environmental isolates 
of V •parahaemolyticus based ion RAPD fingerprinting, 
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8.2. Materials and Methods 
8.2.1 RAPD - PCR of V. parallaemolyticus 
RAPD analysis was performed on 56 isolates of V. parahaemolyticus usmg RAPD 
Analysis Beads (Amersham) containing 6 distinct random 1 0-mer primers as shown in 
Table 8.1. Each bead, when resuspended in a 25 ~-tl volume contained 1 u Amplitaq DNA 
polymerase and Stoffel fragment, 0.4 mM of each dNTP, 2.5 11g BSA and buffer [3 mM 
MgC12, 30 mM KCI and 10 mM Tris, (pH 8.3)]. To each reaction bead 25 pmol (5 ~-tO of 
the appropriate primer and DNA template of appropriate volume equivalent to 10 ng, were 
added to generate optimum banding pattems upon agarose gel electrophoresis. The PCR 
reaction conditions were as follows: 1 cycle at 95°C for 5 min, followed by 45 cycles at 
95°C for 1 min, 36°C for 1 min and 72°C for 2 min. All RAPD products were analysed by 
electrophoresis of 15 ~-tl of each reaction mixture in 2% agarose gels as described in section 
3.6. 
Table 8.1 : RAPD Primers used in this study (Amersham Biosciences). 
RAPD Primers 
PI 
P2 
P3 
P4 
PS 
P6 
Primer Sequence 
5' -d[GGTGCGGGAA]-3 ' 
5' -d[GTTTCGCTCC]-3' 
5'-d[GT AGACCCGT]-3' 
5'-d[AAGAGCCCGT]-3 ' 
5'-d[AACGCGCAAC]-3' 
5'-d[CCCGTCAGCA]-3' 
%GC 
70 
60 
60 
60 
60 
70 
8.2.2 Screening of RAPD primers Pl to P6, singly and in pairs 
Genomic DNA (section 3.3) from a panel of six isolates of V parahaemolyticus was 
screened with single primer, and in all possible paired combinations (15 reactions) with 
primers P I to P6. In order to determine the best discriminating banding patterns. 
Subsequently, primer pair P2 and P3 (designated primer set 1, PSI) was used on a larger 
panel of 18 isolates, before they were applied to all 56 isolates used in the study. Primer 
pair Pl and PS (designated PS2) were also used as a duplicate set of experimental results to 
assess the reliability ofRAPD clustering used in this method. 
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8.2.3 Dendrogram analysis with BioNumerics 
Dendrograms showing relationships amongst clinical and environmental isolates of V 
parahaemolyticus were generated using BioNumerics Software with modules for 
Fingerprints and Cluster Analysis (version 5.1, Applied Maths, Belgium) as explained in 
section 6.2.3. All banding patterns for PSI and PS2 were used for the cluster analysis of 56 
isolates of V parahaemolyticus and to make comparisons between the two sets of data. 
The bands from each lane were subjected to curve calculations and analysis to exclude 
background noise from PCR reactions. The tracks were then normalised using two external 
reference positions that consisted of 100 bp molecular weight markers on either side of the 
gel, and a common band that appeared in several lanes as an internal reference. Up to 13 
bands per lane, many of which were also common between isolates, were scored according 
to their presence or absence within the 1 00 - 2072 bp range only. Dendrograms were 
calculated by the unweighted pair group method by arithmetic averaging (UPGMA) 
algorithm using a Pearson product-moment correlation coefficient. BioNumerics position 
tolerance settings were I% optimisation, a position tolerance of I% of gel and faint bands 
were ignored. Clusters were based on 90 % similarity value in both fingerprint types, PS I 
and PS2. 
8.2.4 Concordance between RAPD -PSl and PS2 typing 
The degree of concordance between RAPD-PS I and RAPD-PS2 was determined using 
BioNumerics software with modules for Fingerprints and Cluster Analysis (version 5.1, 
Applied Maths, Belgium). Values from the similarity matrices of the PS I and PS2 typing 
methods were plotted by BioNumerics on an x-and y- graph. Each dot represents 
corresponding similarity values for two isolates by the typing methods given on the x and y 
axes and thereby gives an indication of concordance between PS I and PS2 typing. The 
congruence between PSI and PS2 was calculated using the Pearson product-moment 
correlation coefficient in BioNumerics. 
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8.3 Results 
8.3.1 Single primer (P2) screening of V. parallaemolyticus 
Two environmental isolates, VP350 and VPSCI, were screened with primer P2 that had 
previously been shown to amplify at least five prominent bands in clinical strains of V 
parahaemolyticus (Okuda et al., 1997b). Between one and four bands were observed; these 
varied considerably based on DNA template concentration and primer concentration used 
(Fig. 8.1 ). Clearly, the use of a single primer failed to give the complexity of banding 
patterns sought. 
8.3.2 Two-primer screening of RAPD reactions 
Between four and 10 bands were observed when two primers were combined (Fig. 8.2). 
Out of the 15 different primer combinations, primers P3/P6, P3/P5, and P4/P4 showed the 
lowest number of bands, whilst most exhibited 5 - I 0 amplicons. A greater number of 
bands were exhibited with primers P2/P3 whereas primers PI/PS showed higher intensities 
of the two main amp I icons generated. Based on these findings, primer combinations P2/P3 
(designated PS 1) and PI/PS (designated PS2) were used to produce fingerprinting patterns 
of a panel strain of 18 clinical and environmental isolates of V parahaemolyticus (Fig 8.3). 
8.3.3 RAPD typing of V. parallaemolyticus and related species with PSI 
A total of 56 isolates of V parahaemolyticus, plus 14 isolates of other Vibrio spp., and nine 
non-vibrio species were typed using PSI (Figs 8.4 to 8.8). There was 100% typeability, 
where all 79 isolates showed comparable banding profiles that largely fell within the range 
of the 100 bp size markers from 100 - 2072 bp (Fig 8.3). A comparison of RAPD-PCR 
reproducibility in a selection of isolates is described in section 8.3.5. Approximately nine 
to 20 bands of varying intensity and size were observed with V parahaemolyticus isolates 
with at least nine common arnplicons of various sizes. Distinct bands of around 180, 200, 
280, 370, 590, 610, 860, 1000, and 1350 bp as well as several higher molecular weight 
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bands were amplified (Fig. 8.3). Significant differences in banding patterns in other Vibrio 
spp. were also identified. Six isolates of V cholerae showed distinct banding patterns (Fig 
8. 7). Likewise, V anguillarum, V alginolyticus, V mimicus, V jluvialis, L. damsela and 
non-vibrios could also be differentiated by unique banding profiles (Figs. 8.5 to 8.8). 
A common band (Band X) of approximately 910 bp was present in 10 out of the 20 clinical 
isolates studied. Other than the possibility of this band present in isolate 1103/9 (Figs. 8.5 
& 8.9), no other environmental isolate seemed to possess this band. However, unlike the 
clinical isolates, Band X appeared very faint in 1103/9. A similar sized amplicon was also 
identified amongst some members of RAPD Types 22 and 23, but appeared 
characteristically smaller (Fig. 8.6) or faint (Fig. 8.8). The 10 clinical isolates were of the 
03:K6, 03:KUT or 05: K68 serovars accounting for seven, two, and one isolate 
respectively (Fig. 8.9). Both 03:K6 isolates from the UK (El55855 & El68143) have been 
shown to be related to the pandemic clones (Wagley et al., 2008). 
At a 90% similarity value based on dendrogram analysis, V parahaemolyticus isolates 
were differentiated into 30 RAPD types (Fig. 8.1 0) with clinical isolates in RAPD types 
(RT) I 0, 11, 12, 15, 21, 24, 26 and 27. Of these, four types only had single members (219, 
224, 2436 and 6316) with the identity of isolate 6316 questioned from earlier chapters. An 
environmental isolate VP416, isolated from the common oyster, was clustered closely with 
a Japanese clinical isolate 6134. Clinical isolates from UK, Japan and Norway were 
clustered into distinct groups. 
Of the 20 environmental types, 13 isolates fell into their own types and could not be 
grouped with other isolates at a 90% similarity level. However, PS 1 clustered 
environmental isolates VP1 to VP4 together and VP6 to VP9 together into two groups (RT 
20 and 16 respectively). Similarly four isolates, Vibl- Vib3 and Vib5 (RT 23) were found 
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to be more closely related than Vib6- ViblO (RT 22) from the Southampton environmental 
isolates (Fig 8.1 0). As with the environmental isolates from Spain, V parahaemolyticus 
isolated from environmental samples in the UK fell generally into a heterogenic 
population. 
8.3.4 RAPD fingerprinting of V. parallaemolyticus based on PS2 
All 79 isolates that included members of other Vibrio spp and non-vibrios were also typed 
using a second set of primers Pl and PS (PS). To ease analysis and comparison of data, 
only V parahaemolyticus isolates are shown (Fig. 8.11 ). As with PS I, there was I 00% 
typeability with approximately nine to 18 bands of varying intensity and size observed for 
V parahaemolyticus. Most isolates showed at least six common amplicons of various 
sizes with bands predominantly around 130, 250, 310, 590, 730 and 1130 bp (Fig. 8.11 ). 
At a 90% similarity value based on UPGMA dendrogram analysis, V parahaemolyticus 
isolates were differentiated into 24 RAPD types (Fig. 8.12) with clinical isolates present in 
seven RAPD types; 02, 08, I 5, 16, 18, 22 and 23. Of these, only one isolate (2436) 
constituted its own group (RT 16). RAPD Type 15 clustered two UK 03:K6 isolates with 
two Japanese 03:K6 isolates, whereas RT 22 and 23 grouped all the Norwegian isolates 
together. As with the previous primer set, the banding pattern of an environmental isolate, 
VP416, closely resembled Japanese clinical isolate, 6134. Furthermore, a common bandY 
of approximately 610 bp was present in 11 out of the 20 clinical isolates studied (Fig. 
8.1 0). This band seemed to be present in some environmental isolates as well but as with 
Band X, appeared distinctly weaker. The 11 clincial isolates included those I 0 previously 
described with PSI that were of03:K6, 03:KUT or OS:K68 serovars, with the addition of 
isolate 221 of the 0 I :KUT serotype (Fig. 8.12). 
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Of the IS environmental types, six isolates were sole representatives of their own types and 
could not be grouped with other isolates at a 90% similarity level. As previously found 
with PS l, PS2 clustered environmental isolates VP 1-VP4 together and VP6-VP9 together 
into two groups (RT 12 and 13 respectively) with VPIO in a distinct RT of its own. As 
with PS l, isolates Vib 1-Vib3 and Vib5 (RT 17) grouped separately to Vib6 - Vib 10 (RT 
09) from the Southampton environmental isolates (Fig 8.12). Environmental isolates from 
Spain fell into four types (RT 04, 05, 07 & l 0) and the remaining environmental isolates 
from Dorset, where clustered, fell into RAPD Types 0 I, 03 and 06 (Fig. 8.12). 
8.3.5 Reproducibility of RAPD-PCR 
A comparison of repeat RAPD-PCR with six isolates is shown in Figure 8.13. Most of the 
bands were present in repeat PCRs (A - F) with variability found in both the presence or 
absence of weak bands and the intensity of what appeared to be the same amplicon (Fig 
8.13). For example, the 610 bp amplicon was present in all six repeats of type strain 1902 
but intensities were variable (Fig. 8.13: Lanes A & B; isolate 1902). At least six faint 
bands were absent in Lane B (reflecting Fig. 8.4) in comparison with the remaining five 
tests where most of these bands could be identified (Fig. 8.13: isolate 1902). Similarly, 
repeat tests with isolate 2436, VP345, Vib2 and 1021/5 identified most of the prominent 
bands with the presence or absence of 2 or 3 very faint bands differentiating amongst the 
repeats (Fig. 8.13). A comparison of repeats with VP2 also demonstrated the degree of 
reproducibility of RAPD-PCR bands. Whereas Lane B (Fig. 8.13: VP2) showed the 
absence of minor bands, certain bands such as the 610 bp amplicon, in contrast, appeared 
brighter. Minor bands were ignored in BioNurnerics cluster analyses. 
8.3.6 Comparison of RAPD-PSI and RAPD-PS2 
RAPD-PS I appeared more discriminating than RAPD-PS2. PS l was able to differentiate 
two clinical isolates (219 and 224) that existed in the same group in PS2. Similarly, PSI 
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differentiated between three Spanish environmental isolates (1022/10, 1023/1 and 1023/3) 
and three UK environmental isolates (VP349, VP350 and VP361) that were grouped 
together in Pulse Types 03 and 06 with PS2. Additionally, PS2 was able to differentiate 
isolates that were grouped together in RAPD-PS I. For example, clinical isolate E154482 
was differentiated from the other two clinical isolates in RT 21 of PS I. A comparison of 
the two typing methods where the values from the similarity matrices were plotted on x 
and y axes showed a congruence of 56.6% with Pearson's correlation showing some 
concordance between the two primer pairs (Fig. 8.14). 
8. 3. 7 Differentiation of clinical and environmental isolates 
It was possible to differentiate clinical isolates from environmental isolates based on the 
RAPD patterns shown (Figs. 8.10 and 8.12). The two markers amongst clinical isolates, 
Band X and Band Y, account for 50% of the clinical isolates studied. Band X was 
approximately 910 bp in size and BandY was approximately 605 bp length (Figs. 8.9, 8.10 
and 8.11 ). Isolates were considered positive for bands X and Y if they appeared distinct 
and intense. However, with a large number of RAPD types, there was no single unique 
banding pattern or the presence or absence of a band that could clearly distinguish 
pathogenic V parahaemolyticus. 
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1 2 3 4 5 6 7 8 9 10 M 
t- 1000 bp 
t- 600 bp 
t- 200 bp 
Figure 8.1: RAPD single primer (Pl) screening of V. p11raltaemolytiCNs environmental Isolates, 
VP350 and VPSCI. Lanes correspond to the following: I and 10; Control DNA (E. coli: BL21 and Cl a 
respectively). Lanes 2, 3, 4 and 5; VP350 {12 ng DNA) with 0, 10, 20 and 30 pmol primer respectively. 
Lanes 6, 7, 8 and 9; VPSCI (25 pmol primer) with 0, 15, 30, 45 ng of template respectively. Lanes M, 
100 bp Ladders (Gibco). Arrows indicate non-specific PCR products typical ofRAPD reactions. 
t• Primer: M Cl C2 PS PS P4 P4 P3 P3 P3 P3 
2od Primer: P6 P6 P6 PS P6 P6 PS P4 
600bp7 
P2 P2 P2 P2 P2 PI PI PI PI PI M 
P6 P6 PS P4 P3 P6 PS P4 P3 P2 
PSI PS2 
IOOOb 
600bp 
200 bp 
Figure 8.l: RAPD double primer screening of V. paraltaenwlytlciiS environmental isolate, VPJSO. 
Primers PI to P6 were used in pairs for RAPD PCR. Lanes M, 100 bp Ladders (Gibco). Lane Cl and C2 
are no DNA template and no primer controls respectively. Primer PS I and PS2 were used for further 
studies. 
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Figure 8.3: RAPD analysis or a panel strain or 16 representative clinical and environmental 
isolates or V. parallamwlydcus with primers Pl and P3 (PSI). Lanes I and 2: no template and no 
primer controls respectively. Lanes 3 to 20 correspond to the following isolates:- 3: E coli BL21 (control 
DNA); 4: V. anguil/arum CMI04; 5: VPSCI; 6:VPECI ; 7: VP939; 8: VP377; 9: VP350; 10: VP345; 11: 
VP7; 12: VP4; 13:VP3; 14: VP2; 15: VPI; 16: 5421; 17: 2436;18: 6316; 19: 1021/5; 20: NCIMB type 
strain 1902. Lanes M1 and M2, IKb and 100 bp ladders respectively, with the sizes of selected markers 
indicated by the arrows. 
M I 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 M 
~ 1000 bp 
~ 600 bp 
~ 200bp 
Figure 8.4: RAPD banding patterns or Norwegian cUnicallsolates or V. parahaemo/yticus with PSl. 
Lane 1; no template control. Lanes 2 to 20 correspond to the following isolates: 2; NCIMB reference strain 
1902, 3; 219, 4; 220, 5; 221, 6; 222. 7; 223, 8; 224, 9; 225, 10; 226, 11; 227, 12; 228, 13; NCTC reference 
strain VPI0884, 14; 2436, 15; E155855, 16; 2053, 17; VP345, 18; 1021/5, 19; Vib2, 20; VP2. Lanes M, 100 
bp ladders with the sizes of selected markers indicated by the arrows. 
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~ 1000 bp 
~ 600bp 
~ 200 bp 
Figure 8.S: RAPD banding pattems ofUK and Spanish environmental isolates of V. parlllftlemolydcus 
with PSI. Lane 1: no template control. Lanes 2 to 20 correspond to the following isolates:- 2: NCJMB 
reference strain 1902 (internal control); 3: 1021/5; 4: 1022/ 10; 5: 1023/ 1; 6: 1023/3; 7: 1024/5; 8: 1103/9; 9: 
VP378; 10: VP33l ; 11 : VP345; 12: VP346; 13: VP349; 14: VP350; 15: VP361; 16: VP377; 17: Proteus 
mirabilis; 18: Salmonella typimurium; 19: E. coli EC5; 20: E.coli Cl a. Lanes M, 100 bp ladders with the 
sizes of selected markers indicated by the arrows. 
M 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 M 
~ 1000 bp 
Band X 
~ 600bp 
~ 200 bp 
Figure 8.6: RAPD banding pattems of Japanese clinical isolates and UK environmental isolates of V. 
portllftlemolyde~~s with PSI and related species. Lane I : no template control. Lanes 2 to 20 correspond to 
the following isolates:- 2: NCJMB reference strain 1902(intemal control) ; 3: 2053; 4: 2436; 5: 542 1; 6: 
6134; 7: 6316; 8: V. a/ginolyticus2341 ; 9: Yib3; 10: Vib5; 11 : VP4 16; 12: VP49 1; 13: VP939; 14: VPECI ; 
15: VPSCI ; 16: V. anguillarum CM104; 17: Escherichia aerogenes EA5; 18: Klebsiella aerogenes KA5; 19: 
Pseudomonas aeruginosa PA I; 20: E. coli BL21 . Lanes M: l OObp ladders with the sizes of selected markers 
indicated by the arrows. 
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~ 200bp 
Figure 8.7: RAPD banding patterns of environmental isolates of V. [HiralraelffO/ytlcus, V. clrolerae and 
related spedes with PSI. Lane 1: no template control. Lanes 2 to 20 correspond to the following isolates:- 2: 
NCIMB reference strain 1902 (internal control); 3: 8042; 4: VC 1; 5: VC2; 6: VC3; 7: VC4; 8: VC5; 9: V. 
alginolyticusVA430; IO: VPI ; ll : VP2; 12: VP3; t3: VP4; 14: VP6; 15: VP7; 16: VP8; 17: VP9; 18: VPIO; 
19: NCTC reference strain VP10884; 20: V. mimicus 499. Lanes M: IOObp ladders with the sizes of selected 
markers indicated by the arrows. 
M I 2 3 4 5 6 7 8 9 I 0 I 1 12 13 14 15 16 17 18 19 20 M 
~ 1200 bp 
Band X 
~ 600 bp 
~ 200 bp 
Figure 8.8: RAPD banding patterns of environmental and clinical isolates of V. paralranno/ydcus and 
related species with PSI. Lane I: no template control. Lanes 2 to 20 correspond to the following isolates:- 2: 
NCIMB reference strain 1902 (internal control); 3: V. jluvialis NCTC type strain 11327; 4: Vib 1; 5: Vib2; 6: 
Vib3; 7: Vib4; 8: Vib5; 9: Vib6; 10: Vib7; 11 : Vib8; 12: ViblO; 13: V. vulnificus KIDBVV; 14: V. vulnificus 
11067; 15: Listonella damselea LD365; 16: El54482; 17: El55855; 18: E l68143; 19: 2436; 20: 61 34. Lanes 
M: tOObp ladders with the sizes of selected markers indicated by the arrows. 
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OType 
KType 
Band X 
M I 2 3 4 5 6 7 8 9 10 M 
1000 bp 
800 bp 
600 bp 
Figure 8.9: A unique RAPD marker (Band X) amongst clinical strains of V. paraht1nnolydcus. Clinical 
isolates correspond to the following lanes:- I: NCIMB reference strain 1902; 2: 220; 3: 221 ; 4: 222; 5: 223; 
6: 225; 7: 226; 8: 227; 9: E155855; 10: 2053. Amplicon also present in isolates 5421 and E168143 (Fig. 8.6: 
Lane 5 and Fig. 8.8: Lane 18 respectively). 0 and K serotypes are indicated in each lane. Lanes M: 100 bp 
ladders with the sizes of selected markers indicated by the arrows. 
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Figure 8.11: RAPD fingerprinting of 56 clinical and environmental isolates of V. partllrtlemolydcus wltb 
PSl. Lanes correspond to the following:- I: NCIMB reference strain 1902; 2: 219;3: 220; 4: 221; 5: 222; 
6:223; 7: 224; 8: 225; 9: 226; 10: 227; 11: 228; 12: 1021 /5; 13: 1022/10; 14: 102311; 15: 1023/3; 16: 1024/5; 
17: 11 03/9; 18: VP378; 19: VP331; 20: VP345; 21 : VP346; 22: VP349; 23: VP350; 24: VP361 : 25: VP377. 
Lane marked - is no template control. Arrow indicates Band Y found mainly in clinical isolates of V. 
parahaemolyticus. Lanes M, I OObp ladders with the sizes of selected markers indicated by the arrows. 
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Figure 8.11: Continued. Lanes correspond to the following:- 26: 2053; 27: 2436; 28: 5421; 29: 6134; 30: 
6316; 31:VP416; 32: VP491 ; 33: VP939; 34: VPECI ; 35: VPSCI ; 36: VPI ; 37: VP2; 38: VP3; 39: VP4; 40: 
VP6; 41: VP7; 42: VP8; 43: VP9; 44: VPIO; 45: NCTC reference strain VPI0884; 46: Vibl; 47: Vib2; 48: 
Vib3 ; 49: Vib5; 50: Vib6; 51 : Vib7; 52: Vib8; 53: VibiO; 54: El54482; 55: El55855; 56: El68143. Arrow 
indicates BandY found mainly in clinical isolates of V. parahaemolyticus. Lanes M: lOObp ladders with the 
sizes of selected markers indicated by the arrows. 
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Figure 8.13: Reproducibility of RAPD fingerprinting profiles in sill isolates of V. parah11emo/ydcus. 
Lanes A to F are comparisons of independent RAPD-PCR and gel runs from Figures 8.3 to 8.8 respectively. 
Reference arrow on the left shows the position of a 610 bp amplicon that appeared in isolates 1902,2436, 
VP2, Vib2 and 1021/5 indicating relative migration of bands on each gel. Isolate VP345 is marked at a 500 
bp amplicon All band sizes are approximate. 
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Figure 8.14: Concordance of stra tification by RAPD-PSI and RAPD-PS2 for 56 isolates of V. 
parahaemolyticus. Each dot represents corresponding similarity va lues for two isolates obtained by both 
primer sets given on the x and y axes. The congruence between the two primer pairs as calculated with the 
Pearson coefficient was 56.5%. Data showed a linear regression fit of 68.8%. 
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8.4 Discussion 
This chapter examined the feasibility of the RAPD technique to differentiate clinical and 
environmental isolates of V parahaemolyticus, as well as assess the reproducibility and 
reliability of the method used. Using pairs of RAPD primers produced a more complex 
banding pattern than single primer alone, as this increases the chances that two priming 
sites are recognised and are sufficiently close to result in a PCR amplification product 
(Welsh & McCielland, 1990). The method was easy to execute and the resulting large 
number of amplicons allowed intra-species differentiation in isolates that were previously 
grouped together using 16S-23S ITS and tDNA-ILPs spacer region analyses. 
The method that was employed also allowed Vibrio species to be clearly differentiated 
from one another with the exception of one isolate, 6316, that could not be grouped with 
other members of V parahaemolyticus. This isolate has repeatedly shown unique banding 
profiles in Chapters 5, 6 and 7 with a fingerprinting profile that is characteristic of V 
mimicus. Further tests would be required to accurately speciate this isolate. 
RAPD is a widely used method that is known to be sensitive in detecting small changes in 
the genome between isolates and is used to determine genetic relatedness both amongst 
species and sub-species. The use of a wide range of RAPD primers have been reported to 
type V parahaemolyticus, but often typing experiments are compromised by the relatively 
small number of bands that are used to discriminate within a typing experiment. This was 
shown by Maluping and colleagues and further supported by this work (Section 8.3.1 and 
Fig. 8.1) (Maluping et al., 2005). This study concentrated on four primers PI, P2, P3 and 
PS that are widely used in typing experiments, but used in pairs to develop and optimise a 
RAPD method that appeared reproducible and that could cluster distinct clinical and 
environmental groups of isolates. 
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8.4.1 Typing of V. parallaenrolyticus based on PSI 
Initial primer screening experiments suggested that pnmers P2 and P3 may produce 
banding patterns of suitable complexity. Up to nine common bands were amplified 
continually in most isolates of V parahaemolyticus, and this allowed confirmation of 
relatedness. Several of these bands were also common in related Vibrio species suggesting 
that this RAPD method may I) be a helpful tool to differentiate V parahaemolyticus from 
other vibrios and 2) be able to differentiate between members of other species such as 
clinically significant and clonally related V cholerae. 
Of the 56 isolates of V parahaemolyticus studied, PS I differentiated the isolates into 30 
RAPD Types (RTs) of which I9 were environmental only, eight were clinical only, a 
single RAPD Type consisting of both on an environmental and clinical isolate, and two 
RAPD types accounted for the two reference type strains. This data suggests that both 
clinical and environmental isolates were discriminated almost equally with PS 1, and that 
RAPD can differentiate clinical isolates that have previously shown to be a more 
homogeneous group (Chapters 4, 6 and 7). The sensitivity of the RAPD technique has been 
widely documented (reviews by Atienzar & Jha, 2006; Y akubu et al., 1999). Clinical 
isolates of219, 224, 2436 (as well as 6316) that fell into their own RAPD types and the 
clustering of a Kanagawa positive (haemolytic) environmental isolate with a Japanese 
clinical isolate is in agreement with PFGE findings (Chapter 5). 
Whilst the RAPD method is sensitive, there are several criticisms of the technique. For 
example, whilst a complex banding profile with two primers was favoured in this study, it 
is likely this contributed to the presence of additional faint bands and possibly reducing the 
intensity of others (Fig 8.13). Weak bands have been shown to be irreproducible in most 
cases as identified in repeat tests. Whilst BioNumerics settings allowed the option of 
omitting very faint bands in cluster analysis it did not account for varying band intensities 
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inherent in the RAPD method that were used in the curve calculations. This may provide at 
least one explanation why the same method with two different sets of random primers 
failed to give a high concordance (i.e. a congruence of greater than 70%) even though 
isolates in both dendrograms initially appeared grouped similar from visual inspection. A 
further explanation for discordance using the same method but a different set of primers 
could be attributed to the GC content of the primers. Whereas primers P2, P3 and PS were 
all 60% GC, primer PI had a 70% GC ratio (Table 8.1). Invariably, such differences in% 
GC are likely to result in considerable changes to primer and template DNA interactions. A 
complex gel banding pattern also meant that agarose gels required adequate running times 
to obtain good resolution. In practice, consistency was difficult to achieve between 
different gel runs even with the use of a tracking dye and thus further reliance on 
BioNumerics normalisation procedures. The use of additional markers within the gel 
would therefore facilitate more accurate normalisation of bands and to adjust for possible 
gel smiling. 
8.4.2 Typing of V. parallaemolyticus based on PS2 
It was necessary to validate groupings and clusters determined with PS I and therefore the 
second primer set PS2 utilised Primers I and 5. Although a smaller number of bands were 
produced, a fair degree of concordance was shown between the two typing experiments. 
Isolates could be characterised within a cluster, forming smaller groups or identified as its 
own type. For example, the lower number of bands produced in PS2 meant that the ability 
to discriminate was less than that of PS I. However, although PS I discriminated 10 isolates 
that were grouped in PS2, PS2 also discriminated three isolates that were grouped in PS 1; 
therefore, the results of the two sets of RAPD primers were complementary rather than 
contradictory. Chapter 10 addresses the evaluation of RAPD typing with other molecular 
typing systems employed. 
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8.4.3 A marker for pandemic serovars? 
One of the most interesting findings of typing V parahaemolyticus with two primers was 
the identification of a band in 10 of the clinical isolates (Fig. 8.9) that was present using 
both primer sets, PS 1 and PS2. These distinct bands were found in isolates of four serovars 
(01 :KUT, 03:K6, 03:KUT and 05:K68) from three different geographical regions, but 
appeared faint in many of the environmental isolates. PFGE grouped them all under one 
cluster at 76% similarity that consisted of Pulse Types 18, 19, 20 and 21 (Fig 5.11) but did 
not manifest as a singularly identifiable band. RAPD dendrogram analysis was also able to 
differentiate these isolates into RAPD types 10, 21 and 24 with PS 1, and RAPD types 15, 
22 and 23 with PS2. In order to confirm the identity of these bands, and whether they are 
truly different to those from environmental isolates, it would be necessary for further 
repeats, as band intensities mentioned earlier, are variable m the RAPD method. 
Furthermore, more reliable band sizing techniques, such as polyacrylamide gel 
electrophoresis, would be necessary for more accurate analysis. This should be followed by 
cloning and sequencing of bands to investigate the 910 bp and 610 bp RAPD markers 
identified in clinical isolates. It has also been proposed that the arbitrary bands produced in 
RAPD do not reflect real and relevant population diversity and as such it would be difficult 
to monitor the stability of the typing system during the time frame of the investigations 
(Burr et a/, 1998). 
8.4.4 Comparison of single and two-primer RAPD methods 
RAPD typically employs the use of short I 0-mer primers. Several workers have used the 
I 0-mer primers PI, P2 and P4 singly to demonstrate clonal relationships in 03:K6 isolates 
of V. parahaemolyticus (Matsumoto et al., 2000; Okuda et al., 1997a; 1997b ). Of all these 
primers used, P I showed the most bands and the presence or absence of one or two bands 
was used as criteria to differentiate the old and new 03:K6 isolates; those that appeared 
before and after 1996 respectively - the latter referring to the more virulent 03 :K6 types. 
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Additionally, the use of Primer 2 showed even fewer total bands and, again, the presence 
or absence of one or two bands differentiated the two groups in a sample of eight 'old' 
03:K6 and nine 'new'03:K6 isolates (Matsumoto et al., 2000). Thus the use of a two-
primer method described here that generated up to 20 bands may be better able to 
differentiate clonally related isolates. It is unfortunate that the study did not contain a 
significant number of comparative old and new 03:K6 types to test this claim. 
PCR product s1ze with single pnmer PI has been shown to range in size from 
approximately 0.6 - 6.5 kbp (Okuda et al., 1997b) whereas this work has demonstrated that 
most of the PCR products could be resolved within 0.1 and 2.0 kbp. This is to be expected 
as the distance between primed sites is likely to be shorter when two different arbitrary 
primers are available than a single primer alone (Welsh & McClelland 1991 b). Shorter 
amplicons may also amplify more efficiently because of the shorter extension times 
required and the increased likelihood that DNA polymerase will complete strand synthesis 
(Hopkins & Hilton, 2001). Therefore the use of two primers would further increase 
efficiency to subtype V parahaemolyticus, by minimising times needed for agarose gel 
electrophoresis. The use of a third primer might be advantageous, but in one reaction this 
has been shown to be inappropriate for typing purposes as PCR product sizes were 
significantly smaller than one- or two-primer PCR reactions and required the use of 
polyacrylamide gels to resolve smaller fragments (Hopkins & Hilton, 2001). This may not 
be practical for routine typing purposes to process a large number of samples. 
Additionally, the presence of too many bands in a typing system increases the complexity 
of the visual interpretation leading to reliance on more sophisticated band analysis 
software. 
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8.4.5 Data analyses 
As with previous chapters, the quantitative assessment of fingerprinting profiles was 
necessary throughout the analysis of RAPD fingerprints. One of two methods usually 
employed are either a densitometric curve based approach (as used in this chapter and 
chapters 6 and 7) or a band based approach as used in Chapter 5. Whereas the binary 
nature of distance matrices in the band based approach scores bands as either present or 
absent, a densitometric curve analysis method takes into account the intensities of different 
bands produced by RAPD. Despite, variation in band intensities shown in the present 
study, this method has been shown to be more reliable in producing RAPD clustering than 
the band based Dice method (Duarte et al 2005). Additionally, the availability of 
fingerprint analysis software facilitated the process of determination of groupings. 
Nonetheless, much caution is still needed in the interpretation of RAPD data. For example, 
the eo-migration of bands may be a result of amplicons of the same size, yet generated 
from different regions of the genome. If the presence of these bands is used to infer 
similarity between isolates, then clearly two identical RAPD patterns may not necessarily 
imply they are the same strain. Therefore, when analysing large amounts of data that are 
used to construct a dendrogram that infers phylogenetic relationships, careful interpretation 
of banding patterns is required. Thus, the use of a second primer set PS2 in this chapter 
was necessary to confirm groupings obtained, and the larger number of amplicons in a 
more complex banding pattern may serve to reduce errors from eo-migration of bands. 
8.4.6 General considerations of a RAPD typing system 
The main advantages of the RAPD method are its relative simplicity to set up and use. 
However, several problems may potentially hamper its use and these have been the subject 
of criticism of the technique. As mentioned, these include the lack of reproducibility 
between laboratories due to sensitivity to changes in reagents, protocols and machines, the 
non-universal use of primers and RAPD markers as well as the aforementioned method of 
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data analysis used (Chang et al., 2007). However, when the same method was used with 
different thermocyclers, comparable results for V parahaemolyticus have been achieved 
(Matsumoto et al., 2000). For example, RAPD profiles generated with a "Hybaid HB-
TRIL" and "Zymoreactor II - AB-1820" thermocyclers were used to reliably compare 
strains from Bangladesh with those isolates from many other countries to study the spread 
of pandemic 03:K6 clones (Matsumoto et al., 2000). In this chapter, internal controls 
using the DNA of several isolates as well as NCIMB reference strain 1902 were used. 
These results have shown some reproducibility and consistency in banding profiles in 
independent PCR reactions (Figs. 8.4 to 8.8), however more thorough inter-laboratory 
comparisons are required to assess the reproducibility of this two-primer method. 
Despite the criticisms, the initial concerns about the reproducibility of RAPD subtyping 
have been partially addressed by the development of more robust RAPD protocols, and in 
particular, standardised RAPD reagents and 'analysis beads'. Therefore, a comparison of 
RAPD with and without the use of analysis beads would be interesting. The RAPD method 
developed in this chapter allowed discrimination equal to that of PFGE, yet requiring a 
fraction of the time to execute. It is estimated that a total of 5 hours of DNA/PCR 
preparation, thermocycling and gel running times gave data comparable to the sensitivity 
ofPFGE with no concerns ofuntypeabilty. This would be more cost and time efficient than 
the recently described PulseNet USA standardised pulsed-field gel electrophoresis protocol 
for subtyping of Vparahaemolyticus (Parsons et al., 2007) Analysis on a larger number of 
samples using primers P2 and P3 would confirm the general usefulness of this method and, 
in particular, to determine if the markers can be used to distinguish clinical isolates. 
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Chapter 9 
VARIATION IN THE TYPE Ill SECRETION SYSTEM 
AMONGST CLINICAL AND ENVIRONMENTAL ISOLATES 
OF VIBRIO PARAHAEMOLYTICUS 
9.1 Introduction 
The type Ill secretion system (TTSS) is an apparatus used by several Gram-negative 
bacteria to secrete and translocate virulence effectors across the bacterial inner and outer 
membranes directly into the cytosol of host eukaryotic cells (Comelis & Van Gijesegem, 
2000; Hueck, 1998; Ghosh, 2004). The TTSS is found in both animal and plant pathogens 
and is composed of more than 20 proteins that form a macromolecular assembly (TTSS I, 
Fig. 9.1 ). The proteins of the TTSS apparatus are highly conserved among bacteria that 
possess the system (Tampakaki, et al., 2004). In contrast, the effector proteins secreted via 
the TTSS are not conserved among those bacteria, and hence, the biological effects vary 
widely in target host cells (Hueck, 1998; He et al., 2004). Genes encoding the TTSS 
apparatus are generally found on pathogenicity islands (PAis) or virulence plasmids 
(Hueck, 1998; Winstanley & Hart, 2001 ). The TTSS has been shown to be especially 
important in the pathogenicity of Yersinia spp., Burkholderia spp., Salmonella spp., 
Shigellajlexneri, and enteropathogenic Escherichia coli (Hueck, 1998; Winstanley & Hart, 
2001). 
Genome sequencing of the clinical V parahaemolyticus isolate RIMD221 0633 revealed 
that the bacterium possesses two sets of genes for a TTSS, termed TTSS I and TTSS2, 
located on chromosomes I and 2 respectively (section 2.1.2) (Makino et al., 2003). The 
gene organization of TTSS I was found to be very similar to that of the TTSSs reported for 
Yersinia species. In contrast, TTSS2 is more similar to that found in non-0 I and non-0 139 
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V. cholerae pathogenic strains and seems to contain at least essential genes for protein 
secretion (Dziejman et al, 2005). The distribution of those genes among various V. 
parahaemolyticus strains and the GC content of the DNA regions containing TTSS I or 
TTSS2 suggested that TTSS I is intrinsic in the species while TTSS2 has a feature of 
laterally transferred DNA (Makino et al., 2003). Other bacterial species also possess two or 
more TTSSs. For example, multiple TTSSs can be found in S. typhimurium and 
Burkholderia spp. (Hueck, 1998; Winstanley & Hart, 200 I). Enterohemorrhagic E. coli 
0157:H7 has been known to possess two TTSSs termed LEE and ETT2 (Perna et a!, 
200 I). LEE is involved in the formation of attaching and effacing lesions in epithelial cells 
whereas the function of ETT2 remains unknown (ldeses et al., 2005). Except for the case 
of the TTSSs in Salmonella spp., the roles of multiple TTSSs in a single bacterium have 
not yet been elucidated. In V. parahaemolyticus, TTSS I was found in all of the strains 
tested while TTSS2 was present only in the KP-positive strains (Makino et al., 2003). 
The present study was conducted to: 
(i) develop multiplex PCRs to assess the distribution of both TTSS systems in 
clinical and environmental isolates that possess the gene tdh and shown to be 
K+ or K- (Chapters 3 and 4) 
(ii) examine variation in both TTSS I and TTSS2 in V. parahaemolyticus isolates 
by the development of probes specific to genes ofTTSSI and TTSS2 and DNA 
hybridisation assays 
(iii) assess the relationships between clinical and environmental isolates possessing 
TTSS I and TTSS2 systems with phylogenetic clusters obtained from typing 
experiments with a view to discrimination of potentially pathogenic isolates. 
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9.2 Materials and Methods 
9.2.1 PCR detection of TTSSI and TTSS2 genes 
Using sequence information from isolate RIMD221 0633 (Makino et al., 2003), three pairs 
of PCR primers spanning each of the TTSSs were designed with the aid of DNA-sis 
(Hitachi Software) and Amplify software (Engels, 1993). The primers were targeted to 
three genes on TTSS I and two genes on TTSS2 as well as a region flanking the TTSS2 
genes representing the V. parahaemolyticus pathogenicity island (Vp-PAI) (Izutsu et a/, 
2008) (Table 9.1, Fig. 9.1). Primers consisting of24 bases were designed on the basis of a 
50% GC ratio, the presence of 2-3 guanine or cytosine bases at the 3' end of the primer 
where possible, a lack of secondary structure and primer dimer formation, and their 
proximity in relation to the desired target sequence (Table 9.2). 
Table 9.1: TTSS gene targets in V. parahaemolyticus used in this study. Genes vcrDI & vscCJ are 
components of the TISSI. Gene vcrD/ has 74% identity to Yersina sp. yscD (encoding the largest protein). 
Gene vscC/ has 48% identity to Yersinia sp. yscC. An absence of these genes is likely to result in defective 
protein secretion via the TISS l. 
Region Gene number Designation Function Reference 
of robe 
lTSSI VPI662 Probe A Low calcium response protein. 
(vcrDI) lTSS structural protein Park et al., 2004b 
VPI680 Probe B 'Cytotoxic effector' protein Ono e/ al., 2006 
(vp/680) 
VPI696 Probe C lTSS structural protein Park e/ al., 2004b 
(vscC/) 
TISS2 VPAI321 ProbeD Cytotoxic necrotizing factor Makino e/ al., 2003 
(vpa/32 /) V. parahaemolyticus PA I 
VPAI339 Probe E Putative lTSS structural protein Dziejman et al., 2005 
(vscC2) 
VPAI355 Probe F Putative TTSS structural protein Dziejman et al., 2005 
(vcrD2) 
The reaction conditions for PCR amplification of V. parahaemolyticus TTSS loci in 
separate reactions are described in section 3.6 except that 25 J.ll rather than 50 J.ll reaction 
volumes were used and consequently half the stated volume of each reagent was added. 
Details of the primers used are provided in Table 9.2. Optimised PCR cycling conditions 
were 2 min at 94°C followed by 30 cycles of I min at 94°C, 45 sec at 65 oc and 90 sec at 
194 
72°C followed by a final extension time of 5 min at 72°C. PCR products were visualised 
by gel electrophoresis of 6- 12 Ill sample volumes on 1.5% agarose gels, as described in 
section 3.8. 
9.2.2 Development of Multiplex PCRs 
Two multiplex PCRs (M-PCR) were developed using the 6 primer pairs described in Table 
9.2. A maximum of three loci per reaction were amplified. The PCR reactions were 
performed in a 50 Jll volume as described in section 3 .6; primers for the TTS 1 regions used 
an equimolar 20 pmol concentration with the same PCR cycling conditions as in section 
9.2.1. Amplification ofTISS2 regions used an equimolar 30 pmol concentration of each of 
the primers. The M-PCR products were visualised by electrophoresis of 10 Jll volumes of 
the reactions in a 1.5 % agarose gel as described in section 3.8. 
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Table 9.2: PCR primer sequences used to detect TTSSl and TTSS2 regions1 
Region Gene %GC Amplicon Primer designation & sequence (5'-3') 
number size (bp) 
TTSS1 VP1662 53.9 458 VP 1662+ 764: TCACCGCTGGT A TT ATCGTT ACGC 
(2127bp) VP 1662-1221: GAGATACAACGCGCGTCTT ACTCT 
VP1680 53.3 183 VP 1680+613: GCCGAAGCGTATCATCA TCAACTC 
(1479bp) VP 1680-795: CACAGAGCTT ACACCAAACGT ACC 
VP1696 52.0 415 VP 1696+655: ATTGCTTCGGT ATTGAGCCGTGTG 
(1899bp) VP 1696-1069: AACTCTGACCACTGCCCAA TGTGA 
TTSS2 VPA1321 36.9 485 VPA1321+195: GGTTAGTGAATCCAACCAAACCGC 
(1107bp) VPA1321-679: TTGCCGTGCATGTCATACAACCAG 
VPA1339 41.6 272 VPA1339+ 398: GACACTCGCTGTTGTTCTCAGGTA 
(1464bp) VP A 1339-669: GT AAGCGCGTGATGTT AGCTCTTC 
VPA1355 40.6 388 VPA1355+747: GGCATGTGGTGTCTATTTGACACG 
(1884bp) VPA1355-1134: TACGACAACTGCAGGTAGTCCAAG 
1Primers based on published sequence of clinical strain RIMD221 0633 (Makino et al., 2003) 
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Figure 9.1: Genetic organisation of TTSSs from V. parahaemolyticus RIMD2210633 showing targets for PCR and DIG labelled probes. Probes A to 
Probe F targeted to approximate regions of the TTSS regions. ProbeD lies outside of the TTSS2 regions identified as a V parahaemolyticus pathogenicity 
island (VpPAl), indicated by flanking black/orange lines (Izutsu et al, 2008). Grey arrows show annotated TTSS genes where known. Unshaded arrows 
indicate hypothetical genes (adapted from Ono et al, 2006 & Dziejman et al., 2005). 
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9.2.3 Production ofTTSSl and TTSS2 specific DIG labelled probes 
PCR products corresponding to six of the TTSS regions from the genome of NCIMB UK 
type strain 1902 was used to develop digoxigenin (DIG) labelled probes and were 
designated Probes A to Probes F, according to PCR amplification regions (Fig 9.1 ). Details 
of probes labelled are shown in Tables 9.1 and 9.2. Additionally, three PCR products 
corresponding to the TTSS2 regions of an 03:K6 clinical isolate (220) that gave a strong 
PCR signal was also used to develop probes. 
The random primed method of labelling of DNA probes was performed according to the 
protocol provided in the Roche instruction manual 'DIG DNA Labeling and Detection 
Kit'. Details of all reagents referred to in this section can be found in Appendix I. PCR 
products were purified using the 'High Pure PCR Product Purification Kit' (Roche) and 
DNA quantified using the methods described in section 3.4. The reactions were performed 
in 0.5 ml Eppendorf tubes, each containing 0.4 - I Jlg of purified PCR product, 2 Jll of 
hexanucleotide mixture (stock concentration I .56 mg/ml), 2 Jll dNTP labelling mixture; the 
mixture was made up to 19 Jll with the addition of molecular grade water and then 1 Ill of 
Klenow enzyme (2 U/Jll), was added. The tubes were vortexed, centrifuged briefly at room 
temperature (13000-16000 x g, 5 s) and incubated at 37°C for at least 1 h, after which 2 Ill 
of0.2M EDTA solution was added to each tube to stop the reactions. 
9.2.4 Preparation of dot-blots 
Genomic DNA was transferred onto positively charged nylon membrane by using a 
Minifold I 96-well dot-blot system (Schleicher & Schuell, Germany) using the 
manufacturer's instructions. A volume corresponding to I 00 ng DNA was diluted to 100 
Ill with molecular grade water, boiled for 10 m in and kept on ice. An equal volume of 
freshly prepared NaOH (1M) was added to the samples and incubated at room temperature 
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for 20 min before transferring onto the nylon membrane. After drying for I 0 m in, the 
membrane was removed from the apparatus and DNA UV cross-linked for a further 5 min 
(Chromato-Vue cabinet, Module: CC-60 UVP Inc), followed by incubation in neutralising 
solution for 30 min. Membrane was rinsed twice in 2 x SSC and air dried and hybridised. 
9.2.5 DNA-DNA Hybridisation 
DIG labelled probes were hybridised in DIG Easy Hyb solution (Roche) according to 
manufacturer's instructions at temperatures of 65 - 68°C. Briefly, 20 m! of DIG Easy Hyb 
solution was preheated to hybridisation temperature in a roller bottle and the blot was 
added and left for 20 min for a prehybridisation wash. DIG labelled DNA probe (prepared 
as in Section 9.2.3) was denatured and added to a preheated 5 m! of Easy Hyb solution at a 
final concentration of 10 ng/ml. Prehybridisation solution was discarded and replaced with 
the probe/DIG Easy Hyb mixture. Probe DNA was hybridised overnight in the roller 
bottles at the appropriate hybridisation temperature. Post hybridisation stringency washes 
were performed twice in 20 m! of 2x SSC containing 0.1% SDS for 5 m in at 20°C, with 
two further washes in 10 m! of 0.5x SSC containing 0.1% SOS at 68°C for 15 m in in roller 
bottles. 
9.2.6 Immunological detection of DNA-DNA bybrids 
Details of all reagents and buffers referred to in this section can be found in Appendix I. 
Immunological detection of DNA hybrids was performed according to the protocol 
provided in the Roche instruction manual 'DIG DNA Labelling and Detection Kit'. Blots 
prepared as previously described were submerged for I min in 200 ml of buffer number I 
with constant gentle agitation, and then placed in 200 m! buffer number 2 for 30 min. The 
membranes were rinsed with buffer 1 then placed in a solution containing anti-digoxygenin 
antibody conjugated to alkaline phosphatase diluted I: 10,000 in buffer I for 2 h at room 
temperature. Any unbound antibody was subsequently removed by washing the 
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membranes twice in buffer I for 15 min. The membranes were equilibrated for 2 min in 
100 ml buffer 3 and then immersed in 70 ml of developing solution. The development 
reaction was allowed to proceed in the dark until a colour precipitate formed. The reaction 
was terminated by washing the membrane several times with TE buffer. Images of the 
developed membranes were captured onto a digital camera (Sony Cybershot DSC-I 0) with 
the macro settings enabled and the intensities of hybridisation signals were scored 0 to 3. 
9.2.7 Sequencing and analysis ofTTSS genes 
Both strands of PCR products corresponding to all six TTSS loci derived from NCIMB UK 
type strain 1902 were sequenced by MWG Biotech AG. For comparative purposes, 
amplicons derived from two additional isolates were also sequenced (03:K6 clinical 
isolate 220 and environmental isolate VP416) These sequences, together with the 
published genome sequence of V parahaemolyticus strain RIMD221 0633, were aligned 
using the online programs MultAiin, Artemis, ACT and Blastn 2. (Carver et al., 2005; 
Corpet, 1988; Makino et al., 2003; Tatiana et al., 1999). Sequences were also compared 
with those from other organisms on the GenBank database using the gapped BLAST 
program at http://blast.ncbi.nlm.nih.gov (Aitschul et al., 1990). 
9.3 Results 
9.3.1 PCR primers targeted to the TTSS loci 
PCR primers based on the published genome sequence of V parahaemolyticus 
RIMD221 0633 successfully an1plified regions of both sets ofTTSS genes in most of the 55 
isolates of V parahaemolyticus tested, as well as in some isolates of V cholerae, V 
vulni.ficus and V alginolyticus (Figs. 9.2, 9.3 & 9.4). Most of the TTSS amplicons from V 
parahaemolyticus appeared consistent in size, with various degrees of intensity. 
Sequencing of the PCR products of three isolates (1902, 220 and VP416) followed by 
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BLAST searches confirmed their identity as TTSS regions of the V parahaemolyticus 
genome (section 9.3.7). 
An annealing temperature of 64°C proved to be the most reliable in the amplification of 
both TTSS1 and TTSS2 genes using the same cycling conditions (Fig 9.2). Two multiplex 
PCRs targeting the TTSS 1 and TTSS2 regions respectively both amplified three loci of 
correct sizes (Table 9.2) in most cases. The bands of the TTSS2 regions appeared weaker 
in the multiplex PCR reactions and an increase of primer concentration by 5 pmol provided 
more consistent results (Fig 9.2). 
9.3.2 PCR amplification of genes from the TTSSl region 
Of the 55 isolates of V parahaemolyticus tested, PCR was positive for all three loci of 
TTSS I (representing the entire TTSS 1 system) in 48 (87%) of the isolates. Of the 
remaining seven isolates, three clinical isolates (2436, VPI0884 and 219) and two 
environmental isolates (VP331 and Vib1) PCR only amplified two out of the three genes 
(Figs. 9.3 & 9.4). Of the five isolates, only the amplicon corresponding to vpl680 showed 
a similar sized PCR product to the other 48 isolates (Figs. 9.3 & 9.4). In isolates 2436, 
VP331 and VP10884 PCR did not amplify vcrDJ whereas in isolates 219 and Vib1 vscCJ 
did not amplify. Repeated PCR on these isolates provided the same results. A further two 
environmental isolates VP345 and VP361 did not amplify any TTSS 1 loci. The absence of 
the TTSS 1 region was confirmed by DNA hybridisation (Table 9.4, section 9.3.5) 
9.3.3 PCR amplification of genes from the TTSS2 region 
The TTSS2 regions in both clinical and environmental isolates of V parahaemolyticus 
showed much more variability in intensity than the TTSS 1 amplicons (Figs. 9.3 & 9.4). 
Genes near the TTSS2 region corresponding to vpa132 1 were not amplified in two clinical 
isolates (2436 and 228) and 20 environmental isolates, accounting for 11% and 59% of the 
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two groups respectively. Clinical isolates that showed weak TTSS2 signals included 219, 
221 and 224. Of the 15 environmental isolates that showed positive PCR for the TTSS2 
region only two isolates (VPI 0 and Vib3) did not give an amplicon corresponding to vscC2 
(Fig 9.4). In most cases apart from isolate VP416, PCR signals for the amplification of 
TTSS2 regions in environmental strains were weak (Fig 9.4). Again, the presence of the 
TTSS2 region was confirmed by DNA hybridisation (Table 9.4, section 9.3.5). 
9.3.4 TTSS probes specificity in dot blots 
DIG labelled probes A to E, developed from the specific PCR products of UK type strain 
1902, hybridised successfully to most of the DNA samples from both clinical and 
environmental isolates (Figs 9.8 and 9.9). The hybridisation data compared well with PCR 
data and in most cases confirmed the presence of TTSS 1 or TTSS2 regions in both clinical 
and environmental isolates of V parahaemolyticus (Table 9.4). However, a weak 
hybridisation signal was obtained with some isolates that did not show the presence of 
TTSS regions by PCR. Additionally, a positive 'halo effect' in some of the samples was 
observed (Figs. 9.8 & 9.9). In such instances, the hybridisation signals were scored by the 
relative intensity of the halo as compared to the positive control. Only scores of 2 or 3,for 
the relative intensity of hybridisation signal, together with the presence of PCR signals 
were counted as positive for the presence of TTSS regions. There was no evidence to 
suggest that TTSS regions existed in multiple copies in any of the 56 isolates tested. 
Results are summarised in Table 9.4. 
9.3.5 Dot blot analysis ofTTSSl genes vcrDJ, vpl680 and vscCJ 
In support of the PCR results, dot blot hybridisation confirmed the presence or absence of 
TTSS I regions in most of the clinical and environmental isolates of V parahaemolyticus. 
Hybridisation signals with probe A (vcrDJ) were present in all clinical isolates including 
isolate 2436 that was negative by PCR. However, five environmental isolates (VP6, VP7, 
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VibiO, 1024/5 and I023/3) that had shown to be positive for the vcrD1 locus by PCR 
appeared negative or showed very weak signals in dot blot analysis. Furthermore, dot blot 
reliably confirmed the absence of vcrD1 in isolates VP331, VP345, VP36I, VPECI and 
VPSCI (Fig 9.6, Rows C & D). 
Signals with probe B, representing the presence of the vp 1680 locus, were present in all of 
the clinical isolates although signals were distinctly weaker in nine out of the I7 isolates 
(Fig 9.7, Rows A and B). However, three environmental isolates, (I022/10, 1024/5 and 
VP7) that were shown to be positive for the vp1680 locus by PCR appeared negative in dot 
blot analysis. Additionally, isolate VP345 that had shown to be PCR negative for vp1680 
also showed a weak hybridisation signal. 
Hybridisation signals with probe C, representing the presence of the vscC I locus were 
present in all the clinical isolates and hybridisation signals were stronger than with Probe B 
(Fig 9.8, Probe C, Rows A and B). However, five environmental isolates (VP7, VP346, 
VP4I9, I 023/3 and I 024/5) that had shown to be positive for the vscC 1 locus by PCR 
appeared negative in dot blot analysis. Furthermore, dot blot reliably confirmed the 
absence ofvscC1 in isolates, VP345, VP36I, VPECI and VPSCI (Fig 9.8, Probe C, Rows 
C&D). 
9.3.6 Dot blot analysis of TTSS2 genes vscC2, vcrD2 and vpa1321 
Analysis of the hybridisation of probes specific to vscC2, vcrD2 and vpa1321 regions all 
gave similar results and in most cases confirmed PCR findings (Figs. 9.8 & 9.9). Clinical 
isolates that gave weak (219, 221 and 224) or no (2436 and 228) PCR signals for all three 
loci also gave weak dot blot hybridisation signals, confirming the presence ofTTSS2 genes 
in all clinical isolates of V parahaemolyticus examined. However, II environmental 
isolates that were negative by PCR for TTSS2 regions demonstrated weak to moderate 
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hybridisation signals in comparison to the negative control isolates. Additionally, three 
environmental isolates (VP331, VP346 and Vib 1 0) that appeared positive in PCR did not 
hybridise to probes D, E or F. All results are summarised in Table 9.4. 
9.3. 7 Conserved sequence identities of V. parallaemolyticus TTSS genes 
Multiple sequence alignments from three isolates together with RMID at all six loci used in 
this investigation revealed I 00% congruence in nucleotide sequence in all three loci of the 
TTSS2 regions (Fig. 9.12). However, the sequences of the three TTSS1 regions showed 
some variation amongst the three isolates studied. Sequencing of PCR amplicons showed 
up to nine single nucleotide polymorphisms (SNPs) present within a fragment size of 458 
bp for vcrDJ (Fig 9.11 ). Additionally, vpl680 and vscCJ showed 11 and 7 nucleotide 
substitutions respectively. These together with the TTSS2 sequence homologies account 
for between 97 and 100% similarity between all three isolates in the TTTSS 1 and TTSS2 
regions. The SNPs do not translate into a different amino acid in vcrDJ, except for one 
codon where isoleucine is encoded in type strain 1902 instead of valine in isolates RlMD, 
220 and VP416 (position 119; Fig. 9.11). In addition to the SNPs, vpl680 also exhibited 
nucleotide deletions at position 30 (in isolates 220, 1902 and VP416) and further deletions 
at positions 40, 50 and 147 in isolate VP416 with a resultant frameshift mutation in vpl680 
(Appendix Ill; Fig. III.7). 
9.3.8 Correlation of phylogenetic clustering of isolates with the presence of TTSSl 
and TTSS2 genes 
Four environmental isolates of V parahaemolyticus that were negative for TTSS 1 region 
(VP345, VP361, VPEC1 and VPSC1) were clustered together and can be found in RAPD 
types 28, 29 and 30 (Chapter 8 & Fig. 9.10) with an additional isolate, VP331. 
Environmental isolates positive for the TTSS2 region generally fell into one group and two 
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sub clusters at a 76% similarity value (Fig 9.1 0). Of these clusters (indicated by red and 
blue in Fig 9.1 0), one group of 8 consisted entirely of environmental isolates and the other 
group consisted of a mixture of three environmental and four clinical isolates. A further 
three environmental isolates (VP2, Vib3 and Vib7) positive for the TTSS2 region were 
found scattered in various clusters (Table 9.4). 
9.3.9 V. parahaemolyticus TTSS regions in other species 
The PCR primers and probes developed from template of V parahaemolyticus type strain 
1902 were found to amplify PCR products in five other species tested including Vibrio 
mimicus (VM499), V vulnificus (VV11067 and KIDBVV), V cholerae (type strain 8042, 
VC3, VC4 and VC5), V alginolyticus (2341) and V anguillarum (Figs. 8.3, 8.4, 8.5, 
Table 8.3) Probes gave no hybridisation signals with Proteus mirabilis (PM5), Salmonella 
typhimurium (ST5), Escherichia aerogenes (EA5), Klebsiella aerogenes (KA5) and 
Pseudomonas aeruginosa (Fig 8.5) 
205 
M 2 3 4 5 6 7 8 9 M 
- -
'" 
•• 
- -
-
-
- -
••• t • 
-
-
-
...... ... 
-
-..... 
tl t t 
M 2 3 4 5 6 7 8 9 M 
-
tll • t 
-
-
- -.. 
-
••• • t 
- -~ -
.,., 
.. .. 
•• .. tl •• 
- -
M 2 3 4 5 6 7 8 9 M 
Figure 9.2: PCR amplification at annealing temperatures of (A) 6JOC, (B) 64°C and (C) 6~°C for 
TISSJ and TISS2 genes In NCfMB type strain 1902 in single and multiplex PCR reactions. Lanes 
correspond to amplicons from the following, with approximate sizes: I: M-PCR for all three ITSS I 
products; 2: VPI662 (458 bp); 3: VPI680 (183 bp); 4: VPI696 (415 bp); 5: M-PCR for all three ITSS2 
products; 6: VPAI321 (485 bp); 7: VPAI339 (272 bp); 8: VPA1355 (388 bp); 9: no template control; M: tOO 
bp markers with selected sizes indicated by arrow. 
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Figure 9.3: PCR of 1TSS lod in clinical isolates of V. JHlralraeMO/ytiCIIS from Japan, UK and Norway. 
(A): amplicons of isolate 542 I derived from primers based on sequences of strain RJMD2210633. (B) and 
(C): For each isolate (as indicated above the lanes) a pair of lanes corresponds to TTSS I and TTSS2 regions 
respectively. Lanes I- 10 Japan isolates with amplicons representative of all six loci ; lanes 11- 16 UK PHLS 
isolates; lanes 17 - 18 NCfMB reference strain VP I 0884; lanes 19 - 20 LD365(L. damsel a); lanes 21 • 40 
Norway isolates. Lane M corresponds to I 00 bp ladders with selected markers indicated on the right. 
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M VPI VP2 VP3 VP4 VP6 VP7 VP8 VP9 VPIO 361 M 
bp 
bp 
M 331 34S 346 349 3SO 377 378 416 491 939 M 
M Vibl Vib2 VibJ VibS Vib6 Vib7 Vib8 VibiO 
bp 
M 1902 102115 1022/10 102311 102313 1024/S 1103/9 VCI 2341 11327 M 
Figure 9.4: PCR of'ITSS loci in 34 environmental isolates of V. parllltaemolyticlls from UK and Spain. 
For each isolate (as indicated above the lanes) a pair of lanes corresponds to ITSSI and ITSS2 regions 
respectively. Lanes I - 18 Southampton isolates; lanes 19 - 40 isolates from Dorset coast; lanes 31 - 56 
Southampton isolates; lanes 57 - 58 unspeciated Vibrio sp. Vib 4; lanes 59 - 60 V. mimicus; lanes 61 - 62 
NCIMB reference (clinical) strain; lanes 63 - 74 Spanish isolates; lanes 75 - 76 V. cho/erae; lanes77-78 V. 
alginolyticus; lanes 79-80 V. jluvialis. Lane M corresponds to I 00 bp ladders 
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A 
B VVII067 KID VA430 VM499 LDJ65 Vanl04 
8042 VCI VC2 VCJ VC4 VCS PMS 
Figure 9.5: PCR and hybridisation signals in VIbrio spp. 
(A) Single primer and multiplex PCR signals of TISS loci in Vibrio species with primers based on V. 
parahaemo/yticus RMD2210633. Lanes l -2: V. cho/erae type strain 8042; lanes 3-6: V. cholerae 
environmental isolates; lanes 7-8: V vulnijicus; lanes 9-14: V. vulnificus VVII067 single primer PCR 
with all six primer sets; lanes 15-20: V. vulnificus environmental isolate KIDBVV single primer PCR 
with all six primer sets respectively. Lane M corresponds to 100 bp markers. 
(B) Dot blot hybridisation signals (probe E) with isolates labelled above the dots. Isolates EC5, PM5, 
STS, EA5, KA5 and PAl are non vibrios. 
Table 9.3: VIbrio species tested for TTSS genes of V. paralulemolytlcus. 
Isolate 
DesipaliOil Species Lotation Solll"tle 
1902 V. porahaemo/yt1CM!J PHLS, UK NCTMB Reference Strain 
8042 V. cho/erae PHLS, UK Ncrc Reference Sttain 
11327 V. fluvial is Oslo, N01W8y NcrC Reference sttain 
2341 V. a/gmo/yticus Kyoto, Japan Clinical 
VCI V. cho/erae Southampton Environmental 
VC2 V. cho/erae Southampton Environmental 
VC3 V. cholerae Southampton Environmental 
VC4 V. cholerae Soutlwnpton Environmental 
VC5 V. cholerae Soutbampton Environmental 
VM499 V. mim1cus Dorset Environmnetal 
VVII067 V. vulnificus Dorset Environmnetal 
KIDBVV V. vulnificw Dorset Environmental 
LD365 Llstonel/a damsellae Dorset Environmental 
Vib4 Vibrio spp. Southampton Environmental 
BL21 E. coli (control) Amersham Unlrnown 
A- E correspond to all six loci described in Fig. 9.1 and Section 9.2 
+/- Presence I absence ofTISS genes based on bolh PCR and dot blot analysis 
ilt Identified with dot blot but not confirmed with PCR 
• Identified with PCR but not confirmed with dot blot 
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2 3 4 5 6 7 8 9 10 11 12 
1902 2053 2436 5421 6134 (6316) (2341) EU4-182 EI$S85S FI6814J 
A 
VPI0884 219 220 221 222 223 224 225 226 227 228 
B 
-ve 331 3-15 346 349 ]50 361 377 378 491 416 
c 
939 ECI SCI 1021/5 1022110 102311 102313 102415 1103/9 
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F 
Figure 9.6: Hybridisation signals of 55 Isolates of V. parallll~molydcus witb Probe A targeted to tbe 
vcrD/Iocus ofTTSSI. The isolate corresponding to each dot is indicated. Rows correspond to the following: 
A and B clinical isolates; C and D environmental isolates from Dorset coast and Spain; E and F 
environmental isolates from Southampton, UK. White regions represent artefacts from photography of wet 
membrane. 
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Probe C 
2 3 4 5 6 7 8 9 10 11 12 
1902 2053 2436 542 1 6134 (63 16) (23-H) El54482 El55855 E168 
A 
VP10884 219 220 221 222 223 224 225 226 227 228 
B 
-ve 331 345 346 349 350 361 377 378 491 416 
c 
939 ECI SC I 102115 1022/10 102311 I 023/3 I 024/5 1103~ 
D 
VPI VP2 VP3 VP4 VP6 VP7 VP8 VP9 VPIO 
E 
Vibl Vib2 Vib3 (Vib4) Vib5 Vll>6 Vib7 Vib8 VibJO 
F 
Figure 9.7: Hybridisation signals of ~5 isolates of V. parahaemolydcus witb Probes 8 and C targeted to 
tbe vp1680 and vscCJ loc:i ofTfSSl respectively. The isolate corresponding to each dot is indicated. Rows 
correspond to the following: A and B clinical isolates; C and D environmental isolates from Dorset coast and 
Spain; E and F environmental isolates from Southampton, UK. 
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2053 2436 5421 6134 (6316) (2341) 
A 
B 
219 220 221 222 223 224 225 226 
c 
331 345 346 349 350 31\1 177 1711 
939 ECI SCI 1021/5 1022110 1023/1 1023/3 
D 
VPI VP2 VP3 VP4 VP6 VP7 VP8 
E 
V1bl Vib2 Vib3 (Vib4) VibS Vib6 Vib7 Vib8 
F 
Figure 9.9: Hybridisation signals of 55 Isolates of V. parahaemolyticus wltb Probe D targeted to the 
vpa/321 locus downstream of tbe lTSSl region of 'pathogenicity island' (Vp-PAl). The isolate 
corresponding to each dot is indicated. Rows correspond to the following: A and B clinical isolates; C and D 
environmental isolates from Dorset coast and Spain; E and F; environmental isolates from Southampton, UK. 
TTSS 
I l 
! ! r 
1022/10 Spain Envronmertal + 
110319 Spain Envronmertai + uc 
102415 Spain Envronmertal uc 
1021/5 Spain Envronmertal + + 
1023/1 Spain Envronmertal + uc 
VP377 Donillt, U< Envronmertal + + 
VP349 Donillt, U< Envronmertal + + 
VP350 Dorset. U< Envronmertal + + 
VP346 Dorset, U< Envronmertal + uc 
1102313 Spain Envronmertal uc 
VP378 Dorset. U< Envronmertal + + 
2053 Japan Clini:al + + 
5421 Japan Clini:al + + 
2436 Jap..-t Cllni:al + + 
6134 Jap.-. Cllni:al + + 
VP416 D01'8111, U< Envronmertal + + 
VP939 Dolll!l, U< Envronmertal + + 
VP491 Donlllt, U< Envronmertal uc 
Figure 9. 10: RAPD-PSJ clustering oflTSSl positive isolates. Three clusters are shown in green, red and 
blue based on a 76% similarity value. Both TTSS 1 and TTS2 correspond to all three loci described. Isolates 
indicated with + were conf11tned by PCR and dot blot whereas isolates marked with uc are unconfirmed by 
either PCR or dot blot. All isolates marked - are negative for both PCR and dot blot. 
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Table 9.4: Comparison of the presence ofTTSS related genes A-F, virulence characteristics and 
phylogenetic RAPD Typing clusters in V. parai/Uemolyticus. 
Isolate 
1902 
10884 
219 
220 
221 
222 
223 
224 
225 
226 
227 
228 
1024/5 
1021/5 
1022/10 
102311 
10231) 
1103/9 
2053 
2436 
5421 
6134 
Vib I 
Vib 2 
Vib 3 
Vib5 
Vib6 
Vib7 
Vib8 
Vib 10 
VPI 
VP2 
VP3 
VP4 
VP6 
VP7 
VP8 
VP9 
VPIO 
El54482 
E155855 
El68143 
VPJJI 
VP345 
VP346 
VP349 
VP350 
VP361 
VP377 
VP378 
VP416 
VP491 
VP939 
VPECI 
VPSC! 
Source 
NCIMB Reference 
NCfC Reference 
Clinical 
Clinical 
Clinical 
Clinical 
Clinical 
Clinical 
Clinical 
Clinical 
Clinical 
Clinical 
Environmental 
Environmental 
Environmemnl 
Environmenull 
Environmental 
Environmema I 
Clinical 
Clinical 
Clinical 
Clinical 
Environmental 
Environmental 
Environmemnl 
Environmental 
Environmental 
Environmental 
Environmental 
Environmental 
Environmental 
Environmental 
Environmental 
Enviromnental 
Environmenral 
Environmental 
Environmental 
Environmental 
Environmental 
Clinical 
Clinical 
Clinical 
Environmental 
Environmental 
Environmental 
Environmental 
Enviromnental 
Environmental 
Environmental 
Environmental 
Environmental 
Environmental 
Environmental 
Environmental 
Environmental 
Virulence 
Choraderi!tics1 
K-, tdh-. trh-
K+, tdh ...... trh-
K-,tdh-. trh-
K+,tcDr+, trh-
K-, tdh-, trh+ 
K+,tdlr+,lrlr+ 
K+,tdlr+, trlr-
K-, tdh ..... trh+ 
K+,tdh+, trh-
K+, tdh+. trlr-
K+,tdh t, trlr-
K-, ufh-, trh+ 
K-
K-,tdh-.trlr-
K-, tdh-, trh-
K-, tdh-, trh-
K-, tdh-, trh-
K-. tdJr-. trh-
K-, tdh 1, trh-
K+,tdJr+. trh+ 
K-, tdh+, trh-
K+,tdh+, trh-
K-, tdh·. trh-
K-, tdh-, trh-
K-, tdh-. trh-
K-, tdh-. trh· 
K-, tdh-. trh-
K-, uih +, trh-
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K-, tdlt+, trh-
K-, tdJr-. lrh-
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K-,Idh-+, lrh-
K-, tdh-. trh-
K-, tcUr+. trlr-
K-, tdh-, trh-
K-, tdh+, trh-
K-,tdh+, rrlr-
K-, tdh-, trh-
K-,tdh·,trh-
K-, tdh-, lrh-
K+,tdh+,trh-
K-. tdh-. trh-
K-, tdlr-. trh-
K-, tdh .... _trh-
K- tdh-, rrh-
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RAPD 
PSI 
20 
18 
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25 
25 
25 
25 
26 
25 
25 
25 
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03 
04 
01 
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12 
11 
13 
24 
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1Virulcnce characteristics 
K: Kanagawa haemolysis and 
virulence genes (tdh. trh) 
+I· Presence /absence ofTTSS 
genes based on both PCR and dot 
blot analysis 
l!> Identified wilh dol blot bul 
not confirmed with PCR 
~ Identified with PCR bui nol 
confirmed wilh dot blot 
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Figure 9.11: Multiple alignments of the vcrDJiocus of TTSSl in isolates of V. parahaemolytkus. RIMD2210633 is a sequenced clinical strain. Sequences 
220A and VP416A are from clinical and environmental isolates respectively and 1902A is NCTC reference strain from which probes were developed (Corpet, 
1988; Makino et al., 2003). Consensus regions are shown in red; blue and black show substitutions or deletions. Codon marked in green is valine (GTC) or 
isoleucine (ATC). Regions marked in dotted line represent quality control clipped regions. SNPs in TISSI are also present in vp1680 and vscCJ (Appendix rrn 
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Figure 9.12: Multiple alignments of the vpal321 locus of TTSS2 in isolates of V. parahaemolytkus. RIMD2210633 is a sequenced clinical strain. 
Sequences 220D and VP416D are from clinical and environmental isolates respectively. (Corpet, 1988; Makino et al., 2003). Consensus regions are shown in 
red, blue and black show substitutions or deletions. Regions marked in dotted line represent clipped regions. Nucleotide sequences of vscC2 and vcrD2 of 
TTSS2 are also conserved (Appendix ill) 
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9.4 Discussion 
Genome sequencing of V parahaemolyticus (RIMD2210633) revealed TTSS regions, one 
with extensive homology to that described for Yersinia spp, and the other that had 
previously not been characterised before but was later found to show similarities to the 
TTSS2 found in non-01 and non-0139 V. choleae (Dziejman et al., 2005). Both TTSSI 
and TTSS2 were shown to be functional and the fact that TTSS2 was only reported in 
Kanagawa positive (~-haemolytic) strains, suggest that it may be employed in the 
pathogenicity of V parahaemolyticus (Ono et al., 2006). The haemolytic reaction of 
thermostable direct haemolysin (TDH) is considered a marker of pathogenic strains 
(Sakurai et al., 1973), although not alltdh bearing isolates exhibit this phenotype (Chapter 
4; Nishibuchi et al., 1989). Thus, the significance of finding tdh alone in environmental 
isolates remains unknown. Additionally, a small proportion of clinical isolates apparently 
lack both tdh and /rh and the exact pathogenesis of V parahaemolyticus has yet to be 
elucidated. The current work was carried out to assess the distribution of TTSS I and 
TTSS2 regions in V parahaemolyticus and may help to differentiate virulent and avirulent 
isolates of V parahaemolyticus. 
9.4.1 Gene targets on the TTSS system of V. paraltaemolyticus 
Three loci in TTSS 1, two in TTSS2 and an additional locus recently identified just outside 
of the TTSS2 border comprising of the V. parahaemolyticus pathogenicity island (Vp-
PAl) were targeted by PCR (Izutsu, et al., 2008; Nishioka et al., 2008). Two genes, vcrDJ 
and vcsCJ targeted on TTSS 1 correspond to structural proteins with homologues found in 
P. aeruginosa, S. typimurium, enteropathogenic E. coli (EPEC), B. pseudomallei as well as 
several other species (Hueck, 1998). Additionally, VPI680 described as a TTSS effector 
protein, to date only described in V parahaemolyticus, was a third target for PCR in this 
study (Ono, Park et al., 2006). The three loci were used to represent the entire TTSS 1 
region of approximately 40 kbp (Park et al., 2004b). Similarly, the three genes vpa1321, 
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vscC2 and vcrD2 were selected to represent the entire TTSS2 region. The TTSS I and 
TTSS2 are two distinct secretion systems. Comelis and Van Gijesegem (2000) classified 
the TTSS of bacteria into three major groups: the Ysc-plus-Psc system, Salmonella 
pathogenicity-island 'S-PAI-plus-Mxi/Spa' system and a 'S-PAI-plus-EPEC-EHEC' 
system that constituted a system of Salmonella, enteropathogenic and enterohaemorrhagic 
E. coli genes. Whereas the TTSSI system falls into the Ysc-plus-Psc system, the TTSS2 of 
V parahaemolyticus is unlike any of the three described (Ono et al., 2006). Sequence 
alignments between vscCJ and vscC2 and between vcrDJ andvcrD2 ofTTSSI and TTSS2 
in three experimental isolates and two sequenced strains revealed no significant 
homologies for the cross hybridisation of probes or PCR primers, thus were used as PCR 
and probe targets. 
9.4.2 Detection of TTSS regions 
Single and multiplex PCR targeted to the six loci described were generally found to be 
specific in amplifying the correct sized fragments in V parahaemolyticus. Upon closer 
inspection, it seems unlikely that isolate Vib I, (red arrow, Fig 9.4) showed an ambiguous 
sized band, as first thought. In this isolate only two TTSS I sections were amplified with 
primers for vcrDJ and vscCJ, showing what appeared to be an ambiguous sized fragment 
between 415 and 458 bp. However, dot blot analysis confirmed that all three loci were 
present and nucleotide sequence analysis would confirm the true identity of these bands. 
Length polymorphisms in both virulence and housekeeping genes are widely reported in 
bacterial species. For example, PCR of the gene encoding toxin A (tcdA) in Clostridium 
difficile has shown length polymorphisms that enable some strains to be distinguished from 
others and a simple PCR to amplify capsule genes of Haemophilus influenzae can be used 
to discriminate between isolates (Rupnik et al., 1998; Falla., et al. 1994). However, in this 
study, it was necessary to confirm isolates lacking a PCR product by hybridisation 
218 
analysis. A lack of a PCR product may be due to nucleotide mismatches, the lack of primer 
target sites in some isolates or even simply due to a reagent missing in the PCR reaction 
mix. Conversely, the presence of priming sites does not necessarily mean the correct 
region is being amplified in a strain especially if amplicon sizes vary from the expected. 
The finding of isolates that were positive for hybridisation and negative for PCR (and vice 
versa) illustrates the need for careful interpretation ofPCR and hybridisation data. 
To overcome the magnitude of large scale Southern blotting and to save time, a dot blot 
hybridisation system was employed. Six DIG-labelled probes were developed based on the 
PCR amplification products that generated two different signals. The type strain 1902 
showed weak PCR signals for the TTSS2 regions (Fig. 9.4) and hence three additional 
probes targeting vpal321, vscC2 and vcrD2 were also developed from an 03:K6 serotype 
isolate 220. Despite isolate 1902 showing low PCR signals for TTSS regions, the probes 
developed from 1902 showed almost identical hybridisation profiles to those of probes 
developed from the template of isolate 220. However, the limitations of the dot blot 
analysis technique meant that a more detailed comparison of TTSS fragments between 
isolates was not possible. The finding of weakly positive signals together with the 'halo 
effect' present on some of the dots (most likely as a result of impurities in the DNA 
mixture deterring DNA cross-linking to membrane) indicate some of the drawbacks of this 
technique. 
9.4.3 Distribution ofTTSSl genes in V. parallaemolyticus 
Genes for TTSS I were found in all 17 clinical isolates of V parahaemolyticus in this 
study, including the two type strains; this is in agreement with previously published work 
(Makino et al., 2003; Ono et al., 2006; Park et al., 2004b). However, the presence of these 
genes in environmental isolates is much more variable. Out of37 environmental isolates of 
V parahaemolyticus used in the study, PCR and dot blot analysis revealed that four 
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isolates (VP345, VP361, VPECl and VPSCl) lacked all three ofthe TTSSl loci examined, 
suggesting that the TTSS 1 may not be an essential component for the survival of V 
parahaemolyticus and may not be intrinsic to this species as suggested previously (Makino 
et al., 2003; Ono et al., 2006). An additional seven isolates (1024/5, 1023/3, ViblO, VP6, 
VP7, VP331 and VP491) were identified as possessing TTSS1 by dot blot hybridisation 
but not by PCR amplification, suggesting a lack of primer target sites. These findings 
support existing studies that have identified TTSS 1 in all isolates of V parahaemolyticus, 
both clinical and environmental (Makino et al., 2003; Ono et al., 2006; Park et al., 2004b). 
A more extensive study with these environmental isolates using Southern hybridisation 
techniques and sequencing the entire TTSS region may help decipher structural variations 
in the TTSS I region. 
9.4.4 Distribution of TTSS2 genes in V. parahaemolyticus 
Genes for TTSS2 were found both in clinical and environmental isolates of V 
parahaemolyticus. These include isolates that showed presence or absence of the virulence 
genes tdh and trh regardless of whether they expressed the Kanagawa W-haemolytic) 
phenotype or not (Table 9.4). This is contrary to earlier published information, suggesting 
that TTSS2 is only present in Kanagawa positive isolates (Makino et al., 2003; Ono et al., 
2006; Park et al., 2004b). However, the findings in this chapter are consistent with the 
latest report that clinical isolates that are not related to the pandemic clone and are not 
Kanagawa positive also exhibit TTSS2 (Meador et al., 2007). Furthermore, as vpal 321 lies 
approximately 10 kbp outside of the recently described boundary of the TTSS2 region 
within the V parahaemolyticus pathogenicity island (Vp-PAI), it can also be proposed that 
all V parahaemolyticus carrying a TTSS2 system reside on the Vp-PAI (Probe D, Fig. 
9.9), which is typical of several pathogenic species with TTSSs (Hueck, 1998; Winstanley 
& Hart, 2001 ). This is further supported by the finding of the eo-presence of the virulence 
gene tdh and TTSS2 in V parahaemolyticus (Table 9.4) in most of the isolates. A copy of 
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the tdh gene (TDH-A) has been shown to lie close to the TTSS2 region approximately 4.3 
kbp downstream of vpal321 and, as expected, all but two isolates (VP7 and Vib9) that 
were positive for the vpa 1321 locus in this study were also positive for tdh (Makino et al., 
2003). The presence of TTSS2 together with the Vp-PAI and tdh all pertain to potentially 
pathogenic V parahaemolyticus and thus routine analysis of all tlu·ee regions rather than 
the tdh alone would better enable the monitoring of these strains. 
Although TTSS systems are present in many Gram-negative species, to date only four 
other species have been characterised to possess two or more different TTSS in the same 
bacterium: S. typhimurium, Enterohaemorraghic E. coli 0157: H7, Yersinia enterocolitica 
and B. psueudomallei (Hueck, 1998; Foultier et a/, 2002; Stevens et al., 2002). In S. 
en/erica, the first TTSS cluster (SPI-I) mediates enterocyte invasion while the second 
(SPI-2) is responsible for the intracellular survival within macrophages (Hensel et al., 
1995). However, whilst the first TTSS of enterohaemorrhagic E. coli (LEE) is responsible 
for the attachment and formation of lesions in epithelial cells, the precise function of the 
second TTSS (LEE2) remains unknown (Ideses et al., 2005). Similarly, the presence of 
both TTSS gene clusters in all clinical isolates may suggest a requirement of both systems 
for the pathogenicity of V. parahaemolyticus. TTSS I has been shown to secrete cytotoxic 
effector proteins from both the TTSS I and TTSS2 regions, but the role of TTSS2 remains 
unclear (Ono et a/, 2006). The finding of TTSS2 in at least I 0 environmental isolates with 
both the presence and absence of tdh and trh genes have demonstrated that TTSS2 is not 
exclusive to clinical isolates as previously thought and these genes are present in other 
members of the Vibrio spp. (Table 9.3, Fig. 9.5). 
9.4.5 Sequence diversity of TTSSl regions 
Sequence analysis of three isolates within the same six loci, together with the comparison 
with a further two sequenced strains has revealed that the TTSS2 regions, where present, 
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are more conserved than TTSS I. Single nucleotide polymorphisms (SNPs) were widely 
found in all three TTSS I regions examined. These polymorphisms usually appeared on the 
third base of the codon and often did not alter the translated amino acid. 
In bacterial pathogens, a variety of SNPs have been identified that may provide selective 
advantage during a course of an infection, epidemic spread or long term evolution of 
virulence (Sokurenko et al., 1999). For example, Boddicker and colleagues observed that 
two strains of S. typhimurium with comparable phenotypes demonstrated an eightfold 
difference in adhesion to human laryngeal epithelial (HEp2) monolayers. Two amino acid 
polymorphisms were identified in the high- bindingfimH locus of the type I fimbriae and 
both changes were identified to two single nucleotide substitutions (Boddicker et a/, 2002). 
Although some SNPs may be favourable and enhance pathogenicity, most cases ofSNPs in 
both eukaryotic and prokaryotic systems are thought to result in gene knockouts 
(Weissman et al., 2003). In the present study, valine was replaced with isoleucine in 
position 119 ofvcrDJ ofTTSS1 in three pandemic 03:K6 strains (RIMD, 220 and VP416) 
upon comparison with the type strain. TTSS 1 of isolate RIMD221 0633 has been shown to 
be functional, and isolates 220 and VP416 exhibit strong ~-haemolysis (Chapter 4). 
However, the large number of base substitutions identified in all three isolates raises the 
issue of whether the TTSSl regions, more specifically the vcrDJ, vpl680 and vscCJ genes, 
are functional and whether the presence of valine is responsible for a more virulent ~­
haemolytic phenotype. The finding of nucleotide deletions with resultant frameshift 
mutations in the vpl680 locus in all three isolates sequenced raises additional support to 
question the functionality of this gene. A further comparison of these loci in a larger 
number of isolates may provide more conclusive information. 
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9.4.6 TTSS genes as epidemiological markers for virulent strains 
To assess whether isolates possessing TTSS fell into distinct epidemiological clusters, 
RAPD-PSI groupings were compared with TTSS positive isolates (Table 9.4). The finding 
that most of the environmental isolates possessing TTSS2 clustered in a hierarchical group 
that included four clinical isolates was of interest. Of the I 0 environmental isolates that 
were confirmed for TTSS2 using both PCR and dot blot analysis, seven isolates fell into 
this unique cluster that was further divided into two sub-clusters (represented in red and 
blue, Fig. 9.1 0). Three isolates exhibited the presence of tdh; however, four isolates 
(1021/5, VP377, VP378 and VP939) in this group, as well as Vib3 from RAPD Type 24, 
were all negative for haemolysin genes tdh and trh. The close hierarchical clustering of 
these isolates negative for haemolysin genes and positive for TTSS2 warrants further 
investigation to determine their virulence status and to assess the feasibility of using 
TTSS2 as an additional virulence marker to tdh and trh. The finding of an environmental 
isolate (VP416) that is Kangawa positive (considered a strong indicator for virulent 
isolates) within this cluster may further suggest that other isolates may also be virulent in 
this group (Miyamoto et al., 1969). 
9.4. 7 Identification of TTSSl and TTSS2 genes in other species 
Since the identification of TTSS in V. parahaemolyticus, genome sequencing of a number 
of related vibrios have shown the presence of TTSS I genes, including V. harveyi, V. 
alginolyticus, and V. tubiashii (Henke & Bassler, 2004; Park et a/, 2004b). This work has 
additionally demonstrated these TTSS genes in V. vulnificus (VV 11 067), V. anguil/arum 
(VanCMI 04) as well as confirming its presence in V. cho/erae and V. alginolyticus 
(Dziejman, et al., 2005). Only the genes in non-01, non-0 139 V. cholerae have so far been 
shown to be homologous to the TTSS2 regions of V. parahaemolyticus (Dziejman, et al., 
2005). Despite the finding of TTSS genes in other species, little is known about their 
activity. The ubiquitous nature of vibrios mean that a large array of virulence genes, 
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including some identified in clinical isolates of other species, may confer upon this 
organism a greater degree of virulence. 
This chapter has described work to determine the presence of TTSS I and TTSS2 genes 
amongst both clinical and environmental isolates, something which had previously been 
thought to be a feature of Kanagawa positive (beta-haemolytic) strains only. Although the 
presence of the TTSSI has been shown to be responsible for translocating virulence 
determinants across the cytosol in V parahaemolyticus, its role in pathogenicity with 
regards to the haemolysins TDH and TRH has not yet been established (Ono et al., 2006). 
It is likely that the presence of both the TTSS systems together with the variously 
described effector molecules result in pathogenicity. The finding ofTTSS2 in a significant 
number of environmental isolates suggests that there may be more potentially pathogenic 
isolates in environmental reservoirs than currently thought. 
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Chapter 10 
A COMPARISON AND EVALUATION OF METHODS USED 
FOR DIFFERENTIATING VIBRIO PARAHAEMOLYTICUS 
10.1 Introduction 
In this present study, several phenotypic, serological and molecular techniques were 
applied in an attempt to assess and develop methods that may help differentiate pathogenic 
and non-pathogenic isolates of V. parahaemolyticus. Isolates were acquired from 
environmental, shellfish and clinical samples from several locations. Although etiological 
conclusions were hampered by the lack of information available on the isolates 
investigated, several techniques were successfully developed and applied. Phenotypic 
methods such as assessments of growth characteristics on general and selective media, P-
haemolysis, 0 and K serotyping provided more discrimination amongst the isolates. The 
ITSl-PCR and tDNA-ILP methods measured localised variation within PCR amplifiable 
16S-23S and tRNA spacer regions, whilst PFGE and RAPD provided a measure of 
interspecies variation throughout the genome. PCR methods, in general, were easy to 
execute and demonstrated varying degrees of diversity. 
Previous chapters have discussed issues of typeability, reproducibility and discriminatory 
abilities of the individual typing system employed. This chapter aims as far as possible, to 
summarise, compare and contrast the properties and groupings obtained between different 
phenotypic and molecular typing systems by assessing measures of discrimination and 
concordance as applied to V. parahaemolyticus isolates throughout the study. 
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10.2 Materials and Methods 
10.2.1 Phenotypic and growth characteristics of V. parahaemolyticus 
Assessments of growth and haemolytic characteristics were summarised together with 
findings of 0- and K- serotyping from Chapter 4. These methods are compared and 
evaluated. 
10.2.2 Discrimination of molecular typing systems 
The discriminatory power of the typing methods was estimated by the use of Simpson's 
index of diversity, as defined by Hunter and Gaston (1988). 
Discrimination index (DI): 
1 s 
D = 1 - """ n-(n -1) 
.£.J J J N(N-1) j=l 
Where N is the total number of strains used in the sample population, s is the total number 
of types described and n1 is the number of strains belonging to the jth type (Hunter & 
Gaston, 1988). For example, PFGE typing with the use of restriction enzyme Notl (Chapter 
5) shows 30 Pulse Types (n1 to n30) where n1 = I, n2 = 1, n3 = 3, 114 = 4, etc and N = 47. 
Calculations employing all 30 types give a discrimination index of 0.976. An index close 
to 0 indicates that little diversity is shown by the typing method whereas a DI approaching 
1.0 reflects increasing diversity identified by the typing system. Discrimination indices 
were calculated for all five typing systems and fingerprint types 
10.2.3 Concordance of molecular typing systems 
The concordance between the four typing systems was determined as previously using 
BioNumerics software (Version 5.1). Values from the similarity matrices of the two typing 
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systems under comparison were plotted on x and y axes. Each dot on the scatterplot 
represents corresponding similarity values for two isolates by any two of the typing 
methods. The graph therefore gives an indication of concordance between two typing 
techniques. The congruence, expressed as a percentage, was calculated in BioNurnerics 
using the Pearson product-moment correlation coefficient (PMCC). The regression (r), 
based on the least square fitting of the regression line for the data points, was also 
calculated in BioNumerics and gives an indication of the reliability of the regression 
model. A first degree (linear) model with monotonous fit was employed. Second (r2) and 
third degree (r3) models were also compared for correlation of x and y data. A dendrogram 
showing the relationships of all the typing systems, including fingerprints from combined 
tDl, tD2 and tD3 data (ID-combined), and well as combined RAPD-PS I and RAPD-PS2 
(RAPD-combined) in the typing of V. parahaemolyticus was also produced. 
10.3 Results 
10.3.1 Growth of V. parallaemolyticus 
Except for two environmental and one clinical isolate, growth on a selection of culture 
media (Chapter 4) in general, did not show any obvious signs of variability. Isolates 
VPECI and VPSCI produced large amounts of exopolysaccharide on Wagatsuma agar and 
appeared clustered together in dendrogram analysis in all four of the molecular typing 
systems employed. The third isolate (6316) produced remarkably small colonies on TCBS 
agar, similar to V mimicus, with unique fingerprint profiles throughout the course of the 
study. Based on Gram-staining, oxidase and basic morphological identification analysis as 
outlined in Chapter 4, all isolates (except 6316) appeared biochemically and 
morphologically indistinguishable with no apparent differences in growth characteristics. 
However, growth kinetics in reduced Na+ levels from 3.0% to 0.5% NaCI, significantly 
increased doubling times by 30% and supports recent evidence of increased fitness of 
environmental isolates at higher salinities (Martinez-Utarza et al., 2006). Environmental 
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isolates also appeared more tolerant to cold temperatures demonstrating increased 
culturabilty from cold storage. 
10.3.2 Haemolytic characteristics 
Out of 27 tdh positive isolates used in the study, only 12 (44%) isolates exhibited ~-
haemolysis; an attribute considered significant amongst clinical strains (Sakurai et al., 
1973; Nishibuchi et al., 1989; Nishibuchi & Kaper, 1995). Of the 12 environmental 
isolates possessing the gene tdh, only a single isolate, VP416, was haemolytic even though 
isolates were confirmed as TTSS2 positive in at least three other environmental isolates. 
The large proportion (29%) of environmental isolates in the study possessing the tdh gene 
is unusually high compared to typical levels of the tdh gene (I - 6 %) found in 
environmental samples (Nishibuchi & Kaper, 1995) and is clearly the result of sampling 
bias and the acquisition of clinically significant isolates from culture collections. The 
suitability of the Kanagawa test as a means of differentiating tdh positive strains is further 
questioned as three clinical isolates (2053, 5421 and El68l43) possessing tdh did not 
exhibit any haemolysis on Wagatsuma agar. This data suggests poor concordance between 
the gene tdh and haemolysis. The difficulty in the availability of fresh rabbit (or human) 
blood, limits the use of KP reaction for the routine surveillance of TDH. Difficulty also 
arose in assessing the degrees of haemolytic activity as it was apparent that varying levels 
of haemolysis were present (section 4.3.4). An attempt to quantify haemolysis levels 
attributed to TDH using a spectrophotometer showed little success. 
10.3.3 Serovar diversity of V. parahaemolyticus 
Out of a total of 63 isolates of V parahaemolyticus, 44 were serotyped into one of 20 O:K 
types (Chapter 4). Serotyping had a good discriminatory power (0.937) where all 0 
antigens were typeable with one of the 13 0-antisera commercially available. However, 
not all K-antigens were typeable and were designated KUT (Tablel0.2 & 10.3). Of the 71 
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K-antigens currently available for V parahaemolyticus, the isolates tested fell into one of 
14 K-types that included KUT. Nine clinical isolates in the study were of the O:K6 
serotype. A further two 03 serotypes (isolates 225 & 226) were K-untypeable but were 
positive for all four ITS! and RAPD markers that are found present in the pandemic clones 
(Table I 0.2). Within clinical isolates, an additional six serovars were present reflecting a 
diverse O:K population of disease causing types. A number of studies have shown a wide 
variety of serovars responsible for human disease (Nair et al., 1985; 2007). Serotypes 
amongst environmental isolates varied widely, with the predominant 01-type, present in 
SS% of environmental isolates. Other than the presence of 03:K6 isolates amongst clinical 
isolates, there appeared to be no other apparent serovar association in clinical and 
environmental isolates or their respective markers. 
As well as serotyping being a discriminative method, it also forms an easily reproducible 
technique due to the standardised reagents available in the serotyping kit. However, 
serotyping proved to be labour intensive and expensive. The availability of antisera for V 
parahaemolyticus 0 and K antigens is difficult, with only a few distributors worldwide 
(Kaysner & DePaola, 2004). With the rise of pandemic clones of serotypes 03:K6, 
01 :KUT, Ol:K25 and 04:K68 as the dominant serovars, the present limited study 
highlights the investigation of the RAPD markers (Bands X and Y) for the potential 
identification of pandemic isolates. 
10.3.4 Comparative analysis of pulsed-field gel electrophoresis 
In chapter five, Noti was used to generate restriction profiles of V parahaemolyticus with 
PFGE. Of the 59 isolates investigated using the methods described, a total of 47 isolates 
were used for dendrogram construction which included isolates that exhibited various 
degrees of DNA degradation. PFGE analysis, together with serotype variation, confirmed a 
heterogeneous population of V parahaemolyticus under investigation with 30 Pulse Types 
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and with the largest clusters (PT 04 & PT 18) containing only 4 isolates each. Despite the 
untypeability of approximately 20% of the isolates, PFGE showed the highest 
discrimination index (0.976) of all typing systems (Table 10.1). Apart from environmental 
isolates from Southampton (Vibl to Vib3 & Vib7 to Vib!O) that appear to be clonally 
related or even the same, isolates from the Dorset coast generally appeared untypeable; 
those that were typeable could not be assigned into clusters based on the location or the 
host source. 
In general, PFGE typing showed low correspondence with all the other typing systems 
(Figs. 10.1- 10.3) with congruence values ranging from 10.5% (with tD3) to 21.6% (with 
RAPD-combined). A comparison of PFGE with RAPD-PS1 and RAPD-PS2 showed that 
RAPD-PS2 was more congruent to PFGE than RAPD-PS I, with the composite RAPD PS 1 
& PS2 data appearing more congruent (Figs. 10.1 & 10.2). 
Isolates that appeared grouped in pairs in PFGE such as VPSC1 and VPSCI or 6134 and 
VP416 were also identified grouped together in RAPD-PSI and RAPD-PS2 (Chapters 5 & 
8: Figs. 5.11, 8.10 & 8.12. Clonally related 03:K6 isolates were also generally grouped 
together in all three fingerprint types to further support the reliability of these groupings. 
However, despite some similar groupings, there appeared general discordance. Firstly, 
isolate El54482 appeared closely related to two clinical isolates from the UK, E155855 
and E168482 in RAPD-PS 1 whereas PFGE and RAPD-PS2 clearly differentiated isolate 
E154482 from the two pandemic 03:K6 isolates. Furthermore, a few groups were 
attributed to different lineages by dendrogram analysis of different fingerprint types. For 
example, isolates Vibl - Vib3 and Vib5- ViblO that were found grouped together in most 
of the fingerprint types, appeared in the same hierarchical branch as pandemic isolates in 
RAPD-PS 1. However, the same isolates appeared to branch off into different groups m 
PFGE. Such differences may explain such low congruence values. 
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10.3.5 16S-23S intergenic spacer (ITSl) based typing 
Independent experiments showed that the ITS 1-PCR typing method developed was 
reproducible with respect to the two main amplicons of approximately 390 and 635 bps. 
Other than isolate 6316, these two bands distinguished V parahaemolyticus from other 
species (Chapter 6). Up to a total of eight bands within 390 to 810 bps were present with 
considerable variability of intensity. At 93% similarity, 13 groups were identified that 
included a single large group accounting for 56% of the isolates. An overall discrimination 
index of 0.665 and 100% typeability amongst the 56 isolates (Table 10.1) was shown with 
ITS 1-PCR. This method was shown to be a simple technique to assess intra-species 
relationships but a thorough investigation with accurate band sizing techniques is required 
to determine whether clinical or environmental isolates possess unique banding patterns. 
Due to the unavailability of a complete set of PFGE data, a visual comparison of groups 
obtained by RAPD-PS I and ITS 1-PCR was made. Clonal groups (Table I 0.2) in ITS 1-
PCR could not be as easily distinguished as RAPD-PSI. Based on ITS1-PCR, these 
clinical isolates appeared indistinguishable from several environmental isolates from Spain 
and Southampton, although at sufficiently high similarly values (>95%), clonal isolates 
appeared to be clustered together (Chapter 6: Fig. 6.11 ). Several other groups such as 
VPEC1 and VPSC1 and Vib1 to Vib!O were also found clustered together in both RAPD-
PS 1 and ITS 1-PCR.In addition to these concordant groups, a larger and significant number 
of discordant types were also identified. A visual representation of the data by means of a 
scatterplot demonstrated low concordance both with RAPD-PS I and RAPD-PS2 with 
values of 25% and 32% respectively (Fig. 10.4). A comparison with PFGE, even though a 
significant number of isolates were untypeable, similarly showed low correspondence (Fig. 
I 0.2: B). It appears that these comparisons do not follow a linear model and using a 
quadratic or higher model (r2 or r3 respectively) demonstrated higher regression values 
(Table 10.3). However, a comparison of ITSI-PCR with tDNA-ILP showed a higher 
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degree of concordance of between 35.5 and 51.8 %. Of the three tDNA-PCR typing 
systems (tDl, tD2 &tD3), tD3 showed at least 16% less concordance of ITSI-PCR than 
tDl or tD2 (Fig. 10.1 ). In general, ITS 1-PCR did not differentiate V. parahaemolyticus 
isolates as well as PFGE or RAPD, but provided general information on the isolates 
available. Almost all of the clonally related (Table 1 0.2) types were found clustered 
together in the largest group (ITS 1-C) and thereby these isolates were not differentiated by 
ITSI-PCR. Vibl to Vib3 and Vib5 to Vib8 and ViblO that clustered together based on 
ITS! polymorphisms, could not be grouped together with any of the tDNA-ILP fingerprint 
types. 
10.3.6 tDNA-ILP based typing 
The use of three sets of consensus tRNA gene primers provided a set of data representative 
oftDNA ILP typing of V. parahaemolyticus. Discrimination indices were 0.724, 0.568 and 
0. 703 (for fingerprint types tDl, tD2 and tD3 respectively) with I 00% typeability in all 
three fingerprint types. Up to eight amplicons were identified in PCR analyses with a good 
degree of reproducibility of the main amplicons in repeat tests. Only a single isolate 
(VP10884) failed to amplify one ofthe four main amplicon of approximately 740 bp found 
amongst the 6 isolates tested. As with ITS 1-PCR, variation in reproducibility lay mainly in 
the amplification of weak bands in tDNA-PCR. A comparison of fingerprint types tDI, 
tD2 and tD3 with the combined data of all three tDNA-PCR experiments showed that tDI 
was the most differentiating of the three sets of primers and therefore used for comparative 
purposes (Fig. 10.1 ). A lower discrimination index was obtained for tD2 even though 
isolates in tD2 were grouped at a higher similarity value of 95% instead of 90% as with 
tDI further suggesting primers for tD2 was the least discriminative of the three sets of 
tDNA primers. 
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Fingerprint type tDNA-ILP (tDI) was compared to RAPD-PSI. A fair degree of 
concordance was demonstrated between the two fingerprint types (Congruence = 47%, r 
= 56.7%, Fig. 10.5:A). For example, isolates VPI to VPIO that formed two groups in 
RAPD-PSI was also identified within a subset of the largest group oftDI (tDI cluster A). 
Similarly, most isolates of the pandemic clonal group (Table 10.2) appeared clustered 
together in the comparison (Fig. 7.6, cluster tDl-C). Two further, smaller, groups 
consisting of isolates VP331, VP345, VP361, VPECI and VPSCl) were also grouped in 
both fingerprint types. It is not known to what extent this could be attributed to isolates 
placed on the same gel and therefore this needs to be addressed in further studies. Most 
other environmental isolates appearing heterogeneous in more sensitive methods such 
RAPD and PFGE were found clustered together and sometimes indistinguishable based on 
tDNA-ILPs. Likewise. a comparison oftDl with RAPD-PS2 demonstrated some degree of 
concordance (Congruence= 56.6%, r = 62.1 %). 
10.3.7 Randomly amplified polymorphic DNA 
RAPD was shown to be the second most discriminative method after PFGE with 
discrimination indices of 0.965 and 0.959 for the two RAPD fingerprint types, PS I and 
PS2 respectively. The two-primer RAPD methods developed were almost as discriminative 
as PFGE (DI = 0.976) but unlike PFGE, did not suffer from issues of untypeability and 
were thus used as a method to which other typing systems were compared. RAPD 
identified 30 and 24 RAPD types at ~ 90% similarity with PS I and PS2 respectively, with 
good correspondence between the two RAPD types (Section 8.3.6 & Fig. 10.6). However, 
despite this discriminatory ability and congruence between two sets of RAPD primers, 
concordance with PFGE was low (Fig I 0.1 ). For example, Vib6 that appeared similar to 
clinical isolate El54482 by PFGE analysis was identified in different groups by both 
RAPD methods. Examination of ITSI-PCR and tDNA-ILPs found little correspondence 
between isolates Vib6 and E I 54482. Thus in this case, similarities observed by PFGE 
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could not be verified by other typing clusters. In addition, the RAPD method appeared to 
be the least reproducible in comparison with ITS 1-PCR and tDNA-ILP. Nonetheless, the 
RAPD method identified two possible markers that corresponded well with the pandemic 
group specific (GS) PCR (Table I 0.2). Further investigation is required to confirm whether 
such bands are unique to pathogenic isolates only. 
1 0.3.8 Evaluation of the TTSS2 in V. paralraemolyticus 
Based on the data presented in Chapter 9, isolates confirmed as possessing the second type 
three secretion system (TTSS2) were those that gave positive signals for both PCR and 
DNA probe hybridisation for at least two of the three loci examined. The groupings and 
comparisons of TTSS2 positive isolates are shown in Table I 0.2. For comparative 
purposes, genotypes and characteristics of TTSS2 positive and TTSS2 negative isolates are 
presented in Tables I 0.2 and 10.3 respectively. It became immediately apparent that all 
clinical isolates and a significant number of environmental isolates possessed a TTSS2. 
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Table 10.1: Discrimination of V. parallaemolyticus typing methods used in this study 
Method Fingerprint No. of Size(%) of oe Similaritl % 
{Ch&(!ter~ T~(!e T~(!eS2 largest l~l!e of t~l!es T~l!eabilit~ + 
Serotyping1 (4) n/a 20 19 0.937 n/a 70 
PFGE (5) Not I 30 4 0.976 ~88% 80 
ITSI-PCR(6) ITS I 13 57 0.665 ~93% 100 
tDNA-ILP (7): tDI 7 45 0.725 ~90% 100 
tD2 7 64 0.568 ~95% 100 
tD3 9 46 0.703 ~95% 100 
RAPD (8): PSI 30 13 0.965 ~90% 100 
PS2 24 11 0.959 >90% 100 
1 Serotyping is character type data; Chapter 4: Table 4.3. Typeability refers to untypeable K-antigen only. All 
0-antigen typing, where performed, were typeable. 
2 Includes types assigned at ~ 88% similarity. 
3 Discrimination Index based on Hunter & Gaston ( 1988); a value closer to 1.0 suggests a more discriminate 
typing system. 
4 Based on dendrogram 
+ Typeability was scored as a percentage of the typing system to assign a type to each isolate (Struelens, 
1996) 
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Figure 10.1: Summary of concordance for aD molecular typing systems. Matrix shows percentage 
congruence values as calculated with the PMCC in BioNumerics. Composite data for all three tDNA-PCR 
and both RAPD experiments are marked as tO-combined and RAPD-combined respectively. Dendrogram 
shows a measure of tl1e relatedness of the molecular typing systems based for the typing of V 
parahaemolyticus. 
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Figure 10.2: Concordance of stratification by PFGE and RAPD for V. parallaemolyticus isolates. Each 
dot represents corresponding similarity values for two isolates obtained by PFGE and RAPD-PS I typing (A) 
and PFGE and RAPD-PS2 typing (B). Concordance as calculated with the PMCC is shown as C and 
regression by r. 
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Table 10.2: Comparison of V. parahaemolyticus TTSS2 isolates and typing groups to distinguish 
vir ulent and potentia lly virulent strains. All isolates are confirmed TTSS2 positive both by PCR and dot 
blot hybridisation. 
PCR Typing groups 
Isolate Serotype KP2 
tdh ,,, GS PF ITS I tDt tD2 tDJ RAPD RAPD 
PSt PS2 
Clinica l 
220• 03 :K6 + + + 2 1 c D A 8 24' 23* 
222• 03 :K6 + + + + 22 c D A 8 24* 23* 
223 • 03:K6 + + + 18 c D A 8 24* 23* 
227• 03:K6 + + + 20 c D A D 24* 23* 
E l 55855e 03 :K6 + + + 18 c A c c 21' 15* 
El68143e 03 :K6 + + 18 c A c 8 21' 15* 
2053 • 03:K6 + + 18 c c F F 10* 15' 
542 1• 03:K6 + + 20 c c A 8 10* 15* 
22 1• OI:KUT + 20 c D A 8 25 22* 
225• 03 :KUT + + UT c D A 8 24* 23* 
226• 03:KUT + + 19 c D A D 24' 23* 
219 06:KUT 27 8 D 8 8 27 22 
224 03:K6 + + 24 c D 8 8 26 22 
228 OII:KUT + 02 c D A D 24 22 
2436 06:Kl8 + + + UT c D A A 11 16 
6134 04:Kl2 + + 09 c D A 8 12 08 
El54482 Ol:Kl + 15 c A A ;\ 21 18 
Type Strains 
1902 O I:Kl 25 A B c G 19 11 
VPI0884 03:K4 + + 07 1-1 D A D 17 20 
Environmental 
102 1/5 02:KUT UT c 8 c 1-1 04 10 
Vib3 Ol:K32 03 K A A B 23 17 
Vib7 NO + 04 c A B 22 09 
VP2 NO + 10 c ;\ A B 20 12 
VPIO NO + + 26 c A A B 18 14 
VP33 1 NO UT c p D c 28 03 
VP349 NO + UT A c E c 06 06 
VP350 NO + 08 L ;\ E c 06 06 
VP377 04:KUT UT E A E c 05 06 
VP378 06:K I8 14 E A E c 09 07 
VP416 04:KUT + + 09 E A E c 12 08 
VP939 04:K I8 23 ~I c E G 13 19 
1 Wagley et al., (2008) 
tdh: thermostable direct haemolysin (TOH) gene 
trh: TOH related haemolysin gene 
GS: Group Specific PCR for pandemic types (Matsumoto et a/, 2000) 
2 Kanagawa phenomenon - P-haemolytic isolates 
3 Groups based on ~88% simi larity. PF: Pulsed-field gel electrophoresis with Notl, ITS: ITS 1-PCR, tO l -t03 : 
tONA-PCR with three primer pairs, RA PO-PS I and RAPO-PS2 types indicated with * correspond to distinct 
amp! icons (Band X and Band Y) as possible markers of pandemic strains in RA PO-PS I and RAPO-PS2 
respectively. 
NO: Not determined 
UT: Untypeable 
Clonal C• ) and clonally related isolates (•) based on GS-PCR, PFGE, RAPO, ITS and IONA PCR. 
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Table 10.3: Comparison ofTTSS2 unconfirmed (UC) or TTSS2 confirmed negative (-) isolates of V. 
parallaemolyticus to potentially distinguish avirulent strains. All isolates are environmental. 
PCR1 Typing groups 
Isolate Serotype KP2 
tdll !rh GS PF ITS I tDI 102 IDJ RAPD RAPD 
PSI PS2 
ITSS2 (UC) 
1023/ 1 OI:K32 UT c A A c 04 04 
1103/9 OI : KI 13 c A A c 02 07 
Vibl OI :K32 03 K A A B 23 17 
Vib3 Ol:K32 03 K A A B 23 17 
Vib6 ND 16 J c A B 22 09 
Vib8 ND 04 E A B 22 09 
Vib!O ND + 04 c A B 22 09 
VPI OI :K33 10 A A A A 20 12 
VP3 ND + 11 c A A B 20 12 
VP4 OI:K33 12 c A A B 20 12 
VP8 ND + + 28 c A A B 16 13 
VP9 ND + + 29 c A A B 16 13 
VP345 ND + UT c F D c 28 03 
VP346 OI:KUT UT D c A c 07 21 
VPECI ND + 05 H F D B 30 01 
TTSS2 (-) 
I 024/5 03:KUT ND ND UT c c A c 03 05 
1022/10 OJI :KUT 01 c A A c 01 04 
1023/3 ND UT c A A c 08 04 
Vib2 OI:K32 03 A A B 13 17 
VibS Ol :K32 10 K A A B 23 17 
Vib9 ND + 0~ ND ND ND ND ND ND 
VP6 02:K28 30 c A A B 16 13 
VP7 ND + + 30 c A A A 16 13 
VP361 O I:KUT UT F F D c 29 03 
VP491 ND UT G A E c 14 24 
VPSCI 08:KUT 05 H I' F E 30 0 1 
1 Wagley et al., (2008) 
tdh: thermostable direct haemolys in (TDH) gene 
trh: TDH related haemolysin gene 
GS: Group Specific PCR for pandemic types (Matsumoto et a/, 2000) 
2 Kanagawa phenomenon - P-haemolytic isolates 
3 Groups based on 2:88% similarity in typing systems. PF: Pulsed-field gel electrophoresis with Not!, ITS: 
ITS I-PCR, tDI-tD3 corresponds to tDNA-PCR with three primer pairs. 
ND: Not determined 
UT: Untypeable 
243 
Table 10.4: Analysis of regression in comparison of typing systems. Regression models r" r2 and r3 
correspond to first, second and third degree regression models respectively. Values are as calculated from 
BioNumerics software using the method of least squares. Figures l 0.2 to l 0.6 show a r1 linear regression line 
whereas in some instances r2 and r3 curves provide better data fit. Increasing regress ion values were obtained 
with higher regression models in comparisons where local ised variation (i.e. typing systems tDNA-PCR or 
ITSI-PCR) was compared with high discriminatory genome-wide variation (i .e. PFGE or RAPD). 
T:yuin2; comuarisons 
Regression PFGE ITS I-PCR tONA-ILP (tO I} 
model PSI PS2 tO I ITS I PS I PS2 PS I PS2 ITS I 
rl 34.4 38.7 18.9 17.4 40.3 46.7 56.7 62.1 62.9 
rz 40.8 51.1 64.4 57.1 58.3 62.7 74.2 78.5 63.3 
rJ 40.9 51.1 79.6 73.8 65.4 67.8 77.2 80.9 63.4 
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10.4 Discussion 
Subtyping or isolate classification can be accomplished by using a number of different 
techniques. These methods must meet several criteria in order to be useful. A comparison 
of different typing methods used in this study has outlined various degrees of typeability, 
reproducibility and discriminatory powers, together with an evaluation of the ease of use of 
a typing system. This chapter aimed to compare and evaluate the groupings obtained to 
help establish relationships and assess the reliability of the methods and the relatedness 
infened by different characterisation and typing systems. 
10.4.1 Phenotypic methods for isolate differentiation 
The TDH phenotype could not be attributed to a significantly large proportion of tdh gene 
possessing isolates. The haemolysin TDH is known to be a pore forming toxin that causes 
cytotoxicity in a Ca2+ independent pathway (Honda et al., 1992; Tang et al., 1995; 
Takahashi et al. , 2006). However, the precise mechanisms of its mode of action still 
remain unknown. The present data show a greater proportion of environmental isolates 
possessing the gene tdh than clinical isolates not exhibiting haemolysis. It is not known 
whether the gene tdh is switched off and/or present in an inactive fonn amongst 
environmental isolates. The conserved nature of tdh (Nishibuchi & Kaper, 1995) may 
suggest, however, that the copy is functional. The significance of finding tdh in 
environmental isolates therefore remains unclear. Of interest would be to assess the actual 
numbers of environmental isolates harbouring tdh genes to exhibit haemolysis. Non-
haemolytic clinical isolates possessing the gene tdh indicate that passage in the human host 
may not be responsible for the activation of tdh genes. 
As far as the author is aware, antisera for V parahaemolyticus 0 and K antigens is only 
produced by Denka-Seiken in Japan with a few distributors worldwide (Kaysner & 
DePaola, 2004 ). The costs and labour associated with serotyping, together with the 
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untypeabilty as shown in the present study, and by others (Nair et al., 1985) suggest that 
serotyping of a large number of environmental isolates may not a feasible option. 
10.4.2 Typing methods of V. parallaemolyticus 
PFGE was performed so that it could be used as a "benchmark" typing method to which 
additional typing systems, which were simpler to perform, could be compared. Despite the 
recent trend towards nucleotide sequencing typing methods, to date, PFGE remains the 
most widely adopted method for typing nosocomial, community acquired and foodborne 
pathogens (Tenover et al., 1997; Hyytia-Trees et al., 2007). Due to the large degree of 
untypeability of V parahaemolyticus by PFGE (and thus the unavailability of a complete 
set of PFGE data) for all 56 isolates of V parahaemoly ticus, an initial comparison of 
PFGE with both RAPD-PS 1 and RAPD-PS2 was undertaken. 
Struelens (1996) suggested that a sufficiently discriminate typing system should have a 
discrimination index of at least 0.950 and therefore both PSI and PS2 have shown to be 
adequate for subtyping of V parahaemolyticus. In a previous comparative study, using a 
single primer RAPD method, Wong et al., (2001) identified several typing systems with 
RAPD as the lowest discrimination index (0.840). The workers found ERIC (DI = 0.980) 
and REP-PCR (DI = 0.97) to be more discriminatory than PFGE (DI = 0.960) based on 40 
strains typed (Wong et al. , 2001). Whilst the present PFGE data (DI = 0.976) support these 
findings, the two-primer RAPD method (DI = 0.959- 0.961) has been shown to be a more 
discriminate method and presents an enhanced typing system achievable without 
significant addition to costs or labour times. However, based on the present study, low 
concordance of PFGE was shown with all the typing systems. PFGE suffered from high 
degrees of DNA degradation where a significant proportion of isolates were not typeable. 
Of those that appeared typeable, a further subset (such as isolate 226 and VP6 - VP9) 
showed distinctly weak bands. It is likely that some bands could not be identified amongst 
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the DNA smears. Furthermore, based on scatterplots and regression analysis it seems likely 
that some of the comparisons could better be associated with quadratic or higher models 
(i.e. r2 or r3) rather than a linear relationship. A comparison between first degree (linear) 
and non-linear models showed better data fit with non-linear models in some instances. 
This seemed more apparent when comparisons were made between high and low 
discriminatory typing systems. BioNwnerics employed a Pearson product-moment 
correlation coefficient to assess the linear relationships between two comparative typing 
methods. As some models don't appear linear, it is possible that small changes apparent in 
ITS 1 and tDNA spacer regions identified from typing experiments could be indicative of 
greater or lesser genome variation as measured by RAPD or PFGE. 
The use of RAPD for typing V parahaemolyticus has been suggested by others, above all 
on the grounds of the ease of use before more labour intensive approaches such as MLST 
and VNTR analyses are performed (Giske et al. , 2006). However, inter-laboratory 
reproducibility of this method is a widespread concern and has been discussed earlier 
(section 8.4.6). Despite this, the data presented in this thesis show some degree of 
reproducibility in independent experiments and tills may be partially due to the use of 
standardised reagents such as RAPD analysis beads (Amersham Biosciences). However, in 
general, levels of reproducibility did not appear to be adequate and further work is 
required. Based on the preliminary studies described in this report, the use of ITS 1-PCR 
and tDNA-ILP offer less discrin1inative alternatives to RAPD. The work was caJ.Tied out 
with standard, easily available laboratory reagents and may prove to be more robust than 
RAPD in inter-laboratory assessments. For example, changing annealing temperatures did 
not significant! y affect banding patterns in ITS 1-PCR in the present study and therefore 
variation arising as a result of PCR amplification at rugh annealing temperatures could be 
more attributed to mutations in the primer binding sites. This is in contrast to the low 
annealing temperatures for RAPD that would result in more non-specific primer 
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hybridisation to DNA template (Bart-Delabesse, et al. , 2001). Therefore, ITSl-PCR and 
tDNA-ILP warrant further analysis on larger sample numbers. 
The use of more sensitive typing methods such as PFGE and RAPD may not always be 
appropriate. For example, environmental populations of V parahaemolyticus, as shown in 
this study, and by others, are genotypically diverse (Nair et al., 1985). Both clinical and 
environmental isolates were identified as single members in 18 and 20 of their own types 
in RAPD-PSI and PFGE respectively. Therefore, methods such as ITSl-PCR or tDNA-
ILP may be satisfactorily used as a first step towards strain confirmation and 
differentiation. The present work has collectively demonstrated that the less discriminate 
methods grouped distantly related V parahaemolyticus isolates and provides useful low 
resolution typing information. Combining data from multiple experiments, when high 
similarities are obtained (i.e. tD-combined) can provide greater differentiation than single 
primer pairs alone but in the present case, combined data appears to group together 
isolates from the same gels more than single gels alone thereby exemplifying the need for 
random isolate distribution on a gel and careful data analysis. 
As described in section 6.4.5, a number of tRNA genes can be found within ITS 1 regions 
of V parahaemolyticus (Makino et al., 2003). Whereas ITS 1-PCR provided a measure of 
spatial heterogeneity between conserved ribosomal genes, the genome wide distribution of 
tRNA genes provided a method in which more of the genome was subject to analysis. This 
may help to explain the discrepancy in concordance of 46.5% (linear regression = 62.6% 
fit) between ITS 1 and tDNA (tD l) ILP typing. It is not known if the tRNA gene primers 
used were specific for particular tDNA regions encoding for specific tRNA classes or 
whether such inferences could be made. However, based on the amplicon sizes it would 
appear that there were limitations posed by PCR amplification conditions. For example, the 
largest amplicon from ITS 1-PCR (81 0 bp) was expected in three copies ((Makino et al., 
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2003; Gonzalez-Escalona et al., 2005b; 2006a) and hence to result in an intense band. 
Clearly this was not the case observed as arnplicons above 700 bp appeared faint (Chapter 
6). Similarly, tDNA-ILP bands (Chapter 7) above 600 bp appeared faint. In both cases, 
there were significant amounts of background PCR noise that would need to be addressed 
in further studies employing these methods. 
10.4.3 General reliability of clustering patterns 
It was apparent that no two typing systems used m the present study gave a high 
concordance and there remain questions on the reliability of the data obtained. The 
discordance of PFGE with other typing systems highlights the need for the use of an 
additional restriction enzyme for PFGE analysis. As both RAPD-PS 1 and RAPD-PS2 
appear congruent to each other and to some degree with ITS 1-PCR and tDNA-PCR typing, 
it is likely that the current PFGE data needs further reassessment. For example, similar 
banding isolates such as VP6 - VP9 appeared distant on the PFGE dendrogram that may 
suggest sub-optimal BioNumerics band tolerance settings. As mentioned earlier, this could 
also arise if faint bands were not selected in the analysis. A similar explanation of isolates 
that appeared to share the same apparent fingerprint pattern yet were clustered differently 
in ITS 1, tON A and RAPD dendrograms can be provided. It is also worthy of note that 
analysis of PFGE was performed using the Dice, band-based method, whereas other typing 
systems employed a curve based method. Analysis of the concordance tests were limited 
by the reliability of the data originally obtained and may further explain low congruence 
values in the comparisons. Discordant results between RAPD and PFGE have been 
reported before. In a recent external quality assessment collaborative study with a network 
of laboratories, RAPD was shown to be 47% concordant to PFGE with Staphylococcus 
aureus isolates (Deplano et al., 2006). In another study, RAPD demonstrated only 26.5% 
concordance with other typing techniques such as RFLP (Bart-Delabesse, et al., 2001). 
Despite such discrepancies, RAPD continues to be widely employed in typing systems. 
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It was found with PFGE that isolate 6316 showed more similarity to Vib6 and El54482 
than any of the other isolates, whereas both lTSl-PCR and tDNA-lLP typing clearly 
discriminated 6316. With a large number of bands (> 15) and a few common bands, this 
isolate did not show as much variability by PFGE for it to be classified as such. As 
mentioned earlier, isolate 63 16 showed unique growth characteristics similar to that of V 
mimicus. The placement of this isolate in the PFGE dendrograrn thus seems inappropriate 
and can be used as a measure to further illustrate the genetic diversity of V 
parahaemolyticus isolates under study. Therefore ITS 1-PCR or tDNA-ILP typing 
provided further evidence that isolate 6316 may not be closely related to V 
parahaemolyticus or may even be a different species altogether. 
Inconsistencies in groupings obtained in the typing systems may also pru1ially be attributed 
to the method used for dendrograrn analysis. In the 'curve based ' analysis methods used, it 
was found that the presence of much darker bands gave unreliable clusters where faint 
bands apperu·ed ignored. Thi s has been identified by others as an inherent problem of curve 
based analysis methods (Werner et al. , 2003; Rasschaert et al. , 2005) and based on present 
data seems more of a concern when there are few bands generated in the typing system. 
10.4.4 Differentiation of clonally related V. parahaemolyticus 
There are an increasing number of reports of the prevalence and dominance of clonally 
related V parahaemoly ticus in disease outbreaks worldwide (Chiou et al., 2000; 
Chowdhury et al., 2004b; Ansaruzzarnan et al., 2005; Rizvi et al., 2006; Serichantalergs, et 
al., 2007). To date, these isolates generally have been shown to fall into one of four 
serotypes: 03:K6, Ol :KUT, 01 :K25, and 04:K68 (Chowdhury et al., 2004a), and appear 
indistinguishable even with PFGE methods, contrary to the belief that isolates with highly 
related PFGE patterns shru·ed the same phenotype (Hall et al., 1996). Only a small number 
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of isolates appeared clonal in the present study (four isolates of PFGE type 18; Fig. 5. 11 ). 
The remaining seven isolates were categorised as clonally related (Table 10. 9) due to 
incomplete isolate histories. Based on this data alone and the limited number of isolates, it 
is difficult to postulate the extent to which PFGE has differentiated clonally related isolates 
in this study. 
Recent developments in MLST for V parahaemolyticus provide more appropriate means 
to assess diversity amongst isolates indistinguishable by PFGE or other means 
(Chowdhury et al., 2004b; Gonzalez-Escalona et al. , 2008). Amongst a total of 37 clinical 
and 63 environmental isolates, three major clonal complexes and 62 sequence types were 
identified amongst seven house-keeping genes (Gonzalez-Escalona et al., 2008). The study 
showed the same MLST sequence type (ST) in four different serotypes and thus further 
supports the non-correspondence between serotype and molecular based typing systems. 
10.4.5 Conclusion 
To date, there appear no published studies of the typing of V parahaemolyticus by ITS 1-
PCR or by tDNA-ILPs. This study is the first to compare these methods with RAPD and 
PFGE typing. The initial findings in this work suggest both ITS 1-PCR and tDNA-ILP 
methods are applicable for routine analysis with a two-primer RAPD method far easier to 
execute than PFGE, but gave almost equivalent discrimination. The different molecular 
typing systems generated different groupings and lineages, and the results, in general 
showed various degrees of concordance. This was expected with different typing systems 
as each typing method targets different loci and in some cases not enough loci may be 
targeted to result in a true reflection of genome diversity. For example, it is unlikely that 
ITS1-PCR typing with species with a low ribosomal RNA copy number would give 
sufficient variation of length polymorphisms to be able to distinguish between isolates. 
Serotype data and the PCR identification of virulence genes in shellfish and seafood 
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samples, although useful adjuncts to characterise pathogenic strains, do not necessarily 
provide useful information about the virulent status of the organism. The identification of 
TTSS2 in all clinical isolates and a significant proportion of environmental ones, may be a 
more useful a marker for virulent V parahaemolyticus. 
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Chapter 11 
GENERAL DISCUSSION AND CONCLUSIONS 
11.1 Introduction 
Members of the genus Vibrio are ubiquitous in the marine and estuarine environment. 
Accurate and reliable methods for the identification and differentiation of pathogenic 
vibrios are thus essential if epidemiological studies are to be successful. This study 
employed several simple methods that could easily be adopted to assess diversity amongst 
populations of Vibrio spp. commonly found in shellfish and other seafood samples. 
Additionally, as conventional approaches to the identification and confirmation of V 
parahaemolyticus are lengthy and labour intensive, some of the methods described in this 
work may help to identify V parahaemolyticus and ease the epidemiological assessment of 
large samples. Methods to rapidly and easily distinguish pathogenic isolates of V 
parahaemolyticus from environmental reservoirs of mixed vibrio populations are necessary 
to (i) address seafood safety concerns; (ii) monitor the spread of vim lent strains; and (iii) to 
study and understand the evolution of V parahaemolyticus. Knowledge of pathogenicity 
traits and specifically the spread of virulent forms, may further enable the development of 
models that may be applicable to other pathogenic bacteria from the marine ecosystem. 
Following on from the methods comparison in the previous chapter, this discussion 
attempts to address the use and applications of the adopted strain differentiation methods 
of V parahaemolyticus in a wider context in light of the findings presented in this thesis 
and recent literature. 
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11.2 Scope and feasibility of the present study 
Although traditional biochemical tests and growth experiments proved to be labour 
intensive, they may still be useful because of some recent evidence to suggest biochemical 
heterogeneity amongst clinical and environmental isolates (Chapter 4; Martinez-Urtaza et 
al., 2006). This study aimed to apply existing molecular typing methods and to develop 
new ones to assess whether pathogenic V parahaemolyticus could be differentiated from 
non-pathogenic isolates. It was envisaged that by targeting different loci with several 
typing systems, the study would (i) establish a measure of the diversity present in V 
parahaemo/yticus genomes; (ii) allow the identification of V parahaemolyticus based on 
source; i.e., environmental or clinical, animal host or geographical location; and (iii) 
determine whether a proportion of environmental isolates may possess characteristic 
attributes similar to established vimlent strains as a means for classifying potentially 
pathogenic isolates. However, the scope of the present work did not include establishing 
the pathogenicity status of any of the environmentally acquired isolates. 
This study was conducted with a limited number of isolates but acquired from several 
sources (section 3.2.1) and therefore forms essentially a preliminary study of general 
molecular typing of V parahaemolyticus. The methods described in this thesis should be 
validated on a larger population of isolates to assess the in-vitro stability of the ITS 1-PCR 
and tDNA-ILP methods. The isolates used were acquired and typed over a period ofthree 
years (2003 to 2006). Based on a single laboratory user, and two PCR machines (section 
3.6), the methods described seem stable, reproducible and applicable to other members of 
the Vibrio genus. The ease of use and reduced time required in comparison to techniques 
such as PFGE facilitated the generation of multiple fingerprint types with different primer 
pairs. Perhaps the most significant advantages of both ITS 1-PCR and tDNA-ILP methods 
are their practicality, as the generation of a small number of amplification bands enables 
easier visual assessment without the need for complicated software analysis. If these 
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methods are to be further explored, a larger proportion of clinical isolates with more 
complete histories and from more diverse geographical sources would be recommended. 
Based on the percentage of tdh and trh genotypes present in the isolates tested, it seems 
unlikely that the environmental isolates used in the study represent a true reflection of tdh 
or trh genes present amongst environmental reservoirs of V parahaemolyticus (section 
1 0.2.2) and therefore, a bias towards potentially pathogenic strains. Such sample bias in 
favour of tdh + isolates may initially have suggested greater relationships amongst those 
environmental and established clinical isolates. Although tdh + isolates were found in 
several clusters, much the same as TTSS2 positive isolates (Table 9.5; Fig. 9.10) there 
appeared little evidence of environmental and clinical tdh + isolates being grouped together. 
This would suggest that such haemolysin genes have been incorporated into the genome 
more recently. However, despite these differences there was some evidence to suggest that 
isolates obtained from the same shellfish species could be clustered using the methods 
described. For example, the majority of isolates sourced from oysters were found in 
separate groups to those isolates from other shellfish species. Isolates VP491, VP939 
(obtained from scallop and crab respectively) were clearly differentiated from each other 
and the majority of those obtained from oysters. 
11.3 Genome plasticity of V. parahaemolyticus 
The isolates were found to be from diverse 0 and K antigenic serotypes and this 
heterogeneity amongst V parahaemolyticus was clearly confirmed by PFGE analysis with 
Notl. Amongst this heterogeneity, and as expected, environmental isolates accounted for 
the majority of the serotypes (70%). In both clinical and environmental cases, isolates of 
the san1e serotype showed distinct PFGE genotypes; conversely, isolates of similar PFGE 
patterns were of different serotypes. This phenomenon has been demonstrated widely in V 
parahaemolyticus, as up to 21 different serovariants have been found to be clonally related 
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to the parent 03:K6 clone (Martinez-Urtaza et al., 2004; Nair et al., 2007). It has been 
suggested that the acquisition of additional serotypes may be a selected response to host 
immunological pressure (Chowdhury et al., 2004b). Such changes in the 0- and K-
antigens thereby clearly illustrate the fluidity of V parahaemolyticus. 
Based on the variations in length polymorphisms identified in both 16S-23S (ITSl) and 
between tRNA genes, it seems highly likely that some of these regions are undergoing 
large degrees of change in V parahaemolyticus populations. Based on banding profiles 
alone, it appears that some of the tDNA regions varied more than others amongst 
environmental isolates. The largest amplicon with primers T3A/T5A (tDl) showed the 
greatest variation, whereas this amplicon appeared uniform in most of the clinical isolates 
(Fig. 7.2). By using another pair of discriminatory primers T3B/T5A (t02) it was possible 
to confirm and establish the differences in relationships. Thus, the use of a secondary or 
even tertiary fingerprint pattern (i.e. t03) would be essential to establish true diversity and 
hence more accurate relationships. The presence or absence of bands in the tDNA-ILPs 
suggests there may be rearrangements in the genome that need to be examined to assess for 
possible insertions of mobile genetic elements. 
Of the typing systems employed, PFGE revealed the most variation in isolates and very 
recently, standardised methods that show increased reliability for typing, have been put 
forward (Wong et al., 2007; Kam et al., 2008). Variations in PFGE and RAPD profiles in 
bacteria are due to discrete insertions or deletions that contribute to restriction or primer 
site changes between strains (Kudva et al., 2002). In E. coli, it is thought that bacteriophage 
variation is a major factor in generating genomic diversity that underlies genomic 
variability detected by PFGE (Ohnishi et al., 2002). With the identification of an 
increasing number of non-host specific vibriophages (Matsuzaki et al., 2000; Millar et al., 
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2003; Comeau et al., 2006) in the marine environment, it is likely that V parahaemolyticus 
will continue to evolve at a relatively fas t rate. 
11.4 The differentiation of clinically significant V. parahaemolyticus 
This work was based on the founding molecular typing principle that epidemiologically 
related isolates are derivatives of a single parent isolate (Streulens, 1998). Therefore, 
pathogenic isolates share characteristics that may differ from those of non-pathogenic 
isolates within the same species. The typing experiments carried out did not give a single 
distinct cluster of pathogenic V parahaemolyticus. Clinical isolates were identified in 
several different clusters and in some cases clinical isolates formed single members (219, 
224,228 and E l 54482) of their own groups. PFGE analysis identified four members of the 
clonal pandemic 03 :K6 group, which belonged to a larger cluster (>76% similarity) of 10 
entirely clinical isolates. Another cluster (>76% similarity) contained five isolates, four of 
which showed P-haemolysis (an environmental and clinical isolate appearing closely 
related) and clustered with an environmental isolate, VP350 (Fig. 5.11). Similar fmdings 
were also observed in RAPD analysis. Whilst these methods clearly generate more diverse 
patterns than ITS 1-PCR or tDNA-PCR, there appears evidence that more discriminate 
methods such as PFGE or ribotyping appear to correspond with strain source even less than 
lesser discriminate methods (Tamplin et al. , 1996; Hoi et al. , 1997; Chatzidaki-Livanis et 
al., 2006; Gonzalez-Escalona et al., 2006a). The inability to identify isolates of single 
pathogenic lineages, even by less discriminate methods such as ITSl-PCR and tDNA-ILP, 
may suggest that acquisition of pathogenicity by V parahaemolyticus is a more recent 
event, occurring by lateral transfer. These findings would support current opinions on the 
acquisition of the ITSS2 by V parahaemolyticus (Park et al., 2004b; Ono et al., 2006; 
Izutsu et al. , 2008) and the hypothesis of a rapidly evolving pathogen. 
257 
The rise and dominance of clonally related 03:K6 V. parahaemolyticus (Chiou et al. , 
2000; Chowdhury. et al., 2004b; Ansaruzzaman et al., 2005 ; Rizvi et al., 2006; 
Serichantalergs, et al. , 2007) amongst infections reported worldwide has prompted the 
development of sequenced based methods (Gonzalex-Escalona et al. , 2008). Presently, it is 
not clear why this particular clone and its derivatives have gained prevalence, although in-
vitro assessments have clearly shown enhanced virulence traits in comparative studies 
between 03 :K6 related and non-03 :K6 related strains and is reviewed by Nair et al. 
(2007). Until the molecular basis of pathogenicity of V. parahaemolyticus is elucidated, it 
seems unlikely that there will be answers to such questions as, 'what makes the 03 :K6 
related strains more dominant amongst clinical strains?' This 'pandemic' isolate is thought 
to have been derived from the acquisition of the gene tdh by a non-pathogenic isolate 
(Okura et al., 2003), and this fact , together with the regional dominance of several other 
serovars both in Asia and the USA, suggests that a particular clone could gain dominance 
at any time. 
Other than the increased hospitalisations due to the 03:K6 clonally related serovariants 
(Nair et al. , 2007), to date there appear no repo11s on the severity of the illnesses associated 
with V. parahaemolylicus infections. This could be attributed to the lack of reporting due 
to the self-limiting nature of the infection and inadequate surveillance due to the present 
inability to differentiate clonally related V. parahaemolyticus. In clonal populations of E. 
coli 0 l57:H7 it was found that a subpopulation belonging to clade 8 was responsible for 
contributing to more severe disease (Manning et al., 2008). This was identified based upon 
the analysis of 96 SNP loci and the identification of 39 SNP polymorphisms differing at 
20% of the SNP loci. This present work has identified at least 34 polymorphic sites on the 
three structural genes of the TTSS l region and hence indicates the potential of SNP typing 
of clonal populations to monitor the severity of disease and better surveillance of V 
parahaemolyticus. Despite the large increase in infections resulting from clonally derived 
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03 :K6 strains, a recent review suggested that these clones do not seem to have the 
propensity for elevating hospital admissions to the same degree as pandemic isolates that 
were initially characterised in 1996. This led Nai r et al., (2007) to speculate that that there 
may be some degree of decay in the epidemic process. Thus, what was essentially 
considered a dominant serovar amongst infections seems to be on the decrease in hospital 
acquired infections in Calcutta, India. This would further support the concept that any one 
of the clones could gain dominance at any time, and highlights the need for increased 
vigilance. 
11.5 Conclusions 
Cleary, the scope of the work presented in this thesis is limited both in isolate numbers, 
and analytical methods employed. This study focussed on three techniques that up until 
now, had not been assessed in V. parahaemolyticus before: a two-primer RAPD method, 
ITSl-PCR and tDNA-ILP typing. The work formed the first of its kind in the UK in 
collaboration with the Community Reference Laboratory for monitoring bacteriological 
and viral contamination of bivalve molluscs (CEF AS). It is hoped that at least some of the 
fmdings would be explored further; possibly a blind inter-laboratory test which examines 
the usefulness of the RAPD markers to distinguish 03 :K6 related isolates and the 
reproducibility of the typing methods in the hands of multiple users. Additional 
suggestions for further work have been described in previous chapters. 
V. parahaemolyticus is genotypically a diverse organism. It appears pathogenic isolates 
possess diverse genotypes that stem from different lineages with evidence of recent lateral 
transfer of virulence determinants. Although most efforts over the last decade have centred 
on the epidemiology of the 03 :K6 clonally related isolates, clinical disease can be caused 
by a wide variety of types. The ability for V. parahaemolyticus to survive and proliferate in 
diverse environmental conditions and exist as various cell types is clearly a result of its 
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genome fluidity. With its remarkably fast growth properties, not only is this a model 
organism to study bacterial growth, but also to study the evolution of marine bacteria. The 
development of simple and more robust typing systems are essential for the routine 
monitoring of this emerging pathogen. The present study has shed some light on the 
genome plasticity of V parahaemolyticus yet many more questions have arisen and remain 
unanswered. 
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Appendix I 
MEDIA, REAGENTS, SOLUTIONS AND SUPPLIERS 
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1.1 Bacteriological media 
Tryptone soya broth (TSB) 
TSB powder was purchased as pre-made media from Oxoid. 30g of media was dissolved in 
1 L of ddH20, the pH adjusted to 7.5 and then autoclaved. The formula of the resulting 
media is as follows: 
Tryptone (casein digest USP) 17.0g 
Soya peptone 3.0g 
Sodium chloride 5.0g 
Dibasic potassium phosphate 2.5g 
Dextrose 2.5g 
Tryptone soy agar (TSA) 
TSA powder was purchased as pre-made media from Oxoid. 37g of media was dissolved 
in 1 L of ddH20, the pH adjusted to 7.5 and then autoclaved. TSA contained the same 
components as stated in the TSB media although TSA with the addition of 1.5% (w/v) 
agar. 
Luria-Bertani medium (LB) 
Per litre of ddH20: 
Tryptone I Og 
Yeast extract 5g 
Sodium Chloride 1 Og 
pH 7.5 
Sterilised by autoclaving 
LB agar was prepared as stated above but with the addition of 1.5% (w/v) agar 
Marine salts broth (MSB) 
Marine Broth 2216 powder was purchased as pre-made media from Becton Dickinson, 
distributors for Difco Labs. 37.4g of media was dissolved in I L of ddH20, boiled for I nun 
to completely dissolve the powder and autoclaved. 
Approximate formula per litre (pH 7.6 ± 0.2 @ 25°C) 
Peptone 5.00 g 
Yeast Extract 1.00 g 
Ferric Citrate 0.10 g 
Sodium Chloride 19.45 g 
Magnesium Chloride 5.90 g 
Magnesium Sulphate 3.24 g 
Calcium Chloride 1.80 g 
Potassium Chloride 0.55 g 
Sodium Bicarbonate 0.16 g 
Potassium Bromide 0.08 g 
Strontium Chloride 34.0 mg 
Boric Acid 22.0 mg 
Sodium Silicate 4.0mg 
Sodium Fluoride 2.4 mg 
Ammonium Nitrate 1.6 mg 
Disodium Phosphate 8.0 mg 
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Marine salts agar (MSA) 
Marine Broth 2216 power (3 7 .4g) of media was dissolved in 1 L of ddH20 with the addition 
of 1.5% w/v agar 
TCBS agar 
TCBS Cholera Mediwn (CM0333) powder was purchased as pre-made media from Oxoid. 
88g of media was dissolved in 1L of ddH20. The formula of the resulting media is as 
follows: 
Yeast extract 
Bacteriological peptone 
Sodiwn thiosulphate 
Sodiwn citrate 
Ox Bile 
Sucrose 
Sodium chloride 
Ferric citrate 
Bromothymol blue 
Thymol blue 
Agar 
pH 8.6 ± 0.2 @ 25°C 
Wagatsuma agar (W A)- M178 
5.00g 
10.00g 
10.00g 
1 O.OOg 
8.00g 
20.00g 
1 O.OOg 
1.00g 
0.04g 
0.04g 
14.00g 
(Bacteriological Analytical Manual, 8th Edition, Revision A, 1998) 
Yeast extract 
Peptone 
NaCl 
K2HP04 
Mannitol 
Crystal violet 
Agar 
Distilled water 
Human or rabbit red blood cells, 
fresh (24 h), with anticoagulant 
3g 
10 g 
70 g 
5g 
10 g 
0.001 g 
15 g 
1 litre 
50 ml 
Fresh rabbit blood was washed with same volwne of physiological saline three times 
(Centrifuge cells at about 4000 x g at 4 °C for 15 m in each time). 
All above ingredients, except blood, was suspended in distilled water and boiled to 
dissolve agar. The pH was adjusted to 8.0 and steam sterilised (30 min). A volume of 50 
ml of washed red blood cells was added to the cooled (45°C) medium. 
263 
1.2 Genomic DNA isolation and purification 
Bacterial genomic DNA was extracted using the ' Puregene D-6000 DNA Isolation Kit ' 
manufactured by Gentra Systems Inc, Minneapolis, MN5544l , USA. Details ofthe 
contents of each solution are as follows. Concentration of individual solution components 
is unknown. 
Cell Suspension Solution 
Tris [hydroxymethyl] aminomethane 
EDTA 
Sorbitol 
Cell Lysis Solution 
Tris [hydroxymethyl] an1inomethane 
EDTA 
SDS 
Protein Precipitation Solution 
Ammonium acetate 
DNA Hydration Solution 
Tris 
EDTA 
Lytic enzyme solution and RNase A stock solution were stored at 4°C. All other Puregene 
reagents were stored at room temperature (21 °C). 
1.3 General molecular biology reagents 
TBE buffer 
TBE was made up at 5x strength according to the following formula and was then diluted 
to lx: 
TRIS-base 
Boric acid 
EDTA 0.5M [pH 8.0] 
TE buffer 
54.0g 
27.5g 
20ml 
TE buffer was prepared either by diluting x 100 TE supplied by Sigma in sterile ' Analar ' 
water or made up as a 1 x solution according to the following: 
Tris-HCL IOmM 
EDTA !mM 
pH 8 
Autoclave 
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Gel loading solutions 
(1) General gel loading (x 6) solution (Sigma): 
Bromophenol blue 0.25% (w/v) 
Xylene cyanole FF 0.25% (w/v) 
Sucrose 40% (w/v) 
(2) Tracking buffer (x 6) for RAPD (Amersham Biosciences) 
30% Glycerol. 
0.125% bromophenol blue 
20 mM Tris-HCl (pH 8.0) 
Roche Taq polymerase 10 x reaction buffer 
Tris-HCl 1 OOmM 
MgCh 15mM 
KCl 500nlM 
pH 8.3 
1.4 Pulsed field gel electrophoresis buffers 
'CHEF Bacterial Genomic DNA Plug Kit ' (BioRad) contained: 
Cell Suspension Buffer (CSB) 
600 U/ml Proteinase K, 
Proteinase K Reaction Buffer 
2% CleanCut Agarose 
I Ox Wash Buffer 
25 mg/ml Lysozyme, 
Lysozyme Buffer 
Contents and concentration of CSB and Wash Buffer are unknown. 
Tris acetate EDT A 
50 x stock: 
Tris base 
Glacial acetic acid 
0.5M EDTA 
pH 8 
242g 
57. L ml 
lOOm! 
This solution was diluted immediately to a 1 x working concentration. 
Tris-borate EDT A (TBE) 
100 x stock: 
Tris base 1 08g 
Boric acid 55g 
0.5M EDT A 40ml 
pH 8 
This solution was diluted immediately to a 0.5 x working concentration. 
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1.5 DNA purification kit solutions 
DNA was purified using the 'High Pure PCR Product Purification Kit' supplied by Roche. 
Details of the content of each solution are as follows: 
Binding Buffer 
3 M guanidine-thiocyanate, 
10 mM Tris- HCl, 
5% ethanol (v/v), 
pH 6.6 (25° C) 
Washing Buffer 
(final concentrations after addition of 40ml ethanol) 
20 mMNaCl, 
2 mM Tris-HCl, pH 7.5 (25°C) 
Elution Buffer 
10 mM Tris-HCI, 
pH 8.5 (25°C) 
1.6 Description of blotting solutions and buffers (Chapter 9) 
Depurination solution 
Per litre of ddH20: 
HCI 0.2M 
Denaturing solution 
Per litre of ddH20: 
NaCl 0.5M 
Tris-HCI 1.5M 
pH 8 
Neutralisation solution 
Per litre of ddH20: 
NaOH 1.5M 
NaCl 0.5M 
20 X SSC 
Per litre of ddH20: 
Sodium chloride 
Sodium citrate 
pH7 
175.32g 
88.23g 
The above solution was diluted to 10 x, 5 x, 2 x, or 0.1 x strength as required with sterile 
' Analar' water. 
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1.7 DNA Labelling and Detection (Chapter 9) 
DNA was labelled using the ' DIG DNA Labeling and Detection Kit' supplied by Roche. 
Details of the content of each solution are as follows: 
Unlabelled control DNA 1 
20 111 pBR328, 100 j.tg/mJ 
pBR328 is digested separately with Barn HI, Bg ll and Hinfl 
Unlabelled control DNA 2 
20 111 pBR328, 200 j.tg/ml 
Linearised with Barn HI 
Labeled Control DNA 
50 111 pBR328 DNA (5 j.tg/ml) 
Linearised with Barn HI 
DNA Dilution Buffer 
50 j.tg/ml herring sperm DNA in 10 mM Tris-HCl, 
1 mMEDTA 
pH 8.0 at 20°C 
Hexanucleotide Mix (1 0 x concentrated hexanucleotide reaction mix) 
Random hexanucleotides 62.5 A26o units/ml (1.56mg/ml) 
Tris-HCl 500mM 
MgCh 100mM 
Dithioerythritol (DTE) l mM 
BSA 2mg/ml 
pH 7.2 
dNTP labelling mixture 
10 x concentrated dNTP labeling mix containing: 
1 mM dATP 
1 mMdGTP 
1 mM dCTP 
0.65 mM dTTP 
0.35 mM DIG-11-dUTP 
pH 7.5 (20° C) 
Klenow enzyme, labelling grade 
Klenow enzyme (2 U/ j.t) 
Anti-Digoxigenin-AP Conjugate 
Polyclonal sheep anti-digoxigenin 
Fah-fragments, conjugated to alkaline phosphatase 
750 U/ml 
NBTIBCIP 
Concentrated stock solution (exact concentration unknown) 
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Buffer 1 - Washing Buffer 
0.1 M Maleic acid 
0.15MNaCl 
pH 7.5 (20° C) 
0.3% (v/v) Tween 20 
Buffer 2 - Blocking reagent 
(content unknown) 
1 Ox stock and 1 x working solutions were prepared with maleic acid buffer 
Buffer 3 - Alkaline phosphatase detection buffer 
M Tris-HCI, 0.1 M NaCI, pH 9.5 (20° C) 
Maleic acid buffer - for dilution of blocking reagent 
0.1 M Maleic acid 
0.15MNaCl 
Adjusted with NaOH (solid) to pH 7.5 (20° C) 
TE-buffer 
10 mM Tris-HCI 
1 mM EDTA 
pH 8.0 
Stripping and reprobing of DNA blots 
Dimethylformamide (DMF) 
0.2 N NaOH, 0.1% SOS (w/v), 2 x SSC 
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1.8 Molecular weight markers 
Tracklt™ 50 bp DNA Ladder Gibco (Invitrogen) 
0.5 ~lane 
Orange 
bp 
-2652 
-800 
-500 
-350 
-150 
-50 
The 50 bp ladders range from 50-800 bp in 
50 bp increments, plus a 2652 bp fragment. 
The 350 bp band is ~ 2 times brighter than 
the others. 
Tracking dyes, Xylene Cyanol FF (XCFF) 
and Orange G, allows tracking of DNA 
migration during electrophoresis and indicate 
when maximum resolution is achieved. 
100 bp Ladders 100 - 2072bp Gibco (Invitrogen) 
0. 5 llgllane) 
-600 
-100 
The 100 bp ladders range from 100-1500 bp 
in 100 bp increments, plus a 2072 bp 
fragment. The 600 bp band is 2-3 times 
brighter than the others. 
During 2% agarose gel electrophoresis with 
tris-acetate (pH 7.6) as the running buffer, 
bromophenol blue migrates near the I 00-bp 
fragment. 
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lkb Ladder 75- 12,216bp Gibco (lnvitrogen) 
0. 5 flg/lane 
10,160 9162 
7126 6144 
Hinf I fragments 
of the vector 
A: Lambda Ladder 48.5- 873 kb (BioRad) 
The 1bkb ladders range from 75bp to 12,216 
bp in various increments. 
B: Saccharomyces cerevisiae Ladders 0.2 - 2.2 MB (BioRad) 
A B 
:2Jtoo kb 
1 .600 
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A: Lambda ladders (concatemers of 
A.cl857sam7) range from 48.5kb - 873 kb in 
48.5kb increments purchased pre-prepared. 
B: Saccharomyces cerevisiae size standards 
range from 0.225 - 2.20 MB. 
1.9 Suppliers 
Becton Dickinson 
The Danby Building 
Edmund Halley Road 
Oxford Science Park 
Oxford 
OX44DQ 
http://www.bd.com 
Bio-Rad Laboratories Ltd. 
Bio-Rad House 
Maxted Road 
Hemel Hempstead 
Hertfordshire HP2 7DX 
Tel: 0800 181134 
www.bio-rad.com 
Fisher Scientific UK Ltd 
Bishop Meadow Road, 
Loughborough, 
Leicestershire 
LE11 5RG 
http://www.fisher.co.uk 
Gentra S~stems (now Qiagen Ltd.) 
13355 101 Avenue North 
Suite 120 
Minneapolis 
MN5544 1 
USA 
lnvitrogen I Gibco 
Invitrogen Ltd 
3 Fountain Drive 
lnchinnan Business Park 
Paisley 
PA4 9RF 
www.invitrogen.com 
MWG Biotech 
Eurofins MWG Operon 
318 Worple Road 
Raynes Park 
London 
SW20 8QU 
http://www.mwg-biotech.com 
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Oxoid Limited 
Wade Road 
Basingstoke 
Hampshire 
RG24 8PW 
hnp://www.oxoid.com 
Qiagen Ltd. 
Qiagen House 
Fleming Way 
Crawley 
West Sussex 
RHlO 9NQ 
Tel: 01293-422-9 11 
www1.qiagen.com 
Roche Molecular Biochemicals 
Bell Lane 
Lewes 
East Sussex 
BN71LG 
www.biochem.roche.com 
Sigma-Aldrich Company Ltd 
Fancy Rd 
Poole 
Dorset 
BH1 2 4QH 
www.sigmaaldrich.com 
Thermo Fisher Scientific 
ABgene House 
Blenheirn Road 
Epsom 
Surrey 
KT19 9AP 
www.thermofisher.com 
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ILl Bacterial DNA quantification 
The concentration of extracted genomic DNA was established by agarose gel 
electrophoresis (Section 3.8). The DNA concentration was estimated for each isolate by 
comparison with a range of the following known amounts of A. DNA standards indicated in 
Figure II.l using UV photo software (UViTec, UK) (Fig. II.l ). For confirmation and 
quantification of DNA of additional isolates, genomic DNA was quantified with a UV 
spectrophotomer (NanoDrop 1 00). 
A 2 3 4 5 6 7 8 9 10 
B 2 3 4 5 6 7 8 9 10 
Figure ll.l: Quantification of DNA extracted from V. parahaemolyticus and other bacterial cultures. 
Panel A: lanes 1-10 correspond to the following, l ; 280ng of!... standard DNA, 2; 140ng ofA. DNA standard, 
3; 70ng of!... standard DNA, 4; 35ng of!... standard DNA, 5; DNA from isolate I 103/9, 6; DNA from isolate 
VC2, 7; DNA from isolate Vib3, 8; DNA from isolate VP6, 9; DNA from isolate Vib6, 10: DNA from isolate 
VC5. 
Panel B: lanes 1-10 correspond to tlte following, 1; 280ng of A. standard DNA, 2; 140ng ofA. DNA standard, 
3; 70ng of A. standard DNA, 4; 35ng of A. standard DNA, 5; DNA from isolate 6 134, 6; DNA from isolate 
VP10884, 7; DNA from isolate Vib5, 8; DNA from isolate VP8, 9; DNA from isolate VCl, 10; DNA from 
isolate 1022/10. 
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c 2 3 4 5 6 7 8 9 10 11 
D 2 3 4 5 6 7 8 9 10 11 
E 2 3 4 5 6 7 8 9 10 11 
Figure 11.1: Cont. 
Panel C: lanes 1-10 correspond to the following, 1; 280ng of/... standard DNA, 2; 140ng on DNA standard, 
3; 70ng of!.. standard DNA, 4; 35ng on standard DNA, 5; DNA from isolate Vibl, 6; DNA from isolate 
1023/1, 7; DNA from isolate VP361, 8; DNA from isolate Vib2, 9; DNA from isolate 11327, 10; DNA from 
isolate VP491, ll ; DNA from isolate VP9. 
Panel D: lanes l -10 correspond to the following, 1; DNA from isolate VM499, 2; DNA from isolate VP33 1, 
3; DNA [rom isolate VP349, 4; DNA from isolate Vib7, 5; DNA from isolate E154482, 6; DNA from isolate 
VA430, 7; DNA from isolate 8042, 8; DNA from isolate VibJO, 9; DNA from isolate VP346, 10; DNA from 
isolate E l 68143, 11; l40ng on standard DNA 
Panel E : lanes 1-lO correspond to the following, J; 280ng orA. standard DNA, 2; 140ng of A. DNA standard, 
3; 70ng on standard DNA, 4; DNA from isolate PM5, 5; DNA from isolate KA5, 6; DNA from isolate 
LD365, 7; DNA from isolate EC5, 8; DNA from isolate Vib4, 9; DNA from isolate ST5, 10; DNA from 
isolate EA5. 11 ; DNA from isolate E l55855. 
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F 2 3 4 5 6 7 8 9 10 ll 
G 1 2 3 4 5 6 7 8 9 10 
H 2 3 4 5 6 7 8 9 10 
Figure ILl: Cont. 
Panel F: lanes l -10 correspond to the following, 1; 280ng oD. standard DNA, 2; 140ng on DNA standard, 
3; 70ng on standard DNA, 4; DNA from isolate 2053, 5; DNA from isolate 2341 , 6; DNA from isolate 
KIDBVV, 7; DNA from isolate Vib3, 8; DNA from isolate 5421 , 9; DNA from isolate VP416, 10; DNA 
from isolate VP378, 11; DNA from isolate Vib5. 
Panel G : lanes l-10 correspond to the following, I ; 280ng oO .. standard DNA, 2; 140ng on DNA standard, 
3; 70ng of A. standard DNA, 4; 35ng of A. standard DNA, 5; 17 ng of A. standard DNA, 6; DNA from isolate 
219, 7; DNA from isolate 220, 8; DNA from isolate 221 , 9; DNA from isolate 222, 10; DNA from isolate 
223. 
Panel H: lanes 1-10 correspond to the following, 1; 280ng of A. standard DNA, 2; l40ng of A. DNA standard, 
3; 70ng on standard DNA, 4; 35ng of A. standard DNA, 5; 17 ng on standard DNA, 6; DNA from isolate 
224, 7; DNA from isolate 225, 8; DNA from isolate 226, 9; DNA from isolate 227, 10; DNA from isolate 
228. 
Note: Plates C - F are scanned digitised images 
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Table 11.1 Genomic DNA concentrations determined from agrose gels. Isolates not in Fig. 11.1 were 
quantified with a UV spectrophotomer. DNA from other species were purchased lyophilised and of 
known concentrations. 
Isolate DNA cone. (ng/!ll) Isolate DNA (ng/111) 
1902 20 £154482 60 
8042 50 £155855 50 
11327 100 £ 168143 70 
1021/5 50 VP331 70 
1022/10 280 VP345 40 
1023/1 30 VP346 70 
1023/3 150 VP349 70 
1024/5 250 VP350 60 
1103/9 30 VP361 100 
2053 50 VP377 20 
2436 50 VP378 100 
5421 50 VP416 150 
6134 90 VP491 100 
6316 50 VP939 50 
2341 200 VPEC1 100 
V Cl 200 VPSC I 100 
VC2 70 VA430 70 
VC3 260 VM499 30 
VC4 150 KIDBVV 250 
VC5 140 LD365 350 
Vibl 50 PM5 200 
Vib2 70 ST5 300 
Vib3 100 EC5 200 
Vib4 350 EA5 350 
Vib5 50 KA5 200 
Vib6 40 PAl 60 
Vib7 30 Van CM104 20 
Vib8 40 VPl 0884 90 
Vib10 70 VV11067 100 
VPl 10 219 50 
VP2 40 220 80 
VP3 30 221 150 
VP4 20 222 40 
VP6 140 223 50 
VP7 200 224 100 
VP8 40 225 100 
VP9 30 226 280 
VP10 30 227 100 
BL21 50 228 80 
Cl a 10 
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ll.2 Phenotypic growth characteristics of V. parahaemolyticus 
Table 11.2: Growth characterist ics of V. parahaemolyticus on non-selective and selective solid med ia 
(Chapter 4) 
Isola te 
1902 
VPI 0884 
VPI0885 
219 
220 
221 
222 
223 
224 
225 
226 
227 
228 
1022/4 
1024/5 
1021/5 
1022/10 
1023/1 
1023/2 
102313 
2053 
2346 
542 1 
6134 
6316 
Vibl 
Vib2 
Vib3 
Vib4 
Vib5 
Vib6 
Vib7 
Vib8 
Vib9 
VibiO 
VPI 
VPI 
VP2 
VP4 
VP5 
VP6 
VP6 
VP6 
VP6 
VP6 
Environmental/CiinicaV ---;-;;;::-:------;:;:::-:-=G:.:r..::o~w..:.lh::...:.:m:::e.:::.d::;ia~1 .,----------
Reference strain 1\JSA TSA W A TCBS 
NCIMB Reference Strain 
NCTC Reference Strain 
Clinical 
Clinical 
Clinical 
Cl inical 
Clinical 
Clinical 
Clinical 
Clinical 
Clinical 
Clinical 
Clinical 
Environmental 
Environmental 
Environmental 
Environmental 
Environmental 
Environmental 
Environmental 
Environmental 
Clinical 
Clinical 
Clinical 
Clinical 
Clinical 
Environmental 
Environmental 
Environmental 
Environmental 
Environmental 
Environmental 
Environmental 
Environmental 
Environmental 
Environmental 
Environmental 
Environmental 
Environmental 
Environmental 
Environmental 
Environmental 
Environmental 
Environmental 
Environmental 
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+++ 
+++ 
+++ 
+++ 
Table 11.2: Cont. 
Environmental/Clinical/ Growth media' 
Jsolote Reference strain MSA TSA WA TCBS 
E154482 Clinical +++ +++ +++ +++ 
E 155855 Clinical +++ +++ +++ +++ 
El68143 Clinical +++ +++ +++ +++ 
VP331 Environmental +++ +++ +++ +++ 
VP345 Environmental +++ +++ +++ +++ 
VP346 Environmental +++ +++ +++ +++ 
VP349 Environmental +++ +++ +++ +++ 
VP350 Environmental +++ +++ + ++ 
VP361 Environmental +++ +++ + +++ 
VP377 Environmental +++ +++ +++ +++ 
VP378 Environmental +++ +++ ++ +++ 
VP416 Environmental +++ +++ +++ +++ 
VP491 Environmental +++ +++ +++ +++ 
VP939 Environmental +++ +++ +++ +++ 
VPECI Environmentol +++ +++ P+++ +++ 
VPSCJ Environmental +++ +++ P+++ +++ 
1 Growth on media: 
MSA: Marine salts agar (Marine Agar) 
TSA: Tryptic soy agar (3% NaCI) 
WA: Wagatsuma agar 
TCBS: Thiosulphate citrate bile salts agar 
Growth was monitored at 18 hours and scored as,+++ Very good,++ Good,+ Poor, -No growth 
Visible exopolysaccharide production in Wagatsuma agar present only in isolates VPECI and VPSCI 
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Table 11.3: Comparison of growth rates of clinical and environmental isolates at 0.5 and 3% NaCI in 
TSB, pH 7.2. Doubling times were obtained by monitoring absorbance at 600nm and graphical plots of log 
absorbance {y) and time (x). Statistical significance testing (/-lest) was carried out on the means and variance 
of data with NCSS statistical software analysis. Box plots (section 4.3.2) show variability of data. 
Clinical 3%NaCI 0.5% NaCI Environmental 3% NaCI 0.5% NaCI 
1902 (Type) 17 28 1022/10 23 32 
VPI0884 (Type) 16 26 1023/2 25 28 
2053 18 23 Vibl 30 38 
2436 16 23 Vib2 22 29 
5421 25 26 Vib3 23 33 
6134 22 24 Vib7 26 28 
6136 22 28 VibiO 23 34 
El54482 21 29 VPI 23 31 
El55855 24 27 VP2 25 36 
El68143 26 34 VP3 22 36 
219 21 29 VP7 21 35 
220 24 28 V PlO 19 31 
221 17 25 VP331 24 38 
222 19 27 VP346 24 37 
223 25 32 VP350 27 35 
224 22 29 VP377 24 26 
225 19 28 VP416 19 23 
226 21 26 VP939 15 23 
227 23 25 VPECI 14 24 
228 24 28 VPSCI 16 25 
279 
--- - ---------------------------------------------------------
. ' 
SEQUENCE DA'F A 
28,0; 
111.1: SEQUENCING DATA RELEVENT TO CHAPTER 9 
Vibrio parahaemolyticus strain RIMD221 0633 sequence information retrieved from: 
http://genome.naist.jplbacteria/vpara/index.html and also available with GenBank 
accession numbers BA00003l and BA000032. Primer binding sites (underlined) for 
ITSS l and ITSS2 genes are shown below (Figs. Ill.! - 111.6) 
>VP1662 
GTGAATCTCATGAATAAGTTGATCGATATTCTAAACAAGGTAGGGCAACGCAAAGACATC 
ATGCTCGCAGTGATGTTGCTGGCGATCGTCTTTATGATGATTTTGCCTTTGCCAACTGCA 
CTAGTGGATGTGCTGATCGGCGCAAACATGAGTATTGCCGTCGTGTTGCTGATGTTGGCG 
ATTTACATCACCACGCCACTGGAGTTTTCGGCGTTTCCGGCAGTATTGTTGATAACGACG 
CTATTTCGTTTGTCCCTGTCTATCACCACGACACGTTTGATCCTGCTTCAAGGCGATGCG 
GGTCAAATCGTTTACACCTTTGGTAACTTTGTTGTTGGCGGCAACCTTGTCGTTGGTATC 
GTGGTCTTCCTGATCATAACTATTGTACAGTTTATGGTGATCACCAAAGGTTCGGAGCGT 
GTTGCTGAAGTTAGTGCTCGATTCTCTCTTGATGCCATGCCGGGCAAACAGATGAGTATC 
GACGGTGACATGCGCGCTGGAGTTATCGATGTTCACGAGGCGCGTCATCGCCGTTCTCTG 
ATCGAGAAAGAGAGTCAAATGTACGGCTCGATGGACGGCGCAATGAAGTTCGTAAAAGGC 
GACTCCATTGCGGGCTTGGTGATCATCATCGTGAACATCTTGGGTGGCGTCACCATTGGC 
GTCACGCAAAAAGGCATGAGCGCGTCAGAGGCGCTTGAGCTGTTTGCGATTTTGACCGTA 
GGGGATGGCTTGGTATCGCAGATTCCTGCGCTATTTATCGCGATCACCGCTGGTATTATC 
GTTACGCGTGTTTCCCACGAAGACTCGGCCGACTTGGGCTCCGACATTGGCGGGCAAGTC 
ACGGCTCAGCCTCGAGCACTGTTGATTGGTGGTGTGCTGCTGGTCTTGTTCGCTCTGATC 
CCTGGCTTTCCGAAAATTACATTCCTAGTGCTGGCTTTGGTGGTCGGTGGCGGCGGTTTT 
TACCTCTTCTATCAACAGAAAAAGCAAACCGAATCAGAAAGCAGCGATCTGCCGAGCTTT 
GTCGCGCAGGGAGCGGGTTCTCCTGCCGCAAAACCCAATAAACCAACGCCGTCTCGTGGT 
AGCAAAGGCAAATTGGGCGAGCAAGAAGAGTTTGCGATGACAGTGCCACTGCTTATCGAT 
CTGGATTCAAGCTTACAAGAAAGCCTAGAAGCCGTCGCACTGAACGACGAACTCGCCAGA 
GTAAGACGCGCGTTGTATCTCGATCTTGGTGTACCGTTTCCGGGAATTCACCTGCGTTTT 
AACGACGGGATGAAAAACGGCGAATACTTGATTCAGTTGCAAGAAGTGCCCGTTGCACGT 
GGTCGTATTGAGAAAGACAAATTGCTGGTCACAGAAGGAAGCGACCAGATTGAGTTGCTT 
GGTGTGCCGTTTGAGCAAGATGACGACTTCCTCCCGGGAGTCTCGAGTCTTTGGGTCGCA 
CAAAGCTATCAAGAGAAGTTGACTGCGAGCCATGTCGGCTTCCTTACACCAGATCGTATT 
TTGACGTTCCATCTATCACACGTATTGAAAGAGTACGCGCAAGATTTTATTGGGATTCAA 
GAAACTCGCTACCTACTTGAGCAAATGGAAGGCAGTTATTCTGAATTGGTGAAAGAGGCG 
CAGCGCATCGTCCCGCTACAAAAAATGACGGAGATTTTGCAACGTTTGGTATCTGAGGAC 
ATTTCGATTCGTAACCTTCGCGTCATTTTGGAGGCCATGGTCGAGTGGGGACAAAAGGAA 
AAAGATGTCGTTCAGTTGACGGAATACATTCGTTCAAGCTTAAAGCGTTACATCTGTTAC 
AAGTACGCGAGCGGTCAGAACATGCTGCCGGCGTACCTTCTCGATCAGAGCCTCGAAGAC 
ACGATTCGCAGCGGTATTCGACAAACCTCGGCGGGCAGCTACTTAGCGCTTGACCCTTCG 
GTTACGCAGCAATTTGTTAGCGACGTAAAACAGACCGTAGGCGATTTAAGCCGTATGCCG 
AACAAGCCTGTTCTGGTGGTTTCTATGGATGTGCGTCGTTATGTTCGAAAGCTGATTGAA 
TCCGAATATTACGATTTGCCCGTTCTATCGTTTCAAGAACTCACTCAGCAGATCAACATT 
CAGCCACTTGGACGGGTAGGGATGTAA 
Figure 111.1: Complete nucleotide sequence of vcrDI. Low calcium response TTSS I 
structural protein. PCR product size: 458 bp. 
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>VP1680 
ATGGTGAATACAACGCAAAAAATCAGTCAAAGCCCAGTACCCGATTTGGAACAGTTTCGT 
GCCATTGCCGCGCAAAAAGATGACCGAGTAATCAGCAAAAGAGGCGAAGTCAAAGAGCCA 
TCTACGTTCCATAAAGGCCACAAGTTTGCTTCGGTTAGCGAAGGCGTATTAAGAAAAAAA 
TACACCAAGTTCTTCCAAGAAAACATCAAAACGCATCTCGACTTGAAGCAGGCACTGCTT 
AAGGAAGAAAAACCAGAAACCGCACTTTTGGCTTATTCATTAGTCAGTCCGTCAGGCTAC 
CGAGGAGAACCATTAACCGAGCGAAAAATTTTGGAAGTGGTGAGCCTACTTGATGAAGTA 
AAAGTCGAAGGCGACACCTATCAGCAGCTCAAAAATACGTTTGATTCGATCAGCAAAGAT 
CCGCGTATGCAGGTCAGTTTGGAAAACCAGTATCCGGGGAAAATGGACGGTTTCGGCGCG 
CAGTTGTTGGAAATGGGAAAAGAGAAGCTGAAAGGCTCGGGTGTTAACGCTGCCATCAAT 
TTGGCGTTACCCGGTGTAGGCTTGCTCGTCGCCACAGGGCGTGAACTTCATAAAGCGTCC 
GTCAATGGCGATGCCGAAGCGTATCATCATCAACTCGAACAAATCTCACAATTGCCGGGA 
AGAGATCAGCGCTTATCGATGCCAATGCAACAAACGTTAGCCATTGGTCACGCGATGTTG 
TCGGCTGAGGGTGCAGTTGGTGCCACACTTGGTATGGCGACAGGCGGTTTGGGTACGTTT 
GGTGTAAGCTCTGTGGCAACGGCAGGAGTTACGCCGATAGCAAAAGAAGCCATTGGAACT 
GCTTTAGCTACTGGCATTATCAGCGGCGGGGGTTTTGTTGCTGGCCAAGCTGGGGCGTAT 
GGCTTAAATAACGAAGTGCAAGACCAACTCAAACAAGGGCCAATGTCTGGTGTGCTGCCA 
CGTTTGGAAATTTCAAACGTGAAGGGCGATTTCACTTTTAGCATGCAGGAGCCGGCGGCA 
GTTCGCGCACTGATGGCGTATCTTGGTCCTAAAGAAGATACATCAATGAGCTCACCTCAA 
GCGCCAAAAGAAGCGCAAGAGATGGAAGCCGCACGCTTAACACTCAAGCAAATGCTTGGC 
TCAAGCCCGAATGAACACCTCGTTCCAGATGTCGATTCACTGCTTAAACTGAGCGATGAA 
GACATGCCAAGTCAGACGGAATCTACGGCGAACGGTGCATTTAAAAAGCTGTTAAGTGAA 
GATTGGGATTGGCTGATGCCTGCTGTCCGAGCAATGGATAAAGGTGAAGCGAACAAAATC 
AACGAGAAGTTGACGTACAAGCTGCCTTTGGACGCGGCAAACGGACGTGTGTATCTCGAT 
AAGAGCCCGAACCTAAGTGGCGCTCAGCTTGACGCATTAGATAAACTCGGCTCACCAAGC 
CAGTTACGACTAATGTACTTAGCCGAAGGCTGGATTTAA 
Figure 111.2: Complete nucleotide sequence of vp/680. 'Cytotoxic effector' protein. 
PCR product size: 183 bp. 
282 
>VP1696 
GTGGTTACCGTAATGCGAACTCTCATGCCAAAAATAGGGCGCATTGCCGCCAAAATGACA 
TTGTGCGCACTGTGTGTCGCTCCGATGTTTTCTGTACAAGCGACAGAGCTCAATTGGCCA 
GAACAACCGTTTCGTTACTATGCCGATAACGATTCGCTGAAAGATCTGCTTAACAACTTT 
GGTGCCAACTATCGAGTATCCGTGTCTGTGAGCGACAAAGTGAATGACCGAGTGAGTGGT 
CGATTCACGCCAGAAGATCCAGCGGAATTTCTCGACTACCTAGCGCAAGTTTACAACTTG 
ATGTGGTACTTCGATGGCGCAGTACTGCACGTTTACAAAGCGACAGAAACGCGCTCCCGA 
TTGCTGCAATTGGAACTGCTTACCGCGCGCGAGCTTCGCAGTACCTTGATTTCAACCGGT 
GTTTGGGATGCTCGTTATGGTTGGCGCGCTGCCGAAAATAAAGGGCTGGTATATCTAGCT 
GGGCCGCCGCGTTACGTTGAGTTGGTGGTGCAAACCGCAGAAGCGTTAGAGAGCCGATTG 
CTGCAAAAGTCCAACTCGACGGATGAGCTGTTTGTGGAACTCATTCCGCTTAAATATGCC 
TCGGCGACGGACAGAAGTATCTCGTATCGCGACCAAAGCATTACCGTTCCGGGGATTGCT 
TCGGTATTGAGCCGTGTGGTTGGCGGTGTTCAAACTCAAATTACGGATTCTGCGTCTGTA 
CAAACATCGTCTGTAAATGGATTACCCGCAGAAGCAGCGAAACCTCGTGGCAAAACTGCG 
TCTGTGCACGGCGGTGCAACCGTAGAAGCGGAGCCGGGGCTGAATGCGATCATCGTTCGC 
GATACCCAAGCAAGACTGCCGTTGTATCGCAAGCTGGTCGCTCAACTCGATCAGCCACAA 
TCTCGTATCGAGGTTGCGTTATCTATTGTGGACATCAGCGCAAACGATTTACGTCAGCTC 
GGTGTGGATTGGCGTGCAGGTGTATCGGTTGGAAACAACCGCATTGTCGACATCAAAACA 
ACCGGCGACGTTGATAACGGTGATGTCACATTGGGCAGTGGTCAGAGTTTCAAGTCCTTG 
TTGGATTCGACCAACTTGAACTACTTGTTGGCGCAAATTCGTTTATTGGAATCGAAAGGC 
AGTGCGCAAGTCGTTTCCAGACCAACGCTGCTCACGCAAGAAAACGTCGAAGCGGTGCTA 
AACAACAGCAGCACGTTTTACGTCAAATTGGTTGGCAAAGAGACGGCGGCTTTGGAAGAA 
GTGACGTATGGCACCTTGTTGCGTATTGTGCCTCGTATCGTCGGCGACAGATTCGCGACG 
CGACCAGAGATCAACTTGAGCCTTCACTTAGAAGATGGCGCAAAGATCCCAGATGGTGGT 
GTGGATGATCTTCCATCAGTACGTAAAACCGAAATCAGTACGTTAGCGACGGTAAAACAA 
GGGCAAAGCTTACTCATTGGTGGCGTATACCGAGACGAAGTTAGCCATCAGCTACGTAAA 
GTCCCGCTGTTGGGCGACATTCCGTACCTAGGTGCTTTGTTCCGTAGTAATACCAACACA 
ACGCGCCGAACAGTTCGCATGTTCATTATCGAGCCGAGAATCGTGGTCGATGGGATTGGC 
GACAGCGTGTTGATAGGTAATGAGCATGATTTGCGCCCGAGTATTGGCCAGCTCAACAAC 
ATTTCGAACAACAGCGCAGAATTTAAATCGGTTGTTGAAGTATTCAGCTGTACGTCAAAA 
ACGCAGGCAGAACGTTACCAACAAGACTTACTGTCACAGCAAAAGTCTTCGCTGCTAACT 
CAATGTCAATTGCCGTCAGGGCAAGTAGGCTGGCGAGTCAAAGTGGCGGAATGTGACCTT 
TCACAGGCCGAATGTGTTCGCCCTTCAGAGGAGCCATAA 
Figure 111.3: Complete nucleotide sequence of vscCJ. TTSS I structural protein. PCR 
product size: 415 bp. 
283 
>VPA1321 
ATGCCAATATTAAATATTAGTAAATTTAGTAATACAGAGTATGCCTTTGTTAATAATCGT 
AAATTAAAAGAGCCATGTATAAAGGTGAAATCTGTTAGAACTAGTAGAGAAGGAGGCGAA 
ATATTATTCATTAATATGCCTAGTAAGTCAAAATATAAAGACTTGAGAGCTATGGTTAAA 
AGCAGCGTGGTGGTTAGTGAATCCAACCAAACCGCTGCTTCTAAATTTGAAAATAATAGT 
AGGTTTAATCGAAATGATATCAATGTAAAAAAAGCAGATGCAAAATCAATAACCGCGCTG 
AAAAGTGGTGATTTGCACATACTTAAAGGCAAGGGAATTATAGGTATGAAGGGGGGAGAT 
AATAAGCTCCCGTTCAAATGTACTATTGTAAATGATGATAAAAATGGTGCGCATCTTAGT 
CAAGGGACTAATTTAGCAACCAATGGTATTAAGAGTATGGCTGGGGATTCAGTTCGTGCC 
GCTCAACTAATCCCTGGTACGCCTCTTGGACAGTTTTATAATAGCGCGCCTCTAGATGAT 
AGCTTTAATGTGGTACATTTACCTAATGGTCAAAGAGGTGTAAATGGACTTAAAATACCA 
CTGTCTGAGTTTTATTCTGAAAAAAAATTTTTATTCTCAAATGGTGCGCTGTCTGGTTGT 
ATGACATGCACGGCAATAGATAAAAATAACCTTTATATCTTTCATGTAGGTAAAGATGGA 
AATGACACATCACCTTGGAAGACAAATGTGGATGGTTCTAGTTTAATACAAAAAAACATG 
AAAATGTTACTTGGCCAAAATTCTGATTCGTTGAATAATGGTATTCAGGGTTTGATAGAC 
TATTGTTCTAAAAACTTTGATAAAGCTATTATTCAATATTGTGGTCACGGAGAACAATAT 
AGTGGTCGAAAAAACATACATTTATTTGATTATAATACTCCTCAAAAAAACAATCCTTTG 
CGTGTAGGAAATAATTTGACATTGATAAGCCATTCTGATAATGGCTCATTGAGTATTTCA 
ACATTGTGTGATGATATGATTATTAATTCAAAAACCTGCGAAACCAACTCTGTTAATAGC 
AAATTAGTGCTATTGAAAAATGGTTAA 
Figure 111.4: Complete nucleotide sequence ofvpa/321. Cytotoxic necrotizing factor. 
PCR product size: 485 bp. 
>VPA1339 
ATGAGGTTTAGTCAACTTTTGCTTGCGCTATGCTGTCTGACCTTTGGCGCGCAAGCCGAT 
GTTTTTATCAAACAAGAAGATATGGATTTGAAGCAGGCGTTGGAAGCCATTGCGAAAGAT 
ATGCAGCTCAAACTGGTGTCTGACATAGATAGCAAAACTAGTAGCCAACCGATAACTCAA 
ACATTATCTGGGTCGGGGCCTATGTTATTGTCAAAGTTATCTTCTGTTTTTGATTTCGAC 
TGGTATACCTTTGGTGGCACGCTGACTATCCAGTCAGGTCAGCAATACGCTAACTATACC 
TATAAGCCTAAAAACATTTCTCCTAGTCAATTACTATCGGAGATGAAGGGGGCGTTTAAA 
ACTAATAGTACAACCAAAATTAAGTTGGTTGAGCGTGGACACTCGCTGTTGTTCTCAGGT 
ACGCGCAAGTTTGTTAACGATGCTATGGGGTATGCCTCTATGGTTGATAGAAACCAGTTT 
TTAGAAAAAGGCAACAACCTTGAAGTGGCTCGTATCGAGTTTAACTATGTTTCGGTTATG 
GATCGAAATATTGCGACTTACGATGGTCAGGTGAACTTTCCTGGCGCTCAATCATTAATT 
GCAGCAGCCATTACGAACATTGGGCAATTCACTAATCTCAATGATGAAGAGCTAACATCA 
CGCGCTTACAGAGTTAAGCTTAGCCAAGGTGAAAAGCAAGCACTCGAAGAGGATGAAAAA 
TCCACGAAGGTTCAGGCGTTGCCGGGAACAAATGCGCTGTTGATTCGCGGAACTCAAGAA 
GAAGTAAAATTAGCTAAACGTATTGCTGCTCTAATTGATGTAAAACGTCGTCAGTTACTG 
TTTTCGCTTAAAGTGTATGATATTTCGGCTGAGCGAAAAGAAAATCTTGGTATTGATAGT 
GGGTGGCTAAATGGTAACCGAGGTATTTACGATATTGTTGTGCCACCTTTTACCGAAACA 
AAGGATTTTGTGAAAAACTTTCAAGCACTTTATTCTAATGGTATTGCTCGTAGTGTCTAT 
GAGACCAACCTAGTGGCATTGGAAAATCAACAAAGTCAGTTTGGTAAAAAGCAAACTGCA 
ACATTGACGTTGATCTCGGACAAGCAAGTTAAAACAGAAAAGATTGAAGCCGATAATAGT 
CTGTATGTGACAGGTCGTTTATTGCCATCAGGTCAAGTGCAAGCTCGTATTCAGTATGTT 
GAGGAGTCTCTAGATGAAGATGATAATGAGGATAGCAATAGACCGCCGCGAGTCAGTTCT 
CAGTCACTCAACTCGGAGGTTTATATTCAACCAAATCAGACTGTAATTTTAGGCGGTTTT 
GATAATACTGTCACGCAACAACAAGAGAGTGGTGTACCAATTATATCGAGTATTCCTTTG 
CTTGGTGAGTTGTTTAAATATACTTCCGAGAGCAAGCATAAATACAAACGTTACGTATCG 
ATTTCATTTCAGGTGATTGAATAA 
Figure 111.5: Complete nucleotide sequence of vscC2. Putative TTSS2 structural protein. 
PCR product size: 272 bp. 
284 
>VPA1355 
ATGATGGCGAAGTTACGTAAATCATCATTATTGTTTAATCCCAGCAGTGTGATGATTGCG 
TTTTTATTACCGACAATCATTCTAGTGACGCTGCCGGGGATTGTGATCGATTTCTTTTTG 
ATGATCAGTTTTATCAGTTCTGCACTGTTATTGGTCATTATGTTAGAAAATGATGAGCCG 
TTGAAAGTGACGTTTCTACCTACAATGGTTCTCTTACTAACAACGTTTCGTTTGTTGCTT 
TCTATTGCGACAACGCGGAATATCATTGCTAATGAAGATGTTGGTCAAGTTATTGAAACG 
GTTGGTCAGTTTGTTATGGGGGGGAACTTACTCTCTGGGCTGCTGATTTTCATCATCATT 
ACTATTGTTCAATTTTTAGTAGTAACCAAAGGTGGTGAACGCGTTGCTGAAGTTGGTGCT 
CGCTTCTCTCTGGATGCGTTGCCTGGTAAACAAATGACCATTGATGGGGATTTAAAAAGC 
GGCTTAATCACCGGGGAGCAAGCTCAAAAATTACGTGCTGATTTAGGGACAGAAAACAGA 
CTTTTTGGTTCTCTTGATGGGGCAATGAAGTTTGTTAAAGGTGATGCGATCGCGGGTATT 
TTGATCAGTTTAGTTAACTTATTCGGCGGTATTTATGTTGGTATTAACCAGTTTGACCTC 
TCTTTAGGAGATAGCGTTAGCCGCTTTTCAGTCTTGACAGTAGGGGATGGGTTAGTATCT 
CAAATACCAAGTTTATTGCTATCTATGGCATGTGGTGTCTATTTGACACGTATTAAAGGT 
TCTGATGATGAGTCTAGCTCATTTATGTCTCAACTAATGTTGCAAATTCGAACCTTTTGG 
AAAAGTTTGTTTGTCATTGGTGGCATCATTATTGTCTTGGGTATTGCTAATCCGAATTTG 
TTGTATGTGTGCTTGCCTCTCGCAGGGGTTTGTGCCGCGTTAGCGATTTGGCTACAAAAA 
AAAGACGGCAGTAAAAATCCAACGCTCAGTTTAGAACCGCAAGGACATGGCTTATTTCAG 
TCTTTAAAGTTTGTTTTCCGAGAAGAGCAATATCAGCACTTGATTCAACGACATGTGGAA 
GAGAAAGAAAAGTCGTTATGGGGACAAGCCCTTGGACTACCTGCAGTTGTCGTAGACCCA 
ACGCTTGATTGCGATATCAAGGTGTACATTTCCGATATCGAAATGTACAGCTATAAAAAT 
ACTGAACCAGGTGTAGTGATTGAAATTCTTAATGATGAGCTTTTGATGTCAAGTCATGAT 
GTGGTGAGTAATATTAATCATATTATAAGCTACTTTATTCATAATCGTTTTGTTGAAAAA 
TATAACCTGCAATACAGCAGCAATATTGTCACAGGTTTAGAACAACAAAGTGAAATTATG 
AAAAGCGAGATTGATTCTGCTGTCGGATTAAACCGAGTGCATGATGTACTGAAGCAGATG 
ATTCGCTCACCTGAGTTTTATTTGGATCGTGTTAGTTTTTTCGAGGCTCTTATCTATTGG 
TCACGCGTAGAGAGTGACCCTCGTAACTGGTTAACACGCATGCGTAGTCAAGCCCGTTAT 
GACATTACAAGCAAATTGTTAAATAGCGAAGGTAAGTTTAATGTCATATTACTGACTCCC 
GAACTTACAGAAGAAATTTCCGGATTTGTTGCTGGTGAGTTTGACGATGCTGAGAGATTG 
ATTTCGGTACAAACTACACTGCGTAGCGAAATAAAACGTTTGCTTTTTCAATACGGTTCG 
AAACCTGTCGTCGTGGTCAATGAAAATGAACTGGATTATATAAAATCATTTTTCCAACAA 
GTTATGAGTAGAATATTTGTATGTAGTCATGCTGATATTGTTAACTCAAACTGTATTGAA 
AATACAGATACAATTCATATTTAA 
Figure 111.6: Complete nucleotide sequence of vcrD:Z. Putative TTSS2 structural protein. 
PCR product size: 388 bp. 
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Figure m 7: Nucleotide sequences and multiple alignments of the vpl680 locus of TTSSl in isolates of V. parahaenwlyticus. RIMD2210633 is a sequenced clinical strain. Sequences 
AQ3810B and 220B are from clinical strains and VP416B from an environmental isolate. 1902B is NCIMB reference strain from which probe was developed. Consensus regions are 
shown in red; blue and black show substitutions or deletions. Isolate VP416 shows Regions marked in dotted line represent quality control clipped regions. SNPs in TISSI are also present 
in vcrDJ and vscCJ . 
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Figure m.s: Nucleotide sequences and multiple alignments of the vscCJlocus of TTSSl in isolates of V. parahaemolyticus. R.IMD2210633 is a sequenced clinical strain. Sequences 
AQ3810C and 220C are from clinical strains and VP416C from an environmental isolate. 1902C is NCIMB reference strain from which probe was developed. Consensus regions are 
shown in red; blue and black show substitutions or deletions. Regions marked in dotted line represent quality control clipped regions. SNPs in TISSI are also present in vcrDJ and 
vpl680. 
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Figure ID.9: Nucleotide sequences and multiple alignments of the vscC2 locus of TTSS2 in isolates of V. p arahaemolyticus. RIMD221 063 3 is a sequenced clinical strain. Nucleotide 
sequence 220E is from a clinical strain and VP416B from an environmental isolate. Consensus regions are shown in red; blue and black show substitutions or deletions. Regions marked in 
dotted line represent quality control clipped regions. Regions within clipped areas were homologous in all three TISS2 loci. 
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TTGTTTTCCGRGRRGRGCRRTRTCRGCRCTTGRTTCRRCGRCRTGTGGRRGRGRRRGRRRRGTCGTTRTGGGGRCRRGCCCTT6GRCTR~TGcai~tg~c2 ••• 
Figure 01.10: Nucleotide sequences and multiple alignments of the vcrD2 locus of TTSS2 in isolates of V. parahaenwlyticus. RIMD2210633 is a sequenced clinical strain. Nucleotide 
sequence 220E is from a clinical strain and VP416B from an environmental isolate. Consensus regions are shown in red; blue and black show substitutions or deletions. Regions marked in 
dotted line represent quality control clipped regions. Regions within clipped areas were homologous in all three TISS2 loci. 
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